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Zusammenfassung 
Burkholderia cenocepacia ist ein Gram-negatives Bakterium, welches ubiquitär in der 
Umwelt vorkommt. Vor drei Jahrzehnten wurde B. cenocepacia als verursachender Erreger 
von schwerwiegenden Lungenentzündungen in Patienten mit zystischer Fibrose (CF) 
identifiziert. Die Infektionen waren von einer charakteristischen Bakteriämie gekennzeichnet 
und führten zum frühen Tod der CF-Kranken. Seither wurde B. cenocepacia als ein 
zunehmend problematisches opportunistisches Pathogen in immunsupprimierten Individuen 
wahrgenommen, welches die Notwendigkeit für die weitere Erforschung und Aufklärung von 
Virulenzfaktoren von B. cenocepacia begründet. Es wurde aufgezeigt, dass die Ausbildung 
von pathogenen Eigenschaften in B. cenocepacia entscheidend durch „Quorum sensing“ (QS) 
beeinflusst wird, welches vor allem duch das CepIR-Regulationssystem vermittelt wird, das  
die Expression bestimmter Gene in Abhängigkeit von der Populationsdichte kontrolliert.   
In der vorliegenden Arbeit wurde das QS-Regulon von B. cenocepacia H111 entschlüsselt 
und detalliert analysiert. Die Identifizierung von CepIR-regulierten Funktionen gelang dabei 
durch die Implementierung einer kombinierten transkriptionellen, proteomischen und 
phänotypischen Herangehensweise. Die Ergebnisse dieser Analyse liefern neue Erkenntnisse 
über im Vorfeld identifizierte QS-regulierte Phänotypen einschliesslich der Bildung von 
Biofilmen und der Pathogenität, und offenbaren wichtige Einblicke in den QS-
Regulationskreislauf von B. cenocepacia H111.  
Im zweiten Teil der Arbeit wurden die Produkte von drei QS-aktivierten Gen-Loci, welche in 
dieser Ausarbeitung identifiziert wurden, funktionell charakterisiert. Diese beinhalteten den 
„verwaisten“ LuxR-homologen Transkriptionsregulator CepR2, die Lektine BclACB und 
BCAM1869, welches von einem Gen kodiert wird, das in der intergenetischen Region 
zwischen den cepR und cepI Genen lokalisiert ist. Die Ergebnisse dieser Arbeit zeigten, dass 
CepR2 ein AHL-unabhängiger Transkriptionsregulator ist. Desweiteren wurde nachgewiesen, 
dass CepR2 die Expression der Siderophore Pyochelin stimuliert und dabei als Downstream-
Regulator im QS-Netzwerk agiert. In der vorliegenden Arbeit wurde die subzelluläre 
Lokalisierung des BclB Lektins determiniert und die Bedeutung der BclACB-Proteine bei der 
strukturellen Entwicklung von Biofilmen in H111 untersucht.  
Zudem wurde ein neuer Regulator, BCAM1869, identifiziert, welcher die Produktion von 
AHL-Molekülen in B. cenocepacia H111 hemmt. Hinzukommend scheint BCAM1869 die 
Aktivität von LuxR-ähnlichen Transkriptionsregulatoren zu beeinträchtigen, einschliesslich 
des Vibrio fischeri LuxR-Regulators. Die Ergebnisse dieser Arbeit weisen auch darauf hin, 
dass BCAM1869 die Aktivität von CepR2 in B. cenocepacia H111 positiv beeinflusst.      
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Summary  
Burkholderia cenocepacia is a Gram-negative bacterium which is ubiquitously found in the 
environment. Three decades ago, B. cenocepacia was identified as the causative agent of 
severe pulmonary infections in patients with cystic fibrosis (CF). The disease was 
accompanied by a characteristic bacteraemia that resulted in the early death of CF individuals. 
Since then, B. cenocepacia has emerged as a problematic opportunistic pathogen in patients 
with immunodeficiency disorders demonstrating the need for further exploration and 
elucidation of factors which contribute to B. cenocepacia virulence. It has become clear that 
the expression of pathogenic traits in B. cenocepacia is at least partly controlled by quorum 
sensing (QS), a cell density-dependent regulatory process. 
 
In the present thesis, the QS regulon of B. cenocepacia H111, which is comprised by the 
cepIR genes, was mapped and studied in detail. CepIR-regulated functions were identified by 
a combined transcriptomic, proteomic and phenotypic approach. The results of this analysis 
provided new insights into the molecular mechanisms of previously identified QS-regulated 
phenotypes, including biofilm formation, and pathogenicity, and revealed novel information 
of the complex QS circuitry operating in B. cenocepacia H111. 
 
In the second part of this thesis, the products of three QS-activated loci, which were identified 
in our mapping study, were further characterized. These included the orphan LuxR 
homologous transcriptional regulator CepR2, the BclACB lectins, and BCAM1869, which is 
encoded by a gene located within the intergenetic region of the cepR and cepI genes. The 
results of this work identified CepR2 as an AHL-independent transcriptional regulator. 
Moreover, CepR2 was shown to stimulate expression of the siderophore pyochelin, while 
acting as a downstream regulator of the H111 QS network. In the present thesis, the 
subcellular localization of lectin BclB was determined, and the importance of the BclACB 
proteins for the structural development of H111 biofilms was investigated. The results 
obtained suggest that BCAM1869 fine-tunes QS regulation: BCAM1869 represses the 
producton of AHL signal molecules in B. cenocepacia H111. Furthermore, BCAM1869 
seems to interfere with the activity of LuxR-like transcriptional regulators, including the 
Vibrio fischeri LuxR protein. The results of this work also suggest that BCAM1869 positively 
influences the activity of CepR2 in B. cenocepacia H111. 
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1 Introduction 
Burkholderia cenocepacia is a Gram-negative bacterium which is prevalent in soil habitats 
(Miller et al., 2002). About three decades ago, B. cenocepacia was identified as a causative 
agent of severe pulmonary infections in patients with cystic fibrosis (CF), the most common 
lethal inherited disease among the Caucasian population (Tummler & Kiewitz, 1999). The 
infections were accompanied by a chronic pneumonia, sepsis and a characteristic bacteraemia 
which resulted in early death of the CF individuals (Isles et al., 1984). Since then, B. 
cenocepacia has emerged as a problematic opportunistic pathogen, which can also cause 
infections in patients with chronic granulomatous disease (CGD), and is responsible for 
several recent nosocomial outbreaks (Speert, 2001, Mahenthiralingam et al., 2005). Whereas 
the identity of many B. cenocepacia virulence factors has not yet been identified, it is known 
that the expression of pathogenic traits is affected by quorum sensing (QS), a cell density-
dependent regulatory process (Sokol et al., 2003, Köthe et al., 2003). Infections with B. 
cenocepacia are highly transmissable and have become particularly problematic with 
increasing numbers of strains that have acquired resistences to clinically important antibiotics. 
For these reasons there is a need for the identification and characterization of B. cenocepacia 
virulence factors.  
 
1.1 The genus Burkholderia 
The genus Burkholderia comprises more then 40 species, which occupy a broad array of 
ecological niches. Most of the species are characterized by a remarkable metabolical 
versatility which allows the adaption to varying environmental conditions including nutrient 
limitation or the presence of antibiotics and toxic compounds (Coenye & Vandamme, 2003). 
Traditionally, Burkholderia species were identified as plant pathogens and soil bacteria with 
two important exceptions, Burkholderia mallei and Burkholderia pseudomallei, which are 
primary pathogens for humans and animals. Burkholderia species have been moreover 
isolated throughout the environment including freshwater or fungal mycelia (Coenye & 
Vandamme, 2007) and are also encountered in human clinical sources where they are 
universal contaminants of cosmetics and other pharmaceutical solutions (Jimenez, 2001). The 
range of interactions between Burkholderia species and their environments or hosts is 
complex, and often contradictory. Their host range can vary dramatically, and the type of 
interaction may be that of a pathogen, but it can also be beneficial, dependening on the host. 
Thus, some species of the genus Burkholderiae exist as free-living cells while others engage 
in endosymbiotic relationships with fungi or plants (Coenye & Vandamme, 2007). 
Introduction 
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Burkholderia kirkii is living inside plant leaf galls (Van Oevelen et al., 2002) and B. 
pseudomonallei was reported to proliferate within macrophages (Jones et al., 1996). The exact 
mechanism by which the bacteria survive and persist within these hosts is not yet understood. 
Within the genus Burkholderia a group of species known as the Burkholderia cepacia 
complex (Bcc) attracted particular interest, mostly because of their recognition as important 
opportunistic pathogens for CF patients.  
 
1.1.1 The Burkholderia cepacia complex (Bcc) 
The Burkholderia cepacia complex (Bcc) is a collection of genetically distinct but 
phenotypically similar Burkholderia which currently comprise 17 validly species (Vanlaere et 
al., 2008a). Bcc species share a high degree of 16S rRNA (98 - 100%) and recA (94 – 95%) 
sequence similarity but only moderate levels of DNA-DNA hybridization (30 – 50%) 
(Vandamme et al., 1997, Vandamme et al., 2003, Coenye et al., 2001, Vermis et al., 2004). 
Bcc species are (Fig. 1): Burkholderia cepacia, Burkholderia multivorans, Burkholderia 
cenocepacia, Burkholderia stabilis, Burkholderia vietnamiensis, Burkholderia dolosa, 
Burkholderia ambifaria, Burkholderia anthina, Burkholderia pyrrocinia, Burkholderia 
ubonensis, Burkholderia latens, Burkholderia diffusa, Burkholderia arboris, Burkholderia 
seminalis, Burkholderia metallica, Burkholderia lata, and Burkholderia contaminans.  
Reflecting their extraordinary metabolic versatility, Bcc species inhabit a wide variety of 
environmental niches, including soil, water, rhizospheres, industrial settings, and cosmetics  
(Mahenthiralingam et al., 2008, Coenye & Vandamme, 2003, Mahenthiralingam et al., 2005). 
Some Bcc strains are moreover capable of degrading organic compounds as for instance 
herbicides (Stanier et al., 1966), pesticides (Holmes et al., 1998), and trichloroethylene 
(Folsom et al., 1990), therefore bearing a great potential as bioremediation agents. Other Bcc 
species, as B. ambifaria, are recognized for their substantial beneficial properties in the 
agricultural industry where they are used as biological control agent (Holmes et al., 1998) or 
biopesticides in the production of crops (Ciccillo et al., 2002). Bcc strains can thereby 
colonize the rhizosphere of several crops including maize, rice, corn, pea, and sunflower 
which results in a significantly increase in the crop yield, an effect referred to as plant growth 
promotion (Parke, 1991, Tran Van, 2000).  
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Fig.  1. Phylogenetic tree of Burkholderia complex bacteria (Bcc) and five novel Bcc clusters derived from 
the analysis of recA gene sequences. Different B. cenocepacia recA lineages are designated IIIA, IIIB, IIIC and 
IIID. The tree was constructed using the neighbour-joining method (Jukes & Cantor parameter). Accession 
numbers are given in parentheses. Bootstrap values (>70 %) are shown for 1000 replicates. B. xenovorans 
LB400
T
 was used as the out group. Scale bar indicates 1% sequence dissimilarity (Vanlaere et al., 2008b). 
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Importantly, besides their biotechnolocial application, Bcc strains also bear a high pathogenic 
potential. Even though B. multivorans and B. cenocepacia are most frequently isolated from 
CF patients, all Bcc species have also been isolated from clinical samples belonging to 
individuals with CF (Lessie et al., 1996, Parke & Gurian-Sherman, 2001, Vanlaere et al., 
2009). The number of human infections caused by Bcc strains has markedly increased in the 
past two decades (Mahenthiralingam et al., 2005, Mahenthiralingam et al., 2008) and Bcc 
strains have moreover caused several outbreaks within and between regional center of CF 
patients (Saiman & Siegel, 2004). 
The need for a taxonomic reclassification of the original as “Pseudomonas cepacia” or 
“Burkholderia  cepacia” named species into distinct genomic (Bcc) species emerged when 
traditional molecular identification approaches including growth on selective media, 
commercial biochemical microtest systems, whole cell fatty acid analysis and several PCR-
based techniques (Bevivino et al., 1994, Tabacchioni et al., 1995, Coenye & Vandamme, 
2007) were demonstrated to be insufficient for a proper classification. Taxonomic studies 
were initiated to determine if clinical Burkholderia isolates also occur in the environment. 
The taxonomic classification into Bcc complex species was implemented by Vandamme and 
collegues in 1997 (Vandamme et al., 1997). They were able to demonstrate that “B. cepacia” 
isolates from CF patients, other human clinical samples, and the environment belonged to at 
least five distinct genomic species (Coenye & Vandamme, 2007). Employing multilocus 
sequence typing (Baldwin et al., 2007) it was later shown that one-fifth of the clinical isolates 
of Bcc species were indistinguishable from environmental isolates. As this finding suggests 
that Bcc infections can be acquired by strains normally living in the environment, the 
commercial use of Bcc species in the agricultural industry has been stopped.  
 
1.1.2 Burkholderia cenocepacia: a problematic opportunistic human pathogen  
Burkholderia cenocepacia, a Burkholderia cepacia complex species (Bcc, see 1.1.1), is 
together with B. multivorans the most clinically important human pathogen which can cause 
life-threatening lung infections in immunocompromised individuals. It has been suggested 
that B. cenocepacia can replace B. multivorans during chronic CF infections 
(Mahenthiralingam et al., 2002). Individuals with CF are particularly vulnerable to acquire 
chronic airway infections because they hold a highly viscous mucus in their lung, which 
impairs a ciliary clearance and often favours the colonization with opportunistic bacterial 
pathogens, particularly Staphylococcus aureus and Haemophilus influenza and, at a later point 
of the infection, P. aeruginosa (Tummler & Kiewitz, 1999, Eberl & Tummler, 2004, Ratjen & 
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Doring, 2003). Bcc strains are often acquired by CF patients in the late process of the disease 
when they are already chronically colonised with P. aeruginosa. The clinical outcome of this 
co-infection is variable and unpredictable and can range from an asymptomatic carriage to a 
fulminant and fatal pneumonia, the so-called „cepacia syndrome‟ (Isles et al., 1984). In 
addition to acquisition from the environment B. cenocepacia has the greatest risk of patient-
to-patient transmission (Mahenthiralingam et al., 2001, LiPuma et al., 1988, Coenye & 
LiPuma, 2002, Chen et al., 2001).  
An important role in the infection process appears to be the formation of biofilms on the 
epithelial cell surface of the lung. It has been suggested that the attachment of Bcc strains is 
facilitated by P. aeruginosa exoproducts which may result in the development of mixed 
biofilms (Saiman et al., 1990). The formation of a biofilm is particularly problematic in 
clinical settings because bacteria living in biofilms can withstand host immune responses and 
exhibit an increased resistance towards antibiotics. 
The pathogenic mechanisms and virulence determinants of Bcc species, including B. 
cenocepacia, are still poorly understood. It has been shown that the production of 
extracellular factors such as siderophores, proteases, and lipases contribute to the 
pathogenicity of B. cenocepacia (Lewenza et al. 1999; Lewenza and Sokol, 2001). The 
expression of B. cenocepacia pathogenic traits has been shown to be at least in part regulated 
by the CepIR quorum sensing network (see 1.2 and 1.3).    
The model strain used in the Zurich laboratory is B. cenocepacia H111, an isolate from a CF 
patient in Hannover (Geisenberger et al., 2000), that is very closely related to the sequenced 
strain B. cenocepacia J2315 (Romling et al., 1994, Gotschlich et al., 2001). However, in 
contrast to J2315, B. cenocepacia H111 does not belong to the epidemic ET12 lineage (see 
1.2.3). 
 
1.2 Cell-to-cell communication via quorum sensing 
The realization that bacteria do not behave as solitary, individual cells, as once thought, but 
rather communicate with each other, certainly accounts for one of the most fascinating 
biological discoveries in the last decades. The cellular concept standing behind this insight 
was originally discovered unraveling the phenomenon of bioluminsense in the Gram-negative 
marine organism Vibrio fischeri (Nealson et al., 1970) and was initially referred to as 
autoinduction (Fuqua et al., 1994) to emphazise that this phenomenon depends on a minimal 
population size, i.e. a critical number or quorum (latin: "of whom") of individual cells to 
trigger gene expression. This phenomenon is commonly refered to as “quorum sensing” (QS). 
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QS can be defined as a generic regulatory process used by bacteria to sense and response to 
the densitiy of bacterial populations in a coordinated way (Fuqua et al., 1994). As QS allows 
populations of bacteria to collectively control gene expression and thus synchronize group 
behaviour, it is seen as a system of cell-to-cell communication, which enables the 
coordination of bacterial cells similar to that of multicellular organisms. Processes controlled 
by QS are therefore typically ones that are unproductive unless many bacteria act together, as 
functions involved in pathogenicity, antibiotic production, or surface colonization. QS 
systems have been identified in Gram-positive and more than 80 species of Gram-negative 
bacteria, in which they regulate a variety of functions including, for instance, the conjugative 
transfer of plasmids (Williams et al., 2007). Cell-to-cell communication via QS relies on 
small signal molecules, of which various have been described. The two most thoroughly 
investigated classes are the N-acyl-homoserine lactones (AHL), which are produced by many 
Gram-negative bacteria, and small peptides, which are utilized by many Gram-positive 
species (Fuqua et al., 1996, Whitehead et al., 2001). 
 
1.3 Genomic structure and quorum sensing circuitry in B. cenocepacia H111  
A common trait of Bcc bacteria is the presence of unusual large genomes which are moreover 
composed of multiple replicons and share high amount of insertion sequences (Lessie et al., 
1996). All characterized Bcc species have a minimum of three large chromosomal replicons 
and an average genome size of 7.5 Mb encoding roughly over 7000 genes (Mahenthiralingam 
et al., 2005). B. cenocepacia H111 is a very closely relative to the sequenced strain B. 
cenocepacia J2315, which genome consists of three circular chromosomes of 3,870,082 bp, 
3,217,062 bp, and 875,977 bp and a plasmid of 92,661 bp (Holden et al., 2009). In costrast to 
J2315, and to all other strains belonging to the epidemic ET12 lineage, the genome of B. 
cenocepacia H111 does not comprise a plasmid. Moreover ET12 lineage strains encode a 31.7 
kb-large pathogenicity island on chromosome 2 (Baldwin et al., 2004, Malott et al., 2005), 
which is also absent in the genome of H111. This island encodes an additional QS system, the 
CciIR system (Malott et al., 2005). B. cenocepacia H111 only contains the CepIR system, 
which is believed to be the ancestral AHL-based QS system in the genus Burkholderia (Fig. 
2). CepIR homologous systems have been identified in all Bcc species (Gotschlich et al., 
2001).  
The CepIR system consists of the transcriptional regulator CepR and the acyl-homoserine 
lactone (AHL) synthase CepI, which directs the synthesis of the two AHLs N-octanoyl-
homoserine lactone (C8-HSL) and, as a minor product, N-hexanoyl-homoserine lactone (C6-
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HSL) (Gotschlich et al., 2001). At low population densities a basal level of AHL molecules is 
synthesized. With increasing cell numbers the concentration of the signal molecules then 
increases and molecules diffuse into the extracellular milieu. On reaching a critical threshold 
concentration, the signal molecules bind to its cognate receptor CepR, which, in this complex, 
then activates or represses the transcription of target genes. As demonstrated by Lewenza and 
coworkers (Lewenza et al., 1999) the transcription of cepI is autoregulated, in that the 
complex of C8-HSL/CepR stimulates the transcription of cepI, presumably by binding to a 
DNA motiv within cepI promoter regions. This 20 bp imperfect palindrome, termed “cep 
box”, resembles the lux box motif described in Vibrio fischeri (Devine et al., 1989, Lewenza 
et al., 1999).  
Functions positively regulated by the CepIR system include the production of extracellular 
proteases and chitinases, the production of the siderophore pyochelin and the synthesis of the 
nematocidal protein AidA (Huber et al., 2001, Huber et al., 2002, Malott et al., 2009, Huber 
et al., 2004, Köthe et al., 2003). Previous work has also demonstrated that both, the ability to 
swarm, and the late stages of biofilm development in B. cenocepacia H111 are QS-regulated 
(Huber et al., 2002). The synthesis of the siderophore ornibactin has by contrast been shown 
to be repressed by QS in strains B. cenocepacia K56-2 (Lewenza & Sokol, 2001) and B. 
cenocepacia H111 (Malott et al., 2009). 
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Fig.  2.  Schematic presentation of the B. cenocepacia H111 genomic structure and QS circuitry. The 
illustration shows the genome structure of B. cenocepacia H111 including the three chromosomal replicons 
(Chr.1, Chr. 2, and Chr. 3), (Mahenthiralingam et al., 2005). The CepIR system, which is present in all Bcc 
species, is encoded on chromosome 2 and comprises the transcriptional regulator CepR and the acyl-homoserine 
lactone (AHL) synthase CepI, which directs the synthesis of the diffusible signal molecules N-octanoyl 
homoserine lactone (C8-HSL) and, to minor amounts N-hexanoyl homoserine lactone (C6-HSL) (Gotschlich et 
al., 2001). When a critical population density has been attained, the CepR protein binds in complex with C8-
HSL to the promoter of target genes and thereby induces or represses the transcription of these genes. Promoter 
binding generally occurs at a specific DNA element, the so-called “cep box” (for sequence see Fig. 6), (Lewenza 
et al., 1999). The expression of cepI has been shown to be positively autoregulated by QS (dashed line, Lewenza 
et al., 1999). Functions which are induced by the B. cenocepacia H111 CepIR system include the production of 
extracellular proteases, chitinases, and the siderophore pyochelin, swarming motility, biofilm formation, and the 
expression of the nematocidal protein AidA (Huber et al., 2004, Huber et al., 2001, Huber et al., 2002, Köthe et 
al., 2003, Malott et al., 2009). The production of ornibactin is repressed by the CepIR system (Malott et al., 
2009).   
Chr. 1 
~3.8Mb 
Chr. 3 
0.87Mb 
Chr. 2 
~3.2Mb 
 
cepR cepI 
/
  
 cep box 
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1.4 Goals of this work 
 
Project I:   The Burkholderia cenocepacia H111 quorum sensing regulon: a 
comparative transcriptomic, proteomic and phenotypic analysis 
Burkholderia cenocepacia H111 utilizes the CepIR quorum sensing (QS) system to express 
various functions in a population density-dependent manner. It has become clear that the 
expression of various pathogenic traits, including the production of extracellular proteases or 
siderophoes, the ability to swarm, and the formation of a biofilm, is QS-regulated in the large 
majority of B. cenocepacia species (Wopperer et al., 2006). Some of these phenotypes have 
been linked to QS-dependent expression of specific genes, as demonstrated for the 
nematocidal protein AidA (Huber et al., 2004). Many of the QS-regulated genes or proteins, 
which account for the pathogenic potential of H111, including those required for the 
formation of a biofilm, have not been identified yet. The aim of this project was to definde the 
B. cenocepacia H111 QS regulon, to understand the impact of cell-to-cell communication on 
the expression of pathogenic traits and factors required for biofilm formation. For that 
purpose, the CepIR regulon was mapped using a combined transcriptomic, proteomic and 
phenotypic approach: transcriptomic profiling employed Agilent B. cenocepacia 
oligonucleotide microarrays, the proteome analysis employed iTRAQ (isobaric tag for relative 
and absolute quantitation), and the phenotypical characterization used BIOLOG microarrays.  
 
Project II: The role of the orphan LuxR homologue CepR2 in the transcriptional 
regulation of H111 genes and its effect on the quorum sensing circuitry 
A previous screening of a Burkholderia cepacia transposon library identified a LuxR 
homologous protein, which was designated CepR2. CepR2 is an “orphaned” LuxR 
transcriptional regulator, since the cepR2 gene (BCAM0188) was found to be located without 
a proximal luxI family gene. This fact, together with findings made in a previous study (A. 
Steidle, diploma thesis, TU Munich, 1999) suggested that CepR2 might regulate the 
transcription of genes independent of the presence of AHL molecules. This project was 
initiated to understand the involvement of CepR2 in the QS network of B. cenocepacia H111 
and to investigate if this regulator plays a role in the expression of virulence factors. It was 
also of particular interest to provide unambiguous evidence that CepR2 functions in an AHL-
independent manner.  
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Project III:  Characterization of the BclACB lectins of B. cenocepacia H111, 
examination of their expression, subcellular localization and their role in 
biofilm formation  
The B. cenocepacia proteins BclA (BCAM0186), BclC (BCAM0185) and BclB 
(BCAM0184) belong to the PA-IIL family of lectins (Lameignere et al., 2008), which are 
commonly thought to play important roles in processes that require cell adhesion or host 
recognition or defence mechanisms (Tielker et al., 2005, Imberty et al., 2005, Sudakevitz et 
al., 2002, Zinger-Yosovich et al., 2006, Imberty & Varrot, 2008). Previous studies focused on 
the analysis of the protein structures of lectin BclA (Lameignere et al., 2008, Lameignere et 
al., 2010) and lectin BclC (Sulak et al., 2010), and described the binding affinity of these 
lectins to carbohydrate ligands. The aim of this project was to elucidate the function of the Bcl 
proteins in B. cenocepacia H111 biofilm formation. Furthermore, it was also investigated, 
whether the Bcl proteins are, like other PA-IIL family proteins, associated with the bacterial 
cell surface. Finally, the impact of QS on the expression of BclACB was examined.   
 
Project IV: Characterization of the RsaM regulator  
In a previous study, a B. cenocepacia H111 transposon library (B. Huber et al., 2002) was 
screened for mutants attenuated in C. elegans pathogenicity (M. Köthe, 2003, F. Feldmann, 
2004). One mutant was of particular interest, because the strain not only exhibited a reduced 
virulence but was also found to produce increased levels of extracellular AHL signal 
molecules, as observed in this thesis. Sequences analyses revealed that the transponson had 
inserted in the intergenetic region of coding sequences belonging to the cepR and cepI genes, 
upstream of the ORF BCAM1869, which is predicted to encode a functionally unknown 
hypothetical protein (Wopperer, 2008, Dissertation, University of Zurich). The initial task of 
this project was to verify that BCAM1869, referred to as RsaM, encodes a protein. To 
determine the cellular role of BCAM1869 the transposon insertion mutant and a defined 
H111-rsaM mutant were phenotypically characterized. These investigations revealed that 
BCAM1869 exhibits a regulatory effect on the CepIR system as well as on the transcriptional 
regulators CepR and the orphan LuxR homologue CepR2. Finally, the impact of BCAM1869 
on other LuxR-like proteins, including the LuxR transcriptional regulator, was examined.     
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2 Material and Methods 
2.1 Material 
2.1.1 Bacterial strains and plasmids 
The bacterial strains and plamids used in this study are listed below. 
 
Strain or DNA Genotype or description Source or reference 
Strains   
Escherichia coli  
BL21 (DE3)  F- dcm ompT hsdS(rB
- mB
-) gal λ(DE3) (Weiner MP, 1994), Novagen 
DH5α 
 
F- Φ80lacZ∆M15 ∆(lacZYA-argF) recA1 endA gyrA96 thi-1 hsdR17 
supE44 relAl deoR(U169)        
(Hanahan, 1983), Invitrogen 
 
HB101 (pRK600) 
 
F- supE44 hsdS20 (rB
- mB
-) recA13 ara-14 proA2 lacY1 galK2 rpsL20 
xyl-5 mtl-1 recA thi pro leu hsdR- M+ Smr;  
(Boyer & Roulland-Dussoix, 
1969) 
MM294 
(pRK2013) 
 
F- endA1 hsdR17 supE44(AS) rfbD1 spoT1 thi-1; RK2 derivative, 
mob+ tra+ ori ColE1; Kmr 
(Meselson & Yuan, 1968) 
(Figurski & Helinski, 1979)  
SY327λpir F- araD ∆(lac-pro) argE (Am) Rifr  nalA recA56 λpir (Miller & Mekalanos, 1988) 
TOP10 
 
F- mcrA ∆(mrr-hsdRMS-mcrBC) Φ80lacZ_M15 ∆lacX74 deoR recA1 
araD139 ∆(ara-leu)7697 galU galK rpsL(Str) endA1 nupG 
Invitrogen 
 
XL1-Blue 
 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1  lac [F´ proAB lacIq 
Z∆M15 Tn10 (Tcr)] 
Stratagene 
 
MT102 (pSB403) 
 
luxRI::luxCDABE transcriptional fusion, bioluminescent AHL sensor, 
Tcr  
(Winson et al., 1998) 
OP50 food source strain for C. elegans, uracil auxotrophic (Brenner, 1974) 
   
Pseudomonas putida 
F117 IsoF, mutation in ppuI, (AHL-negativ) (Steidle et al., 2001) 
F117 (pAS-C8)  F117 with pBBR1MCS-5 carrying PcepI::gfp(ASV) Plac::cepR; Gm
r   (Riedel et al., 2001) 
   
Chromobacterium violaceum 
CV026 ATCC 31532 derivative, cviI::Tn5 xylE; Kmr, Smr  (McClean et al., 1997) 
   
Burkholderia cenocepacia 
H111 CF isolate from Germany, genomovar III 
(Romling et al., 1994) 
(Gotschlich et al., 2001) 
K56-2  CF isolate, BCESM+, cblA+ 
(Mahenthiralingam et al., 
2000) 
H111-I cepI::km derivative of H111; Kmr Huber et al., 2001 
H111-I/R 
marker less deletion mutant of cepI, rsaM  and cepR,                  
genotype: cepI/R::FRT 
A. Carlier 
H111-R cepR::km mutant of H111; Kmr  Huber et al., 2001 
H111-R2 cepR2::pEX18Gm mutant of H111; Gmr This study 
H111-R/R2 cepR2::pEX18Gm mutant of H111-R; Kmr, Gmr  This study 
H111-bclABC bclA-C::km mutant of H111; Kmr  This study 
H111-rsaM rsaM::km mutant of H111; Kmr (mutant H111-V)  A. Carlier 
   
Plasmids 
pASS2.10 
 
SacI-fragment of subclone S2, containing the B. cenocepacia cepR2 
pBBR1MCS2 background, Kanr  
A. Steidle, 2002 
 
pAH1B.1 
EcoRI-fragment of B. cepacia, clinical isolate, Nr. 767,  
puC18 background, Ampr 
A. Steidle, 2002 
pAUC40 suicide vector ; Smr, Cmr (Carlier et al., 2009) 
pAUC40-bcl 
 
pAUC40 containing the pKD4 kanamycin cassette and flanking regions 
of the B. cenocepacia H111 bcl operon (bclA-C) 
This study 
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Table 1. Bacterial strains and plasmids used in this study. Antibiotic resistances are: Ampicillin (Ap
r
), 
Chloramphenicol (Cm
r
), Gentamicin (Gm
r
), Kanamycin (Km
r
), Streptomycin (Sm
r
) and Trimethoprim (Tp
r
). 
 
2.1.2 Media, chemicals and other material 
Culture media used in this study are listed below, antibiotics and other supplements which 
were employed in this work are given in Table 2. Unless otherwise stated all media were 
autoclaved at 121°C for 20 min and supplements or other chemicals were subsequently added. 
Solid media contained routinely 1.5% (w/v) agar, soft agar contained 0.75% agar. 
Pseudomonadae and Burkholderiae were selected on PIA-agar (Becton Dickinson, 
Switzerland) which was prepared according to the instructions of the manufacturers. All 
media were ordered from Becton Dickinson (Switzerland), chemicals were purchased from 
Fluka (Buchs, Switzerland) or Sigma-Aldrich (Buchs, Switzerland). Enzymes and material 
used for molecular work were purchased from various companies including Invitrogen (Basel, 
Switzerland), MBI Fermentas (Glen Burnie, USA, New England Biolabs (Ipswich, USA), 
pBAH8 pBBR1MCS-5 containing PA1/04/03-gfp mut3-To-T1; Gmr  Huber et al., 2002 
pBAH27 pBBR1MCS-5 containing the cepR gene of B. cenocepacia H111, Gmr Huber et al., 2001 
pBBR1MCS broad host-range cloning vector; Cmr (Kovach et al., 1994) 
pBBR1MCS-2 broad host-range cloning vector; Kmr (Kovach et al., 1995) 
pBBR1MCS-5 broad host-range cloning vector; Gmr (Kovach et al., 1995) 
pBBR-cepR pBBR1MCS containing the cepR gene of B. cenocepacia H111; Cmr S. Schmidt  
pBBRrsaM pBBR1MCS containing the rsaM gene of B. cenocepacia H111; Cmr This study 
pBBRrsaM_FS pBBR1MCS containing a frameshifted rsaM ORF of H111; Cmr This study 
pCR2.1 cloning vector for PCR products; Ampr, Kmr  Invitrogen 
pDONR221 cloning vector; Kmr Invitrogen 
pEX18Gm oriT+ sacB+; pUC18 MCS, gene replacement vector; Gmr (Hoang et al., 1998) 
pEX19Gm oriT+, sacB+, pUC19 MCS, gene replacement vector; Gmr (Hoang et al., 1998) 
pEX18Gm-
cepR2 
Gmr; oriT+ sacB+; Genaustauschvektor für H111-R2 und H111-R/R2 
 
This study 
 
pET28a expression vector, T7 promoter; Kmr  Novagen 
pJBA89  pUC18Not-luxR-PluxI-RBSII-gfp(ASV)-T0-T1; Ap
r (Andersen et al., 1998) 
pJBA89luxR- Apr, pUC18Not-PluxI-RBSII-gfp(ASV)-T0-T1; Ap
r  This study 
pET-HisBclB pET28a derivate carrying the bclC gene of B. cenocepacia H111; Kmr This study, A. Grunau 
pJTR2 pBBR1MCS containing the cepR2 gene of B. cenocepacia H111; Cmr This study 
pKD4 kanamycin cassette template; Ampr, Kmr (Datsenko & Wanner, 2000) 
pRN3 promoter probe vector, pSU11 derivative; Tpr This study 
pRK2013 RK2 derivative, mob+ tra+ ori ColE1; Kmr (Figurski & Helinski, 1979) 
pSU11 promoter probe vector; Gmr S. Uehlinger,  
PaidA1-lacZ 
 
pSU11/pRN3 containing a long H111 aidA promoter region; Gmr/ Tpr 
 
S. Uehlinger 
 ParaC-lacZ 
 
pSU11/pRN3 containing the putative H111 bclA promoter; Gmr/ Tpr 
 
This study 
PbclA-lacZ pSU11/pRN3 containing the putative bclA promoter region; Gm
r/ Tpr This study 
PcepIlong-lacZ pRN3 containing H111 cepI promoter region (416 bp); Tp
r This study 
PcepR2-lacZ pRN3 containing the putative H111 cepR2 promoter region; Tp
r This study 
PpchD-lacZ pSU11/pRN3 containing putative H111 pchD promoter region; Gm
r/ 
Tpr 
This study 
PpchR-lacZ pSU11 containing the putative H111 pchR promoter region; Gm
r/ Tpr This study 
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Promega (Madison, USA), Roche (Rotkreuz, Switzerland) and Ambion (Austin, USA). The 
composition of buffers is described along with the experiments.  
 
ABC/ ABG minimal medium (Clark & Maaløe, 1967) 
For V = 1 liter autoclave component A and B separately, then combine 1 part of A with 
component B (9 parts) and add citrate (C) or glucose (G) as a carbon source. 
 
Component A (10x) 
(NH4)2SO4  0.15 M 
Na2HPO4 0.42 M 
KH2PO4 0.22 M 
NaCl 0.51 M 
 
Component B (for V = 1 liter)  
1 M MgCl2 x 6 H2O 2.0 ml 
0.5 M CaCl2 x 2 H2O  0.2 ml 
0.01 M FeCl3 x 6 H2O 0.3 ml 
dH20 ad 900 ml 
 
 
Component C (final concentration) 
10 mM sodium citrate or 10 mM D-glucose 
 
 
 
 
 
 
 
 
 
 
FAB-medium (modified) (Heydorn et al., 2000)  
Components are essentially as in AB minimal medium with the following exception: the 
component B contains trace metal solution (1 ml/l of 10x solution, see below) instead of 
FeCl3. 
 
10x trace metal solution 
CaSO4 x 2H2O  0.2 g/100 ml 
FeSO4 x 7H2O 0.2 g/100 ml 
CuSO4 x 5H2O 0.02 g/100 ml 
ZnSO4 x 7H2O 0.02 g/100 ml 
MnSO4 x H2O 0.02 g/100 ml 
CoSO4 x 7H2O 0.01 g/100 ml 
NaMoO4 x H2O 0.01 g/100 ml 
H3BO3 0.005 g/100 ml 
 
 
LB-medium (Luria Bertani-medium) (Andersen et al., 1998) 
Caseinhydrolysate (Tryptone)       1% (w/v)  
Yeast extract  0.5% 
NaCl   0.4% 
 pH 7.4 
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M9 medium (Johnson et al., 2008) 
5x M9 salts 
Na2HPO4 x 7 H2O 64.0 g 
KH2PO4 15.0 g 
NaCl   2.5 g 
NH4Cl   5.0 g 
dH20 ad 1000 ml 
 
 
Mineral Salt Medium (Lindhardt TJ, 1989) 
NaNO3         15.0 g 
KCl           1.1 g 
NaCl           1.1 g 
FeSO4 x 7 H2O           0.00028 g 
KH2PO4           3.4 g 
K2HPO4           4.4 g 
MgSO4 x 7 H2O           0.5 g 
Yeast extract           0.5 g 
dH20         ad 1000 ml 
SOC-medium (Sambrook, 1989) 
Tryptone  2% 
Yeast  0.5% 
NaCl  10 mM 
MgCl2
 
 10 mM 
MgS04
 
 10 mM 
D-glucose  20 mM 
     pH 7.0 
 
Succinate medium (Meyer, 1978) 
K2HPO4 6.0 g 
KH2PO4 3.0 g 
(NH4)2SO4 1.0 g 
MgSO4 x 7H2O 0.2 g 
Succinic acid 4.0 g 
dH20 ad 1000 ml; pH 7.0 
Chromazurol-S (CAS) agar  
See Material and Methods (2.4.4). 
 
Swarming/ Swimming-agar  
Components are ABC minimal medium with 0.2% (w/v) agar (swimming agar) or 0.4% (w/v) 
agar (swarming agar) supplemented with casamino acids [0.1%]. 
 
Milk-agar  
LB-agar supplemented with 2% (w/v) skim milk powder in dH2O (boiled for sterilization). 
Substrate Stock concentration Final concentration  Solvent 
Ampicillin 100 mg/ml 100 μg/ml 50% EtOH 
Chloramphenicol   20 mg/ml   25 μg/ml 50% EtOH 
Gentamicin   20 mg/ml   20 μg/ml dH20 
Kanamycin   50 mg/ml   50 μg/ml dH20 
Streptomycin   50 mg/ml   50 μg/ml dH20 
Trimethroprim 100 mg/ml 100 μg/ml DMSO 
Casamino acids   20% (w/v)     0.1% (w/v) dH20 
Cholesterol   10 mg/ml     5 μg/ml 100% EtOH 
IPTG 100 mM 100 μM dH20 
Paraformaldehyde     4% (w/v)    4% (w/v) PBS, ad NaOH 
Propidiume iodide     2 mM    0.5 μM DMSO 
Uracil     2 mg/ml    2 μg/ml dH20, heat 
X-Galactose   40 mg/ml  40 μg/ml DMF 
Table 2. Antibiotics and other supplements used in this study (stored at -20°C). 
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2.1.3 Oligonucleotides 
Oligonucleotide primers were ordered exclusively from MWG Biotech AG (Ebersberg, 
Germany) and are listed in Table 3. Unless otherwise noted, primers were designed based on 
the B. cenocepacia J2315 sequence (Holden et al., 2009).  
Oligonucleotide Sequence 5’-3’ Reference 
araCP-F  GGCTCGAGCGTGCAGTATTGTCAGGTC This study 
araCP-R  GGAAGCTTGTCTTGAACGCTGGTCATGG This study 
cepR2-F  CGCAAGCTTGCTCGGATTCCGGTA This study 
cepR2-R  ACCAAGCTTGAGAGGCTCCGCACAGG This study 
cepR2pBBR-F  CGCAAGCTTCTT TTGAACAGGATACGC This study 
cepR2pBBR-R TGCACTAGTCATAAGCGGGTCGAAAC This study 
cepR2P-F GGAAGCTTGTCTTGAACGCTGGTCATGG This study 
cepR2P-R GGCTCGAGCGTGCAGTATTGTCAGGT This study 
cepVpBBR-F CGGATATCTTCCGCGCATGACTTCACC This study 
cepVpBBR-R TAGGATCCGTTGTCACTGGAGCGTCG This study 
cepVpBBR-F_FS CGGATATCTTCCGCGCATGACTCTCACCCTTGCT This study 
cepVpBBR-R_FS TAGGATCCGTTGTCATGGAGCGTCGGAC This study 
cepVupGW TACAAAAAAGCAGGCTACCGACAATCCGAATCGCG A. Carlier 
cepVDnGW TACAAGAAAGCTGGGTACATCCGCACATGTCGCCGT A. Carlier 
cepVUpRkan GAACTTCGAAGCAGCTCCAGCCTAACATGGTCGAGCACGAGTGC A. Carlier 
cepVDnFkan CGGAATAGGAACTAAGGAGGATATTCATATGACATCGGCATGTTGCGCACG A. Carlier 
GW-attB1  GGGGACAAGTTTGTACAAAAAAGCAGGCT  Invitrogen 
GW-attB2 GGGGACCACTTTGTACAAGAAAGCTGGGT Invitrogen 
kanDnFwd CGAAATGACCGACCAAGCGA This study 
kanUpRev ACGTGTTCCGCTTCCTTTAGC This study 
lacZ-R TGCTGCAAGGCGATTAAG This study 
lecB2-dn GAATGGAAGGTTCCGCATCG This study 
lecB2-up TGACGCACGTTCGACGA This study 
lecB3-F TTCCATGGCACAACCCTT TACCCACG This study 
lecB3-R_his AACTCGAGACCCAGCGGCCAGTTCAGG    This study 
lecBP4 GGAAGCTTTCATGATGTCGGTCCTCGGT This study 
lecDn-GW TACAAGAAAGCTGGGTTAGCGTGCGTCAACCCAGCG This study 
lecDn-kan CGGAATAGGAACTAAGGAGGATATTTCATATG This study 
lecUp-GW TACAAAAAAGCAGGCTCGCCGGTGAGGCCCTATTCATG This study 
lecUp-kan GAACTTCGAAGCAGCTCCAGCCTAGCGCGGTTGGATGACGTTG This study 
M13-F TGTAAAACGACGGCCAG Standard 
M13-R CAGGAAACAGCTATGACC Standard 
PcepI-F  GGCTCGAGGGCCGCGATTCCTCTGACG  S. Uehlinger 
PcepI-R  GGAAGCTTGCCGATAGCGCCCGAGATCC S. Uehlinger 
PcepVdnXho GGCTCGAGATCGGCATGTTGCGCACG  This study 
PlecB-dn GGCTCGAGAGTCGTAGCGAGAAGAGGA This study 
PlecB-up GGAAGCTTTTGAGAATCAGCCATGCGT This study 
pyo2231P-F  GGCTCGAGGAGGAAGGGGAGGATT This study 
pyo2231P-R GAAAGCTTGGTGACGTCGTGACGAA This study 
pyo2232P-F CACTCGAGGTGACGAAGCGAAGAA This study 
pyo2232P-R  GGAAGCTTGAGGAAGGGGAGGATT This study 
Table 3. Oligonucleotides used in this study. Restriction endonuclease sites are underlined. All primers were 
diluted to working concentrations of 20 µM.  
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2.2 Molecular biological methods 
2.2.1 Cultivation of bacterial strains and growth conditions 
Unless otherwise stated bacterial strains were incubated at 30°C or 37°C in liquid or solid 
media as listed previously. Liquid cultures were grown while shaking (225 rpm).  
Pseudomonadae and Burkholderia were selected on PIA-agar plates (2.1.2). For the selection 
of strains or plasmids antibiotics were added to final concentrations as listed (Table 2, 2.1.2). 
Bacterial strains were stored in 15% glycerol at -80°C.  
 
2.2.2 Manipulation of DNA 
2.2.2.1 DNA preparation and characterization 
Analytical amounts of plasmid DNA were isolated as described (Birnboim, 1983), and 
preparative amounts were purified with Qiagen columns following the instructions of the 
manufacturers (Qiagen, Hilden, Germany). Chromosomal DNA (total DNA) of B. 
cenocepacia was isolated by sarcosylpronase lysis as previously described (Better et al., 
1983). Briefly, 2 ml of a bacterial overnight culture were precipitated and the pellet was 
resuspended in 2 ml of TE-buffer (50 mM Tris, 20 mM EDTA, pH 8). To this bacterial 
suspension, 2.5 ml of 2% sarcosyl (Sigma, Buchs, Switzerland) were added and the mix was 
homogenized by inverting the tube. After the addition of 0.5 ml of pronase (5mg/ml, Sigma, 
Buchs, Switzerland) and tube invertion the cells were incubated at 37°C until the solution has 
cleared (10 - 30 min). The sample was vortexed (2 min) and the cell lysate was extracted once 
with phenol/chloroform/iso-amyl alcohol (25:24:1) and then once with chloroform (Sigma, 
Buchs, Switzerland). After centrifugation (5000 rpm, 5 min), the liquid phase was transferred 
to a new collection tube and DNA was precipitated by adding NaCl (stock solution: 5 M, final 
concentration: 0.2 M) and an equal volume of isopropanol. After inverting the tube the DNA 
was pelleted by centrifugation (max. speed, 15 min), shortly washed with 70% ethanol 
(pipette tip), air-dried and resuspended in 500 µl TE-buffer.  
 
DNA characterization was achieved employing standard techniques (Sambrook et al., 1989) 
including agarose gel electrophoresis, polymerase chain reactions (PCR) and restriction 
analyses with endonucleases. Positive transformants were initially detected by direct PCR 
(colony-PCR) with DNA deriving from bacterial liquid cultures (1 μl) or bacterial cultures 
grown on agar plates. DNA was added to 4 μl of lysis mixture (50 mM KCl, 0.1% Tween-20, 
10 mM Tris-HCl, pH 8.3) and PCR reactions were performed routinely.  DNA was extracted 
from agarose gels using a Qiaquick gel extraction kit (Qiagen, Hilden, Germany) and further 
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concentrated if nessecary by standard ethanol precipitation (Sambrook et al., 1989). Southern 
blot hybridisation was employed for the characterization of mutant H111-R2 as described 
below.  
  
2.2.2.2 Southern blot hybridization 
The mutation in cepR2 (mutant H111-R2 and mutant H111-R/R2) was verified by Southern 
blot analyses employing standard techniques (Southern, 1975). Chromosomal DNA of the 
H111 wild type and of mutant H111-R2 or H111-R/R2 was digested with restriction 
endonucleases, reported by agarose electrophoreses and then transferred to a nylon 
membrane. The membrane was then hybridized to a labelled cepR2-RNA-polynucleotide 
probe. The probe was enzyme-linked and could therefore be visualized with a colorimetric 
reaction. The DNA probe was constructed as followed: a DNA fragment comprising cepR2 
encoding sequences (primers cepR2-R and cepR2-F, 2.1.3) was labelled with dioxygenin 
(DIG) using the Random Prime DNA Labeling Kit (Roche, Mannheim, Germany) following 
the instructions of the manufacturers. Approximately 5 to 10 μg of chromosomal DNA of the 
H111 wild type and mutant H111-R2 or mutant H111-R/R2 were digested with restriction 
enzyme BamHI (37°C,  include RNase A, overnight). BamHI cleavage sites are among others 
present in the multiple cloning site of plasmid pEX18Gm, which was employed for the 
construction of the cepR2 insertion mutants (2.2.4.1), and in the up- and downstream DNA 
regions of the cepR2 gene (see Fig. 5, J. Toller, Master thesis, 2008). The DNA was then 
separated by electrophoresis (1% agarose gel), and the DIG labelled molecular marker II 
(Roche) was moreover employed as a control in the gel. After destaining to remove ethidium 
bromide the gel was washed in solution A (15 min, 0.25 M HCl), solution B (30 min, 0.5 M 
NaOH, 1.5 M NaCl) and solution C (40 min, 1 M Tris base, 1.5 M NaCl, pH 7.5), then blotted 
(pressure 80 mm Hg, 1 h) to a HybondTM-N
+
 nylon membrane (Amersham, Cleveland, USA) 
in a Stratagene blotting chamber (Heidelberg, Germany). The DNA was then cross-linked to 
the dry membrane under UV light (3 min). Prior the addition of the polynucleotide probe, the 
membrane was pre-hybridized in DIG Easy Hyb buffer (Roche) at 52.8 °C for 4h. The 
hybridization temperature was thereby calculated according to the instructions of the 
manufacturers (see J. Toller, Master thesis, 2008). The polynucleotide probe was first 
denaturated (100°C, 10 min), cooled on ice, and added to the pre-hybridization buffer. After 
hybridization (overnight), the membrane was washed (2 x 5 min, RT) in 25 ml of wash 
solution 1 (2x SSC, 0.1% SDS [20x SSC: 3 M NaCl, 0.3 M sodium citrate, pH 7.0]), then (2 x 
15 min, 68°C) in wash solution 2 (0.5x SSC, 0.1% SDS). After further incubation (5 min) in 
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maleic acid buffer (0.1 M maleic acid, 0.15 M NaCl, pH 7.5), the membrane was saturated 
(30 min) in blocking solution (10x blocking solution: 1:10 diluted maleic acid buffer) and 
finally incubated (30 min) in the antibody solution (150 mU/ml Anti-DIG AP conjugate in 1x 
blocking solution,  Roche). The wash step in maleic acid buffer was repeated (2 x 15 min) 
followed by the equilibration of the membrane in detection buffer (0.1 M Tris base, 0.1 M 
NaCl, pH 9.5). For the colorimetric reaction, the membrane was transferred to a freshly 
prepared NBT/BCIP solution (200 μl NBT/BCIP (Roche) in 10 ml detection buffer) following 
incubation of the membrane for 1-3 h in the dark, until colored bands became visible. 
 
2.2.2.3 Precipitation of DNA and RNA and quality analysis by gel electrophoresis  
DNA was precipitated with ethanol by standard techniques (Sambrook et al., 1989). Briefly 
cations of the DNA solution were adjusted by adding sodium acetate (stock solution 3 M, pH 
5.2) to a final concetration of 0.3 M. After adding two volumes of ice-cold ethanol (100%) the 
solution was mixed and stored on ice to allow precipitation (30 min). The DNA was pelleted 
by centrifugation (max. speed, 10 min, 4°C), the precipitate washed in 70% ethanol and the 
tube centrifuged (max. speed, 2 min, 4°C). The washing step was repeated once and the open 
tube stored at RT for the evaporation of remaining ethanol. The DNA pellet was resolved in 
TE-buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8).  
RNA was precipitated with lithium-chloride as follows: concentration of RNA samples were 
adjusted with 8 M LiCl to obtain a concentration of 2.5 M (use RNAse-free water, final 
volume of 1 ml). After incubuation of samples (30 min, -20°C), tubes were centrifuged (max. 
speed, 5 min, RT), and pellets were stored at RT to air-dry, then resuspended in ddH2O (20 µl, 
RNase-free) and stored at -80°C. RNA quality (for further usage in the transcriptome 
analysis) was analysed by agarose gel electrophoresis as follows: 0.3 µl of the concentrated 
RNA samples (200 ng of RNA is good visilbe on a gel, mixed with 5 µl of ddH2O and 3 µl of 
loading dye) were separated on a 0.5% agarose gel employing TAE-buffer (40 mM Tris-
Acetat, 1 mM EDTA, pH 7.5). The gel was analysed for clear 16S and 23S rRNA bands (5S 
rRNA band is often difficult to see) and for smear (indicates DNA contamination and/or RNA 
degradation). 
For inactivation of RNases all buffers were treated with DEPC (diethyl pyrocarbonate, final 
concentration: 0.1%). Here, DEPC was added to solutions and buffers which were incubated 
at 37°C (overnight), followed by the break-down of DEPC through autoclaving. In order to 
avoid enzyme degradation of RNA all equipment and the working place were cleaned with 
ethanol (100%), pipettes and plastic wear were moreover rinsed with 0.1 N NaOH. 
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2.2.2.4 Recombinant DNA techniques 
Digestion with enzymes, agarose gel electrophoreses, purification of DNA fragments, 
dephosporylation of plasmid DNA, ligation with T4 DNA ligase, end filling with Klenow 
fragment of DNA polymerase were performed as described (Sambrook, 1989). 
Transformation of plasmid DNA in E. coli was performed by electroporation with a BioRad 
Gene pulser (BioRad, Hercules, USA) at 200 Ω, 25 μF and 2.5 kV. Glycerol-treated 
electrocompetent cells were prepared as described (Sambrook et al., 1989). Cells were 
resuspended in SOC-medium (see 2.1.2) following the transformation and incubated at 37°C 
(1h) prior the selection on agar plates containing appropriate antibiotics.   
Tri-parental matings from E. coli to B. cenocepacia were performed with helper strains E. coli 
MM294 (pRK2013) and E. coli HB101 (pRK600) (2.1.1) according to a previously described 
procedure (De Lorenzo & Timmis, 1994). Briefly, overnight cultures of the donor strain, the 
helper strain, and the Burkholderia recipient strain were harvested and washed in LB-medium 
to remove residual antibiotics. Culture samples of the donor and the helper strain (100 μl 
each) were mixed and incubated for 10 min at RT. A volume of 200 μl of the recipient strain 
was added and the mixture was plated in 50 μl spots on prewarmed LB-agar plates. After 
incubation at 37°C (at least 8h or overnight) bacteria were resuspended in volumes of 0.9% 
sodium chloride, transferred to selective PIA agar plates and further incubated at 37°C. 
 
2.2.3 DNA sequence determination and database analysis 
Sequencing reactions were performed employing the ABI BigDye® Terminator Cycle 
Sequencing Kit (Applied Biosystems, Foster City, USA). Briefly, DNA (ca. 100-180 ng) was 
mixed with 0.8 μl BigDye, 0.5 μM primer, 1x sequencing buffer and 5% DMSO in a total 
volume of 10 μl. Sequencing reactions were routinely performed as followed: 94°C for 2 min, 
96°C for 10 s, 50°C for 5 s, 60°C for 3 min; applying 60 cycles. Subsequent purification and 
electrophoresis steps were performed using the ABI 3730 DNA analyzer (Applied 
Biosystems, Institute sequencing service) and analysed with the software Chromas 2. 
The following databases and softwares were used for the analyses of DNA or protein 
sequences/ structure: KEGG (Kyoto Encyclopedia of Genes and Genomes, 
http://www.genome.jp/kegg/), the Burkholderia genome database, 
http://www.burkholderia.com/), The Welcome Trust  Sanger Institute,   
http://www.sanger.ac.uk/Projects/B_cenocepacia/, NCBI (http://www.ncbi.nlm.nih.gov/), 
EMBL (http://www.embl.de/), Softberry, http://linux1.softberry.com/berry.phtml), DOE Joint 
Genome Institute, http://www.jgi.doe.gov/), CLC DNA workbench, iTASSER 
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(http://zhanglab.ccmb.med.umich.edu/I-TASSER/) and Phyre 
(http://www.sbg.bio.ic.ac.uk/~phyre/). 
 
2.2.4 Allelic replacement and mutagenesis in B. cenocepacia H111 
2.2.4.1 Generation of mutant H111-R2 and H111-R/R2 
A H111 cepR2 mutant (designated as H111-R2) was constructed as follows: a 384 bp internal 
fragment of cepR2 was amplified with primers cepR2-R and cepR2-F (2.1.3), digested with 
HindIII, ligated into the gene replacement vector pEX18Gm (2.1.1), and transformed into E. 
coli XL1-Blue. The final construct was transferred to H111 by triparental mating according to 
De Lorenzo et al. (1994) and allelic exchange of mutant strains was later confirmed by PCR 
and southern blot hybridization (see Results: 3.2 and Master thesis of J. Toller, 2008). The 
H111 cepR cepR2 double mutant, designated H111-R/R2, was constructed in an analogous 
manner using the H111 cepR mutant (H111-R) as the recipient strain (see 3.2).  
 
2.2.4.2 Generation of deletion mutant H111-bclACB and H111-rsaM 
A lectin deficient H111 mutant, referred to as H111-bclABC, was generated by allelic 
replacement of the lectin-encoding operon using a modified protocol of the Gateway cloning 
technology (Carlier et al., 2009). Briefly, flanking regions of bclA and bclB were amplified by 
PCR using the oligonucleotides lecDn-GW and lecDn-kan and lecUp-kan and lecUp-GW 
(2.1.3 and 3.3). A kanamycin cassette derived from plasmid pKD4 (2.1.1) was then inserted 
between the flanking regions by means of an overlap PCR reaction. The resulting PCR 
products were cloned into the Gateway Entry vector pDONR221 (2.1.1) using BP Enzyme II 
Mix (Invitrogen, Carlbach, USA) and then transferred into the suicide vector pAUC40 (2.1.1) 
using the LR Enzyme II Mix (Invitrogen, Carlbach, USA) following the instructions supplied 
by the manufacturer. The resulting plasmid (pAUC40-bcl, see 3.3) was conjugated into B. 
cenocepacia by triparental mating (2.2.2.4), and transconjugants were selected for 
kanamycin-resistence and streptomycin-sensitivity. Allelic replacements were verified by 
PCR using oligonucleotides lecB2-up and lecB2-dn and primers KanUpRev and KanDnFwd 
(2.1.3 and 3.3) and by Western immunoblotting with BclC antibodies (2.3.4 and 3.3). The 
H111 rsaM (BCAM1869) deletion mutant H111-rsaM was contructed by A. Carlier using the 
Gateway cloning technology analogous as described above. Primers used for the mutagenesis 
are: cepVupGW, cepVDnGW, cepVUpkan and cepVDnFkan (Table 3, 2.1.3).  
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2.2.5 Construction of plasmid pJTR2, pBBRrsaM and pBBRrsaM_FS 
For complementation analyses we constructed the cepR2 expressing plasmid pJTR2, plasmid 
pBBRrsaM, expressing the rsaM gene, and plasmid pBBRrsaM_FS, which encodes a 
framshiftet ORF of rsaM. The cepR2 ORF was amplified from genomic DNA of H111 by 
PCR employing primers cepR2pBBR-F and cepR2pBBR-R (2.1.3). Subsequently the DNA 
was first subcloned into plasmid pCR2.1Topo (Invitrogen) and then inserted into plasmid 
pBBR1MCS (2.1.1) using the EcoRV and BamHI restriction sites to create pJTR2 (for 
plasmid map see Master thesis J. Toller, 2008). 
For the construction of plasmid pBBRrsaM a 572 bp DNA fragment comprising the coding-
sequences of the predicted rsaM gene was amplified by PCR with primers cepVpBBR-F and 
cepVpBBR-R (2.1.3). A frameshifted rsaM ORF (followed by a translational STOP codon) 
was generated employing primers cepVpBBR-F_FS and cepVpBBR-R_FS (2.1.3). 
Amplicons of DNA sequences were generated by PCR and inserted into plasmid pBBR1MCS 
as described above (if necessary the DNA was subcloned into plasmid pCR2.1Topo, 
Invitrogen).    
 
2.2.6 Generation of plasmid pJBA89luxR- by partial digestion 
Plasmid pJBA89luxR 
- 
was constructed by partial digestion of pJBA89 with restriction 
enzymes EcoRI and HindIII, in which a 703 bp DNA fragment containing luxR (HindIII-
digestion side 55 bp downstream of the start codon) was removed from plasmid pJBA89. 
Protruding 3‟-termini were filled in with Klenow fragment and blunt ends were reunited 
employing T4-ligase. 
 
2.2.7 Generation of plasmid pET-HisBclB 
The BclB (LecB3)-encoding sequence was amplified by PCR employing primers lecB3-F and 
lecB3-R_his (2.1.3). The amplicon was inserted into pCR2.1 Topo (Invitrogen), cut-out off 
the vector and cloned into plasmid pET28a (Novagen, Madison, USA) to generate a 
translational fusion of the histidine tag and bclB. For protein overexpression, see 2.3.3. 
Cloning was done by Alexander Grunau. 
 
2.2.8 Transcriptional fusions to lacZ 
Transcriptional fusions were constructed encoding upstream regions of putative promoters of 
the following genes: araC (BCAM0189), bclA, cepI, cepR2, pchD and pchR. Promoter 
regions were amplified by PCR using oligonucleotides araCP-F, araCP-R; PlecB-up, PlecB-
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dn; PcepI-F, PcepI-R; PcepI-F, CepVdn-Xho; cepR2P-F, cepR2P-R; pyo2231P-F, pyo2231P-
R and pyo2232P-F, pyo2232P-R (Table 3, 2.1.3). The PCR fragments were cloned as XhoI 
and HindIII fragments into the respective sites of the promoter-probe vector pSU11 or pRN3 
(see 2.1.1) generating plasmids ParaC-lacZ, PbclA-lacZ, PcepI-lacZ, PcepIlong-lacZ, PpchD-lacZ and 
PpchR-lacZ (Table 1, 2.1.1). Promoter fusion PaidA1-lacZ comprises a long fragment of the aidA 
promoter (aidA1, see S. Uehlinger, Dissertation, 2009). The transcriptional fusions were 
analysed by PCR employing the primers listed above and primer lacZ-R (2.1.3). Plasmids 
were transferred to B. cenocepacia by means of triparental mating (2.2.2.4). 
 
2.2.9 RNA extraction and transcriptome analysis 
For the extraction of RNA, overnight cultures of planktonic cells were inoculated in 10 ml 
LB-medium to an OD600 of 0.02. The following strains were employed for the microarray 
profiling: the H111 wild type, the cepR mutant H111-R, and the plasmid pBAH27 (2.1.1) 
harbouring complemented strain H111-R (cepR
+
). Cells were harvested at stationary phase 
growth at an OD600 of 2.5, because the expression of aidA (a stringently QS-regulated 
virulence factor, see 3.1) as well as production of signal molecules was found to be maximal 
at this density. RNA was extracted and purified as recommended by the RiboPure
TM
-Bacteria 
Kit (Ambion) with the following modifications: the lysate-ethanol mixture from two tubes of 
each sample was transferred to one filter cartridge to improve RNA yield. To remove trace 
amounts of genomic DNA extracts were treated with DNase Ι for 60 minutes at 37°C. RNA 
concentration and integrity was monitored applying NanoDrop and agarose gel 
electrophoresis.  
Two-color microarray experiments were performed at the School of Biosciences at Cardiff 
University using Agilent 4-pack BCC gene chips, which were designed on the basis of the 
sequenced Burkholderia cenocepacia J2315 genome (Holden et al., 2009). The gene chip 
comprised 10264 gene probes with 8741 sequences of B. cenocepacia strain J2315, 1070 gene 
sequences belonging to Burkholderia cenocepacia strain AU1054 and 387 gene sequences of 
Burkholderia cenocepacia HI2424. In total, 3 biological replicates of each of the analysed 
strains, the H111 wild type (control), mutant H111-R and H111-R (cepR
+
) were prepared. 
Total RNA (10-20 µg) was used for synthesis of cDNA. Labelling of first strand cDNA was 
performed according to the CyScribe Post-Labelling Kit Protokol (GE Healthcare) as briefly 
followed: random nonamers, anchored oligonucleotides and control spikes (Two-Color 
Microarray-Based Gene Expression Analysis, Agilent) were added to the RNA samples and 
allowed to anneal to the mRNA (70°C for 5 min, RT for 10 min). In the second step cDNA 
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was synthesized using CyScript reverse transcriptase incorporating aminoallyl-dUTP 
according to the manufactor´s instruction (GE Healthcare Amersham CyScribe Post-Labelling 
Kit). RNA was removed by alkaline treatment and subsequent neutralization. After 
purification of cDNA (CyScribe GFX Purification Kit, GE Healthcare), the cDNA was 
coupled with CyDye NHS ester. The CyDye labelled cDNA was again purified (CyScribe 
Post-Labelling Kit, GE Healthcare). Hybridizing the DNA to the microarray (Two-Color 
Microarray-Based Gene Expression Analysis Kit, Agilent, and GE hybridization buffer) 
control-DNA (Cystic fibrosis foundation therapeutics (CFFT) at the University of North 
Carolina) was again incorporated. Microarray washing was performed according to the 
instructions of the manufacturer (Agilent).    
 
Transcriptome data processing and interpretation 
Transcriptome analyses were performed in colaboration with the CFFT (cystic fibrosis 
foundation therapeutics) at the University of North Carolina. Signal intensities were first 
detected and analysed towards quality with Agilent Feature extraction software (v.9.5). The 
dataset was then incorporated into GeneSpring (v.7.3.1) and processed using the “Affimetrix 
FE” data normalization procedure recommended for Agilent arrays, i.e., first data 
transformation to set measurements of below 0.01 to 0.01 followed by a per-chip 
normalization to the 50
th
 percentile and a per-spot normalization to median. Incorrect probes 
as well as genes, which were not present in at least 3 arrays, were further excluded from the 
data set. The remaining probes were filtered using a fold change value of ≥3. Statistical 
analysis of the remaining genes was carried out using ANOVA along with the “Benjamini and 
Hochberg False Discovery Rate (BH_FDR) multiple testing correction”. Differentially 
expressed genes that hybridized to array probes belonging to B. cenocepacia strain AU1054 
including CDSs for genes (6), tRNA genes (19 CDSs), as well as intergenetic regions (21 
CDSs), were excluded in this study.  
 
2.3 Protein biochemical methods 
2.3.1 Extraction of proteins and determination of protein amount 
The extraction of extracellular and whole cell protein fractions which were analysed by 
iTRAQ is described in 2.3.6. For the Western immunoblot analyses of BclB (2.3.4) we 
employed extracellular and whole cell protein samples of planktonic cells, which were 
prepared as followed: B. cenocepacia H111 wt and mutants were grown while shaking in LB-
medium (V = 300 ml, 37°C, inoculation from over night culture to an OD600 of 0.1). 50 ml 
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culture samples were collected at different cellular densities as determined by absorbance at 
600 nm over a period of 24h (see 3.3). After centrifugation (5000 rpm, 30 min, 4°C), 
supernatants were transferred to a schott bottle (for the precipitation of extracellur proteins) 
and cell pellets were washed in 50 ml PBS, then resuspended in 20 ml of 50 mM Tris-HCl, 
pH 7.5, 1% SDS. In order to concentrate and adjust cell densities of the probes, samples were 
centrifugated (5000 rpm, 30 min, 4°C) and cell pellets were resuspended in 50 mM Tris-HCl, 
pH 7.5, 1% SDS with final volumes ranging from 400 to 6000 µl. (The cell pellet deriving 
from a cell cultures of 20 ml with a measured OD600 of 1.0 was resuspended in 400 µl of 
buffer, other samples were resolved proportional). The protein concentration was quantified 
according to Bradford (Bradford, 1976) employing the Pierce Protein Assay (Pierce, 
Rockford, USA). Protein amounts of the samples determined by Bradford were approximately 
2 mg/ml.   
Extracellular proteins (see above) were extracted with TCA (15%, w/v) and samples were 
incubated overnight for protein precipitation under agitation at 4°C. After pelleting (5000 
rpm, 90 min, 4°C) proteins were once washed with 70% ethanol then washed with ice-cold 
acetone and again centrifuged (8500 rpm, 20 min, 4°C). Pellets were air-dried and solved in a 
final volume of 400 μl 50 mM Tris-HCl, pH 7.5, 1% SDS. Protein amounts determined by 
Bradford were approximately 2 mg/ml). In all cases, equal amounts of protein (30 µl of 
protein samples) were mixed with spratt buffer, partially sonicated, and loaded on a 15% SDS 
gel for gel electrophoreses as described below. 
 
2.3.2 SDS-gel electrophoresis and protein visualization  
For analytical analyses proteins were routinely separated according to their molecular weight 
through a discontinued sodium dodecyl sulfate gel electrophoresis (SDS–PAGE) (Laemmli, 
1970). The composition of a 15% SDS-gel consisting of the two denaturing gels, the stacking-
gel (5% (w/v) acrylamide) and the separating-gel (15% (w/v) acrylamide) is listed in Table 4. 
Gel  (% Acrylamide) Acrylamide
a)
 Buffer dH2O APS
d)
/ Temed
e)
 
Stacking-gel        (5%) 3.34 ml 5 ml buffer 
b)
 11.6 ml 150 μl/ 15 μl 
Separating-gel    (15%) 20 ml 10 ml buffer 
c)
 10 ml 250 μl/ 25 μl 
Table 4. Composition scheme for the preparation of three 15% SDS-gels (V = 20 ml each).  
a)
: 30% Acrylamid, 1.5% N,N-Methylenbisacrylamid in dH2O 
b)
: 0.5 M Tris-HCl, pH 6.8 
c) 
: 1.5 M Tris-HCl, pH 8.8 
d): TEMED = N,N,N‟,N‟ – Tetramethylendiamin 
e)
: APS =Ammonium peroxodisulfate 
 
Material and Methods 
25 
 
Prior the probe application on the gel, samples were combined with spratt buffer (1/3 of the 
volume; 50 mM Tris-HCl, pH 6.8, 40% (w/v) glycerol, 6% (w/v) SDS, 15% (w/v) glycerol, 
5% (v/v) ß-mercaptoethanol and some bromophenol blue cristals), and boiled for 10 min at 
100°C. The samples were centrifuged and those containing whole cells proteins were 
furthermore exposed to sonication (40% amplitude, 30 s). Electrophoresis was performed 
employing standard electrophoresis buffer (20 mM Tris, 192 mM Glycin, 0.1% SDS (w/v) 
and applying an initial current of 15 mA (45 min) followed by a current at 35 mA (1 h). 
Protein standards were included as a marker (precision plus protein standards all-blue, 
BioRad). If the gel was not furter employed for Western immunoblotting, proteins were 
subsequently visualized by staining with the dye Serva Blue G (Serva, Heidelberg, Germany) 
according to the instructions of the manufacturers.  
 
2.3.3 Overproduction and purification of lectin BclB (BCAM0184) 
For protein overexpression plasmid pET-HisBclB (2.2.7) was transformed into E. coli BL21 
(DE3) and gene expression was induced by the addition of 1 mM isopropyl-l-thio-β-D-
galactopyranoside. BclB expression was analysed by SDS-PAGE as described (2.3.2). 
Purification of BclB was performed by affinity-chromatography on a Ni-NTA-HisTrap FF 
column (GE Healthcare) followed by gel filtration on a Superose 12 10/300 GL column (GE 
Healthcare) using an ÄKTA Purifier 10-UPC950 FPLC system, GE Healthcare). 
 
2.3.4 Generation of BclB antibodies and Western immunoblot analysis   
Polyclonal antibodies directed against BclB were generated using the purified protein (Coring 
System Diagnostix GmbH, Germany). The immunoblotting was conducted employing 
fractions of whole cell proteins or extracellular proteins. All steps were performed at RT. 
Protein samples (2 mg/ml protein, see 2.3.1) were loaded on a 15% SDS gel (2.3.2) and 
separated by electrophoresis. Protein blotting was prepared by transferring nine sheets of 
Whatman paper (3MM, Whatman, Maidstone, UK) soaked in transfer buffer (48 mM Tris, 38 
mM glycine, 0.04% SDS (w/v), 20% methanol (v/v), pH 8.3) to the anode of a semi-dry 
blotting apparatus (NovaBlot 2117 250, GE Healthcare, UK). A polyvinylidene difluoride 
(PVDF) membrane (Amersham Hybond
TM
-P, GE-Healthcare, cut to the size of the gel) was 
quickly equilibrated in methanol and transfer buffer and placed onto the paper stack avoiding 
the formation of bubbles. After a 20 min incubation period in transfer buffer, the gel was 
subsequently transferred to the membrane, covered with nine additional sheets of Whatman 
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paper (soaked in transfer buffer) and sealed by the cathode of the apparatus. Protein transfer 
was conducted at 0.8 mA/cm
2
 gel for 1 h. 
For the subsequent detection of BclB the membrane was washed twice (each 10 min) in TBS 
buffer (10 mM Tris-HCl, pH 7.5, 50 mM NaCl), then incubated for 1 h in blocking solution 
(TBS buffer containing 3 % (w/v) bovine serum albumine). Following two washing steps (10 
min each) in TBS-T buffer (20 mM Tris-HCl, pH 7.5, 500 mM NaCl; 0.05% Tween-20 (v/v), 
0.2% Triton-X100 (v/v)) and one incubation period in TBS buffer, the membrane was 
transferred to the binding solution (one volume blocking solution, one volume TBS buffer), 
which was supplemented with the BclB-antibody (1: 5000). Antibody binding was allowed 
for 1h and the membane was again washed prior incubation with the second antibody (twice 
in TBS-T buffer, once in TBS buffer, 10 min each). Following 1 h of incubation in binding 
buffer containing alkaline-phosphate conjugated anti-rabbit immunoglobulin G (1:7000, 
Sigma, Deisenhofen, Germany), the membrane was exposed to four final washing steps in 
TBS-T buffer and subsequently equilibrated in reaction buffer (100 mM Tris-HCl, pH 9.5; 
100 mM NaCl, 5 mM MgCl2). Enzyme activity was detected employing NBT/BCIP dye (200 
μl in 10 ml reaction buffer, Roche, Penzberg, Germany) according to the instructions of the 
manufacturers.  
 
2.3.5 Detection of BclB by immunofluorescence microscopy  
To determine the subcellular localization of the BclB lectin in B. cenocepacia H111, 
polyclonal antibodies directed against the BclB protein (2.3.4) were labelled with the dye 
Alexa Fluor 594 (Invitrogen) according to the instructions of the manufacturer (the labelling 
was done by Alexander Grunau). The calculated concentration of labelled protein measured 
by absorbance at 280 nm and 590 nm (instructions of the manufacturers) was 0.2 mg/ml in 
PBS. For the assay we employed cells of bacterial cultures (100 ml volumes) which were 
grown at 37°C with agitation to an OD600 of 2.5. Bacterial cells (pelleted from 500 µl 
volumes) were fixed by incubation in 4% para-formaldehyde in PBS (10 min, RT), followed 
by a washing step with PBS. To permealize cell membranes and enable antibody binding to 
intracellular proteins samples aliquots were moreover incubated in PBS containing 0.2% 
Triton X-100 (10 min, RT) and subsequently washed with PBS. To reduce non-specific 
binding of the antibodies the cells were incubated in 1% bovine serum albumin in PBS (40 
min, RT). All cellular preparations were washed twice with PBS and resuspended in a final 
volume of 50 µl. Cell labelling was achieved by adding the Alexa 594-conjugated BclB 
antibodies (4:5 diluted in cellular sample preparations), followed by incubation in the dark for 
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2h at RT. Labelling reactions were further kept at 4°C overnight, then washed with PBS 
(three times) and analysed by fluorescence microscopy (Center of Microscopy, University of 
Zurich).        
 
2.3.6 Protein extraction and analysis by iTRAQ (isobaric tag for relative and absolute     
quantitation) 
For comparative proteome analyses 500 ml LB-medium in 3 l Erlenmeyerflasks were 
inoculated with overnight cultures of the H111 wild type, the cepR mutant H111-R, and the 
cepI mutant H111-I (2.1.1) to an OD600 of 0.05 and incubated at 37°C under vigorous shaking 
(225 rpm). One out of two H111-I cultures was supplemented with 1 μM C8-HSL. To 
optimize the proteome-transcriptome comparison, cells were harvested at an OD600 of 3.0, 
where the abundance of AidA has been observed highest in the wild type strain. After 
centrifugation (5000 rpm, 15 min) supernatants were separated from bacterial cell pellets and 
sterile filtered. 
Extracellular (EC) proteins were precipitated from sterile filtered culture supernatants with 
15% trichloroacetic acid (TCA). Protein pellets were washed with acetone, dried at RT and 
resuspended in 50 mM Tris-HCl, pH 7.5. Proteins were further purified by phenol extraction 
as described elsewhere (Riedel et al., 2003). To extract whole cell (WC) proteins bacteria cell 
pellets were resuspended in 4 ml of 0.5 M triethylammonium bicarbonate (TEAB) buffer and 
sonicated four times for 1 min on ice. After pelletting the cell debris (20.000 rpm, 30 min), 
proteins were precipitated from the supernatant with 6 volumes of acetone at -20°C overnight. 
Following centrifugation (20.000 rpm, 20 min) pellets were again resolved in 0.5 M TEAB 
buffer and stored at -80°C. The protein concentration was quantified according to Bradford 
(2.3.1). Subsequently, 100 μg of each protein sample were dried and resolved in 20 l 0.05% 
SDS as stated in the iTRAQ Reagents Protocol (Applied Biosystems, Foster City, USA). 
After reduction of proteins and alkylation of cysteine residues, peptides were digested with 
trypsin and labelled with iTRAQ reagents. Four independent protein analyses were 
performed, in which the peptides were tagged with the different iTRAQ labels. In analysis I 
(WC proteins) and analysis II (EC proteins) we used tag 117 for H111 wild type peptides, tag 
116 for H111-R peptides, tag 115 for H111-I peptides, and tag 114 for AHL-complemented 
H111-I peptides. In analysis III (biological replicate WC proteins) and analysis IV (biological 
replicate EC proteins) we used tag 114 for H111 WT peptides, tag 115 H111-R peptides, tag 
116 for H111-I peptides, and tag 117 for complemented H111-I peptides. Prior to LC-MS/MS 
the tagged peptides from each analysis were combined.  
Material and Methods 
28 
 
For analytical protein analyses samples were separated by sodium dodecyl sulfate gel 
electrophoresis (SDS–PAGE) and bands were visualized by Coomassie blue staining (Serva 
Blue G; Serva, Heidelberg, Germany, 2.3.2).  
 
Strong cation exchange chromatography (SCX) 
The iTRAQ samples were separated into 27 fractions on a cation-exchange column (2.1 mm x 
200 mm SCX-column, PolySULPHOETHYL A, 5 m, 300-Å, PolyLC, Columbia, USA) 
using the gradient solutions mobile phase A (10 mM KH2PO4, 25% acetonitrile, pH 3) and 
phase B (10 mM KH2PO4, 25% acetonitrile, and 35 mM KCl, pH 3). Peptides were eluted at a 
flow rate of 0.3 ml/min over the following gradient: 10 min 100% mobile phase A, 40 min 0-
50% mobile phase B, 10 min 100% mobile phase B. Fractions were pooled to four master-
fractions according to the SCX spectrum and purified using a C-18 column (Sep-Pak 
cartridge, Waters Corporation, USA). 
 
Nano-LC separation and MALDI target spotting of tryptic peptides 
Samples were further analysed by nano-liquid chromatography coupled to matrix-assisted 
laser desorption/ionization time-of flight/time-of-flight tandem mass spectrometry (nano-LC-
MALDI-TOF/TOF MS). Peptide separation was performed on an Ultimate chromatography 
system (Dionex - LC Packings, Sunnyvale, CA) equipped with a Probot MALDI spotting 
device. 5 µl of the samples were injected by using a Famos autosampler (Dionex - LC 
Packings) and loaded directly onto a 75 µm x 150 mm reversed-phase column (PepMap 100, 
3 mm; Dionex - LC Packings). Peptides were eluted at a flow rate of 300 nl/min by using the 
following gradient: 0-10 min, 0% solvent B; 10-105 min, 0-50% solvent B; and 105-115 min, 
50-100% solvent B. Solvent A contained 0.1% TFA in 95:5 water/acetonitrile, and solvent B 
contained 0.1% TFA in 20:80 water/acetonitrile. For MALDI analysis, the column effluent 
was directly mixed with MALDI matrix (3 mg/ml a-cyano-4-hydroxycinnamic acid in 70 % 
acetonitrile/0.1 % TFA) at a flow rate of 1.1 µl/min via a µ-Tee fitting. Fractions were 
automatically deposited every 10 s onto a MALDI target plate (Applied Biosystems, Toronto, 
Canada) using a Probot micro fraction collector. A total of 416 spots were collected from each 
HPLC run. 
 
MALDI-TOF/TOF mass spectrometry 
MALDI plates were analysed on a 4800 MALDI TOF/TOF system (Applied Biosystems, 
Toronto, Canada) equipped with a Nd:YAG laser operating at 200 Hz. All mass spectra were 
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recorded in positive reflector mode and generated by accumulating data from 800 laser shots. 
First, MS spectra were recorded from peptide standards on each of the six calibration spots, 
and the default calibration parameters were updated. Second, MS spectra were recorded for all 
sample spots on the MALDI target plate (416 spots per sample, 4 samples per plate). The MS 
spectra were recalibrated internally based on the ion signal of neurotensin peptide (Sigma, 
Buchs, Switzerland). Spectral peaks that met the threshold criteria and were not on the 
exclusion list were included in the acquisition list for the MS/MS spectra. The following 
threshold criteria and settings were used: Mass range: 800 to 4000 Da; minimum signal-to-
noise (S/N) for MS/MS acquisition: 100; maximum number of peaks/spot: 8. Peptide CID 
was performed at a collision energy of 1 kV and a collision gas pressure of approximately 2.5 
x 10-6 Torr. During MS/MS data acquisition, a method with a stop condition was used. In this 
method, a minimum of 1000 shots (20 sub-spectra accumulated from 50 laser shots each) and 
a maximum of 2000 shots (40 sub-spectra) were allowed for each spectrum. The 
accumulation of additional laser shots was halted whenever at least 6 ion signals with a S/N of 
at least 60 were present in the accumulated MS/MS spectrum, in the region above m/z 200. 
 
Protein identification and relative quantification 
GPS (Global Proteomics Server) Explorer Software (Applied Biosystems, Foster City, USA) 
was used for submitting data acquired with the MALDI-TOF/TOF mass spectrometer for 
database searching. The MS and MS/MS data were searched using Mascot version 2.1.0 
(Matrix Science, London, UK) as the search engine (Perkins et al., 1999). The following 
search settings were used: maximum missed cleavages: 1; maximum number of signals per 
spectrum: 55; peptide mass tolerance: 35 ppm MS/MS tolerance: 0.2 or 0.25 Da. ITRAQ 
labelling of lysine and of the N-terminal amino group of peptides and methyl 
methanthiosulfonate (MMTS) derivatization of cysteine were specified as fixed 
modifications. All searches were performed against two databases (p142_burkhold, 148894 
entries and p142_ceno_J2315, 7525 entries) comprising annotated proteins of various 
Burkholderia species (Burkholderia cenocepacia J2315, Burkholderia cenocepacia AU 1054, 
Burkholderia cenocepacia HI2424, Burkholderia cepacia AMMD,  Burkholderia sp. 383, 
Burkholderia mallei ATCC 23344, Burkholderia mallei NCTC 10229, Burkholderia mallei 
NCTC 10247, Burkholderia mallei SAVP1, Burkholderia pseudomallei 1106a, Burkholderia 
pseudomallei 1710b, Burkholderia pseudomallei 668, Burkholderia pseudomallei 305, 
Burkholderia pseudomallei K96243, Burkholderia thailandensis E264, Burkholderia 
vietnamiensis G4, Burkholderia xenovorans LB400, Burkholderia ambifaria MC40-6, 
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Burkholderia cenocepacia MC0-3, Burkholderia multivorans ATCC 17616, Burkholderia 
phymatum STM815, Burkholderia phytofirmans PsJN) and proteins of the closest relative of 
H111, B. cenocepacia J2315, respectively. Moreover, common contaminants such as trypsin 
and keratin were added to both of the databases to avoid false positive identification of 
proteins.  
The ratio of peak areas between iTRAQ reporter ions 114, 115, 116 and 117 (analyses I and 
II) and reporter ions 117, 116, 115 and 114 (analyses III and IV) was used to determine the 
relative abundance of proteins in each protein sample. For normalization the ratio of each 
protein sample from iTRAQ analyses I or II and III or IV were multiplied. The root of the 
product was then extracted and further referred to as “normalized”. The mean, standard 
deviation, and p-values to estimate statistical significance of protein quantification were 
calculated by the Mascot software. Proteins were assigned as QS-regulated when the 
regulation factors were higher than 1.5 in both independent analyses of either EC and/or WC 
proteins of the cepR and/or cepI mutant and the corresponding p-values were below 0.05.  
 
2.4 Phenotypical assays 
2.4.1 Analyses of gene expression measuring β-galactosidase activity 
This assay was used to quantify promoter activities of genes by analysing the activity of a 
promoter-fused reporter gene, in this case the enzyme β-galactosidase. The analysis was 
conducted with plasmid pSU11 or pRN3 (2.1.1, see plasmid map below and dissertation S. 
Uehlinger, 2009). Plasmid pSU11 expresses the E. coli lacZ gene and comprises a multiple 
cloning side (XhoI and HindIII are preferentially used for ligation of DNA sequences) and a 
mob gene for plasmid mobilisation. The reporter activity was determined by the 
spectrometrically measurement of the product ONP (Ortho-nitrophenol, absorption 
wavelenght 420 nm) as described by Miller (Miller, 1972). 
 
 
BamHI 
AgeI 
KpnI 
ApaI 
XhoI 
SalI 
Bsp106 
ClaI 
HindIII 
SmaI 
pSU11 
 9000 bp 
 
ter 
rep 
GmR 
mob 
lacZ 
lacZα 
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Overnight cultures of strains (grown in LB-medium supplemented with appropriate antibiotic 
or minimal medium) containing the transcriptional promoter-lacZ fusion were inoculated in 
the appropriate medium (OD600 of 0.01) and aliquots were withdrawn during bacterial growth. 
Volumes of aliquots were varying between 200 – 800 μl depending on the expected promoter 
activities. At each time point, the adsorbance at 600 nm was recorded and bacterial cells were 
pelleted for storage (-20°C) or for the subsequent analysis of promoter activity resuspended in 
1 ml of Z-buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, 50 mM β-
mercaptoethanol, pH 7.0). Cell membranes were permealized by the addition of either toluene 
or 0.1% SDS-solution and chloroform. When adding toluene (a drop), cell samples were 
further incubated at 30°C (overnight). The enzyme assay was performed at 30°C, started by 
the addition of 200 μl of ONPG (4 mg/ml, o-nitrophenyl-β-D-galactopyranoside, Sigma) and 
stopped when the solution turned yellow by supplying 0.5 ml of 1 M Na2CO3. The reaction 
time was recorded, cell debris were removed by centrifugation, and absorbance was measured 
at 420 nm. Specific Miller units were calculated as follows: 1000 x OD420/ (t x V x OD600), 
with t = reaction time and V = culture volume. Cell membranes were permealized with SDS 
and chloroform by the addition of each 20 μl to the samples, followed by vortexing and 
incubation of the samples for 8 min. Further steps of the assay were then performed as 
described above.  
 
2.4.2 Extraction and detection of acyl-homoserine lactone (AHL) molecules  
2.4.2.1 Detection of AHL molecules employing sensor plasmids 
The detection of acyl-homoserine lactone (AHL) molecules was accomplished employing 
bacterial reporter systems (2.1.1. and see below). These systems differ in the type of reporter 
and in their detection specificity of AHL molecules.  
 
Escherichia coli MT102 (pSB403): bioluminescent AHL sensor plasmid; pRK415 plasmid 
backbone with luxRI::luxCDABE transcriptional fusion (Winsor et al., 1998). (Vibrio fischeri 
luxR gene and transcriptional fusion of Vibrio fischeri luxI promoter to luxCDABE of 
Photorhabdus luminescens. Reporter is most sensitive to 3-oxo-C6-HSL.)  
 
Pseudomonas putida F117 (pAS-C8): gfp-based AHL sensor plasmid; pBBR1MCS-5 
plasmid backbone with PcepI::gfp(ASV) Plac::cepR (Steidle et al., 2001, Riedel et al., 2001). 
(B. cenocepacia H111 cepR gene under control of the Plac and transcriptional fusion of H111 
PcepI to gfp(ASV). Reporter most sensitive for C8-HSL). 
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Pseudomonas putida (pKR-C12): gfp-based sensor plasmid, pBBR1MCS-5 plasmid 
backbone with PlasB::gfp(ASV) Plac::lasR (Riedel et al., 2001). (P. aeruginosa PAO1 lasR 
gene under control of Plac and transcriptional fusion of PlasB to gfp(ASV). Reporter highly 
sensitive to 3-oxo-C12-HSL and 3-oxo-C10-HSL). 
 
Chromobacterium violaceum CV026: reporter based on violacein production, C. violaceum 
ATCC 31532 derivative, cviI::Tn5 (McClean et al., 1997). The production of the violet 
pigment violacein is positively-regulated via quorum sensing in C. violaceum. Mutant CV026 
has a mutation in the luxI homologous gene cviI and produces violacein only when AHL 
molecules are externally added. This sensor is highly sensitive to unsubstituted short-chain 
AHL molecules but quite insensitive to other AHLs (McClean et al., 1997). 
 
E. coli MT102 pJBA89: gfp-based sensor plasmid, pUC18Not-luxR-PluxI-RBSII-gfp(ASV)-
T0-T1 (Andersen et al., 1998).  
 
E. coli MT102 pJBA89luxR
-
: luxR-deficient derivate of pJBA89, pUC18Not-PluxI-RBSII-
gfp(ASV)-T0-T1 (see 2.2.6 and (Malott et al., 2009). 
 
2.4.2.2 Qualitative and quantitative detection of AHL molecules 
For the qualitative detection of AHL molecules, test strains were streaked on LB-agar plates 
in a 90° angle to a sensor strain without contact (“cross streaking”). The plates were incubated 
(1-3 days, at 30°C and 37°C) and analysed for reporter activity. The expression of GFP (green 
fluorescent protein) was monitored in a dark box by illumination with blue light (HQ 480/80 
filter F44-001; AHF-Analysentechnik, Tübingen, Germany, light source Intralux 5000-1 
halogen lamp; Volpi, Schlieren, Switzerland). The expression of bioluminescence was 
determined in a dark box and documented with a light-sensitive camera (Hamamatsu 
Photonics, Herrsching, Germany).  
The quantity of AHL molecules was measured by detecting the reporter activity of sensor 
plasmids grown in wells of microtitre plates (FluoroNunc Polysorp microtiter plate (Nunc, 
Roskilde, Danmark). To analyse promoter binding of CepR2 we performed assays using 
sensor plasmids pJBA89 and pJBA89luxR
-
 respectively, for the detection of AHL production 
characterizing the RsaM protein we employed sensor pAS-C8 (see below). In all cases, GFP-
expression was analysed by determining the relative fluorescence units (RFU) using a 
microtiter reader (Synergy HT; Bio-Tek, Bad Friedrichshall, Germany) with excitation 
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wavelength of 485 nm and detection of emission at 528 nm. In all assays background 
fluorescence (sensor strain with LB-medium) was subtracted and data were plotted as relative 
fluorescent units (RFU). 
 
2.4.2.3 Analyses employing reporter strains pJBA89 and pJBA89luxR- 
Overnight cultures of E. coli MT102 harboring plasmid pJBA89 or pJBA89luxR
-
 were 
subcultured in 50 ml LB-medium in the presence or absence of plasmid pJTR2 (2.1.1) 
containing appropriate antibiotics to an OD600 of 0.1. At an OD600 of 1.5, cells were 
distributed in 200 μl aliquots into wells of a microtiter plate as described above. The wells 
contained no HSL or C14-HSL, 3-oxo-C12-HSL, C12-HSL, 3-oxo-C10-HSL, C10-HSL, 3-
oxo-C8-HSL, C8-HSL, 3-oxo-C6-HSL, C6-HSL, or C4-HSL at final concentrations of 1500, 
750, 375, 187.5, 93.8, 46.9, and 23.4 nM. After incubation of the plates at 30°C for 6 h, the 
green fluorescence of the sensor strains was measured as stated above. 
 
2.4.2.4 Analyses of AHL production throughout the growth curve 
For the characterization of RsaM overnight cultures of strains were washed and resuspended 
in 200 µl LB-medium to an OD600 of 0.05. Cells of exponentially-phase-grown Pseudomonas 
putida F117 (pAS-C8) were added obtaining final volumes of 300 µl. Samples were 
transferred to wells of microtitre dishes and incubated for 48h hours at 30°C. Expression of 
GFP was measured every hour and data were plotted as described above.   
 
2.4.2.5 Extraction of AHL molecules and detection by thin layer chromatography  
Acyl-homoserine lactone (AHL) molecules were extracted from supernatants of 100 ml 
overnight grown bacterial cultures in LB-medium. Briefly, cell cultures were centrifuged 
(5000 rpm, 20 min, 4°C), supernatants were acidified with 1 M HCL to yield pH 2.0 and 
transferred to a separating funnel. AHL molecules were extracted twice from organic phases 
by the addition of each 50 ml dichloromethane. The removal of remaining water was achieved 
by the addition of dehydrated MgSO4 to the collected dichloromethane extracts. After filtering 
the solution through whatman paper, extracts were dried on a rotary evaporator using vaccum 
and the remainder (ca. 400 µl) was resolved in 200 µl of acidified ethyl acetate. AHL extracts 
were kept at -20°C and analysed by reverse-phase thin layer chromatography (TLC) as 
described in the following: 10 µl of AHL extracts and 1 µl of AHL standards [1 mM]  were 
dropped on RP-TLC plates (RP-18 F254s, 20x20cm, Merck) and compounds were separated 
using a mobile phase with 60% methanol in dH20. The detection of AHL molecules was 
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achieved by overlaying the dried plates with LB soft agar (2.1.2) containing 10 ml of 
exponentially-phase sensor strains (see above). Following an incubation period for 24 - 48h at 
30°C, plates were examined for the extent of reporter activity as previously described.  
 
2.4.3 Detection of extracellular protease activity  
For the detection of extracellular protease production, 5 µl of liquid overnight cultures were 
spotted on milk-agar plates (2.1.2). The plates were then incubated at 37°C for 24 to 48h. 
Proteases activity was determined by measuring the clearing zones surrounding bacterial 
colonies.  
 
2.4.4 Extraction and detection of siderophores  
2.4.4.1 Extraction of pyochelin  
The siderophore pyochelin was extracted from supernatants of bacterial cultures grown in 
succinate medium (2.1.2). For that purpose, overnight cultures were initially incubated in 50 
ml succinate medium to an OD600 of 0.05 and grown with agitation for 40h at 37°C. The cells 
were pelleted (5000 rpm, 20 min, 4°C), the collected supernatant was acidified for the 
stabilization of the siderophore (addition of 1M HCL to yield pH 2.0) and transferred to a 
separating funnel. Pyochelin was extracted with 20 ml of dichloromethane (twice), organic 
phases were collected and exposed to dehydrated MgSO4 in order to remove remaining water. 
Filtered extracts were dried on a rotary evaporator to about 50 - 100 µl, then resuspended in 
100 – 200 µl of methanol. For further concentration pyochelin extracts were dried (speed-vac 
or at 42°C in a heating block) and resuspended in a final volume of 20 µl of methanol. 
Pyochelin extracts were stored at -20°C and later on analysed employing CAS plates or by 
thin layer chromatography (2.4.4.3).  
 
2.4.4.2 Extraction of ornibaction 
Ornibactin was extracted from supernatants of 50 ml bacterial cultures grown in succinate 
medium as described for the extraction of pyochelin except that the culture media were 
amended with ornithine [10 mM L-ornithine dihydrochloride]. The cells were pelleted (5000 
rpm, 20 min, 4°C) and the supernatant acidified for the stabilization of the siderophore as 
described, then transferred to a separating funnel. Ornibactin was extracted with 20 ml of 
dichloromethane (twice) from aquarous phases, which were collected and dried on a rotary 
evaporator to about 50 - 100 µl using vacuum and heating (40°C). Extracts were resuspended 
in 100 – 1000 µl of methanol and transferred to a collection tube (salt precipitations were 
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transferred along). After centrifugation (8000 rpm, 10 min, 4°C) and transfer of the 
supernatant to a new collection tube, the pellet was again resuspended in methanol (200 – 500 
µl) to remove the remaining ornibactin. Samples were again centrifuged (8000 rpm, 10 min, 
4°C), the supernatant was combined with the one collected at the beginning and ornibactin 
extracts were further dried on a rotary evaporator to a final volume of 1 ml. Extracts were 
stored at -20°C and later on analysed using CAS plates or by thin layer chromatography 
(2.4.4.3).  
 
2.4.4.3 Detection of siderophores on CAS plates and by thin layer chromatography  
The production of siderophores was determined employing the chrome azurol S (CAS) assay 
(Schwyn, 1987) with the following modifications: agar was prepared without MM9 buffer 
and contained LB-medium instead of casamino acids as a carbon source. When iron is 
removed from the original CAS-Fe(III) complex during siderophore production blue-to-
orange halos surround bacterial colonies. Formation of halos is then evaluated following 1 or 
2 days of plate incubation at 37°C. The assay was employed for the analysis of siderophores 
produced by bacterial colonies grown on CAS plates or siderophore extracts spotted on the 
agar. In each case, a volume of 5 μl (overnight cultures of bacterial strains grown in LB-
medium or siderophore extracts, see before) was dropped. 
 
CAS-agar plates were made by freshly preparing solution 1 and solution 2 (see below). 10 ml 
of the Fe
3+
-solution were gently added to solution 1, then solution 2 was added to obtain the 
chromazurol S/ Fe
3+
/HDTMA complex (notice a change in colour from red to violet).  For the 
preparation of LB-PIPES, PIPES was first dissolved in dH2O and stired while supplying 
NaOH [10M] until the solution became clear. The remaining components for LB-PIPES (see 
below) were added and the pH of the solution was titrated to pH 6.8. After autoclaving both 
solutions, the chromazurol S/ Fe
3+
/HDTMA complex solution and the LB-PIPES agar, the 
former complex solution was poured into the LB-PIPES agar, shortly mixed and used for the 
preparation of CAS plates.  
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Solution 1 Solution 2 
Chromazurol S  60.5 mg 
ddH2O  ad 50 ml 
 
HDTMA 72.9 mg 
ddH2O  ad 40 ml
 
Fe
3+
-Solution   
FeCl3   1 mM 
HCl 10 mM 
ddH2O ad 100 ml  
 
 
 
LB-PIPES agar 
PIPES (Sigma) 30.24 g 
Bacto tryptone 10.00 g 
Bacto yeast extract   5.00 g 
NaCl   4.00 g 
Agar  12.00g 
ddH2O ad 900 ml 
 
Siderophore extracts were also analysed employing thin layer chromatography (TLC, see J. 
Toller, Master thesis, 2008, for a detailed description). Briefly, 10 - 15 μl of siderophore 
extracts were spotted on TLC silica plates 60 F254 (Merck, Darmstadt, Germany), and 
compounds were separated using a mobile phase with chloroform: acetic acid: ethanol 
(90:5:2.5) (Cox & Graham, 1979, Visca et al., 1992). Salicylic acid (7 μl of a 500 mM stock 
solution) was dropped on the plates as a standard. Plates were analysed under UV light (254 
nm, 366 nm, green filter (Cosmicar Pentax, CCTV Camera Lens). Siderophores were also 
detected by spraying an iron reagent solution (0.1 M FeCl3 in 0.1 M HCl) on the TLC plates 
(Visca et al., 1992). 
 
2.4.5 Analysis of bacterial motility 
The ability to swarm or swim was assayed on swarming or swimming agar plates (see 2.1.2) 
at RT, 30°C and 37°C. The conditions used were those found to be best for the analyses of 
bacterial strains. For H111 these conditions were an incubation period at 30°C for 48h. 
 
2.4.6 Analysis of biofilm formation 
2.4.6.1 Biofilm formation under static conditions in microtitre plates 
Biofilm development in polystyrene microtitre plates (Sarstedt, Newton, USA) was assayed 
as described (O'Toole & Kolter, 1998) and (Huber et al., 2001) after an incubation period of 
48h at 30
o
C. Biofilms were grown in AB media supplemented with either 10 mM citrate or 10 
mM D-glucose (2.1.2). The media was also adjusted to pH 7 with 100 mM phosphate buffer. 
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2.4.6.2 Biofilm formation under dynamic conditions in artificial flow chambers 
To monitor biofilm formation under dynamic conditions, strains were genetically tagged with 
the green fluorescent protein (GFP) encoded on plasmid pBAH8 (2.1.1), and biofilms were 
grown at 30°C in artificial flow-through chambers (see below) supplied with FAB-medium 
containing 1 mM D-glucose (2.1.2).  
 
Set-up and sterilization of the biofilm system 
The system was assembled as previously described (Christensen et al., 1999). Prior 
inoculation of flow chambers with bacteria the channels were sterilised with 0.5% 
hypochloride (at least 3 - 4 h), followed by a washing step with dH20 overnight. The bacterial 
growth medium (FAB-medium supplemented with 1 mM D-glucose, 2.1.2) was then pumped 
at a constant flow rate of 0.2 mm/s with a Watson-Marlow 205S peristaltic pump through the 
system. 
 
Inoculation of flow chambers, growth and analyses of biofilms 
Overnight cultures of bacterial strains (grown in LB-medium) were inoculated in FAB-
medium to an OD600 of 0.1. Approximately 800 µl of this suspension were then injected into 
sterile flow chambers employing a syringe. For the initial attachment of bacteria onto the glas 
slide the flow chambers were inverted and incubated for one hour at RT, then again flipped 
and exposed to a constant medium flow at a rate of 0.5 mm/s using a Watson-Marlow 205S 
peristaltic pump. Biofilms were grown at 30°C and inspected microscopically (12h to 96h) 
with a confocal laser scanning microscope (Leica, DM 5500). Data were analysed with Leica 
Application Suite (Mannheim, Germany) and Imaris software package (Bitplane, 
Switzerland). Images were prepared for publication using Photoshop CS (Adobe). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.  3. System set-up of biofilms (Jan Molin, 2000). 
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2.4.6.3 Visualization of dead bacteria by staining with propidiume iodide 
Dead cells were visualized by cellular staining (20 - 30 min, flow rate as above) with 0.5 μM 
propidium iodide (Fluka, Buchs, Switzerland) in FAB-medium (2.1.2 for propidiume iodide 
stock solutions). Fluorescence was detected by confocal laser scanning microscopy (Leica, 
DM 5500 Q) with laserline 532. 
 
2.4.7 Metabolic profiling employing BIOLOG microarrays 
BIOLOG phenotypic microarray system consists of 96 well microtiter plates containing 
minimal medium supplemented with varying carbon (PM1), nitrogen (PM2), sulfur (PM3) 
and phosphorus sources (PM4). The assay uses a reporter which monitors cell respiration 
reflecting the bacterial growth. If the phenotype is strongly "positive" in a well, the cells 
respire actively and reduce a tetrazolium dye, which results in the development of a strong 
color (blue to violet). If it is weakly positive or negative, respiration is slowed or stopped, and 
less color or no color is visible. The exact formulation of the media is proprietary of 
BIOLOG, Inc. (Hayward, USA), and was moreover described by Bochner and collegues 
(Bochner et al., 2001). Minimal medium used in the study contained 100 mM NaCl, 30 mM 
triethanolamine HCI (pH 7.1), 25 mM sodium pyruvate, 5 mM NH4Cl, 2 mM NaH2PO4, 0.25 
mM Na2SO4, 0.05 mM MgCl2, 1 mM KCl, 1 mM FeCl3, and 0.01% tetrazolium violet.  
The assay was performed following the protocol of BIOLOG, Inc. (see S. Uehlinger, 
Dissertation, 2009) as followed: strains were grown overnight on R2A agar (Becton-
Dickinson) and resuspended in IF-0 inoculation fluid corresponding to the turbidity of the 
85%T turbidity standard (both supplied by the company). After addition of the tetrazolium 
redox dye (supplied by the company), the suspension was distributed in volumes of 100 μl to 
the wells of the microtiter plates. For PM 3 and 4, an extra supplementation with a carbon 
source was required, consisting of 20 mM sodium succinate and of 2 μM ferric citrate. The 
plates were incubated at 37°C for 24 hours and scanned for visual analysis. 
 
2.4.8 Pathogenicity model experiments 
2.4.8.1 The Caenorhabditis elegans infection model  
Caenorhabditis elegans slow-killing assays were performed as described by Koethe and co-
workers (Köthe et al., 2003). In this assay larvae of C. elegans Bristol N2 (nematodes were 
obtained from the Caenorhabditis Genetics Centre, University of Minnesota, USA) are fed on 
bacterial lawns, which results in the bacterial colonization of the intestine followed by 
nematode death over a period of 2 to 3 days. Overnight cultures of bacterial strains were 
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plated on 6-well plates containing NGM II nematode growth medium (51 mM NaCl, 0.35% 
(w/v) bactopeptone, 1.7% agar, (Tan et al., 1999) with supplements (25 mM KPO4 buffer, pH 
6, 1 mM CaCl2, 1 mM MgSO4, 2 μg/ml uracil, 5 μg/ml cholesterol, 50 μg/ml nystatine 
solution). Buffers and stock solutions are listed below. The plates were incubated at 37°C for 
24h. Approximately 20 to 40 hypochlorite-synchronized larvae (see egg preparation) were 
then dropped on bacterial lawns, followed by incubation of the plates at 20°C. Worms were 
counted after an incubation period of 24h, 48h and 72h using a Leica M165FC 
stereomicroscope. C. elegans were cultivated on NGM I nematode growth medium (51 mM 
NaCl, 0.25% (w/v) tryptone, 1.7% (w/v) agar with supplements (see above,(Hope, 1999) at 
20°C with E. coli strain OP50 (2.1.1) as a food source. For the cultivation of C. elegans small 
agar pieces with nematodes were transferred onto fresh E. coli lawns on NGM I plates once a 
week.  
 
Nystatin-solution: 10 mg/ml in 100% ethanol and 7.5 M ammonium acetate 
KPO4 buffer: 0.8 M KH2PO4, 0.2 M K2HPO4, pH 6.0 
M9 buffer: 22 mM KH2PO4, 42 mM Na2HPO4, 85 mM NaCl, 1 mM MgSO4 
 
Cholestrol and Uracil stock solutions: see 2.1.2. NGM I growth medium was filled in Petri 
dishes (5.5 cm in diameter, Greiner, Frickenhausen, Germany), NGM II growth medium was 
poured into 6 well plates (4 ml/well, Greiner, Frickenhausen, Germany). 
 
Egg preparation for the synchronization of C. elegans 
All pathogenicity assays were performed with a synchronized C. elegans population of L4 
stage worms. For that purpose nematode eggs were separated from adult worms using the 
following bleaching method: NGMI-agar plates that contained a large number of eggs were 
rinsed four times with sterile water, and the suspension was distributed (each ca. 1ml) into 
three 2 ml collection tubes. 500 μl of bleaching solution (600 μl sterile MQ water, 500 μl of 
12% sodium hypochlorite, 400 μl 6 M NaOH) was added to each tube and tubes were 
incubated for 8 to ca. 10 min and occassionally inverted. After centrifugation (3200 rpm, 1 
min) pellets were washed with sterile water and the suspension was again centrifuged, and 
pellets were resuspended and combined in a final volume of 100 μl of M9 buffer (22 mM 
KH2PO4, 42 mM Na2HPO4, 85 mM NaCl, 1 mM MgSO4). The eggs were transferred to a 
NGM I-agar plate containing E. coli OP50 and incubated for the development to L4-larvae at 
20°C for 48h. 
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2.4.8.2 Galleria mellonella killing assay 
As an alternative model organism to study the pathogenicity of Burkholderia strains, the 
larvae of the greater wax moth G. mellonella were used. The assay was done as described by 
Uehlinger and collegues (Uehlinger et al., 2009) and (Jander et al., 2000, Seed & Dennis, 
2008). G. mellonella caterpillars in the fifth instar were obtained in fishing equipment stores 
(Brumann, Zürich or Hebeisen, Zürich) and stored at 15°C. They were used no later than 2 to 
3 weeks from the date of purchase. Bacterial overnight cultures grown in LB broth were 
diluted 1:100 in 30 ml of the same medium and cultivated to an optical density at 600 nm 
(OD600) of 0.4 to 0.7 (logarithmic growth phase). Cultures were centrifuged, and pellets were 
resuspended in 10 mM MgSO4 to an OD600 of 1. Four 2-fold dilutions were prepared in 10 
mM MgSO4, resulting in dilutions of OD600 of 0.5, 0.25, 0.125 and 0.0625. To determine the 
CFU per injection volume, serial dilutions were made and aliquots were plated on LB agar. 
Colonies were counted and the number of bacteria was calculated. A 1 ml syringe (BD 
Plastipak, Madrid, Spain) with a 27G x 7/8” needle (Rose GmbH, Trier, Germany) was used 
to inject a 10 μl aliquot into G. mellonella via the hindmost proleg. The injection area was 
previously disinfected with a cotton swab soaked in ethanol. Ten to fourteen healthy, 
randomly chosen larvae were injected per strain and dilution and incubated in Petri dishes (in 
the dark, 30°C). A control injection with 10 μl of 10 mM MgSO4 that contained antibiotics 
that were used to grow bacterial cultures was performed to monitor killing of animals due to 
physical injury or infection by contaminating pathogens. Likewise, the toxicity of an 
antibiotic compound was excluded. The number of dead larvae was scored 24, 48 and 72 h 
after infection. Dead larvae showed discoloration due to melanization and did not display 
movement in response to touch. Experiments with more than one dead larva in the control 
group were not considered and repeated. Experiments were repeated at least three times. 
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3 Results 
3.1 Project I: The Burkholderia cenocepacia H111 quorum sensing regulon: a 
 comparative transcriptomic, proteomic and phenotypic analysis 
This project aimed at the identification of genes and proteins that are regulated by the CepIR 
quorum sensing (QS) system in B. cenocepacia H111. For this purpose, the H111 QS regulon 
was mapped employing a combination of the following approaches: we performed two-color 
microarray analyses, proteome studies employing iTRAQ (isobaric tag for relative and 
absolute quantitation), and experiments using phenotypic microarrays, where the importance 
of QS for the utilization of various substrates was examined. Our investigations led to the 
identification of known and potential virulence factors as well as functions that may  
contribute to bacterial adhesion and biofilm formation.   
 
3.1.1 Mapping the CepR regulon of B. cenocepacia H111 by transcriptomics 
To identify CepR-regulated genes in B. cenocepacia H111 we compared the transcriptome of 
the wild type strain with the one of the cepR mutant H111-R using a custom B. cenocepacia 
oligonucleotide microarray. As a control we included the complemented cepR mutant H111-R 
(pBAH27) in these experiments. Bacterial strains were grown as described (2.2.1) and total 
RNA was extracted when the cultures had reached an OD600 of 2.5 (2.2.9). At this density 
transcription of aidA, a stringently CepR-regulated gene, was found to be maximal (Fig. A1, 
Appendix). Transcriptomic expression trends are as follows: From a starting set of 9622 
genetic elements (CDSs, rRNA, tRNA and intergenetic regions) microarray analysis, using an 
initial filtering with an arbitrary cut-off value of 2-fold ratio change, revealed 156 genetic 
elements down- and 60 elements up-regulated in the transcriptome of H111-R, whereas 
transcript levels of 236 genetic elements were down- and 185 elements up-regulated in the 
transcriptome of H111-R (cepR
+
), respectively (see Table A1 and A2, Appendix). For a more 
detailed analysis the most stringently CepR-activated genes, i.e. those 48 genes which 
exhibited a ≥3-fold reduction in transcript levels in the H111-R transcriptome, were chosen 
(Table 5). The transcriptome of strain H111-R (cepR
+
) and the proteomes of mutant H111-R 
and H111-I were subsequently examined for the differential expression of these genes or 
proteins (Table 5). In fact, complementation of H111-R with cepR on plasmid pBAH27 
rescued expression of genes in the mutant strain in most cases (Table 5 and Table A2). 
Notably, several of the CepR-activated genes were found to be even more strongly expressed 
in the complemented cepR mutant than in the wild type, probably due to the increased copy 
number of cepR. Some of these up-regulated genes were only slightly down-regulated in the 
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cepR mutant H111-R (Table 5 and Table A1/A2), suggesting that expression of these genes 
may be maximal at another time point during growth. Alternatively, activation of these genes 
may be the result of unspecific binding of CepR to operator sequences.  
Several of the CepR-activated genes appear to be organized in operons, as they are transcribed 
in the same orientation and show similar levels of regulation. We therefore also visualized 
potential QS-activated operons that were identified in this study and report cep boxes that 
have been identified within promoter regions of these genes (Fig. 6).  
 
3.1.2 Identification of QS-regulated proteins in B. cenocepacia H111 
To confirm and extend our transcriptome analysis we compared the proteome of the wild type 
with the one of mutant H111-R and the proteomes of mutant H111-I grown in the presence or 
absence of 200 nM C8-HSL. Extracellular (EC) and whole cell (WC) protein fractions were 
extracted from cultures grown to an OD600 of 3.0, a culture density, at which AidA was 
maximally expressed as previously identified by Western blotting (data not shown). Only 
those proteins, which were identified in both of the two independently performed proteome 
analyses, and which were found to be at least 1.5-fold differentially expressed when wild type 
and mutant strains were compared (2.3.6) were considered as QS-regulated (Table A3, 
Appendix). Using iTRAQ coupled with tandem mass-spectrometry (MS/MS, 2.3.6) we 
identified 1257 protein in total, of which 218 proteins (17.3%) were up- and 210 proteins 
(16.7%) down-regulated in either the cepR and/or the cepI mutant relative to the wild type 
strain.  
The proportional quantity of 1.5-fold up- or down-regulated EC or WC proteins in mutant 
H111-R and mutant H111-I is depictured in Fig. 4. Noticeable, the expression of a 
comparatively large number of proteins in the H111-R proteome seems to be up-regulated. As 
most of these proteins were identified in the EC protein fractions (Fig. 4), it might be 
speculated that the observed differences result from cell lysis, which might have occured 
during sample preparation.  
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Fig.  4. Circular chart of QS-
regulated proteins identified in 
two independent iTRAQ 
analyses. Depicted is the quantity 
of proteins identified in the cepR 
mutant H111-R or in the cepI 
mutant H111-I, with an 
unchanged (black background) or 
a more than 1.5-fold up-regulated 
(light grey background) or down-
regulated (dark grey background) 
expression when compared to the 
proteome of the H111 wild type. 
EC: extra-cellular proteins; WC: 
whole cell proteins. Data are 
derived from two independent 
iTRAQ experiments. 
 
3.1.3 Correlation between transcriptomic and proteomic data 
Our study identified 18 genes encoding differentially expressed proteins (≥1.5-fold regulated 
in the proteomes of mutant H111-R and/or H111-I, Table A3, Appendix) which were also 
among the ≥2-fold regulated genes identified in the transcriptome analysis (Table A1/A2).  
Transcriptomic expression trends compared to the quantity of proteins identified by iTRAQ 
are moreover shown in an overlap analyses of 3-fold differentially expressed genes or proteins 
in strains H111-R and H111-R (cepR
+
) (Fig. 5). It must be noted that a direct comparison 
between QS-controlled genes and proteins should probably be taken with caution, since the 
microarray and iTRAQ analyses exhibit method-specific differences in the detection 
sensitivities and in the susceptibility to errors, as for instance the possible occurance of cell 
lysis during the extraction of EC proteins. Employing a cut-off of 3-fold ratio change for the 
proteome data of the cepR mutant, a threshold that was previously used to identify the most 
stringently controlled CepR-regulated genes (Table 5), 34 proteins (2.7%) reveal an up-
regulated, and 13 proteins (1.0%) a reduced expression in the EC and/or WC protein fractions 
of the H111-R proteome (Fig. 5 and Table A3). Overall, we were able to identify an adequate 
proportion of ≥3-fold CepR-regulated genes or proteins of B. cenocepacia H111 employing 
transcriptomics (1.4%) or proteomics (3.7%).  
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Fig.  5. Overlap analysis of 3-fold 
differentially expressed genes and gene 
products. Genes or proteins with a ≥3-fold 
differentially regulated expression in 
comparison to the wild type were identified in 
the transcriptomes (T) of mutant H111-R (light 
grey background) and mutant H111-R (cepR
+
) 
(dark grey background), and in the proteome of 
the cepR mutant (P, EC and WC protein 
fractions). Numbers indicate the number of 
genes/proteins with increased (above the 
horizontal line; I) and decreased (below the 
horizontal line; D) expression. Bold numbers 
represent genes/proteins which were seen ≥3-
fold positively regulated by CepR in the 
transcriptomes of mutant H111-R and H111-R 
(cepR
+
) and in the EC and/or WC fractions of 
the H111-R proteome (see Table 5). 
 
 
3.1.4 The H111 CepR-activated regulon identified by transcriptomics and proteomics  
Genes or proteins, which comprise the H111 CepR-activated regulon, are listed in Table 5. 
They include those 48 genes, whose expression was seen most strongly induced by CepR      
(≥ 3-fold reduction of transcript levels in H111-R). Transcript levels of 32 out of these genes 
were, in turn, increased when cepR was provided in trans and protein amounts of 12 genes 
were also reduced in mutant H111-R or mutant H111-I as identified by iTRAQ analyses. 
Table 5 depicts genes which have been repeatedly reported as QS-controlled, including three 
well characterized virulence factors. These genes are: the zinc metalloproteases ZmpA 
(BCAS0409), (Sokol et al., 2003), (Chambers et al., 2006), (Subsin et al., 2007) and ZmpB 
(BCAM2307), (Riedel et al., 2003), (Kooi et al., 2006) and the protein AidA (BCAS0293), 
(Riedel et al., 2003), (Huber et al., 2004), (Wopperer et al., 2006). While both proteases are 
thought to be important for the infection of mammalian hosts, it was recently shown that 
AidA exerts a high specificity for C. elegans pathogenicity (Uehlinger et al., 2009). Our data 
show that expression of AidA is in fact strongly dependent on an intact CepIR system and 
thus aidA exhibits the greatest changes of transcript levels in the microarray profiling (-167.2-
fold) and its product is the most QS-induced protein in B. cenocepacia H111 (Table A3, 
Appendix).  
Notably, 31 of the 48 listed CepR-induced genes (Table 5) have so far not been associated 
with cell density-dependent expression, even though several attempts have been undertaken to 
identify QS-regulated genes in B. cenocepacia species (for references see Table A1, 
Appendix). Our study identified 14 genes which have also been reported as QS-regulated in a 
recent transcriptome mapping of B. cenocepacia K56-2 using the same custom 
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oligonucleotide microarrays (O'Grady et al., 2009), (Table 5, indicated by bold type). B. 
cenocepacia QS-regulated genes, which were identified in this study but have not been 
described so far include the cable pilus associated adhesin protein bapA (BCAM2143) and the 
downstream genes BCAM2142-40, and fimA (BCAL1677) plus the adjacent genes 
BCAL1678-BCAL1681 (Table 5). Three more gene clusters seem to be under QS control as 
indicated by our transcriptomic and proteomic profiling (Table 5 and Fig. 6). They comprise 
the functionally unknown gene BCAL0834, the putative beta-lactamase BCAM0393, the 
LysR family regulatory protein BCAL3178, the putative D-lactate dehydrogenase 
BCAL3179, as well as BCAM2308, encoding a putative leucyl aminopeptidase precursor, 
located downstream of the QS-regulated gene zmpB (Kooi et al., 2006). To our knowledge, 
the expression of these genes has not previously been reported to be QS-regulated, indicating 
strain specific differences of the CepIR regulons of Bcc species. Other genes with a ≥3-fold 
decrease in expression levels which are unique for strain H111 include BCAL0121, 
BCAL0510, BCAL1813, BCAL1921, BCAL3285, BCAM0028 and BCAM0030, 
BCAM0835, BCAM2684, BCAM2720, BCAS0236 and BCAS0498 (Table 5, Table A1). 
  
Gene no. 
a
 Description  Transcriptome 
b
 Proteome 
c
 
(EC and WC proteins)  
  Fold change  
  H111-R H111-R 
(cepR
+
) 
H111-R and/or 
H111-I 
BCAL0121 aquaporin Z   -3.3 *      –      – 
BCAL0358 metallo peptidase, family M1   -4.7     2.5      ↓ 
BCAL0510 conserved hypothetical protein   -5.7      –      – 
BCAL0831 putative storage protein   -3.2     2.3      ↓ 
BCAL0833 putative Acetoacetyl-CoA reductase   -3.0     4.6      – 
BCAL1677 putative type-1 fimbrial protein   -8.7       –      ↓ 
BCAL1678 putative outer membrane usher protein precursor   -6.4       –      – 
BCAL1679 putative fimbrial chaperone   -5.5       –      – 
BCAL1680 putative type-1 fimbrial protein   -6.2       –      – 
BCAL1681 putative exported protein   -8.6       –      – 
BCAL1813 multidrug efflux system outer membrane protein   -5.3 *     4.1 *      – 
BCAL1921 conserved hypothetical protein   -3.5       –      – 
BCAL3178 LysR family regulatory protein   -5.0 *       –      ↓ 
BCAL3179 probable D-lactate dehydrogenase   -3.4 *      2.6      – 
BCAL3285 Flavohemoprotein -25.8       –      – 
BCAM0028 putative FHA-domain protein   -5.1       –      – 
BCAM0030 conserved hypothetical protein    -3.1      4.2 *      – 
BCAM0184 BclC lectin    -5.1 *      3.3      ↓ 
BCAM0185 BclB lectin    -3.3 *       –      – 
BCAM0186 BclA lectin    -9.0      5.1 *      ↓ 
BCAM0188 N-acylhomoserine lactone dependent regulatory    -4.1 *      4.5 *      – 
BCAM0189 AraC family regulatory protein    -3.9      2.4      – 
BCAM0190 putative aminotransferase – class III   -22.1 *      6.0      – 
BCAM0191 putative non-ribosomal peptide synthetase   -12.8 *      3.5 *      – 
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BCAM0192 conserved hypothetical protein   -46.8 *      6.2      – 
BCAM0193 conserved hypothetical protein   -47.7 *      6.8      –  
BCAM0194 conserved hypothetical protein   -52.2 *      8.4      – 
BCAM0195 putative non-ribosomal peptide synthetase   -34.0 *      6.9 *      – 
BCAM0196 conserved hypothetical protein   -37.7 *      6.3 *      – 
BCAM0200 efflux system transport protein     -9.2 *    15.0 *      – 
BCAM0392 putative acetyltransferase     -3.8 *      3.9 *      – 
BCAM0393 putative beta-lactamase, class D     -4.1 *      5.6 *      – 
BCAM0835 AraC family regulatory protein     -4.3      3.5      – 
BCAM1869 conserved hypothetical protein      -6.1 *       –      – 
BCAM1870 N-acylhomoserine lactone synthase CepI   -27.0 *       –      – 
BCAM1871 conserved hypothetical protein   -32.5 *      2.3      – 
BCAM2140 transporter system transport protein     -3.1 *      2.4      – 
BCAM2141 ABC transporter ATP-binding membrane protein     -4.4 *       –      – 
BCAM2142 transport system outer membrane protein     -5.3 *       –      – 
BCAM2143 cable pilus associated adhesin protein     -5.1 *      2.6      ↓ 
BCAM2307 zinc metalloprotease ZmpB     -8.7 *      6.8      ↓ 
BCAM2308 putative leucyl aminopeptidase precursor     -5.3 *      5.7      ↓ 
BCAM2720 putative phospholipase C     -4.4     -2.3      – 
BCAS0236 putative haemagglutinin-related autotransporter     -5.4     -2.1      – 
BCAS0292 conserved hypothetical protein -138.1 *      7.8 *      ↓ 
BCAS0293 nematocidal protein AidA -167.2 *    24.0 *      ↓ 
BCAS0409 zinc metalloprotease ZmpA     -4.4      3.5      ↓ 
BCAS0498 muconate cycloisomerase I 2     -4.9     -2.4      – 
Table 5. CepR-induced genes and proteins. Listed are genes and ORFs (nomenclature according to Holden et 
al. (2009); a), whose expression is at least 3-fold reduced in the B. cenocepacia H111-R transcriptome relative  
to the wild type; b. Some genes are also found to be overexpressed in the complemented mutant H111-R (cepR
+
). 
A corresponding decrease in extracellular (EC) or whole cell (WC) proteins in the H111-R and H111-I proteome 
is indicated by an arrow (c, see Table A3, Appendix, for iTRAQ data). P-values (<0.05) of significantly 
regulated genes are indicated by an asterisk. B. cenocepacia K56-2 QS-regulated genes which were identified in 
a previous study are displayed in bold type (O'Grady et al., 2009). QS-regulated factors of Bcc species which 
were identified by alternative methods are highlighted in grey (see Table A1 for references). 
 
The CepIR system is autoregulated in that CepR positively regulates the expression of the 
cepI gene (Lewenza et al., 1999) and accordingly the transcript levels of cepI were found to 
be reduced in mutant strain H111-R (Table 5, Fig. 6). Interestingly, transcription of the 
adjacent genes BCAM1869 (-6.1-fold) and BCAM1871 (-32.5-fold) was also diminished in 
the H111-R mutant. This result is in full agreement with the study of O‟Grady and colleagues 
(O'Grady et al., 2009). Both genes BCAM1869 and BCAM1871 are conserved among Bcc 
species but their functions remain to be elucidated (Winsor et al., 2008). 
Other genes, whose expression was found to be stimulated by CepR in both B. cenocepacia 
strains H111 (≥ 2-fold reduced transcript levels in H111-R) and K56-2 (O'Grady et al., 2009), 
(see Table A1/A2, Appendix, genes in bold type) include the cold shock-like protein CspA 
(BCAL3006), the chitinase BCAL1722 (Huber et al., 2001), (-2.1-fold reduced in the H111-R 
transcriptome) and the putative lipoprotein BCAL1520 (-2.0-fold reduced in the H111-R 
transcriptome). Interestingly, transcript levels of shvR (BCAS0225), encoding a regulator 
involved in a switch from rought to shiny colony morphology (O'Grady et al., 2009), were 
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also deminished in strain H111-R (-2.4-fold). However, in contrast to the study by O‟Grady 
and colleagues, we did not observe any QS regulation of the genes located in the vicinity of 
shvR (Table A1). Among other interesting CepR-regulated genes that were identified in the 
transcriptome analysis were BCAM2340 and BCAM2338, encoding proteins with a potential 
function in the synthesis of rhamnolipids (Table A1).  
Remarkably, the transcription of genes encoding QS-controlled proteins identified by iTRAQ 
was in many cases not differentially regulated as seen in the microarray profiling (Table A3, 
Appendix). It is therefore reasonable to assume that at least some of these proteins are 
modulated at the posttranscriptional level by QS circuitry, as it was suggested in a previous 
study on the P. aeruginosa QS-regulated proteome (Arevalo-Ferro C & K, 2003).    
 
 
 
Fig.  6. Predicted QS-regulated operons in B. cenocepacia H111. Arrows indicate the direction of 
transcription and fold change-values (H111-R transcriptome) are indicated below individual genes. Genes in 
light grey were differentially expressed as seen in the microarray data, the expression of genes in dark grey was 
observed to be under QS control in both transcriptome and proteome analyses. Numbers refer to B. cenocepacia 
J2315 annotated genes (Holden et al., 2009). Previously described cep boxes were reported to be present 
upstream of BCAL0831 and BCAM1868 (Chambers et al., 2006), BCAM1870 
(CCCTGTAAGAGTTACCAGTT, Huber et al., 2001), BCAM0189 (Malott et al., 2009) and BCAS0293 (Huber 
et al., 2004).   
 
The following three QS-activated loci (see Table 5 and Fig. 6) were further characterized in 
this work: the orphan LuxR homologous transcriptional regulator CepR2 (BCAM0188, see 
3.2), the BclACB lectins (BCAM0184-186, see 3.3), and BCAM1869, a protein of unknown 
function (see 3.4). As previous work has demonstrated that biofilm formation of B. 
cenocepacia H111 is regulated by a cell density-dependent expression (Huber et al., 2001), 
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our intention was also to identify QS-regulated factors that would potentially link QS and 
biofilm formation. Here, we focused on analysing the contribution of the BclACB proteins to 
the development of bacterial biofilms (see 3.3). 
 
3.1.5 Overexpression of CepR leads to reduced expression of motility-associated genes 
Previously, we observed that transcription of some of the CepR-regulated genes was only 
slightly altered in mutant H111-R but greatly affected in the cepR complemented strain H111-
R (cepR
+
). For that reason, we hypothesized that gene expression in B. cenocepacia H111 
might be dependend on the cellular amount of the CepR protein. This regulatory trend 
becomes apparent when analysing the expression changes of motility-associated genes: 
transcript levels of 39 genes encoding proteins involved in flagellar biosynthesis, assembly or 
chemotaxis were down-regulated in strain H111-R (cepR
+
) (Table A2, Appendix). By 
contrast, transcription of only one of these genes, flhD (BCAL0124), which encodes the 
flagellar master regulator was differentially expressed in the transcriptome of mutant H111-R 
(2.2-fold up-regulated, Table A1).  
The investigation of swimming motility of the H111 wild type and QS mutant strains revealed 
a negative effect of the CepIR system (Fig. 7).  
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Fig.  7. Swimming activity of B. cenocepacia H111 wild type, mutants and complemented strains. (A) 
Bacterial cells of the wild type (wt), the cepR mutant H111-R, the cepI mutant H111-I and the cepR 
complemented strain H111-R (cepR
+
) were spotted on AB minimal medium solidified with 0.2% agar and 
supplemented with 10 mM sodium citrate and 0.1% casamino acids (2.1.2). Swimming motility of the H111-I 
mutant was also examined in the presence of 0.2 µM N-octanoyl-homoserine lactone (C8-HSL). (B) 
Quantification of swimming motility was analysed after 48h of incubation at 30°C by measurement of 
swimming zones (2.4.5). Values are ± the standard error of the mean of n = 4. 
H111 wt H111-R H111-I H111-R (cepR
+
) H111-I [0.2 µM C8-HSL] A 
B 
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The differences in swimming motility were most evident when the behaviour of the wild type 
was compared with the one of mutant H111-R (strain H111-R exhibited about 20% increased 
swimming, Fig. 7). An impact of QS regulation on the expression of flagellar genes has also 
been observed in B. cenocepacia strain K56-2 (O´Grady et al., 2009).  
 
3.1.6 QS appears to only slightly affect B. cenocepacia H111 metabolism 
The majority of the identified QS-regulated genes are involved in bacterial motility, adhesion, 
iron acquisition or the production of known or potential virulence factors (Table 5 and Table 
A1, Appendix). We wondered if the bacteria primarily utilise QS to trigger the expression of 
pathogenic traits or if cell-to-cell communication also affects primary metabolism of B. 
cenocepacia H111. To analyse the importance of QS for the utilization of nutrients we 
performed a metabolic profiling of the H111 wild type strain, mutant H111-R, and the 
complemented mutant H111-R (cepR
+
) employing BIOLOG phenotypic microarrays (Fig. 
A2, Appendix, 2.4.7). The utilization of various carbon sources (PM1 and PM2), nitrogen 
(PM 3) and phosphorus and sulfur sources (PM 4), only showed minor differences: the mutant 
utilized L-threonine, D-arabinose, sorbic acid, D-glucosamine, thymine, thymidine, uracil, 
methylene diphosphonic acid and p-amino-benzene sulfonic acid better than the wild type  
(Table 6 and Fig. A2, Appendix). The most dramatic example was sorbic acid carbon source, 
since it could only be utilized by mutant H111-R but not the wild type. It is important to note 
that we did not detect any growth differences between the H111 wild type, mutant H111-R 
and the complemented cepR mutant when the strains were grown in LB-medium for the 
transcriptomic and proteomic investigations.  
To validate the results obtained from the metabolic profiling the designated strains were also 
grown in liquid cultures or on agar plates (48h, 37°C) consisting of minimal medium (M9 
minimal medium, (Johnson et al., 2008) or mineral salt medium, (Lindhardt TJ, 1989) (2.1.2), 
which was amended with selected C-sources including amongst others 10 mM citrate, 
butanol, catechol, L-threonine, L-histidine and D-arabinose. However, and in contrast with 
the results obtained with the BIOLOG plates, growth differences were only observed when 
the strains were grown in mineral salt medium with D-arabinose as C-source (Fig. A3, 
Appendix). It should be noted that these observations were made with strains grown on agar 
plates and it might be speculated that not only the bacterial growth but the production of 
extracellular polymeric substances (EPS) is affected by the presence of D-arabinose under 
these conditions (Fig. A3). Taken together, these results imply that QS does only marginally 
affect primary metabolism of B. cenocepacia H111. The observation that QS seems to have a 
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negative impact on bacterial growth might have been caused by the metabolic burden when 
QS induced concertedly many cellular functions. 
 
Microarray Substrate Growth 
  H111 wt H111-R H111-R (cepR
+
) 
PM1 (Carbon) L-Threonine + +++ + 
PM2 (Carbon) D-Arabinose + +++ - 
 Sorbic acid - + - 
PM3 (Nitrogen) D-Glucosamine + +++ + 
 Thymine ++ +++ ++ 
 Thymidine ++ +++ ++ 
 Uracil ++ +++ ++ 
PM4 (Phosphorus  
and Sulfur) 
Methylene 
diphosphonic acid 
- ++ + 
P-Amino-benzene 
sulfonic acid 
- +++ +++ 
Table 6. Growth differences between the H111 wild type (wt), the cepR mutant H111-R and the 
complemented mutant H111-R (cepR
+
). BIOLOG phenotypical microtitre plates comprising different substrate 
components (2.4.7) were inoculated with bacterial suspensions in minimal medium. Plates were incubated at 
37°C for 24h and bacterial growth was visually detected upon a blue colour development of the solution (Fig. 
A2, Appendix). 
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3.2 Project II: The role of the orphan LuxR homologue CepR2 in the transcriptional 
regulation of H111 genes and its effect on the quorum sensing circuitry  
Previous work has identified the B. cenocepacia CepR homologous protein CepR2, which due 
to the absence of a chromosomal-encoded proximal LuxI-like protein is a member of the so-
called orphan LuxR transcriptional regulators (A. Steidle, diploma thesis, TU Munich, 1999). 
CepR2 consists of 237 amino acids with a predicted molecular mass of 26,046 Da. The 
protein shares about 38% amino acid sequence identity with the Ralstonia solanacearum SolR 
protein (accession no. AAC45947) and the Vibrio fischeri LuxR regulator (AAQ90231), and 
36% sequence identity with the B. cenocepacia CepR transcriptional regulator (AAD12726). 
As visualized by the alignment of deduced amino acid sequences (Fig. 8), CepR2 possesses 
all features which are characteristic for LuxR-response regulators: a helix-turn-helix DNA 
binding motif, the seven among LuxR proteins conserved amino acid residues, and a 
postulated AHL-binding domain (Fuqua et al., 1994, Malott et al., 2009). 
 
 
Fig.  8. Amino acid sequence alignment of CepR2 with LuxR-type transcriptional regulators. Aligned are 
deduced amino acid sequences of the B. cenocepacia H111 CepR2 protein with the H111 CepR transcriptional 
regulator, Ralstonia solanacearum SolR and LuxR of Vibrio fischeri with * (identical amino acids), : (conserved 
amino acids), . (weakly conserved amino acids). Amino acids which are conserved among LuxR family proteins 
are marked by grey backgrounds. Regions that constitute the postulated AHL-binding domain are indicated by a 
bold line, and amino acids comprising the helix-turn-helix DNA binding motif are surrounded by a box (Fuqua 
et al., 1994, Malott et al., 2009).  
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3.2.1 Construction and characterization of a cepR2 mutant in H111  
The impact of CepR2 on B. cenocepacia gene expression was examined by the functional 
characterization of a H111 cepR2 insertion mutant. The mutant strain, referred to as H111-R2, 
was constructed via single cross-over recombination events, and the interruption of cepR2 was 
analysed by southern blot hybridization (Fig. 9A, 2.2.2.2). Complementation studies with 
CepR2 were achieved employing plasmid pJTR2, which encodes the H111 cepR2 gene on 
plasmid backbone pBBR1MCS (2.2.5). To exclude an effect of CepR on the functioning of 
CepR2 when providing cepR2 in trans, we also inactivated the cepR2 gene in the cepR mutant 
H111-R, generating the double mutant H111-R/R2 (Fig. 9B). Several experiments were 
conducted to phenotypically characterize mutant H111-R2, including investigations on the 
production of extracellular proteases, swarming motility, and biofilm formation. Moreover, 
we examined the degree of antibiotic resistances in mutant H111-R2, the production of AHL 
signal molecules, its pathogenic potential in the C. elegans infection model, and the 
production of siderophores (see J. Toller, Master thesis, University of Zurich, 2008). The 
results obtained in these analyses strongly suggest that CepR2 functions as a regulator of 
pyochelin production.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig.  9. Interruption of the B. 
cenocepacia cepR2 gene via single 
cross-over recombination events. 
(A) CepR2 was mutated in the H111 
wild type generating mutant H111-R2 
and (B) in the cepR mutant generating 
mutant H111-R/R2. Mutations were 
generated by employing the  
replacement vector pEX18Gm-cepR2 
(2.1.1). Southern blot analyis 
(2.2.2.1) showed the hybridization of 
a DIG-labelled polynucleotide sonde 
to BamHI-digested chromosomal 
DNA of the wild type and mutants, 
precisely to the unmodified cepR2 
encoding DNA fragment (2, 1287 bp) 
and to the plasmid interrupted 
BamHI-digested cepR2 fragments (3, 
6808 bp and 4, 688 bp). 
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3.2.2 CepR2 is involved in the production of pyochelin in B. cenocepacia H111 
Burkholderia species produce up to four different siderophores: salicyl acid, cepabactin, 
ornibactin and pyochelin  (Sokol, 1986), of which pyochelin and ornibactin are detectable on 
CAS plates (Schwyn, 1987). Whereas mutant H111-R2 was indistinguishable from the parent 
strain in most of the tested phenotypes, we discovered that the production of siderophores, 
precisely pyochelin, was greatly influenced by CepR2. When the B. cenocepacia strains were 
tested on CAS plates, no significant siderophore activity was observed with mutants H111-
R2, the cepR mutant H111-R, and the double mutant H111-R/R2 (Fig. 10). The presence of 
cepR2 on plasmid pJTR2 by contrast greatly stimulated the synthesis of iron-chelators to a 
degree that was well above the level of production observed in the parent strain. When cepR 
was provided in trans on plasmid pBBR-cepR (2.2.1), the mutant phenotype of H111-R, but 
not the one of H111-R2 or H111-R/R2, was rescued. These data indicate that the production 
of at least one siderophore is CepR2-regulated and suggest a regulatory cascade in which 
CepR is required for the expression of CepR2 in B. cenocepacia H111.  
 
Fig.  10. CAS activity of B. cenocepacia 
strains. Siderophore activity of the H111 
wild type (wt), the cepR mutant H111-R, 
the cepR2 mutant H111-R2, and the cepR 
cepR2 double mutant H111-R/R2, as well 
as activities of cepR or cepR2 
complemented mutants were analyszed on 
CAS plates.  Plates were incubated for 2 
days at 37°C. B. cenocepacia strain K56-2 
was included as a control and is unable to 
produce pyochelin as a result of a point 
mutation in the pyochelin synthetase gene 
pchF (BCAM2228), (Holden et al., 2009).  
 
To determine the contribution of pyochelin and ornibactin to the overall siderophore activity 
seen on CAS plates, supernatants of cultures grown in succinate medium were extracted with 
dichloromethane (2.4.4), and the organic and aqueous fractions were spotted on CAS plates 
(Fig. 11). Analyses of the organic fractions revealed that H111 produced only minute amounts 
of pyochelin under these conditions (Fig. 11A). Likewise, extracts of H111-R, H111-R2, or 
H111-R/R2 cultures showed no activity, and complementation of the mutant strains with cepR 
did not stimulate pyochelin production. Complementation with cepR2 resulted in strong 
overproduction of pyochelin in all three mutants, indicating that CepR2 is a major regulator of 
pyochelin biosynthesis. Analysis of the aqueous fractions showed that CepR2 has no 
influence on ornibactin production (Fig. 11B). However, we observed that inactivation of 
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cepR stimulated ornibactin synthesis and that complementation of the mutants with cepR 
repressed ornibactin production. These results are in full agreement with previous work 
demonstrating that the CepIR system is a negative regulator of ornibactin biosynthesis in B. 
cenocepacia K56-2 (Lewenza & Sokol, 2001).  
 
 
Fig.  11. Production of pyochelin (A) and ornibactin (B) in B. cenocepacia strains. Siderophore production is 
shown for the H111 parent (wt), the cepR mutant H111-R, the cepR2 mutant H111-R2, and the cepR cepR2 
double mutant H111-R/R2, as well as for cepR or cepR2 complemented strains. Supernatants of cultures grown 
in minimal medium were extracted with dichloromethane, and the organic and aqueous fractions were analysed 
separately on CAS plates (2.4.4). Extracts of supernatants of B. cenocepacia H111 and B. cenocepacia K56-2 
were included as controls.  
 
To further analyse the role of CepR2 in the regulation of pyochelin biosynthesis, the 
promotorless lacZ gene was fused to the promoter regions of pchR (BCAM2231, encoding an 
AraC family transcriptional regulator of pyochelin production) and pchD (BCAM2232, the 
first gene in the pyochelin biosynthesis gene cluster, 2.2.8). In LB-medium no -galactosidase 
activity was detected examining the pchD promoter construct (Fig. 12B) while fusion PpchR-
lacZ showed high activity in the early growth phase in both H111 wild type and H111-R (Fig. 
12A). Consistent with our data on pyochelin production, the PpchR-lacZ fusion did not show 
any activity in H111-R2. In succinate minimal medium both promoters were active in the 
H111 parent (Fig. 12C and D). As it was in LB-medium, expression of the PpchR-lacZ fusion 
was dramatically decreased in the cepR2 mutant, while the activity of fusion PpchD-lacZ was 
slightly reduced in mutant H111-R2. These data support a model in which CepR negatively 
regulates expression of ornibactin biosynthesis genes and positively regulates expression of 
cepR2, which in turn is required for full expression of pyochelin biosynthesis genes. 
 
  
A B 
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Fig.  12. CepR2 controls the activity of the pchR promoter. (A and C) Activities of the pchR (BCAM2231) 
promoter driving expression of the pyochelin gene cluster (BCAM2231 to BCAM2221) and (B and D) of the 
pchD promoter (BAM2232) driving expression of the pyochelin biosynthesis operon (BCAM2232 to 
BCAM2235) were determined using LB-medium (A and B) and succinate medium (C and D). Growth (open 
symbols) and -galactosidase activities (filled symbols) were monitored throughout the growth curve as 
measured by absorbance at 600 nm (OD600). The transcriptional fusions were analysed in the H111 parent 
(squares), the cepR mutant H111-R (triangles), and in the cepR2 mutant H111-R2 (circles). Values are means ± 
standard deviations (n = 3). 
 
3.2.3 CepR2 – an AHL-independent transcriptional regulator 
While examining siderophore activities in strain H111, we observed that the production of 
pyochelin by the cepR mutant and the cepR cepR2 double mutant was restored by 
complementation with cepR2 (Fig. 10 and Fig. 11A). As neither of these mutants produces 
AHL molecules, we hypothesized that CepR2 may not require signal molecules for its 
activity. To test this hypothesis, plasmid pJTR2 (2.2.1) was transferred into E. coli MT102 
harbouring the green fluorescent protein gfp-based AHL sensor plasmid pJBA89 (Fig. 13A 
and 2.4.2.1). To rule out the possibility that the luxR gene encoded on pJBA89 influences the 
activity of CepR2, luxR was moreover deleted generating plasmid pJBA89luxR
-
 (Fig. 13B - D 
and 2.4.2.3). The reporter activity of all strains was determined in LB-medium (2.4.2.3).  
C D 
 
A B 
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Fig.  13. Deletion of luxR from plasmid pJBA89 by partial digestion with HindIII. (A) DNA was extracted 
from plasmid pJBA89, plasmid map after (Andersen et al., 2001, Winson et al., 1998). (B) The EcoRI-linearized 
DNA was partially digested with restriction enzyme HindIII, then separated by agarose gel electrophoreses for 
the preparative analyses. Generation of plasmid pJBA89luxR
-
 (2.2.6, deletion of a 703 bp-fragment containing 
luxR) was verified by digestion with restriction enzymes EcoRI and HindIII (C) and HindIII (D) of plasmid 
DNA extracted from pJBA89 (1) and pJBA89luxR
-
 (2).  
 
As shown in Fig. 14A, plasmid pJBA89 is based on the genetic elements of the LuxIR QS 
system of Vibrio fischeri and thus is most sensitive to 3-oxo-C6-HSL, but it is also responsive 
(with decreased sensitivity) to various related AHL molecules. In the presence of cepR2 
(pJTR2, 2.2.1), the GFP expression of the sensor plasmid was strongly induced, and addition 
of AHL signal molecules did not further increase the fluorescence (Fig. 14C). Plasmid 
pJBA89luxR
-
 could, as expected, not be activated by the external addition of AHL molecules 
(Fig. 14B). However, when plasmid pJTR2 was provided in trans, GFP expression was 
strongly stimulated independent of the presence or absence of AHL molecules (Fig. 14D). 
Taken together, these results strongly suggest that CepR2 acts as a transcriptional activator in 
an AHL-independent manner.  
NotI pJBA89
 
~ 5900 bp 
 
pMB1ori 
luxR 
bla 
HindIII 
HindIII 
EcoRI NotI 
T1 
gfp (ASV) 
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Fig.  14. CepR2 activates a PluxI-gfp transcriptional fusion in an AHL-independent manner. The GFP 
expression (RFU, relative fluorescence units) of the AHL biosensor E. coli MT102 (pJBA89) (A and C) and its 
luxR deletion derivative E. coli MT102 (pJBA89luxR
-
) (B and D) was measured in the absence (A and B) and in 
the presence (C and D) of plasmid pJTR2. Measurements were also obtained in the absence or presence of 
various amounts of different AHL signal molecules (2.4.2.3), (Malott et al., 2009). 
 
As the sensor plasmid contains a lux box operator sequence that is similar but not identical to 
the cep box sequence of B. cenocepacia (Lewenza et al., 1999) we also analysed the effect of 
CepR2 on the transcription of the H111 cepI gene. For this purpose we determined the 
activities of the promoter fusion PcepI-lacZ (2.2.8) in an E. coli background while 
simultaneously providing cepR2 on plasmid pAH1B.1 (2.2.1). The activities were very low (1 
Miller Unit) independent of whether cepR2 was present in trans, moreover, the addition of 
200 nM C8-HSL to the medium did not affect transcriptional activities (data not shown). 
These observations indicate that CepR2 does not recognize the cep box sequence upstream of 
cepI but may bind a somewhat different operator sequence that is more similar to a lux box 
sequence. Since we observed that the transcription of the pyochelin regulator pchR is 
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dependent on CepR2 (Fig. 12), we also measured the activity of promoter fusion PpchR-lacZ in 
E. coli in the presence or absence of cepR2 as before. Here, we observed an approximately 
threefold C8-HSL-independent induction of -galactosidase activities when cepR2 was 
present, however, promoter activities were very low (1.3 ± 0.6 and 5.2 ± 1.9 Miller units in 
the absence and presence of cepR2, respectively). Given the strong effect of CepR2 on the 
transcription of pchR in H111, it might be speculated that either additional host factors are 
required for full activation of the promoter, or that CepR2 controls the expression of a 
downstream regulator, which stimulates pchR transcription. The fact that the inspection of 
putative pchR promoter regions did not reveal any obvious lux or cep box-like sequences may 
favour the latter possibility. 
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3.3 Project III: Characterization of the BclACB lectins of B. cenocepacia H111, 
examination of their expression, subcellular localization and their role in biofilm 
formation 
The following section describes the characterization of the B. cenocepacia H111 lectin-
deficient mutant H111-bclACB including the impact of the BclACB proteins on the structural 
development of biofilms. Moreover, in this chapter data are presented demonstrating that 
transcription of the bclACB operon is QS-regulated. It is also shown, that expression of lectin 
BclB is growth phase-dependent and the subcellular localization of lectin BclB by 
immunofluorescence labelling experiments is investigated.  
  
3.3.1 BclACB lectins are required for biofilm structural development 
To understand the impact of the BclACB lectins on cellular functions in B. cenocepacia 
H111, a lectin-deficient mutant, named H111-bclACB, was constructed. This mutant was 
generated by allelic replacement of the H111 lectin-encoding operon bclACB (BCAM0186 -
BCAM0184, Fig. 15 and Fig. 20) using a modified protocol of the Gateway cloning 
technology (2.2.4.2), (Carlier et al., 2009). Allelic replacement was achieved employing 
plasmid pAUC40-bcl, which contains a kanamycin cassette embraced by flanking regions of 
the bclACB genes (Fig. 15A). Positive clones were analysed by PCR as illustrated in Fig. 15B 
and the deletion of the lectin-encoding genes was additionally verified by Western 
immunoblot analyses (see 3.3.4). 
The Bcl proteins are homologues of the Pseudomonas aeruginosa fucose-binding lectin PA-
IIL, also referred to as LecB (Lameignere et al. 2008). PA-IIL-family proteins are thought to 
play important roles in processes that require cell adhesion, host recognition or defence 
mechanisms (Tielker et al., 2001, Sudakevitz et al., 2002, Zinger-Yosovich et al., 2006, 
Imberty et al., 2005, Imberty and Varrot 2008). For the characterization of mutant H111-
bclACB we therefore focused on phenotypes that most probably require the attachment of the 
bacteria. These phenotypes included the ability to swim and swarm (2.4.5), the formation of 
biofilms under both static and dynamic conditions (2.4.6) and the potential to cause infection 
in the nematode C. elegans or the greater wax moth Galleria mellonella (2.4.8). As described 
in the following paragraph, mutant H111-bclACB exhibited differences when compared to the 
wild type in the structural development of biofilms in flow-through cells and in regard to its 
pathogenic potential in the nematode C. elegans (see 3.3.2). However, the deletion of bclACB 
did neither affect the ability of the bacteria to swim or swarm, nor to cause disease in G. 
mellonella (data not shown).  
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Fig.  15. Generation of the lectin deletion mutant H111-bclACB. The bclACB genes were deleted using a gene 
replacement procedure as shown. (A) Primers used are (2.1.3): kanDnFwd (a), kanUpRev (b), lecDn-GW (c), 
lecDn-kan (d), lecB2-up (e), lecB2-dn (f) lecUp-kan (g), lecUp-GW (h) and lecB4P (i) with M (DNA marker, 
2.2.2). (B) Deletion of bclACB was verified by PCR employing primers used in A and chromosomal DNA of the 
H111 wild type (wt) and H111-bclACB mutant clones 7 (7) and 24 (24). 
 
We were unable to detect significant differences in biofilm formation between the H111 wild 
type and mutant H111-bclACB when strains were inoculated from overnight cultures in 
polystyrene microtitre-dishes and grown for 48h at 30°C (Fig. 16A, 2.4.6). This observation 
was independent of whether the AB minimal medium used in this experiment was 
supplemented with 10 mM sodium citrate or 10 mM D-glucose. In contrast, the cepR mutant 
H111-R, which was included in these experiments as a control, was defective in biofilm 
formation under both conditions. In some assays we observed that the bclACB mutant was 
slightly impaired in its ability to develop biofilms when strains were incubated for shorter 
time periods at 30 °C (12h or 24h). These observations suggested that the Bcl proteins might 
affect the early stages of biofilm formation. To test this hypothesis, overnight cultures of 
bacteria were inoculated to an optical density (OD600) of 0.2 into wells of microtitre-dishes, 
B 
A 
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which were then placed at 30°C for a period of 6h (Huber et al., 2002). Interestingly, under 
these conditions, the biofilm mass was decreased by about 20% in mutant H111-bclACB in 
comparison to the wild type (Fig. 16B). These differences were, however, only observed 
when strains were grown in AB minimal medium supplemented with 10 mM sodium citrate 
and not in medium amended with glucose. As described in section 3.3.3, transcription of the 
bclACB operon was found to be induced by the transcriptional regulator CepR2. For that 
reason we also included the cepR2 mutant H111-R2 in these experiments. Notably, similar to 
the observation made with the H111 bcl mutant, mutation of cepR2 did not affect the  
development of biofilms in microtitre-dishes when cells were adjusted from overnight 
cultures to an OD600 of 0.01 and incubated for a period of 48h (Malott et al., 2009). However, 
when cells were adjusted to an OD600 of 0.2 and grown for 6h at 30°C in AB medium 
supplemented with citrate, strain H111-R2 showed a reduction of approximately 30% in 
biofilm mass relative to the wild type, similar to what was observed with mutant H111-
bclACB (Fig. 16B).  
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Fig.  16. Biofilm formation of B. cenocepacia H111 wild type and mutants in polystyrene microtitre-dishes. 
(A) B. cenocepacia wild type (wt), the cepR mutant H111-R, mutant H111-bclACB, H111-bclACB mutant clone 
7 (H111-bclACB_7), and the cepR2 mutant H111-R2 were grown in buffered AB minimal media (pH 7) 
supplemented with 10 mM sodium citrate (dark grey bars) or 10 mM D-glucose (light grey bars). Cells were 
adjusted from overnight cultures to an OD600 of 0.01 and incubated for 48h at 30°C in wells of polystyrene 
microtitre-dishes or, (B) for the analyses of initial attachment, to an OD600 of 0.2 followed by an incubation 
period of 6h at 30°C. After the incubation planktonic cells were removed and attached cells were stained with 
crystal violet (2.4.6.1). Error bars represent the standard error of the mean of six independent wells.  
B
A 
A
A 
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We also analysed the development of biofilms of mutant H111-bclACB in flow-through cells, 
which allows the visualization of biofilm development and the determination of biofilm 
structures (Christensen et al., 1999). For that purpose, the wild type and mutant strain were 
genetically tagged with the green fluorescent protein (GFP) and biofilm development was 
investigated over 96 hours. As depicted in Fig. 17A, cells of the wild type usually attach to 
the surface and proliferate to form characteristic irregularly shaped microcolonies, thereafter 
the void space between the microcolonies becomes colonized to cover the entire substratum 
eventually (Huber et al., 2002). As depicted in Fig. 17B, we observed significant differences 
in cell-attachment and biofilm structure that were unique for the lectin-deficient mutant H111-
bclACB: the mutant was impaired in the initial colonization of the glas surface but then the 
cells aggregated into comparatively tall microcolonies, which were visible already 24h post 
inoculum (Fig. 4B). The colonies then developed into hollow volcano-like structures, in 
which the inner region remained uncolonized. These structures, which were most evident after 
72h of biofilm development, then often converged at the upper part to form cupola-like 
structures whereas others remained open.   
 
 
 
 
Fig.  17. Biofilm structures of the B. cenocepacia H111 wild type and mutant H111-bclACB. (A) Flow 
chambers were inoculated with gfp-tagged derivatives of the H111 wild type and (B) lectin mutant H111-
bclACB. Biofilms were grown in buffered AB minimal medium (pH 7) supplemented with 10 mM D-glucose 
(2.4.6.2). CLSM pictures were taken at 24h, 48h and 72h post-inoculation.   
24h 48h 72h 
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Notably, in aged biofilms of the H111 wild type (incubation periods of 96h or later) we also 
observed the appearance of hollows but these were generally smaller in size. Staining with 
propidium iodide (2.4.6.3) moreover indicated that these hollows are the result of localized 
cell death (Fig. 18A), as it has been previously described for aged P. aeruginosa biofilms 
(Webb et al., 2003), (Ma et al., 2009). In contrast to an aged wild type biofilm the hollows 
observed in a H111-bclACB biofilm did not contain dead cells (Fig. 18B), suggesting that the 
formation of these structures is the result of an altered cellular aggregation behaviour of the 
strain rather than a consequence of cell death. 
 
 
Fig.  18. Hollow colonies in mutant H111-bclACB are not due to cell death. (A) To visualize bacterial death 
within biofilms, gfp-tagged cells of the B. cenocepacia H111 parent and mutant H111-bclACB were stained with 
propidium iodide (2.4.6.3). The arrow indicates dead cells visible in the inner part of microcolonies formed by 
the H111 wild type at 96h post-inoculation. (B) Hollow microcolonies were observed already at 48h of biofilm 
development in the bcl mutant however no cell death was detected in the inner part of the microcolonies after 
staining with propidium iodide. 
 
3.3.2 The Bcl orthologues are required for virulence in a C. elegans infection model 
Many persistant and chronic infections are intrinsically linked to the ability of a pathogen to 
form biofilms (Davies, 2003). Moreover, lectins have been recognized as domains of bacterial 
toxins (Imberty et al., 2005). For these reasons, we tested the pathogenicity of lectin mutant 
H111-bclACB using the nematode Caenorhabditis elegans and the larvae of the greater wax 
moth Galleria mellonella as infection hosts (2.4.8). When tested in the C. elegans infection 
model (Fig. 19), mutant H111-bclACB showed a modest but significant attenuation (p < 0.05; 
n = 8), indicating that the lectins may contribute to the strong nematode pathogenicity of 
strain H111 (Köthe et al., 2003), (Uehlinger et al., 2009). By contrast, no differences between 
the wild type strain and the lectin mutant were observed when determining the pathogenic 
potential in the G. melonella infection model (data not shown). 
A 
20 μm 
B 
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Fig.  19. Killing of nematodes is reduced in B. 
cenocepacia mutant H111-bclACB in comparison 
to the wild type. Caenorhabditis elegans slow-
killing assays were performed with the H111 wild 
type (black bars), mutant H111-R (light-shaded 
bars) and mutant H111-bclACB (dark-shaded bars) 
after an incubation of 48h and 72h. Error bars 
represent the standard error of the mean of n = 8. 
The asterisk indicates significant differences when 
compared to the wild type (Student‟s t-test, p < 
0.05). 
 
 
3.3.3 Expression of the bclACB operon is CepR-induced and dependent on CepR2 
Both the transcriptome and the proteome analyses revealed that the expression of the lectin-
encoding operon, comprising genes bclA (BCAM0186), bclC (BCAM0185) and bclB 
(BCAM0184), is QS-regulated (see 3.1 and Fig. 20). Transcript levels of bclA were -9.0-fold 
reduced in the cepR mutant and transcript levels of bclC and bclB were -3.3-fold and -5.1-fold 
reduced in mutant H111-R. Moreover, protein levels of BclA and BclB were diminished in 
the whole cell fractions of the H111-R and H111-I proteomes (see 3.1 Fig. 6 and Table A3, 
Appendix), and amounts of BclA were decreased in the extracellular protein fractions of both 
mutant strains (Table A3). In support of our findings, H111 BclC has been previously 
identified as a cep-regulated homologue of PA-IIL family proteins (Riedel et al., 2003). 
Because of the observed similarity in the extent of QS regulation, and due to the fact that we 
did not identify promoter regions upstream of genes bclC or bclB, it seems most likely that 
the three lectins comprise a co-transcribed unit, which, in this study, is referred to as the 
bclACB operon. 
 
 
 
Fig.  20. Organisation of the bclACB genes on B. cenocepacia chromosome 2. The potential lectin operon 
bclACB comprises genes bclA (390 bp), bclC (819 bp) and bclB (735 bp). The orphan LuxR homologue CepR2 
(BCAM0188, see 3.2) is encoded downstream of the bclACB operon. A potential cep box motif 
(CTGTTCAAAAGGACAGTT, black box) has been identified within potential promoter regions of the araC 
gene. 
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The sequence inspection of the putative promoter regions of bclA (we examined genome 
sequences of B. cenocepacia J2315 and H111) did not reveal the presence of any obvious lux 
or cep box like elements which are typically found within promoter sequences of cep-
regulated genes, as for instance cepI or aidA (Huber et al., 2001, Huber et al., 2004, Fig. 6). 
The QS-dependent transcription of the bclACB genes was therefore confirmed by performing 
ß-galactosidase assays (2.4.1). Transcriptional activities of the bclA gene (promoter fusion 
PbclA-lacZ, 2.2.8) were determined in the wild type, the cepR mutant H111-R and in 
backgrounds of the cepR2 mutant H111-R2, as the proximal gene location of cepR2 and bclA 
(Fig. 20) suggested an impact of CepR2 on bclA expression. As depicted in Fig. 21, mutations 
in cepR and cepR2 similarly affected PbclA-lacZ activities, leading to reduction of about half of 
the transcriptional activity that was determined in the wild type. These results strongly 
suggest that bclA transcription is dependent on the CepR protein and its homologue 
transcriptional regulator CepR2. The observations moreover favour our model in which CepR 
is required for the expression of CepR2, which in turn acts as a transcriptional regulator of 
gene expression via the binding to yet undefined operator sequences at promoter regions (3.2), 
(Malott et al., 2009). However, as PbclA-lacZ activities are not completely lost in the absence 
of the downstream regulator CepR2, it seems likely that the transcription of bclA is regulated 
in conjunction with other yet unidentified genetic elements in B. cenocepacia H111.  
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Fig.  21. Transcription of bclA is 
induced by CepR and CepR2. A trans-
criptional fusion of the bclA gene (PbclA-
lacZ) was assayed for ß-galactosidase 
activities in the B. cenocepacia H111 
parent (open rectangles), the cepR mutant 
H111-R (closed triangles), and the cepR2 
mutant H111-R2 (closed circles) 
throughout the growth curve. Growth of 
the H111 wild type (dashed line) is 
reflected by measurement of absorbance 
at 600 nm (OD600). Strains were grown in 
LB-medium and values are means ± 
standard error of the mean (n = 3). 
 
3.3.4 Analyses of BclB expression by Western immunoblotting 
The QS-dependent expression of the Bcl proteins was also revealed by Western immunoblot 
analysis using polyclonal antibodies raised against the purified BclB protein (BCAM0184 or 
BC2L-B, Fig. 20). As expected (Fig. 22A), amounts of BclB were absent in fractions of 
whole cell proteins extracted from lectin mutant H111-bclACB and the cepR mutant H111-R. 
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Protein levels could be restored when cepR was provided in trans. The microarray profiling 
(see 3.1) and the analysis of promoter activites of bclA suggested a positive impact of the 
transcriptional regulator CepR2 on the expression of BclACB. For that reason we also 
analysed the amounts of BclB in extracts of whole cell proteins belonging to mutant H111-
R2. However, and in contrast to our expectations, BclB amounts were not diminished in the 
cepR2 mutant strain in comparison to wild type (Fig. 22A). Interestingly, the cellular presence 
of BclB seemed to be restricted to a short period within the stationary-phase of growth, since 
BclB amounts were greatly reduced in the whole cell protein fractions of cultures that were 
grown overnight (OD600 >4) (Fig. 22A). Lectin BclB was also identified in the H111 
extracellular protein fractions (Fig. 22B) which were extracted from corresponding culture 
supernatants that were used for the whole cell analyses (2.3.1). Here, BclB levels were also 
reduced in extracellular protein extracts belonging to cultures of late-stationary phases. For 
that reason it seems unlikely that the decrease in BclB amounts observed when analysing 
whole cell proteins of an OD600 >4 occurred because of a cell lysis.  
 
 
 
Fig.  22. QS-dependent expression of lectin BclB. Depicted is a Western immunoblot analyses of the B. 
cenocepacia H111 wild type (wt), lectin mutant H111-bclACB, the cepR mutant H111-R, the cepR2 mutant 
H111-R2, and the cepR complemented strain H111-R (cepR
+
) using polyclonal antibodies directed against the 
purified BclB protein. BclB was detected employing fractions of whole cell proteins (A) or extracellular proteins 
(B) extracted from culture supernatants of samples in A (2.3.1). Strains were grown in LB-medium and samples 
of 50 ml volumes were taken at different cellular densities over a period of 24h as determined by absorbance at 
600 nm (OD600). In all cases, equal amounts of proteins were loaded, as visualized by Coomassie-blue staining of 
proteins separated on a 15% SDS-PAGE (C) (2.3.2). Proteins loaded on the gel were extracted from cultures of 
OD600 2.5 and >4 of whole cells belonging to the wild type (1,2), mutant H111-bclACB (3,4), mutant H111-R 
(5,6), the complemented mutant H111-R (cepR
+
) (7,8) and mutant H111-R2 (9,10), and of H111 wild type 
extracellular protein fractions (11,12). The QS-dependent expression of AidA (indicated by an arrow) served as a 
control.   
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3.3.5 Lectin BclB is associated with the bacterial surface 
Recent work has described the protein structures of B. cenocepacia lectins BclA (Lameignere 
et al., 2008, Lameignere et al., 2010) and BclC (Sulak et al., 2010), as well as their binding 
affinity to carbohydrate ligands. The subcellular localization of the Bcl orthologues has, 
however, not been studied in detail. The finding that the lectin-deficient strain H111-bclACB 
was impaired in the structural development of biofilms prompted us to determine the surface-
associated localization of the Bcl proteins. For this purpose, we performed 
immunofluorescence labelling reactions where we used Alexa Fluor
® 
594-conjugated 
antibodies raised against the purified H111 BclB protein (see 2.3.5). Samples of the B. 
cenocepacia H111 wild type which were tagged with the gfp-expressing plasmid pBAH8 
(2.2.1), were taken from liquid cultures at an OD600 of 2.5 (a cell density at which BclB was 
seen to be well expressed, Fig. 22). One part of the cells was subsequently fixed with para-
formaldehyde, washed, and incubated with the labelled antibodies (2.3.5). The remaining cells 
were first exposed to triton to permealize cell membranes (2.3.5), then washed, fixed and 
labelled as before. This step was used as a control to enable antibody binding to intracellular 
BclB. The lectin-deficient mutant H111-bclACB was also included as a control and cells from 
two independent experiments were analysed. As determined by confocal laser scanning 
microscopy, we observed that cells of the H111 parent strain were red fluorescent (Fig. 23A), 
whereas lectin-deficient H111-bclACB cells did not emit red light (Fig. 23B). Samples of 
H111 (pBAH8) which were treated with triton showed more red fluorescence than those that 
were not treated with the detergent. Due to the overlap of the GFP signal with the signal 
generated by the Alexa Fluor
® 
dye, cells of the H111 wild type appeared yellow, whereas 
those cells of mutant H111-bclACB were only green fluorescent. These results suggest that 
BclB is associated with the bacterial cell surface. The fluorescence seemed to be equally 
distributed over the cell surface, implying that BclB is not localized at a particular site on the 
H111 cell membrane.  
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Fig.  23. Binding of Alexa Fluor® 594-conjugated BclB antibodies to the cell surface of GFP-fluorescent B. 
cenocepacia H111. The B. cenocepacia H111 wild type strain (A) and the lectin-deficient mutant H111-bclACB 
(B) were tagged with the gfp-expressing plasmid pBAH8 and grown in LB-medium to an OD600 of 2.5, a cell 
density at which BclB expression was found to be maximal. Cells were fixed and incubated with Alexa Fluor® 
594-labelled antibodies directed against lectin BclB (2.3.5). Samples were analysed by determining the emission 
of green (left images) or red (middle images) fluorescence by confocal laser scanning microscopy. The overlay 
of green and red fluorescence is depicted in the images to the right. 
A B 
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3.4 Project IV: Characterization of the RsaM regulator  
A previous screening of a B. cenocepacia H111 transposon library for mutants defective in C. 
elegans pathogenicity led to the identification of mutant R26. Strain R26 not only exhibited a 
reduced virulence but also produced increased amounts of AHL molecules. It was determined 
that the miniTn5-transposon had inserted in the intergenetic region between ORFs of cepR 
and cepI, 9 bp upstream of the annotated ORF BCAM1869 (Fig. 24), (Wopperer, 2008, 
Dissertation, University of Zurich). BCAM1869, designated rsaM (see 4.1.1, Discussion), is 
predicted to encode a protein of unknown function. To investigate the function of RsaM in the 
QS circuitry and in virulence of B. cenocepacia H111 a series of experiments were 
performed. Mutant R26 was initially characterized by phenotypic investigations including the 
analysis of the following QS-regulated functions: swarming motility, biofilm formation in 
polystyrene microtitre plates, the production of extracellular proteases and siderophores, 
pathogenicity in C. elegans and the qualitative detection of AHL molecules via cross-
streaking. Subsequently, the transcriptome of mutant R26 was determined using two-color 
microarrays. To exclude any polar effects of the transposon insertion on the expression of 
cepR, a defined rsaM deletion mutant, named H111-rsaM, was constructed and  subjected to 
the same phenotypic characterization as strain R26. Complementation assays were performed 
employing plasmid pBBRrsaM, containing a wild type rsaM allele and, as a control, plasmid 
pBBRrsaM_FS encoding the rsaM gene with a frameshift in the DNA sequence (2.2.5). To 
determine if RsaM affects the expression or the activity of the transcriptional regulators CepR 
or CepR2 (see Project II, 3.2), mutants R26 and H111-rsaM were also complemented with 
plasmid pBBR-cepR harbouring the H111 cepR gene as well as with plasmid pJTR2 carrying 
the H111 cepR2 gene (2.2.5).  
 
3.4.1 RsaM affects the QS circuitry and encodes a protein of unknown function 
As depicted in Fig. 24, the H111 rsaM gene (BCAM1869, 444 bp) is divergently transcribed 
from cepR and orientated in the same direction as the cepI gene. The two putative starting 
methionine codons of CepR and RsaM are separated by 73 bp. BCAM1869 is conserved 
among Bcc species and is present in other proteobacteria as Pseudomonas fuscovaginae or 
Thiomonas sp., where it is in all cases located upstream of an AHL synthase-encoding gene 
(see 4.1.1, Discussion). The function of RsaM is not known, and was also not predictable by 
the inspection of RsaM or RsaM homologues for conserved domains in current protein 
databases (2.2.3). The analysis of the H111-R transcriptome (3.1, Table 5 and Fig. 6) revealed 
that transcript levels of rsaM were reduced (-6.1-fold) in the cepR mutant, indicating that 
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transcription of rsaM is induced by the CepIR system. These findings are in agreement with 
the identification of a putative cep box located upstream of a -35-consensus sequence in the 
rsaM promoter (Fig. 24). The close vicinity of the rsaM promoter elements to the predicted 
translational start site led us to question if the annotated ORF does in fact encode a protein, 
even though sequence analysis of rsaM did not predict any secondary structure motifs, as it is 
characteristic for sRNAs. The observation that plasmid pBBRrsaM carrying a wild type rsaM 
gene, but not plasmid pBBRrsaM_FS which encodes a frameshift-mutated rsaM sequence 
(2.2.5) was able to restore mutant phenotypes (3.4.3), suggests that rsaM encodes a functional 
protein. Since sequence inspection (2.2.3) of RsaM did not reveal a DNA-binding domain, the 
possibility that RsaM might function as a transcriptional regulator of genes was excluded. 
 
 
Fig.  24. Genetic organisation of the Burkholderia 
cenocepacia cepR (BCAM1868), rsaM (BCAM1869) 
and cepI (BCAM1870) genes. DNA sequences of cep 
boxes located within promoter regions of cepI, and 
within intergenetic regions of cepR and rsaM are 
GCTGTCATACTTGTCAGGT (1) and 
CCTGTCAAATTTATCAGTT (2). 
 
 
3.4.2 Phenotypic characterization and transcriptome analyses of mutant R26 
Characterization of transposon insertion mutant R26 
To determine if RsaM is involved in QS regulation, mutant R26 was analysed with respect to 
several QS-regulated phenotypes. Two observations appeared most striking: Firstly, the 
various CepR-activated functions, as shown in Table 8 (3.4.3), were negatively affected so 
that R26 displayed in many cases a behaviour similar but not identical to that of the cepR 
mutant H111-R. Secondly, R26 activated the AHL reporter strains Chromobacterium 
violaceum CV026 and Pseudomonas putida F117 (pAS-C8) (2.4.2.1) to greater extents than 
the wild type (Fig. 30, 3.4.3), suggesting that R26 produces increased levels of AHL 
molecules. 
The decline of the above specified CepR-induced functions in strain R26 led to the 
speculation that transcription of cepR might be diminished, possibly due to polar effects of the 
inserted transposon. This assumption was found to be, at least partly, true, since mutant R26 
could successfully be complemented with cepR in trans with regard to the production of 
proteases and pathogenicity in C. elegans (Fig. 27 and Fig. 28, 3.4.3). To understand the 
extent to which the behaviour of R26 is triggered by the inactivation of rsaM or rather results 
BCAM1868 70 69 
rsaM cepI cepR 
1 2 
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from an impaired transcription of cepR, we analysed the transcriptome of transposon insertion 
mutant R26 and compared it with the one of mutant H111-R (Wopperer, 2008, Dissertation).  
 
The R26 transcriptome suggests QS-dependent expression of genes  
The transcriptome analysis of transposon insertion mutant R26 was assayed employing two-
color microarrays analogous to previously described methods, and is presented in detail in the 
thesis of Wopperer et al. (Wopperer, 2008). Genes and ORFs whose expression was ≥3-fold 
reduced in mutant R26 as compared to wild type are depicted below (Table 7).  
 
Gene no. a Description 
a
 Fold  
change
 b 
BCAS0292 conserved hypothetical protein  -105.9 * 
BCAM2232 putative pyochelin biosynthetic 
protein PchD  
-101.6 * 
BCAS0293 nematocidal protein AidA    -96.8 * 
BCAM2233 putative pyochelin biosynthetic 
protein PchC  
  -94.5 * 
BCAM0194 conserved hypothetical protein    -79.8 * 
BCAM0193 conserved hypothetical protein    -70.8 * 
BCAM0192 conserved hypothetical protein    -64.3 * 
BCAM2234 putative pyochelin biosynthetic 
protein PchB  
  -54.9 * 
BCAM0196 conserved hypothetical protein    -47.2 * 
BCAM2224 putative pyochelin receptor FptA    -45.0 * 
BCAM2235 putative pyochelin biosynthetic 
protein PchA  
  -36.1 * 
BCAL3285 flavohemoprotein    -33.1 * 
BCAM0195 putative non-ribosomal peptide 
synthetase  
  -28.5 * 
BCAM0190 put. aminotransferase - class III    -22.3 * 
BCAM2230 dihydroaeruginoic acid 
synthetase PchE  
  -22.1 * 
BCAM0191 put. non-ribosomal peptide 
synthetase  
  -11.3 * 
BCAM0186 BclA lectin    -10.7 * 
BCAM2223 putative iron uptake protein    -10.3 * 
BCAM0811 putative aromatic oxygenase    -10.1 
BCAL3178 LysR family regulatory protein      -9.6 * 
BCAM0028 putative FHA-domain protein      -9.2 * 
BCAM2222 putative membrane protein      -9.0 * 
BCAM2684 putative acetyltransferase      -9.0 
BCAM0810 putative aromatic oxygenase      -9.0 
BCAM0189 AraC family regulatory protein      -8.9  
BCAS0409 zinc metalloprotease ZmpA     -8.9 
BCAM1869 conserved hypothetical protein      -8.7 * 
BCAM2307 zinc metalloprotease ZmpB      -8.6 * 
BCAL1677 putative type-1 fimbrial protein      -8.6  
BCAM2685 conserved hypothetical protein      -8.6 
BCAM2227 
putative pyochelin biosynthetic 
protein PchG  
    -8.5 * 
BCAM0200 efflux system transport protein      -6.9 * 
BCAL2246 histidine ammonia-lyase      -6.3 
BCAL1681 putative exported protein      -6.1  
BCAM2142 
transport system outer membrane 
protein  
    -5.8 * 
BCAL1678 
putative outer membrane usher 
protein precursor  
    -5.7  
BCAL1813 
multidrug efflux system outer 
membrane protein  
    -5.6 * 
BCAM0166 NADH dehydrogenase      -5.5 
BCAM0695 putative lipoprotein      -5.4 * 
BCAM2226 ABC transporter ATP-binding      -5.3 * 
BCAM0188 
N-acylhomoserine lactone 
dependent regulatory  
    -5.2 * 
BCAM0476 hypothetical protein      -5.2 * 
BCAL1731 
Major Facilitator Superfamily 
protein  
    -5.1 
BCAS0236 
putative haemagglutinin-related 
autotransporter  
    -5.0 
BCAL1680 putative type-1 fimbrial protein      -4.8 
BCAM1745 putative Mg-transporting ATPase     -4.8 
BCAS0498 muconate cycloisomerase I 2     -4.7 
BCAS0154 conserved hypothetical protein     -4.6 
BCAM1927 putative exported protein      -4.5 
BCAM1871 conserved hypothetical protein      -4.5 * 
BCAM2141 ABC transporter  protein      -4.5 * 
BCAL0510 conserved hypothetical protein      -4.4 
BCAS0613 AraC family regulatory protein      -4.3 * 
BCAM0950 lipase chaperone      -4.3 
BCAL0660 biotin carboxylase      -4.1 
BCAL0659 allophanate hydrolase subunit 1     -4.1 
BCAL2244 urocanate hydratase      -4.1 
BCAL2353 putative sulfate transporter      -4.0 * 
BCAL2791 putative kynureninase      -3.9 
BCAL0358 metallo peptidase, family M1     -3.9 
BCAM2720 putative phospholipase C      -3.9 
BCAL3179 probable D-lactate 
dehydrogenase  
    -3.8 * 
BCAM1811 conserved hypothetical protein      -3.8 * 
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BCAL2451 putative membrane protein      -3.8 
BCAM2514 putative fatty aldehyde 
dehydrogenase  
    -3.8 *  
BCAM1713 putative ionic antiporter      -3.8 
BCAM0634 hypothetical protein      -3.8 
BCAL2450 putative metal transporter      -3.8 * 
BCAM0805 muconate cycloisomerase I 1     -3.7 
BCAL0852 conserved hypothetical protein      -3.7 * 
BCAL2241 putative hlorohydrolase      -3.7 
BCAM0030 conserved hypothetical protein      -3.7 
BCAM1870 N-acylhomoserine lactone 
synthase CepI  
    -3.7* 
BCAS0155 conserved hypothetical protein      -3.6 
BCAM1413 conserved hypothetical protein      -3.6 
BCAM0185 BclC lectin      -3.5 * 
BCAM0184 BclB lectin      -3.5 * 
BCAL1249 putative PHB depolymerase      -3.5 * 
BCAM0392 putative acetyltransferase      -3.4 * 
BCAL1921 conserved hypothetical protein      -3.4  
BCAL2243 conserved hypothetical protein      -3.4 
BCAM2153 putative cytochrome P450 
oxidoreductase  
    -3.4 
BCAL0744 Appr-1-p processing enzyme 
family protein  
    -3.4 * 
BCAL0831 putative storage protein      -3.4 
BCAM2215 putative copper resistance protein 
C precursor  
    -3.4 
BCAM0491 TonB-dependent receptor      -3.3 
BCAM1706 putative membrane protein      -3.3 * 
BCAM1005 putative acyltransferase      -3.3 
BCAM2429 3 putative lipoprotein     -3.3 * 
BCAL3187 putative oxidoreductase      -3.3 
BCAL1752 conserved hypothetical protein      -3.2 
BCAL0661 putative biotin-binding protein      -3.2 
BCAL0552 allophanate hydrolase subunit 1     -3.2 
BCAL1524 putative lipoprotein      -3.2 
BCAS0636 conserved hypothetical protein      -3.2 
BCAL2980 putative oxygenase      -3.2 
BCAL0121 aquaporin Z      -3.2 
BCAM2308 putative leucyl aminopeptidase 
precursor  
    -3.2 
BCAM2231 transcriptional regulator PchR      -3.2 
BCAM2444 putative exported protein       -3.1 
BCAL2734 conserved hypothetical protein      -3.1 
BCAL0662 LamB/YcsF family protein      -3.1 
BCAM2055 type III secretion system protein      -3.1 
BCAL0431 conserved hypothetical protein      -3.1 
BCAM1554 putative diguanylate cyclase      -3.1 
BCAM0633 conserved hypothetical protein      -3.0 
BCAL1268 dihydropteroate synthase      -3.0 
BCAL2245 putative histidine utilization 
repressor  
    -3.0 
BCAM0804 catechol 1,2-dioxygenase 1     -3.0 
BCAM0393 putative beta-lactamase, class D      -3.0 
BCAM2216 putative exported protein      -3.0 
BCAL3136 bis(5'-nucleosyl)-
tetraphosphatase, symmetrical  
    -3.0 
BCAM2143 cable pilus associated adhesin 
protein  
    -3.0 
BCAL0343 conserved hypothetical protein      -3.0 
BCAM2062 conserved hypothetical protein      -3.0 
BCAL1753 LysR family regulatory protein      -3.0 
BCAM2482 agmatinase      -3.0 
BCAM2426 putative diguanylate 
phosphodiesterase  
    -3.0 
Table 7. Differentially regulated genes and ORFs in the transposon insertion mutant R26. Listed are genes 
(nomenclature according to Holden et al. (2009); a), whose expression is at least 3-fold reduced in the R26 
transcriptome as compared to wild type; b. Genes and ORFs which were also seen regulated by CepR in a 
previous transcriptome analysis (3.1) are highlighted in grey. P-values (<0.05) of significantly regulated genes 
are indicated by an asterisk.  
 
Notably, the transcription of 61 of the 118 listed genes (highlighted in grey) has previously 
been shown to be induced by CepR (Table A1 and A2, Appendix). These findings are in 
agreement with the observation that transcript levels of cepR (BCAM1868) are reduced in the 
R26 transcriptome (-2.8-fold) (Wopperer, 2008). Importantly, as transcript levels of cepI 
(BCAM1870) are only marginally decreased in the R26 transcriptome (-3.7-fold) relative to 
the expression changes that were observed in the transcriptome of the cepR mutant H111-R   
(-28-fold), it remains unclear to which extent the transcription of cepR is affected in mutant 
R26. The fact that both phenotypes of R26 the ability to cause infection in C. elegans, and the 
production of extracellular proteases could be rescued by providing cepR in trans, supports 
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the hypothesis that expression or activity of CepR is diminished in mutant R26 (Fig. 27 and 
Fig. 28, 3.4.3).  
The R26 transcriptome comprises highly regulated genes which were not identified in the 
H111-R transcriptome, indicating that transcription of these genes may be regulated by RsaM 
(Table 7), (Wopperer, 2008). These genes include amongst others: BCAM2232-35 encoding 
pyochelin biosyntheses genes, BCAM2224 encoding a putative pyochelin receptor protein 
FptA, and BCAM2230 encoding the dihydroaeruginoic acid synthetase PchE.  
 
3.4.3 Phenotypic characterization of mutant H111-rsaM and complementation  
To unambiguously investigate the role of RsaM in global gene regulation in B. cenocepacia 
H111, a defined rsaM deletion mutant was constructed. This mutant, as well as the transposon 
insertion mutant R26, was compared with the H111 wild type strain. Complementation of 
both mutants with rsaM was achieved employing plasmid pBBRrsaM (2.2.8). To determine if 
RsaM influences the expression or activity of CepR or CepR2, mutants were complemented 
with the respective wild type genes (2.2.1). The expression of the investigated phenotypic 
traits was compared with the behaviour of the wild type as summarized below (Table 8). 
Phenotypic trait  H111-R R26 H111-rsaM 
Swarming motility 
a)
 -  -  - -  -   -   
Biofilm formation 
b)
 -  -  - -  -   -   
Protease production 
c)
 -  -  - -  -   -   
Pathogenicity in C. elegans 
d)
 -  -  - -  -   / (-) 
Siderophore production 
e)    
 
 
-  -  - -  -   -  
Production of C8-HSL/ C6-HSL 
f)
 -  -  - + + 
Table 8. Expression of QS-activated functions in the H111 mutants H111-R, R26 and H111-rsaM in 
comparison to the wild type. Phenotypic traits of the cepR mutant, mutant R26 and the rsaM mutant H111-
rsaM are reduced (-), increased (+), or unchanged/ marginally reduced (/ (  )), in comparison to the wild type. 
a)
: Swarming mortility was analysed as described in 2.4.5 and illustrated in Fig. 25.  
b)
: Biofilm formation was assayed in polysterol microtitre plates and bacterial strains were grown in AB minimal 
medium supplemented with 10 mM sodium citrate (2.4.6.1 and Fig. 26).  
c)
: The production of extracellular proteases was identified employing milk-agar plates (2.4.3 and Fig. 27). 
d)
: The pathogenic potential was examined employing the C. elegans slow-killing assay (2.4.8.1 and Fig. 28). 
e)
: CAS agar plates were employed for the detection of siderophore activities (2.4.4 and Fig. 29). 
f)
: The production of AHL molecules was analysed via cross-streaking (2.4.2.2 and Fig. 30), by TLC (2.4.2.5 and 
Fig. 35), and along the bacterial growth curves employing AHL sensor strains (2.4.2.1 and Fig. 36).  
 
Mutant H111-rsaM exhibited a reduced swarming motility on AB medium supplemented with 
sodium citrate (Fig. 25), and was impaired in biofilm formation when bacteria were grown in 
polystyrene microtitre plates (Fig. 26). Swarming behaviour of the rsaM mutant could be 
restored when rsaM was provided in trans, and AHL molecules were externally provided. 
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Importantly, the presence of plasmid pBBR-cepR in R26 (data not shown) and mutant H111-
rsaM (Fig. 25) did not restore the motility of the strains, indicating that the effect of RsaM on 
swarming motility is CepR-independent. AHL molecules were added to the medium, because 
rsaM overexpression strongly decreased the production of AHL molecules in H111 (see 
3.4.5). Biofilm formation of mutant H111-rsaM was also rescued in the presence of 
pBBRrsaM. Surprisingly, this was possible without the external addition of AHLs (Fig. 26). 
Given the fact, that the presence of the empty plasmid pBBR1MCS in mutant H111-rsaM also 
resulted in increased biofilm formation (Fig. 26), it seems most likely that the elevated 
biofilm formation of strain H111-rsaM (rsaM
+
) was only triggered by the cloning vector.  
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Fig.  25. Swarming activities of the B. cenocepacia H111 wild type, mutants and complemented strains. 
Bacterial cultures of the wild type (wt), the cepR mutant H111-R, the transposon insertion mutant R26, the rsaM 
mutant H111-rsaM, as well as the cepR and rsaM complemented mutant, were spotted on AB minimal medium 
solidified with 0.4% agar and supplemented with 10 mM sodium citrate and 0.1% casamino acids (2.2.2). The 
motility was determined after incubation of 48h at 30°C (2.4.5). The rsaM complemented strain H111-rsaM 
(rsaM
+
) was also examined in the presence of 0.2 µM N-octanoyl-homoserine lactone (C8-HSL). Error bars are 
values ± the standard error of the mean of n = 4. 
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Fig.  26. Biofilm formation of the B. cenocepacia H111 wild type, QS mutant and complemented strains. 
The B. cenocepacia H111 wild type (wt), the cepR mutant H111-R, the transposon insertion mutant R26, the 
rsaM mutant H111-rsaM, as well as the rsaM complemented mutant, were grown in polystyrene microtitre 
dishes using buffered AB medium (pH 7) supplemented with 10 mM sodium citrate. Biofilm formation of the 
rsaM complemented H111-rsaM mutant was also examined in the presence of 0.2 µM N-octanoyl-homoserine 
lactone (C8-HSL). Strain H111-rsaM was also complemented with plasmid pBBR1MCS (pBBR) as a vector 
control. After the incubation for 48h at 30°C planktonic cells were removed and attached cells were stained with 
crystal violet as described (2.4.6.1). Error bars represent the standard error of the mean of six independent wells.  
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In contrast to mutant R26 we observed that the expression of some QS-induced phenotypes 
was only weakly affected in mutant H111-rsaM (Table 8), including the production of 
extracellular proteases (Fig. 27) and the production of siderophores (Fig. 29). Moreover, 
mutant H111-rsaM exhibited a slight reduction of virulence in the C. elegans infection model 
when compared to the wild type. However, these differences were not statistical significant 
with n = 4 (Fig. 28).  
Fig.  27. Protease activities of the B. cenocepacia H111 wild type, mutants and complemented strains. The 
B. cenocepacia H111 wild type (wt), the cepR mutant H111-R, the transposon insertion mutant R26, the rsaM 
mutant H111-rsaM, as well as the cepI mutant H111-I and mutant H111-I/R (2.1.1) which has a deletion in all 
three genes cepR, rsaM and cepI were analysed for the production of extracellular proteases on milk-agar plates 
(24h at 30°C, 2.4.3). Complementation of strains was achieved by providing cepR (pBBR-cepR), cepR2 (pJTR2) 
or rsaM (pBBRrsaM) in trans (2.2.1). RsaM complemented strains were additionally analysed on plates 
containing 0.2 µM N-octanoyl-homoserine lactone (C8-HSL).   
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Fig.  28. Killing of nematodes by the B. cenocepacia H111 parent, mutants and complemented strains. 
Caenorhabditis elegans slow-killing assays (2.4.8.1) were performed employing the H111 wild type (wt), the 
cepR mutant H111-R, the transposon insertion mutant R26, the rsaM mutant H111-rsaM, as well as cepR and 
rsaM complemented mutants. The mortality of the nematodes was determined after 48h (light-shaded bars) and 
72h (dark-shaded times) at 20°C. RsaM complemented strains were additionally analysed on NGMII-plates 
containing 0.2 µM N-octanoyl-homoserine lactone (C8-HSL). Error bars represent the standard error of the mean 
of n = 4. The asterisk indicates significant differences when compared to the wild type (Student‟s t-test, p < 
0.05). 
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The following observations were made when analysing siderophore production of B. 
cenocepacia H111 strains on CAS agar (see also 3.2.2), which visualizes siderophore 
activities of pyochelin (violet) and of ornibactin (yellow): siderophore production was 
diminished in mutant R26 to a similar extent as observed in mutant H111-R, whereas the 
amounts of siderophores produced by mutant H111-rsaM were only marginally decreased in 
comparison to the wild type (Fig. 29). The complementation of R26 with rsaM could restore 
the wild type phenotype, and rsaM complementation also resulted in a slightly increased 
production of pyochelin in mutant H111-rsaM. The H111 cepR2 mutant, by contrast, could 
not be complemented with plasmid pBBRrsaM. As expected, the presence of CepR2 led to an 
increased production of pyochelin in all mutant strains (see also 3.2.2). 
These observations allow the following conclusions: RsaM stimulates the production of the 
siderophore pyochelin, and this stimulation appears to be dependent on the presence of 
CepR2.  
Previoulsy, we have shown that the production of ornibactin is negatively regulated by CepR  
(3.2.2, Fig. 11B). For this reason, complementation of the wild type with cepR resulted in a 
reduced zone of activity. Interestingly, this effect was not observed with the rsaM mutant 
(Fig. 29). 
 
Fig.  29. CAS activities of the B. cenocepacia H111 wild type, mutants and complemented strains. The B. 
cenocepacia H111 wild type strain (wt), the cepR2  mutant H111-R2, transposon insertion mutant R26, the rsaM 
mutant H111-rsaM, the cepR mutant H111-R , the cepI mutant H111-I and mutant H111-I/R, which has a 
deletion in all three genes, cepR, rsaM and cepI (2.1.1), were spotted on CAS agar plates and analysed for the 
production of siderophores after 48h at 37°C (2.4.4). Complementation of strains was achieved by providing 
cepR (pBBR-cepR), cepR2 (pJTR2) or rsaM (pBBRrsaM) in trans (2.2.1).  
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We noticed that mutant H111-rsaM exhibited increased extracellular levels of AHL signal 
molecules, an observation also made in cross-streak experiments of the transposon insertion 
mutant R26 (Fig. 30). Notably, the production of AHL molecules was diminished when rsaM 
was provided in trans in strains R26 or H111-rsaM (Fig. 30 and 3.4.5).  
 
 
Fig.  30. Detection of AHL production of the B. cenocepacia H111 parent and mutants via cross-streaking. 
The B. cenocepacia H111 wild type (1), transposon insertion mutant R26 (2), the rsaM mutant H111-rsaM (3) 
and transconjugants R26 (rsaM
+
) (4) and H111-rsaM (rsaM
+
) (5) were streaked against reporter strains 
Chromobacterium violaceum CV026 (A) and Pseudomonas putida F117 (pAS-C8) (B) (2.4.2.1). Plates were 
analysed for the development of violacein or the expression of GFP following incubation for 24h at 30°C.  
 
3.4.4 RsaM seems to modulate the activity of LuxR family transcriptional regulators 
3.4.4.1 RsaM seems to influence the activity of CepR2 
The following observations suggested that RsaM might influence the expression or the 
activity of the orphan LuxR homologue CepR2, which has been identified to stimulate the 
production of pyochelin in B. cenocepacia H111 (3.2): i) transcript levels of pyochelin 
biosynthesis genes were highly down-regulated in the transcriptome of mutant R26 in 
comparison to the transcriptome of the wild type (3.4.2) and ii) complementation with rsaM 
increased pyochelin production in all mutant strains except in mutant H111-R2 (Fig. 29, 
3.4.3). Complementation with rsaM moreover enhanced the production of pyochelin in 
mutant R26 to similar amounts as observed in the wild type, and mutant H111-R 
complemented with rsaM exhibited an increased production of pyochelin (Fig. 29). To further 
investigate the impact of RsaM on the expression of pyochelin we analysed the activities of 
the pchD promoter (the first gene of the pyochelin biosynthesis operon BCAM2232 to 
BCAM2235) as well as of the divergently transcribed pchR gene (BCAM2231, encoding a 
transcriptional regulator of pyochelin production) in the mutant background R26 and H111-
rsaM. Furthermore, we determined the CAS activities of pyochelin extracts of the H111 
mutants and their rsaM complemented derivates. 
The microarray profiling revealed that pyochelin biosynthesis genes were down-regulated to a 
greater extent in the transcriptome of mutant R26 than in the transcriptome of mutant      
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H111-R. Regulated genes comprised BCAM2232 to 35, a gene cluster required for pyochelin 
biosynthesis, which was not at all differentially regulated in the H111-R transcriptome (Table 
7, 3.4.2). These observations suggested that RsaM might influence the expression of 
pyochelin by regulating the expression of BCAM2232 to 35. We therefore investigated the 
promoter activities of pchD (BAM2232, driving expression of the pyochelin biosynthesis 
operon BCAM2232 to BCAM2235). Promoter activities were not seen to be diminished in 
mutant R26 or mutant H111-rsaM (data not shown). However, differences were difficult to 
determine, as Miller Units measured for the PpchD-lacZ fusion (2.2.8) were generally low, 
independent of whether the assay was performed in LB-medium or in iron-depleted succinate 
medium (see 3.2.2, Fig. 12). We then analysed the transcription of the gene pchR 
(BCAM2231), encoding a transcriptional regulator of pyochelin production. The expression 
of pchR has been shown to be stimulated by CepR2 (3.2.2, Fig. 12), since promoter activities 
of PpchR-lacZ (2.2.8) are almost completely lost in mutant H111-R2 (Fig. 31). As before, pchR 
promoter activities were not decreased in mutant R26 or in mutant H111-rsaM in comparison 
to the activities observed in the wild type when strains were grown in LB-medium (Fig. 31). 
Miller Units of R26 and H111-rsaM also resemble those of the wild type when strains were 
cultured in succinate medium (data not shown).   
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Fig.  31. Promoter activities of pchR 
are not reduced in mutant H111-
rsaM. Activities of the pchR 
(BCAM2231) promoter driving 
expression of one of the pyochelin 
biosynthesis operons were determined 
when strains were grown in LB-
medium. Growth (dashed line, wild 
type) and -galactosidase activities of 
the H111 wild type (closed rectangles), 
the transposon insertion mutant R26 
(open triangle), the rsaM mutant H111-
rsaM (open circles) and the cepR2 
mutant H111-R2 (stars) were 
monitored throughout the growth 
curve. The values are means ± the 
standard error of the mean (n = 3). 
To further determine the impact of RsaM on the expression of pyochelin, we also extracted 
pyochelin from liquid cultures of the H111 parent, mutant, and the rsaM complemented 
strains, and analysed the CAS activities as described before (2.4.4). However, pyochelin 
extracts showed so little activity that no firm conclusion could be made (data not shown). 
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3.4.4.2 RsaM seems to indirectly affect the transcription of CepR-regulated genes  
We observed that mutant H111-rsaM was impaired in the ability to swarm and to form a 
biofilm (3.4.3, Fig. 25 and 26). CAS activities of transconjugants R26 (cepR
+
) and H111-
rsaM (cepR
+
) suggested that the function of CepR might be dependent on the presence of 
RsaM (3.4.3, Fig. 29). To address this issue, we determined the -galactosidase activitities of 
CepR-activated promoters (cepI and aidA) in the mutant background R26 and H111-rsaM, 
and compared the activities with those obtained in the H111 wild type. As depicted in Fig. 
32A, promoter activities of cepI (fusion PcepIlong-lacZ, 2.2.8) were approximately 10-fold 
reduced in both mutant strains. We also determined the activity of the PcepIlong-lacZ fusion in 
the wild type strain amended with AHL molecules (C8-HSL) to ensure that transcription is 
not affected by the increased levels of AHL molecules in strains R26 and H111-rsaM (3.4.5). 
However, the addition of signal molecules to the medium did not influence promoter activities 
in the wild type strain (data not shown). When analysing the activity of the aidA promoter 
(promoter fusion PaidA1-lacZ, 2.2.8) similar expression trends were observed (Fig. 32B). Here, 
Miller Units were reduced by approximately 50% in the exponentially growth phase in the 
rsaM mutant relative to the wild type. After 24h of growth the activities of PaidA1-lacZ 
detected in the wild type and mutant H111-rsaM were found to be similar.  
It is important to note, that the orphan LuxR homologue CepR2 was previously found to be 
important for full activity of the aidA promoter (Toller, 2008). Even though CepR2 did not 
activate the H111 cepI promoter in an E. coli background (3.2.4), it cannot be excluded that 
the decreased promoter activities of cepI and aidA in R26 and H111-rsaM are due to lowered 
CepR2 levels or altered CepR2 activity.  
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Fig.  32. Activities of the cepI promoter (A) and the aidA promoter (B) are dependent on RsaM. The 
transcription of the cepI gene (promoter fusion PcepIlong-lacZ) and of aidA (fusion PaidA-lacZ) was determined in 
the H111 wild type (wt, closed rectangles), the cepR mutant H111-R (open rectangles), the R26 transposon 
insertion mutant (open triangles) and in the rsaM mutant H111-rsaM (open circles). -galactosidase activities 
were monitored in LB-medium throughout the growth curve (dashed line, wt). Values are means ± the standard 
error of the mean (n = 3). 
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The effect of RsaM on the activity of CepR was further investigated by employing the cep-
based reporter plasmid pAS-C8 (2.4.2.1) in different strain backgrounds (H111 wild type and 
mutants H111-I, H111-I/R and H111-rsaM). The activity of CepR was considered to be 
directly proportional to the GFP fluorescence. To this end, the various strains were grown for 
48h at 30°C in the presence or absence of C8-HSL. As depicted in Fig. 33, expression of GFP 
was only observed in cultures of the H111 wild type and the H111-rsaM mutant when no 
signal molecules were added to the medium. Moreover, strain H111-rsaM (pAS-C8) exhibited 
an approximately 25% increased fluorescence relative to the wild type strain harbouring the 
sensor plasmid, most likely because of the elevated AHL levels produced by the rsaM mutant 
(3.4.5). The addition of C8-HSL led to an activation of the reporter plasmid in the cepI mutant 
H111-I and in mutant H111-I/R, in which all three genes cepR, rsaM and cepI are deleted 
(2.1.1). Even though the expression of GFP constituted only about 2/3 of the RFU determined 
in the wild type, we observed a similar activation of the reporter plasmid in the mutant 
background of H111-I or H111-I/R when C8-HSL were provided to the medium. These 
observations suggest that RsaM does not stimulate the activity of CepR, at least under the 
conditions used in this assay.  
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Fig.  33. RsaM does not seem to stimulate the CepR-mediated activation of a PcepI-gfp transcriptional 
fusion. The expression of GFP (RFU, relative fluorescence units) of the AHL biosensor pAS-C8 (2.4.2.1) was 
measured in the H111 wild type (wt), the cepI mutant H111-I, mutant H111-I/R, in which all three genes, cepR, 
rsaM and cepI are deleted, and in the rsaM mutant H111-rsaM (2.1.1). Measurements were performed in the 
presence of different concentrations of N-octanoyl-homoserine lactone (C8-HSL) after incubation for 48h at 
30°C.  
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3.4.4.3 RsaM seems to modulate the protein activity of LuxR  
The observation that RsaM may modulate the activity of the orphan LuxR homologue CepR2 
(3.4.4.1) raised the question if the protein might function as an effector of LuxR-like proteins. 
To investigate if RsaM influences the activity of the Vibrio fischeri LuxR transcriptional 
regulator, plasmid pBBRrsaM and, as a control, plasmid pBBRrsaM_FS encoding a 
frameshifted rsaM sequence (2.2.1) were transferred into E. coli MT102 harbouring the gfp-
expressing lux-based AHL sensor plasmid pJBA89 (2.4.2.1). As expected, the presence of 
plasmid pBBRrsaM_FS did not affect GFP expression of the plasmid (Fig. 34) when AHL 
molecules were provided: pJBA89 is based on components of the LuxIR QS system of Vibrio 
fischeri, and thus is more sensitive to 3-oxo-C8-HSL than to C8-HSL. Interestingly, when 
rsaM was provided in trans the expression of GFP was inhibited, and the addition of 
increasing concentration of AHL molecules (3-oxo-C8-HSL and C8-HSL) did not induce the 
expression of GFP. To exclude the possibility that the added AHL molecules are degraded we 
determined the AHL levels in the wells after the experiments employing E. coli MT102 
(pJBA89). However, no inactivation could be seen, suggesting that RsaM does not function as 
a lactonase (Fig. 34). As it seems unlikely that RsaM acts as a transcriptional repressor (see 
3.4.1), it can be speculated that RsaM may interfere with the activity of LuxR.  
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Fig.  34. RsaM seems to repress the LuxR-mediated activation of a PluxI-gfp transcriptional fusion. The 
GFP expression (RFU, relative fluorescence units) of the AHL biosensor E. coli MT102 (pJBA89) was measured 
in the presence of plasmid pBBRrsaM_FS (rsaM_FS) encoding a frameshifted rsaM sequence, and plasmid 
pBBRrsaM (rsaM) encoding rsaM (2.2.1). Measurements were obtained in the presence of different 
concentrations of N-octanoyl-homoserine lactone (C8-HSL) and N-3-oxo-octanoyl-homoserine lactone (3-oxo-
C8-HSL) after an incubation for 6h at 30°C. Culture samples of exponentially phase-grown E. coli MT102 
(pJBA89) were added after the measurement to the wells with AHL concentrations of 375 nM and incubated for 
another 6h at 30°C to determine the AHL concentration at the end of the experiments (AHL control). 
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3.4.5 RsaM negatively affects extracellular levels of AHL signal molecules 
Experiments employing cross-streaks of the transposon insertion mutant R26, mutant H111-
rsaM and the rsaM complemented mutants (3.4.3, Fig. 30) suggested that RsaM negatively 
affects the production or the efflux of AHL molecules. The possibility that RsaM functions as 
a lactonase was found to be unlikely (3.2.4). As both the transposon insertion mutant R26 and 
the defined mutant H111-rsaM revealed the same increase in the extracellular amounts of 
AHL molecules in the analyses described below, the impact of RsaM on the production of 
AHLs will only be illustrated by the characterization of mutant H111-rsaM. To investigate if 
the production of both signal molecules synthesized by B. cenocepacia H111, N-
hexanoylhomoserine lactone (C6-HSL) and N-octanoyl-homoserine lactone (C8-HSL), which 
are produced in a ratio of 1:10 (Gottschlich et al., 2001), are equally affected by RsaM, AHL 
molecules were extracted from bacterial cultures of the H111 rsaM mutant and rsaM 
complementated strains (2.4.2). The HSL were then separated by thin layer chromatography 
and visualized by means of the reporter plasmid pAS-C8 (2.4.2). As shown in Fig. 35, mutant 
H111-rsaM exhibited an at least two-fold increase in the amounts of both molecules, C6-HSL 
and C8-HSL. In agreement with earlier findings, the complementation of mutant H111-rsaM 
and the H111 parent with plasmid pBBRrsaM strongly impaired the production of both AHL 
molecules.  
 
Fig.  35. Detection of AHL molecules by thin layer chromatography and AHL sensor plasmid pAS-C8. 
AHL molecules were extracted from supernatants of overnight cultures of the B. cenocepacia H111 wild type 
(wt), mutant H111-rsaM, and rsaM complemented strains, separated by RP-TLC (2.4.2.5) and detected by 
determining the expression of GFP from reporter strain P. putida (pAS-C8) (2.4.2.2). AHL standards [1 mM] are 
N-hexanoyl-homoserine lactone (C6-HSL) and N-octanoyl-homoserine lactone (C8-HSL).  
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The production of AHL molecules was also monitored along the bacterial growth curve, as 
shown in Fig. 36. For that purpose, the bacterial strains were cultured in wells of microtitre 
dishes and inoculated in LB-medium with exponentially phase-grown cells of the gfp-
expressing reporter strain P. putida F117 (pAS-C8) (2.4.2.4). It was seen that the expression 
of GFP in those wells that were inoculated with the rsaM mutant was already induced in the 
early growth phase, exhibiting an activation peak at around 6 - 10h of growth. These results 
suggest that RsaM might be important for the timing of AHL production.  
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Fig.  36. Analysis of AHL 
production along the bacterial  
growth curve. Overnight cultures 
of the B. cenocepacia H111 wild 
type (wt, closed rectangles), the 
rsaM mutant H111-rsaM (open 
circles), rsaM complemented 
strains H111-rsaM (rsaM
+
) 
(dashed line) and H111 wt 
(rsaM
+
) (open rectangles), and 
mutant H111-rsaM harbouring 
plasmid pBBRrsaM_FS encoding 
a frameshifted rsaM ORF (2.2.5, 
closed circles) were inoculated to 
an OD600 of 0.05 in wells of 
microtitre dishes. Cells of 
exponentially-phase-grown P. 
putida F117 (pAS-C8) were 
added, obtaining final volumes of 
300 µl. Samples were incubated 
for 48h at 30°C,  and the 
expression of GFP was detected 
as described (2.4.2.4). 
Measurements derived from two 
independent experiments are 
shown (A and B).  
Recently, it was observed that the QS-regulated phenotypes of the H111 cepI mutant could 
not entirely be rescued by complementation with plasmid pBBR1MCS5cepI, carrying the 
H111 cepI gene under the control of the lac promoter of the plasmid (Uehlinger, 2009, 
Dissertation). Since this might be caused by the negative effect of RsaM, plasmid 
pBBR1MCS5cepI was transferred into mutant H111-R, in which transcription of rsaM has 
been shown to be decreased (see 3.4.1), and in mutant H111-I/R, in which all three genes, 
cepR, rsaM and cepI are deleted (2.1.1). Transconjugants were then compared with regard to 
their ability to activate the AHL sensor plasmid pAS-C8 via cross-streaking (Fig. 37). CepI 
was not overexpressed in strain H111-rsaM, because the mutant already produces increased 
B 
A 
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amounts of AHL molecules, thus making it difficult to detect differences in AHL production 
under the experimental conditions. Interestingly, when plasmid pBBR1MCS5cepI was 
introduced into mutant H111-R (Fig. 37B) and mutant H111-I/R (Fig. 37C) the reporter strain 
was activated to a greater extent than in mutant H111-I complemented with cepI (Fig. 37A). 
These findings may indicate that RsaM represses the production of AHL molecules by a 
posttranscriptional mechanism (see 4.1.1, Discussion).  
 
 
 
Fig.  37. AHL production of B. cenocepacia H111 mutants (1) and cepI complemented mutants harbouring 
plasmid pBBR1MCScepI (2). The H111 cepI mutant H111-I (A), the cepR mutant H111-R (B) and mutant 
H111-I/R, which has a deletion in all three genes cepR, rsaM and cepI (C), were streaked against the reporter 
strain Pseudomonas putida  F117 (pAS-C8) (2.1.1). The expression of GFP was visualized after an incubation 
time of 24h at 30°C (2.4.2.2). 
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4 Discussion and Outlook 
4.1. Quorum sensing in B. cenocepacia H111 
Our understanding of the QS circuitry has expanded with the identification and 
characterization of the B. cenocepacia regulatory protein RsaM and the orphan LuxR 
homologue CepR2. The current knowledge of the CepIR network of B. cenocepacia H111 
and the regulatory dependencies observed in this study are summarised and described in the 
hypothetical model below (Fig. 38). It is important to note, that RsaM and CepR2 seem to 
function as downstream regulators of the CepIR systems, and might be important for 
balancing and fine-tuning of the QS network in B. cenocepacia H111. It seems remarkable 
that the deletion of rsaM or cepR2 did only slightly affect the expression of QS-regulated 
traits in H111 which have been analysed in this study.  
 
 
 
Fig.  38. Hypothetical model of the CepIR QS network in B. cenocepacia H111. Shown is the CepIR system 
which comprises cepR encoding the transcriptional regulator CepR, and cepI encoding the acyl-homoserine 
lactone (AHL) synthase CepI. The picture illustrates the genes rsaM encoding a protein of unknown function  
which affects the QS circuitry, and cepR2 encoding the orphan LuxR homologue CepR2. In complex with AHL 
molecules, CepR functions as an activator of transcription (dashes lines) of the genes rsaM, cepI and cepR2. The 
complex then binds to promoter regions containing cep boxes (upstream of rsaM and cepI), and stimulates the 
expression of cepR2 through the activation of downstream regulators (indirectly) or by binding to yet 
unidentified elements within the promoter region of cepR2. CepR2 is thought to act as an AHL-independent 
transcriptional regulator by binding to yet unknown promoter elements which resemble a lux box motif. Four 
regulatory dependencies, possibly acting at a posttranscriptional level, might be proposed on the basis of 
observations made in this study: RsaM functions as a repressor of CepI activity (AHL synthesis/ efflux) (1), 
stimulates the activity of the CepR2 protein (2), modulates the activity of CepR (3), and CepR2 and CepR 
interact with each other and thereby modulate their activities (4). 
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4.1.1. The RsaM regulator and production of AHL molecules 
A recent study reported the identification of two QS systems in the plant pathogen 
Pseudomonas fuscovaginae (Mattiuzzo et al., 2010). One of the QS systems contains a gene, 
named rsaM, encoding a protein of 167 amino acids. This protein was shown to function as a 
negative regulator of AHL production. In this study, we characterized the RsaM homologue 
(BCAM1869) of B. cenocepacia H111. BCAM1869 is well conserved among Bcc species, 
albeit the protein lengths can vary considerably, as for instance BCAM1869 (147 amino 
acids) and Bamb_6054 in Burkholderia ambifaria (165 amino acids, Fig. 39).  
 
 
Fig.  39. Amino acid sequence alignment of B. cenocepacia RsaM with homologous proteins. Aligned are 
deduced amino acid sequences of B. cenocepacia H111 RsaM (BCAM1869), an RsaM homologue of B. 
ambifaria (Bamb_6054), and the RsaM protein of Pseudomonas fuscovaginae (RsaM) with * (identical amino 
acids), : (conserved amino acids), . (weakly conserved amino acids). 
 
The close vicinity of the rsaM promoter elements to the predicted translational start 
methionine of BCAM1869 led us to speculate if the start codon of RsaM might rather be an 
alternative start amino acid, possibly the first leucine in the annotated sequence (Fig. 39). 
Interestingly, the genes encoding B. cenocepacia RsaM or homologues are in all cases located 
upstream of an AHL synthase-encoding gene, and are also always orientated in the same 
direction. This observation might indicate that i) the two genes are cotranscribed and that ii) 
RsaM might be important for the functioning of LuxI-like proteins. RsaM paralogues are 
found in Burkholderia ambifaria, Burkholderia pseudomallei and Burkholderia thailandiensis 
but RsaM homologous proteins are missing in Burkholderia xenovorans and Burkholderia 
phymatum.  
In analogy to the observations made in P. fuscovaginae, RsaM has been identified as a 
repressor of AHL production in B. cenocepacia H111 (Fig. 37). Whereas RsaM has been 
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suggested to control transcription of the AHL synthase PfsI in P. fuscovaginae (Mattiuzzo et 
al., 2010), our study indicated that the reduction of AHL levels in B. cenocepacia H111 is 
most likely not due to inhibition of cepI transcription by RsaM. In fact, transcription of cepI 
was strongly down-regulated in the rsaM mutant (see 4.1.2). Also, the transcriptome of 
mutant R26 showed reduced levels of cepI transcripts. Overexpression of cepI under the 
control of the lac promoter (plasmid pBBR1MCS5cepI) enhanced the production of AHL 
molecules in the absence of RsaM. The possibility that RsaM encodes for an AHL lactonase 
was excluded in this study because i) sequence inspection of the RsaM protein did not reveal 
any obvious metal binding motifs characteristic of lactonases and ii) the overexpression of 
rsaM did not result in the degradation of AHL molecules in an E. coli background. It is 
important to note that the experiments in this work showed that RsaM negatively affects 
extracellular levels of AHL molecules in strain H111. As it seems possible that RsaM might 
affect the efflux of AHL molecules rather than their synthesis it would be revealing to 
quantify the cellular amounts of AHL molecules in mutant H111-rsaM and rsaM 
complemented strains as it has been described in another study (Chan et al., 2007).  
QS systems have been shown to be subject to complex regulation by the aid of various global 
regulators (Venturi, 2006). A major regulator of AHL production in P. aeruginosa is the RsaL 
protein which represses the transcription of the P. aeruginosa lasI and P. putida ppuI AHL 
synthases (Rampioni et al., 2006, Rampioni et al., 2007). Interestingly, rsaL is also localized 
between the genes encoding the LasIR or PpuIR QS systems but, in contrast to rsaM, 
divergently transcribed from the AHL synthase-encoding genes. Notably, RsaL homologues 
seem to be also encoded in genomes of B. xenovorans and B. phymatum, which, on the other 
hand, do not seem to contain a rsaM gene. Other Pseudomonas regulators which function as 
QS repressors include the LuxR-like orphan QscR (see 4.1.2), the post-transcriptional 
regulator RsmA, and the Pseudomonas putida Lon protease, which has been demonstrated to 
affect PpuR protein levels (Bertani et al., 2007). RsmA, the regulator of secondary 
metabolites, is considered to function as an RNA-binding protein that reduces transcript levels 
of expI in Erwinia carotovora (Cui et al., 1995) or levels of rhlI and lasI in P. aeruginosa 
(Pessi et al., 2001). It was shown that RsmA specifically binds to promoter region of target 
genes at the RBS, thereby affecting their translation rate (Pessi et al., 2001, Heeb et al., 2006). 
It seems possible, that RsmA and RsaM have a similar mode of action. The finding that 
promoter activities of cepI were decreased in the H111 rsaM mutant does not seem to 
correlate with the observation that mutant H111-rsaM exhibited approximately two-fold 
elevated levels of C6-HSL and C8-HSL. Interestingly, similar regulatory trends were also 
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observed for the P. aeruginosa RsmA regulator. It was found that the mutant produced 
increased levels of C4-HSL but activities of a translational rhlI-lacZ fusion were diminished 
when rsmA was deleted (Pessi et al., 2001).  
 
Our studies suggest that RsaM may boost the activity of the orphan LuxR homologue CepR2, 
which has been identified to control the production of the siderophore pyochelin (see 4.1.2). 
This hypothesis is mainly based on the observation that pyochelin biosynthesis genes were 
strongly down-regulated in the transposon insertion mutant R26, but that overexpression of 
rsaM stimulated the CepR2-mediated production of pyochelin. We have suggested a similar 
regulatory model in which the transcriptional regulator CepR is required for the expression of 
CepR2, which, in turn, activates the expression of pyochelin biosynthesis genes (Malott et al., 
2009) (see 4.1.2). The production of pyochelin was clearly reduced when culture samples of 
mutant H111-R and mutant R26 were spotted on CAS agar. However, the rsaM mutant 
exhibited only a minor decrease in pyochelin production when compared to the wild type 
under the same assay conditions. These results indicated that i) RsaM may modulate the 
activity of CepR2 only when it is present at high concentrations or ii) the lack of the CepR 
regulator in the rsaM complemented mutant R26 and mutant H111-R might favour a 
stimulation of RsaM thus affecting activity of CepR2. The observed stimulation of RsaM on 
the expression of siderophores does not seem to trigger an overproduction of pyochelin as 
observed with pyochelin extracts from cepR2 complemented H111 strains which were grown 
in liquid cultures. However, an overproduction of pyochelin was also not observed when 
pyochelin extracts of cepR complemented strains were analysed on CAS agar.  
The finding that RsaM may interact with QS transcriptional regulators of other bacterial 
genera, such as LuxR from Vibrio fischeri, supports our assumption that RsaM influences the 
activity of LuxR-like proteins (see 4.1.2). It seems likely that RsaM also governs the activity 
of the CepR transcriptional regulator, either directly or indirectly, by influencing the activities 
of CepR2 (Fig. 38, see 4.1.2). This assumption is supported by the finding that mutant H111-
rsaM was impaired in the ability to swarm or to form a biofilm, phenoytpes which are 
positively regulated by CepIR circuitries. However, the observation that RsaM did not 
influence CepR-mediated activation of the reporter plasmid pAS-C8 in B. cenocepacia H111, 
contradicts the assumption that RsaM modulates the function of CepR.   
 
The orphan LuxR homologue CepR2 has been shown to function as an AHL-independent 
transcriptional regulator (Malott et al., 2009). A regulatory model (Fig. 38), in which RsaM 
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represses the production of AHL molecules, thereby diminishing the functioning of CepR, 
and then again stimulates the activity of CepR2, has been proposed. It is important to note that 
the results obtained in this study do not indicate that CepR2 is involved in the repression of 
AHL production, as complementation of mutant H111-R2 with rsaM diminished the 
production of AHL signal molecules. The decrease of cepI promoter activity in the rsaM 
mutant might, on the other hand, be caused by an altered activity of CepR2 (see 4.1.2).     
 
4.1.2. The orphan LuxR homologue CepR2 
CepR2 belongs to the “orphaned” LuxR homologues, since the cepR2 gene is not 
accompanied by an adjacent gene encoding a LuxI-like protein. CepR2 is the first orphan 
LuxR homologue which has been identified in Bcc species (Malott et al., 2009). Orphan 
LuxR regulators have, however, been previously identified in B. pseudomallei (Kiratisin & 
Sanmee, 2008), B. mallei (Ulrich et al., 2004), and with QscR, the quorum sensing control 
repressor, in Pseudomonas aeruginosa (Chugani et al., 2001). Our study has revealed that 
CepR2 acts as an AHL-independent transcriptional regulator: the LuxR orphan was shown to 
induce the transcription of the Vibrio fischeri luxI gene in an E. coli background, and the 
expression of luxI was not enhanced but also not impaired when AHL molecules were 
amended to the medium. Against our perceptions, we observed that CepR2 does not seem to 
activate the promoter of the H111 cepI gene. These results are rather surprising, also, since 
orphan LuxR homologues like BpsR4 and BpsR5 in B. pseudomallei (Kiratisin & Sanmee, 
2008) or QscR in P. aeruginosa (Chugani et al., 2001) have been recognized as 
transcriptional regulators of AHL synthase-encoding genes. However, and in agreement with 
our findings, we did not detect any obvious differences between the amounts of AHL 
molecules produced by the H111 cepR2 mutant and by the wild type strain. CepR2 was 
moreover seen to stimulate the transcription of pchR encoding a transcriptional regulator of 
pyochelin production, and the transcription of the lectin-encoding operon bclACB in B. 
cenocepacia H111. Promoter sequences of these genes did not exhibit motifs similar to that of 
a lux box. Preliminary experiments have indicated that CepR2 seems to specifically bind C8-
HSL, C10-HSL, and to a minor degree also 3-oxo-C12-HSL, whereas CepR2 did not seem to 
interact with C6-HSL (K. Riedel, personal note). 
 
In this study, the B. cenocepacia orphan LuxR homologue CepR2 was identified as a positive 
regulator of pyochelin production in B. cenocepacia H111 (Malott et al., 2009). While 
analysing the siderophore production of H111 mutants and complemented strains we 
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suggested a regulatory cascade in which CepR induces the expression of CepR2 in B. 
cenocepacia (Fig. 38), (Malott et al., 2009). In fact, our microarray profiling provides the first 
data in support of this hypothesis, as cepR2 transcript levels are significantly reduced              
(-4.1-fold) in the mutant strain H111-R and likewise increased (4.5-fold) in the cepR 
complemented mutant H111-R (cepR
+
). Moreover, transcript levels of pyochelin expression 
genes are reduced in H111-R and increased in H111-R (cepR
+
). Genes comprising the B. 
cenocepacia K56-2 CepR2 regulon have been identified in a transcriptomic profiling of a 
cepR2 mutant (Malott et al., 2009). The regulon consists mostly of those genes which are 
located adjacent to the cepR2 locus, including BCAM0184 - 0186 encoding the BclACB 
lectins, and genes belonging to three yet uncharacterized transcriptional units (BCAM0191 
and BCAM0190, BCAM0192 to BCAM0196, and BCAM0199 to BCAM0202). 
Interestingly, transcription of most of these genes was highly down-regulated in the 
transcriptome of the H111 cepR mutant, suggesting that the expression of these genes is 
additionally regulated, likely through stimulation of CepR2. In fact, CepR2 was found to be 
necessary for the full transcription of the bclACB operon in strain H111.  
Contrary to our microarray data, transcription of the genes comprising the CepR2 regulon was 
seen to be repressed by CepR2 in strain K56-2, including BCAM0189 (encoding an AraC 
family regulatory protein), whose transcription was most increased in the absence of cepR2 
(Malott et al., 2009). These differences might be caused by a regulation which is triggered by 
the in strain H111 absent CciIR QS system, which has been suggested to repress the 
expression of cepR2 in B. cenocepacia K56-2 (O'Grady et al., 2009). 
 
The identification and characterization of CepR2 raises many interesting questions. For 
instance, the biochemistry of CepR2 is unknown: CepR2 might exist as a homodimer even in 
the absence of AHL molecules, and it might possibly form heterodimers with the CepR 
regulator. This complex could activate or repress the transcription of QS-regulated genes. The 
formation of protein complexes of orphan LuxR homologues with other LuxR-like proteins 
has been shown for BspR4 of B. pseudomallei using a LexA-based bacterial protein 
interaction assay (Kiratisin & Sanmee, 2008). It might be of interest to perform similar 
experiments in strain H111 for the further characterization of CepR2, since some results 
obtained in this study suggest that CepR2 influences the activity of CepR, which might be 
caused by the formation of CepR2-CepR heterodimers.  
Indeed, CepR2 seems to be important for full transcriptional activation of CepR-regulated 
genes in B. cenocepacia H111. However, as CepR2 does not appear to bind to H111 DNA 
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promoter regions comprising a cep box motif it may be assumed that CepR2 interacts with 
additional factors which are absent in E. coli. For that reason it will be interesting to 
determine if CepR2 influences the transcription of cepI in different cell backgrounds of B. 
cenocepacia H111. One possibility might be that certain cellular conditions (for instance low 
concentration of AHL molecules) favour the formation of a CepR2-CepR heterodimer which 
then acts as a transcriptional regulator of genes. In has to be kept in mind that the activity of 
CepR2 seems to be affected by RsaM (Fig. 38). In fact, activities of RsaM and CepR2 might 
even complement one another. Interestingly, both RsaM and CepR2 have independently been 
shown to be significantly involved in the regulation of the Vibrio fischeri LuxIR system: 
RsaM was shown to repress the activity of the LuxR protein, whereas CepR2 was found to 
activate the luxI promoter regardless of the presence of absence of AHL molecules. It is 
currently not know, and might therefore be interesting to determine, if the presence of RsaM 
influences CepR2-mediated, AHL-independent activation of the luxI promoter.  
 
4.2. The BclACB lectins 
Despite the large amount of information available on lectin structure and carbohydrate 
binding specificity, relatively little is known about the biological significances of these 
proteins. Bacterial lectins are commonly thought to play important roles in processes that 
require cell adhesion, host recognition or defence mechanisms. Expectedly, genomes of 
bacteria which act as opportunistic pathogens and which interact and compete with their 
hosts, often comprise one or even several copies of genes which encode lectins (Sudakevitz et 
al., 2002, Zinger-Yosovich et al., 2006, Imberty et al., 2005, Imberty & Varrot, 2008). The B. 
cenocepacia lectins are orthologues of the extensively studied Pseudomonas aeruginosa 
fucose-binding lectin PA-IIL, also referred to as LecB (Lameignere et al., 2008). All three 
lectins, BclA (BCAM0186), BclC (BCAM0185), and BclB (BCAM0184) share a C-terminal 
lectin domain with similarity to that of PA-IIL. Lectin BclA is with 129 amino acids the 
smallest protein among them. This protein has been intensively analysed with respect of its 
calcium-dependent dimeric arrangement, its binding preference for mannosides, and its strict 
specificity for oligomannose-type N-glycan structures that are for instance present on human 
glycoproteins (Lameignere et al., 2008, Lameignere et al., 2010). 
This study showed that the B. cenocepacia lectins are important for the structural 
development of biofilms, thereby providing information on the role of these proteins in vivo. 
A similar observation was made in a study of P. aeruginosa PAO1, where a PA-IIL-deficient 
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mutant was seen to develop thinner biofilms on glass slides than the wild type (Tielker et al., 
2005). In full agreement with our findings, PA-IIL was shown to be necessary for the 
bacterial colonization of surfaces. We observed that the absence of bclACB did not affect 
biofilm formation in a microtitre-dish bases assay after an incubation period of two days. 
Therefore, it has to be assumed that the interaction between Bcl proteins and carbohydrate 
complexes excreted by B. cenocepacia only occurs under certain cellular or environmental 
conditions. These conditions appear to prevail when biofilms were grown in flow-cells. 
Interestingly, transcriptome analysis in P. aeruginosa also showed that PA-IIL is up-regulated 
in growing and developing biofilms (Hentzer et al., 2005). Importantly, lectin expression does 
not seem to be restricted to a sessile lifestyle of the bacteria as PA-IIL (Tielker et al., 2005), 
and in this study BclB, were also detected in planktonic cells. The glycans or 
exopolysaccharides (EPS) which are produced by Bcc strains (Cerantola et al., 2000), and 
which might serve as Bcl carbohydrate ligands within developing biofilms, remain to be 
identified. An interesting candidate for lectin binding might be the heptasaccharide cepacian 
(Sist et al., 2003), which has been shown to play a role in the establishment of thick biofilms 
in B. cenocepacia (Cunha et al., 2004), and moreover comprises monosaccharide units of D-
mannose that might enable lectin binding. It is likely that not only the production of EPS but 
also its distribution within the biofilm matrix is triggered by certain factors, therefore 
significantly affecting lectin binding or the structural development of a biofilm. The formation 
of holes within the B. cenocepacia biofilm matrix, as we have observed it with the lectin 
mutant H111-bclACB, suggests that Bcl function goes beyond that of a mediator of cell 
adhesion. Instead, the Bcl proteins seem to also exert a stabilizing function in a biofilm by 
specifically cross-linking bacterial cells to carbohydrate complexes which are present in inner 
parts of microcolonies.  
 
Our study identified that the transcription of the lectin-encoding operon bclACB is induced by 
the CepIR QS system in B. cenocepacia H111. A regulatory role of QS on the expression of 
lectins has been previously suggested in P. aeruginosa for PA-IIL, and more recently for 
BclA in B. cenocepacia. In the former case Winzer and colleagues performed immunoblot 
analysis and showed that PA-IIL synthesis is induced by the LasIR and the RhlIR QS systems 
(Winzer et al., 2000). Similarly, transcriptome analyses in B. cenocepacia K56-2, which used 
the same custom microarrays as employed in this study, suggested that bclA transcription is 
positively affected by the CepIR system. Importantly, the inspection of the bclA promoter 
regions did not reveal any obvious lux box-like elements as they have been identified within 
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upstream regions of the PA-IIL-encoding gene (Gilboa-Garber et al., 2000). In fact, several 
observation made in this study indicate that QS is likely to affect BclACB expression on 
different levels, and that this regulation might involve the activity of other regulators than 
CepR. The B. cenocepacia orphan LuxR homologue CepR2 for instance (Malott et al., 2009), 
was seen to act as a positive regulator of bclACB transcription in this study, even though this 
regulatory trend was not observed in a Western immunoblot analysis. In contrast to our 
findings, transcription of bclA was seen to be negatively affected by the CepR2 transcriptional 
regulator in strain K56-2 (Malott et al., 2009). In this regard, it is important to note that B. 
cenocepacia H111 does not encode the CciIR QS-system, which is characteristic for B. 
cenocepacia ET12 lineage strains such as K56-2. Both the expression of CepR2 and the 
expression of BclA have been suggested to be additionally controlled by CciIR networking 
(O'Grady et al., 2009). These circumstances might partly explain the observed strain 
differences in respect to the transcriptional regulation of the bclACB operon. The fact that 
transcriptional activities of bclA were not completely diminished in both cepR and cepR2 
mutant backgrounds, moreover suggests that bclACB transcription might be additionally 
controlled by yet unknown factors, which might act independent of QS. For P. aeruginosa 
PA-IIL it was shown that its transcription is also regulated by the alternative sigma factor 
RpoS (Winzer et al., 2000).  
Employing immunofluorescence labelling we could show that lectin BclB is associated with 
the cellular surface of B. cenocepacia H111. Through Western immunoblot analyses of 
planktonic cells we were able to identify lectin BclB in not only whole cell but also in the 
extracellular protein fraction. The finding that the amounts of BclB were greatly diminished 
in late-stationary phase cultures of H111 was unexpected and would be of interest for future 
investigations. Notably, the mechanism by which PA-IIL lectins are translocated across the 
bacterial cytoplasmic membrane raises questions, since a typical secretion signal seems to be 
missing in Bcl as well as in PA-IIL (Tielker et al., 2005). Genes encoding exported proteins 
have been successfully identified in Burkholderia spp. by mutagenesis experiments 
employing Tn5-based transposons which contain truncated phoA gene fusions (Burtnick et 
al., 2001). This approach relies on the fact that PhoA (alkaline phosphatase) activity in an 
acid phosphatase (acpA)-negative mutant can only be detected, if the truncated phoA is fused 
to a gene that encodes an extracytoplasmatically product. Sine acpA has been identified in 
Burkholderia spp. (Burtnick et al., 2001), the generation of a H111 acpA mutant should not 
be a problem. In earlier studies in was suggested that lectin PA-IIL mainly localizes in the 
bacterial cytoplasm (Gilboa-Garber, 1982), and it was also assumed that cell lysis was 
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responsible for the release of PA-IIL into the extracellular environment (Wentworth J S, 
1991). However, subsequent work provided clear evidence that the protein is localized in the 
outer-membrane of P. aeruginosa (Tielker et al., 2005). 
 
While PA-IIL family proteins are present as a single copy in the genome of P. aeruginosa 
(PA-IIL), as well as in Chromobacterium violaceum (CV-IIL) and Ralstonia solanacearum 
(RS-IIL) (Sudakevitz et al., 2002, Zinger-Yosovich et al., 2006), it is surprising that the 
genomes of Bcc species encode multiple PA-IIL-like proteins, some of which carrying an 
additional N-terminal domain that is variable in size and sequence. Most recently, lectin BclC 
was shown to encode a superlectin containing in fact two functional lectin domains: the C-
terminal BclA-like domain and an N-terminal tumor necrosis factor-like domain encoding a 
novel lectin with specificity to fucosylated human blood group epitopes (Sulak et al., 2010). 
Because of the differences with respect to their structures and binding affinities it seems very 
likely that the three Bcl proteins carry out several functions in B. cenocepacia. The 
performance of more detailed investigations on their biological roles will be a challenging 
task in the future.  
 
 
References 
95 
 
5 References 
 
Andersen, J. B., A. Heydorn, M. Hentzer, L. Eberl, O. Geisenberger, B. B. Christensen, S. 
Molin & M. Givskov, (2001) gfp-based N-acyl homoserine-lactone sensor systems for 
detection of bacterial communication. Appl Environ Microbiol 67: 575-585. 
Andersen, J. B., C. Sternberg, L. K. Poulsen, S. P. Bjorn, M. Givskov & S. Molin, (1998) 
New unstable variants of green fluorescent protein for studies of transient gene 
expression in bacteria. Appl Environ Microbiol 64: 2240-2246. 
Arevalo-Ferro C, H. M., Reil G, Görg A, Kjelleberg S, Givskov M, Riedel & E. L. K, (2003) 
Identification of quorum-sensing regulated proteins in the opportunistic pathogen 
Pseudomonas aeruginosa by proteomics. . Environ Microbiol 5: 1350-1369. 
Baldwin, A., E. Mahenthiralingam, P. Drevinek, P. Vandamme, J. R. Govan, D. J. Waine, J. J. 
LiPuma, L. Chiarini, C. Dalmastri, D. A. Henry, D. P. Speert, D. Honeybourne, M. C. 
Maiden & C. G. Dowson, (2007) Environmental Burkholderia cepacia complex 
isolates in human infections. Emerg Infect Dis 13: 458-461. 
Baldwin, A., P. A. Sokol, J. Parkhill & E. Mahenthiralingam, (2004) The Burkholderia 
cepacia epidemic strain marker is part of a novel genomic island encoding both 
virulence and metabolism-associated genes in Burkholderia cenocepacia. Infect Immun 
72: 1537-1547. 
Bertani, I., G. Rampioni, L. Leoni & V. Venturi, (2007) The Pseudomonas putida Lon 
protease is involved in N-acyl homoserine lactone quorum sensing regulation. BMC 
Microbiol 7: 71. 
Better, M., B. Lewis, D. Corbin, G. Ditta & D. R. Helinski, (1983) Structural relationships 
among Rhizobium meliloti symbiotic promoters. Cell 35: 479-485. 
Bevivino, A., S. Tabacchioni, L. Chiarini, M. V. Carusi, M. Del Gallo & P. Visca, (1994) 
Phenotypic comparison between rhizosphere and clinical isolates of Burkholderia 
cepacia. Microbiology 140 ( Pt 5): 1069-1077. 
Birnboim, H. C., (1983) A rapid alkaline extraction method for the isolation of plasmid DNA. 
Methods Enzymol 100: 243-255. 
Bochner, B. R., P. Gadzinski & E. Panomitros, (2001) Phenotype microarrays for high-
throughput phenotypic testing and assay of gene function. Genome Res 11: 1246-
1255. 
Boyer, H. W. & D. Roulland-Dussoix, (1969) A complementation analysis of the restriction 
and modification of DNA in Escherichia coli. J Mol Biol 41: 459-472. 
Bradford, M. M., (1976) A rapid and sensitive method for the quantitation of microgram 
quantities of protein utilizing the principle of protein-dye binding. Analytical 
Biochemistry 72: 248-254. 
Brenner, S., (1974) The Genetics of CAENORHABDITIS ELEGANS. Genetics 77: 71-94. 
Burtnick, M., A. Bolton, P. Brett, D. Watanabe & D. Woods, (2001) Identification of the acid 
phosphatase (acpA) gene homologous in pathogenic and non-pathogenic Burkholderia 
spp. facilitates TnphoA mutagenesis. Microbiology 147: 111-120. 
Carlier, A., L. Burbank & S. B. von Bodman, (2009) Identification and characterization of 
three novel EsaI/EsaR quorum-sensing controlled stewartan exopolysaccharide 
biosynthetic genes in Pantoea stewartii ssp. stewartii. Mol Microbiol 74: 903-913. 
Cerantola, S., J. Bounery, C. Segonds, N. Marty & H. Montrozier, (2000) Exopolysaccharide 
production by mucoid and non-mucoid strains of Burkholderia cepacia. FEMS 
Microbiol Lett 185: 243-246. 
Chambers, C. E., E. I. Lutter, M. B. Visser, P. P. Law & P. A. Sokol, (2006) Identification of 
potential CepR regulated genes using a cep box motif-based search of the 
Burkholderia cenocepacia genome. BMC Microbiol 6: 104. 
References 
96 
 
Chan, Y. Y., H. S. Bian, T. M. Tan, M. E. Mattmann, G. D. Geske, J. Igarashi, T. Hatano, H. 
Suga, H. E. Blackwell & K. L. Chua, (2007) Control of quorum sensing by a 
Burkholderia pseudomallei multidrug efflux pump. J Bacteriol 189: 4320-4324. 
Chen, J. S., K. A. Witzmann, T. Spilker, R. J. Fink & J. J. LiPuma, (2001) Endemicity and 
inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. J Pediatr 
139: 643-649. 
Christensen, B. B., C. Sternberg, J. B. Andersen, R. J. Palmer, Jr., A. T. Nielsen, M. Givskov 
& S. Molin, (1999) Molecular tools for study of biofilm physiology. Methods Enzymol 
310: 20-42. 
Chugani, S. A., M. Whiteley, K. M. Lee, D. D'Argenio, C. Manoil & E. P. Greenberg, (2001) 
QscR, a modulator of quorum-sensing signal synthesis and virulence in Pseudomonas 
aeruginosa. Proc Natl Acad Sci U S A 98: 2752-2757. 
Ciccillo, F., A. Fiore, A. Bevivino, C. Dalmastri, S. Tabacchioni & L. Chiarini, (2002) Effects 
of two different application methods of Burkholderia ambifaria MCI 7 on plant growth 
and rhizospheric bacterial diversity. Environ Microbiol 4: 238-245. 
Clark, D. J. & O. Maaløe, (1967) DNA replication and the division cycle in Escherichia coli. 
Journal of Molecular Biology 23: 99-112. 
Coenye, T. & J. J. LiPuma, (2002) Multilocus restriction typing: a novel tool for studying 
global epidemiology of Burkholderia cepacia complex infection in cystic fibrosis. J 
Infect Dis 185: 1454-1462. 
Coenye, T., E. Mahenthiralingam, D. Henry, J. J. LiPuma, S. Laevens, M. Gillis, D. P. Speert 
& P. Vandamme, (2001) Burkholderia ambifaria sp. nov., a novel member of the 
Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. 
Int J Syst Evol Microbiol 51: 1481-1490. 
Coenye, T. & P. Vandamme, (2003) Diversity and significance of Burkholderia species 
occupying diverse ecological niches. Environ Microbiol 5: 719-729. 
Coenye, T. & P. Vandamme, (2007) Burkholderia: Molecular Microbiology and Genomics. 
Horizon Bioscience. 
Cox, C. D. & R. Graham, (1979) Isolation of an iron-binding compound from Pseudomonas 
aeruginosa. J Bacteriol 137: 357-364. 
Cui, Y., A. Chatterjee, Y. Liu, C. K. Dumenyo & A. K. Chatterjee, (1995) Identification of a 
global repressor gene, rsmA, of Erwinia carotovora subsp. carotovora that controls 
extracellular enzymes, N-(3-oxohexanoyl)-L-homoserine lactone, and pathogenicity in 
soft-rotting Erwinia spp. J Bacteriol 177: 5108-5115. 
Cunha, M. V., S. A. Sousa, J. H. Leitao, L. M. Moreira, P. A. Videira & I. Sa-Correia, (2004) 
Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-
associated isolates of the Burkholderia cepacia complex in biofilm formation and in 
persistence of respiratory infections. J Clin Microbiol 42: 3052-3058. 
Datsenko, K. A. & B. L. Wanner, (2000) One-step inactivation of chromosomal genes in 
Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97: 6640-6645. 
Davies, D., (2003) Understanding biofilm resistance to antibacterial agents. Nat Rev Drug 
Discov 2: 114-122. 
De Lorenzo, V. & K. N. Timmis, (1994) Analysis and construction of stable phenotypes in 
gram-negative bacteria with Tn5- and Tn10-derived minitransposons. Methods 
Enzymol 235: 386-405. 
Devine, J. H., G. S. Shadel & T. O. Baldwin, (1989) Identification of the operator of the lux 
regulon from the Vibrio fischeri strain ATCC7744. Proc Natl Acad Sci U S A 86: 
5688-5692. 
Eberl, L. & B. Tummler, (2004) Pseudomonas aeruginosa and Burkholderia cepacia in cystic 
fibrosis: genome evolution, interactions and adaptation. Int J Med Microbiol 294: 123-
131. 
References 
97 
 
Figurski, D. H. & D. R. Helinski, (1979) Replication of an origin-containing derivative of 
plasmid RK2 dependent on a plasmid function provided in trans. Proc Natl Acad Sci 
U S A 76: 1648-1652. 
Folsom, B. R., P. J. Chapman & P. H. Pritchard, (1990) Phenol and trichloroethylene 
degradation by Pseudomonas cepacia G4: kinetics and interactions between substrates. 
Appl Environ Microbiol 56: 1279-1285. 
Fuqua, C., S. C. Winans & E. P. Greenberg, (1996) Census and consensus in bacterial 
ecosystems: the LuxR-LuxI family of quorum-sensing transcriptional regulators. Annu 
Rev Microbiol 50: 727-751. 
Fuqua, W. C., S. C. Winans & E. P. Greenberg, (1994) Quorum sensing in bacteria: the 
LuxR-LuxI family of cell density-responsive transcriptional regulators. J Bacteriol 
176: 269-275. 
Geisenberger, O., M. Givskov, K. Riedel, N. Hoiby, B. Tummler & L. Eberl, (2000) 
Production of N-acyl-L-homoserine lactones by P. aeruginosa isolates from chronic 
lung infections associated with cystic fibrosis. FEMS Microbiol Lett 184: 273-278. 
Gilboa-Garber, N., (1982) Pseudomonas aeruginosa lectins. Methods Enzymol 83: 378-385. 
Gilboa-Garber, N., D. J. Katcoff & N. C. Garber, (2000) Identification and characterization of 
pseudomonas aeruginosa PA-IIL lectin gene and protein compared to PA-IL. FEMS 
Immunol Med Microbiol 29: 53-57. 
Gotschlich, A., B. Huber, O. Geisenberger, A. Togl, A. Steidle, K. Riedel, P. Hill, B. 
Tummler, P. Vandamme, B. Middleton, M. Camara, P. Williams, A. Hardman & L. 
Eberl, (2001) Synthesis of multiple N-acylhomoserine lactones is wide-spread among 
the members of the Burkholderia cepacia complex. Syst Appl Microbiol 24: 1-14. 
Hanahan, D., (1983) Studies on transformation of Escherichia coli with plasmids. J Mol Biol 
166: 557-580. 
Heeb, S., S. A. Kuehne, M. Bycroft, S. Crivii, M. D. Allen, D. Haas, M. Camara & P. 
Williams, (2006) Functional analysis of the post-transcriptional regulator RsmA 
reveals a novel RNA-binding site. J Mol Biol 355: 1026-1036. 
Hentzer, M., L. Eberl & M. Givskov, (2005) Transcriptome analysis of Pseudomonas 
aeruginosa biofilm development: anaerobic respiration and iron limitation. Biofilms 2: 
37-61. 
Heydorn, A., A. T. Nielsen, M. Hentzer, C. Sternberg, M. Givskov, B. K. Ersboll & S. Molin, 
(2000) Quantification of biofilm structures by the novel computer program 
COMSTAT. Microbiology 146 ( Pt 10): 2395-2407. 
Hoang, T. T., R. R. Karkhoff-Schweizer, A. J. Kutchma & H. P. Schweizer, (1998) A broad-
host-range Flp-FRT recombination system for site-specific excision of 
chromosomally-located DNA sequences: application for isolation of unmarked 
Pseudomonas aeruginosa mutants. Gene 212: 77-86. 
Holden, M. T., H. M. Seth-Smith, L. C. Crossman, M. Sebaihia, S. D. Bentley, A. M. 
Cerdeno-Tarraga, N. R. Thomson, N. Bason, M. A. Quail, S. Sharp, I. Cherevach, C. 
Churcher, I. Goodhead, H. Hauser, N. Holroyd, K. Mungall, P. Scott, D. Walker, B. 
White, H. Rose, P. Iversen, D. Mil-Homens, E. P. Rocha, A. M. Fialho, A. Baldwin, 
C. Dowson, B. G. Barrell, J. R. Govan, P. Vandamme, C. A. Hart, E. 
Mahenthiralingam & J. Parkhill, (2009) The genome of Burkholderia cenocepacia 
J2315, an epidemic pathogen of cystic fibrosis patients. J Bacteriol 191: 261-277. 
Holmes, A., J. Govan & R. Goldstein, (1998) Agricultural use of Burkholderia 
(Pseudomonas) cepacia: a threat to human health? Emerg Infect Dis 4: 221-227. 
Hope, I. A., (1999) C. elegans : a practical approach, p. xv, 281 p. Oxford University Press, 
Oxford. 
References 
98 
 
Huber, B., F. Feldmann, M. Kothe, P. Vandamme, J. Wopperer, K. Riedel & L. Eberl, (2004) 
Identification of a novel virulence factor in Burkholderia cenocepacia H111 required 
for efficient slow killing of Caenorhabditis elegans. Infect Immun 72: 7220-7230. 
Huber, B., K. Riedel, M. Hentzer, A. Heydorn, A. Gotschlich, M. Givskov, S. Molin & L. 
Eberl, (2001) The cep quorum-sensing system of Burkholderia cepacia H111 controls 
biofilm formation and swarming motility. Microbiology 147: 2517-2528. 
Huber, B., K. Riedel, M. Kothe, M. Givskov, S. Molin & L. Eberl, (2002) Genetic analysis of 
functions involved in the late stages of biofilm development in Burkholderia cepacia 
H111. Mol Microbiol 46: 411-426. 
Imberty, A., E. P. Mitchell & M. Wimmerova, (2005) Structural basis of high-affinity glycan 
recognition by bacterial and fungal lectins. Curr Opin Struct Biol 15: 525-534. 
Imberty, A. & A. Varrot, (2008) Microbial recognition of human cell surface glycoconjugates. 
Curr Opin Struct Biol 18: 567-576. 
Isles, A., I. Maclusky, M. Corey, R. Gold, C. Prober, P. Fleming & H. Levison, (1984) 
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 104: 
206-210. 
Jan Molin, S. M., (2000) Complex Adaptive Systems Ecology. Technical University of 
Denmark. 
Jander, G., L. G. Rahme & F. M. Ausubel, (2000) Positive correlation between virulence of 
Pseudomonas aeruginosa mutants in mice and insects. J Bacteriol 182: 3843-3845. 
Jimenez, L., (2001) Molecular diagnosis of microbial contamination in cosmetic and 
pharmaceutical products: a review. J AOAC Int 84: 671-675. 
Johnson, D. A., S. G. Tetu, K. Phillippy, J. Chen, Q. Ren & I. T. Paulsen, (2008) High-
throughput phenotypic characterization of Pseudomonas aeruginosa membrane 
transport genes. PLoS Genet 4: e1000211. 
Jones, A. L., T. J. Beveridge & D. E. Woods, (1996) Intracellular survival of Burkholderia 
pseudomallei. Infect Immun 64: 782-790. 
Kiratisin, P. & S. Sanmee, (2008) Roles and interactions of Burkholderia pseudomallei BpsIR 
quorum-sensing system determinants. J Bacteriol 190: 7291-7297. 
Kooi, C., B. Subsin, R. Chen, B. Pohorelic & P. A. Sokol, (2006) Burkholderia cenocepacia 
ZmpB is a broad-specificity zinc metalloprotease involved in virulence. Infect Immun 
74: 4083-4093. 
Köthe, M., M. Antl, B. Huber, K. Stoecker, D. Ebrecht, I. Steinmetz & L. Eberl, (2003) 
Killing of Caenorhabditis elegans by Burkholderia cepacia is controlled by the cep 
quorum-sensing system. Cell Microbiol 5: 343-351. 
Kovach, M. E., P. H. Elzer, D. S. Hill, G. T. Robertson, M. A. Farris, R. M. Roop, 2nd & K. 
M. Peterson, (1995) Four new derivatives of the broad-host-range cloning vector 
pBBR1MCS, carrying different antibiotic-resistance cassettes. Gene 166: 175-176. 
Kovach, M. E., R. W. Phillips, P. H. Elzer, R. M. Roop, 2nd & K. M. Peterson, (1994) 
pBBR1MCS: a broad-host-range cloning vector. Biotechniques 16: 800-802. 
Laemmli, U. K., (1970) Cleavage of structural proteins during the assembly of the head of 
bacteriophage T4. Nature 227: 680-685. 
Lameignere, E., L. Malinovska, M. Slavikova, E. Duchaud, E. P. Mitchell, A. Varrot, O. 
Sedo, A. Imberty & M. Wimmerova, (2008) Structural basis for mannose recognition 
by a lectin from opportunistic bacteria Burkholderia cenocepacia. Biochem J 411: 307-
318. 
Lameignere, E., T. C. , R. R. Shiao, M. Wimmerova, F. Dubreuil & A. V. A. Imberty, (2010) 
Structural basis of the affinity for oligomannosides and analogs displayed by BC2L-A, 
a Burkholderia cenocepacia soluble lectin. Glycobiology 20: 87-98. 
Lessie, T. G., W. Hendrickson, B. D. Manning & R. Devereux, (1996) Genomic complexity 
and plasticity of Burkholderia cepacia. FEMS Microbiol Lett 144: 117-128. 
References 
99 
 
Lewenza, S., B. Conway, E. P. Greenberg & P. A. Sokol, (1999) Quorum sensing in 
Burkholderia cepacia: identification of the LuxRI homologs CepRI. J Bacteriol 181: 
748-756. 
Lewenza, S. & P. A. Sokol, (2001) Regulation of ornibactin biosynthesis and N-acyl-L-
homoserine lactone production by CepR in Burkholderia cepacia. J Bacteriol 183: 
2212-2218. 
Lindhardt TJ, B. R., Danies L, Mayerl R, Pickenhagen W, (1989) Microbially produced 
rhamnolipid as a source of rhamnose. Biotechnol. Bioeng. 33: 365-368. 
LiPuma, J. J., J. E. Mortensen, S. E. Dasen, T. D. Edlind, D. V. Schidlow, J. L. Burns & T. L. 
Stull, (1988) Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment 
centers. J Pediatr 113: 859-862. 
Ma, L., M. Conover, H. Lu, M. R. Parsek, K. Bayles & D. J. Wozniak, (2009) Assembly and 
development of the Pseudomonas aeruginosa biofilm matrix. PLoS Pathog 5: 
e1000354. 
Mahenthiralingam, E., A. Baldwin & C. G. Dowson, (2008) Burkholderia cepacia complex 
bacteria: opportunistic pathogens with important natural biology. J Appl Microbiol 
104: 1539-1551. 
Mahenthiralingam, E., A. Baldwin & P. Vandamme, (2002) Burkholderia cepacia complex 
infection in patients with cystic fibrosis. J Med Microbiol 51: 533-538. 
Mahenthiralingam, E., T. Coenye, J. W. Chung, D. P. Speert, J. R. Govan, P. Taylor & P. 
Vandamme, (2000) Diagnostically and experimentally useful panel of strains from the 
Burkholderia cepacia complex. J Clin Microbiol 38: 910-913. 
Mahenthiralingam, E., T. A. Urban & J. B. Goldberg, (2005) The multifarious, multireplicon 
Burkholderia cepacia complex. Nat Rev Microbiol 3: 144-156. 
Mahenthiralingam, E., P. Vandamme, M. E. Campbell, D. A. Henry, A. M. Gravelle, L. T. 
Wong, A. G. Davidson, P. G. Wilcox, B. Nakielna & D. P. Speert, (2001) Infection 
with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: 
virulent transmissible strains of genomovar III can replace Burkholderia multivorans. 
Clin Infect Dis 33: 1469-1475. 
Malott, R. J., A. Baldwin, E. Mahenthiralingam & P. A. Sokol, (2005) Characterization of the 
cciIR quorum-sensing system in Burkholderia cenocepacia. Infect Immun 73: 4982-
4992. 
Malott, R. J., E. P. O'Grady, J. Toller, S. Inhulsen, L. Eberl & P. A. Sokol, (2009) A 
Burkholderia cenocepacia orphan LuxR homolog is involved in quorum-sensing 
regulation. J Bacteriol 191: 2447-2460. 
Mattiuzzo, M., I. Bertani, S. Ferluga, L. Cabrio, J. Bigirimana, C. Guarnaccia, S. Pongor, H. 
Maraite & V. Venturi, (2010) The plant pathogen Pseudomonas fuscovaginae contains 
two conserved quorum sensing systems involved in virulence and negatively regulated 
by RsaL and the novel regulator RsaM. Environ Microbiol. 
McClean, K. H., M. K. Winson, L. Fish, A. Taylor, S. R. Chhabra, M. Camara, M. Daykin, J. 
H. Lamb, S. Swift, B. W. Bycroft, G. S. Stewart & P. Williams, (1997) Quorum 
sensing and Chromobacterium violaceum: exploitation of violacein production and 
inhibition for the detection of N-acylhomoserine lactones. Microbiology 143 ( Pt 12): 
3703-3711. 
Meselson, M. & R. Yuan, (1968) DNA restriction enzyme from E. coli. Nature 217: 1110-
1114. 
Meyer, J. M., and M. A. Abdallah, (1978) The fluorescent pigment of Pseudomonas 
fluorescens: biosyntehsis, purification and physico-chemical properties. J. Gen. 
Microbiol 107: 319-328. 
Miller, J., (1972) Experiments in Molecular Genetics. Cold Spring Harbor Laboratory, Cold 
Spring Harbor, NY. 
References 
100 
 
Miller, S. C., J. J. LiPuma & J. L. Parke, (2002) Culture-based and non-growth-dependent 
detection of the Burkholderia cepacia complex in soil environments. Appl Environ 
Microbiol 68: 3750-3758. 
Miller, V. L. & J. J. Mekalanos, (1988) A novel suicide vector and its use in construction of 
insertion mutations: osmoregulation of outer membrane proteins and virulence 
determinants in Vibrio cholerae requires toxR. J Bacteriol 170: 2575-2583. 
Nealson, K. H., T. Platt & J. W. Hastings, (1970) Cellular control of the synthesis and activity 
of the bacterial luminescent system. J Bacteriol 104: 313-322. 
O'Grady, E. P., D. F. Viteri, R. J. Malott & P. A. Sokol, (2009) Reciprocal regulation by the 
CepIR and CciIR quorum sensing systems in Burkholderia cenocepacia. BMC 
Genomics 10: 441. 
O'Toole, G. A. & R. Kolter, (1998) Initiation of biofilm formation in Pseudomonas 
fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic 
analysis. Mol Microbiol 28: 449-461. 
Parke, J. L. & D. Gurian-Sherman, (2001) Diversity of the Burkholderia cepacia complex and 
implications for risk assessment of biological control strains. Annu Rev Phytopathol 
39: 225-258. 
Parke, J. L., R.E. Rand, A.E. Joy, E.B. and King, (1991) Biological control of Pythium 
damping-off and Aphanomyces root rot of peas by application of Pseudomonas 
cepacia or P. fluorescens to seed. Plant Dis 75: 987-992. 
Perkins, D. N., D. J. Pappin, D. M. Creasy & J. S. Cottrell, (1999) Probability-based protein 
identification by searching sequence databases using mass spectrometry data. 
Electrophoresis 20: 3551-3567. 
Pessi, G., F. Williams, Z. Hindle, K. Heurlier, M. T. Holden, M. Camara, D. Haas & P. 
Williams, (2001) The global posttranscriptional regulator RsmA modulates production 
of virulence determinants and N-acylhomoserine lactones in Pseudomonas aeruginosa. 
J Bacteriol 183: 6676-6683. 
Rampioni, G., I. Bertani, E. Zennaro, F. Polticelli, V. Venturi & L. Leoni, (2006) The 
quorum-sensing negative regulator RsaL of Pseudomonas aeruginosa binds to the lasI 
promoter. J Bacteriol 188: 815-819. 
Rampioni, G., F. Polticelli, I. Bertani, K. Righetti, V. Venturi, E. Zennaro & L. Leoni, (2007) 
The Pseudomonas quorum-sensing regulator RsaL belongs to the tetrahelical 
superclass of H-T-H proteins. J Bacteriol 189: 1922-1930. 
Ratjen, F. & G. Doring, (2003) Cystic fibrosis. Lancet 361: 681-689. 
Riedel, K., C. Arevalo-Ferro, G. Reil, A. Gorg, F. Lottspeich & L. Eberl, (2003) Analysis of 
the quorum-sensing regulon of the opportunistic pathogen Burkholderia cepacia H111 
by proteomics. Electrophoresis 24: 740-750. 
Riedel, K., M. Hentzer, O. Geisenberger, B. Huber, A. Steidle, H. Wu, N. Hoiby, M. Givskov, 
S. Molin & L. Eberl, (2001) N-acylhomoserine-lactone-mediated communication 
between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms. 
Microbiology 147: 3249-3262. 
Romling, U., B. Fiedler, J. Bosshammer, D. Grothues, J. Greipel, H. von der Hardt & B. 
Tummler, (1994) Epidemiology of chronic Pseudomonas aeruginosa infections in 
cystic fibrosis. J Infect Dis 170: 1616-1621. 
Ryan, R. P., Y. McCarthy, S. A. Watt, K. Niehaus & J. M. Dow, (2009) Intraspecies signaling 
involving the diffusible signal factor BDSF (cis-2-dodecenoic acid) influences 
virulence in Burkholderia cenocepacia. J Bacteriol 191: 5013-5019. 
Saiman, L., G. Cacalano & A. Prince, (1990) Pseudomonas cepacia adherence to respiratory 
epithelial cells is enhanced by Pseudomonas aeruginosa. Infect Immun 58: 2578-2584. 
Saiman, L. & J. Siegel, (2004) Infection control in cystic fibrosis. Clin Microbiol Rev 17: 57-
71. 
References 
101 
 
Sambrook, J., Fritsch, E. F. & T. Maniatis      (1989) Molecular Cloning: a Laboratory 
Manual, 2nd edn. . Cold Spring Harbor, NY: Cold Spring Harbor Laboratory. 
Schwyn, B., and J. B. Neilands, (1987) Universal chemical assay for the detection and 
determination of siderophores. Anal. Biochem. 160: 47-56. 
Seed, K. D. & J. J. Dennis, (2008) Development of Galleria mellonella as an alternative 
infection model for the Burkholderia cepacia complex. Infect Immun 76: 1267-1275. 
Sist, P., P. Cescutti, S. Skerlavaj, R. Urbani, J. H. Leitao, I. Sa-Correia & R. Rizzo, (2003) 
Macromolecular and solution properties of Cepacian: the exopolysaccharide produced 
by a strain of Burkholderia cepacia isolated from a cystic fibrosis patient. Carbohydr 
Res 338: 1861-1867. 
Sokol, P. A., (1986) Production and utilization of pyochelin by clinical isolates of 
Pseudomonas cepacia. J Clin Microbiol 23: 560-562. 
Sokol, P. A., U. Sajjan, M. B. Visser, S. Gingues, J. Forstner & C. Kooi, (2003) The CepIR 
quorum-sensing system contributes to the virulence of Burkholderia cenocepacia 
respiratory infections. Microbiology 149: 3649-3658. 
Southern, E. M., (1975) Detection of specific sequences among DNA fragments separated by 
gel electrophoresis. J Mol Biol 98: 503-517. 
Speert, D. P., (2001) Understanding Burkholderia cepacia: epidemiology, genomovars, and 
virulence. Infect. Med. 18: 49–56. 
Stanier, R. Y., N. J. Palleroni & M. Doudoroff, (1966) The aerobic pseudomonads: a 
taxonomic study. J Gen Microbiol 43: 159-271. 
Steidle, A., K. Sigl, R. Schuhegger, A. Ihring, M. Schmid, S. Gantner, M. Stoffels, K. Riedel, 
M. Givskov, A. Hartmann, C. Langebartels & L. Eberl, (2001) Visualization of N-
acylhomoserine lactone-mediated cell-cell communication between bacteria 
colonizing the tomato rhizosphere. Appl Environ Microbiol 67: 5761-5770. 
Subsin, B., C. E. Chambers, M. B. Visser & P. A. Sokol, (2007) Identification of genes 
regulated by the cepIR quorum-sensing system in Burkholderia cenocepacia by high-
throughput screening of a random promoter library. J Bacteriol 189: 968-979. 
Sudakevitz, D., A. Imberty & N. Gilboa-Garber, (2002) Production, properties and specificity 
of a new bacterial L-fucose- and D-arabinose-binding lectin of the plant aggressive 
pathogen Ralstonia solanacearum, and its comparison to related plant and microbial 
lectins. J Biochem 132: 353-358. 
Sulak, O., G. Cioci, M. Delia, M. Lahmann, A. Varrot & A. I. M. Wimmerova, (2010) A 
TNF-like trimeric lectin domain from Burkholderia cenocepacia with specificity for 
fucosylated human histo-blood group antigens. Structure 18: 59-72. 
Tabacchioni, S., P. Visca, L. Chiarini, A. Bevivino, C. Di Serio, S. Fancelli & R. Fani, (1995) 
Molecular characterization of rhizosphere and clinical isolates of Burkholderia 
cepacia. Res Microbiol 146: 531-542. 
Tan, M. W., S. Mahajan-Miklos & F. M. Ausubel, (1999) Killing of Caenorhabditis elegans 
by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis. Proc 
Natl Acad Sci U S A 96: 715-720. 
Tielker, D., S. Hacker, R. Loris, M. Strathmann, J. Wingender, S. Wilhelm, F. Rosenau & K. 
E. Jaeger, (2005) Pseudomonas aeruginosa lectin LecB is located in the outer 
membrane and is involved in biofilm formation. Microbiology 151: 1313-1323. 
Toller, J., (2008) Untersuchungen zur Funktion von CepR2 im "Quorum sensing" von 
Burkholderia cenocepacia. Master Thesis, Universität Zürich. 
Tran Van, V., O. Berge, S. Ngo Ke, J. Balandreau, and T. Heulin (2000) Repeated beneficial 
effects of rice inoculation with a strain of Burkholderia vietnamiensis on early and late 
yield components in low fertility sulphate acid soils of Vietnam. Plant Soil 218: 273-
284. 
References 
102 
 
Tummler, B. & C. Kiewitz, (1999) Cystic fibrosis: an inherited susceptibility to bacterial 
respiratory infections. Mol Med Today 5: 351-358. 
Uehlinger, S., (2009) Identification of Virulence Factors in Burkholderia sp. Using Diverse 
Infection Hosts. Dissertation, University of Zurich. 
Uehlinger, S., S. Schwager, S. P. Bernier, K. Riedel, D. T. Nguyen, P. A. Sokol & L. Eberl, 
(2009) Identification of specific and universal virulence factors in Burkholderia 
cenocepacia strains by using multiple infection hosts. Infect Immun 77: 4102-4110. 
Ulrich, R. L., D. Deshazer, H. B. Hines & J. A. Jeddeloh, (2004) Quorum sensing: a 
transcriptional regulatory system involved in the pathogenicity of Burkholderia mallei. 
Infect Immun 72: 6589-6596. 
Van Oevelen, S., R. De Wachter, P. Vandamme, E. Robbrecht & E. Prinsen, (2002) 
Identification of the bacterial endosymbionts in leaf galls of Psychotria (Rubiaceae, 
angiosperms) and proposal of 'Candidatus Burkholderia kirkii' sp. nov. Int J Syst Evol 
Microbiol 52: 2023-2027. 
Vandamme, P., B. Holmes, T. Coenye, J. Goris, E. Mahenthiralingam, J. J. LiPuma & J. R. 
Govan, (2003) Burkholderia cenocepacia sp. nov.--a new twist to an old story. Res 
Microbiol 154: 91-96. 
Vandamme, P., B. Holmes, M. Vancanneyt, T. Coenye, B. Hoste, R. Coopman, H. Revets, S. 
Lauwers, M. Gillis, K. Kersters & J. R. Govan, (1997) Occurrence of multiple 
genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of 
Burkholderia multivorans sp. nov. Int J Syst Bacteriol 47: 1188-1200. 
Vanlaere, E., A. Baldwin, D. Gevers, D. Henry, E. De Brandt, J. J. LiPuma, E. 
Mahenthiralingam, D. P. Speert, C. Dowson & P. Vandamme, (2009) Taxon K, a 
complex within the Burkholderia cepacia complex, comprises at least two novel 
species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. Int J Syst 
Evol Microbiol 59: 102-111. 
Vanlaere, E., A. Baldwin, D. Gevers, D. A. Henry, J. J. Lipuma, E. Mahenthiralingam, D. 
Speert, C. Dowson & P. Vandamme, (2008a) Taxon K, a complex within the 
Burkholderia cepacia complex comprises at least two novel species: Burkholderia 
contaminans sp. nov. and Burkholderia lata sp. nov. . Int J Syst Evol Microbiol. 
Vanlaere, E., J. J. Lipuma, A. Baldwin, D. Henry, E. De Brandt, E. Mahenthiralingam, D. 
Speert, C. Dowson & P. Vandamme, (2008b) Burkholderia latens sp. nov., 
Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis 
sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia 
cepacia complex. Int J Syst Evol Microbiol 58: 1580-1590. 
Venturi, V., (2006) Regulation of quorum sensing in Pseudomonas. FEMS Microbiol Rev 30: 
274-291. 
Vermis, K., T. Coenye, J. J. LiPuma, E. Mahenthiralingam, H. J. Nelis & P. Vandamme, 
(2004) Proposal to accommodate Burkholderia cepacia genomovar VI as Burkholderia 
dolosa sp. nov. Int J Syst Evol Microbiol 54: 689-691. 
Visca, P., G. Colotti, L. Serino, D. Verzili, N. Orsi & E. Chiancone, (1992) Metal regulation 
of siderophore synthesis in Pseudomonas aeruginosa and functional effects of 
siderophore-metal complexes. Appl Environ Microbiol 58: 2886-2893. 
Webb, J. S., L. S. Thompson, S. James, T. Charlton, T. Tolker-Nielsen, B. Koch, M. Givskov 
& S. Kjelleberg, (2003) Cell death in Pseudomonas aeruginosa biofilm development. J 
Bacteriol 185: 4585-4592. 
Weiner MP, A. C., Jerpseth B, Wells S, Johnson-Browne B, Vaillancourt P (1994) Studier 
pET system vectors and hosts. Strateg Mol Biol 7: 41–43  
 
 
References 
103 
 
Weingart, C. L., C. E. White, S. Liu, Y. Chai, H. Cho, C. S. Tsai, Y. Wei, N. R. Delay, M. R. 
Gronquist, A. Eberhard & S. C. Winans, (2005) Direct binding of the quorum sensing 
regulator CepR of Burkholderia cenocepacia to two target promoters in vitro. Mol 
Microbiol 57: 452-467. 
Wentworth J S, A. F. E., Garber N C, Gilboa-Garber N, Paterson C A, Doyle R J. , (1991) 
Cytoplasmic lectins contribute to the adhesion of P. aeruginosa. Biofouling 4: 99–104. 
Whitehead, N. A., A. M. Barnard, H. Slater, N. J. Simpson & G. P. Salmond, (2001) Quorum-
sensing in Gram-negative bacteria. FEMS Microbiol Rev 25: 365-404. 
Williams, P., K. Winzer, W. C. Chan & M. Camara, (2007) Look who's talking: 
communication and quorum sensing in the bacterial world. Philos Trans R Soc Lond B 
Biol Sci 362: 1119-1134. 
Winson, M. K., S. Swift, L. Fish, J. P. Throup, F. Jorgensen, S. R. Chhabra, B. W. Bycroft, P. 
Williams & G. S. Stewart, (1998) Construction and analysis of luxCDABE-based 
plasmid sensors for investigating N-acyl homoserine lactone-mediated quorum 
sensing. FEMS Microbiol Lett 163: 185-192. 
Winsor, G. L., B. Khaira, T. Van Rossum, R. Lo, M. D. Whiteside & F. S. Brinkman, (2008) 
The Burkholderia Genome Database: facilitating flexible queries and comparative 
analyses. Bioinformatics 24: 2803-2804. 
Winzer, K., C. Falconer, N. C. Garber, S. P. Diggle, M. Camara & P. Williams, (2000) The 
Pseudomonas aeruginosa lectins PA-IL and PA-IIL are controlled by quorum sensing 
and by RpoS. J Bacteriol 182: 6401-6411. 
Wopperer, J., S. T. Cardona, B. Huber, C. A. Jacobi, M. A. Valvano & L. Eberl, (2006) A 
quorum-quenching approach to investigate the conservation of quorum-sensing-
regulated functions within the Burkholderia cepacia complex. Appl Environ Microbiol 
72: 1579-1587. 
Wopperer, J. D., (2008) Quorum Sensing and Virulence in Members of the Genus 
Burkholderia. Dissertation, University of Zurich. 
Zinger-Yosovich, K., D. Sudakevitz, A. Imberty, N. C. Garber & N. Gilboa-Garber, (2006) 
Production and properties of the native Chromobacterium violaceum fucose-binding 
lectin (CV-IIL) compared to homologous lectins of Pseudomonas aeruginosa (PA-IIL) 
and Ralstonia solanacearum (RS-IIL). Microbiology 152: 457-463. 
 
 
Appendix 
104 
 
6 Appendix 
 
Figure A1 
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Fig. A1. Transcription of aidA is stringently regulated by CepR. The diagram shows a representative 
example of the promoter activities of aidA determined in the B. cenocepacia H111 parent (filled circles), and in 
the cepR mutant H111-R (open circels). Transcription of aidA (BAS0293) is maximal at an optical density 
(OD600) of 2.5. ß-galactosidase activities of promoter fusion PaidA1-lacZ (2.2.8) were determined in LB-medium 
throughout the growth curve as measured by absorbance at 600 nm.  
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Figure A2 
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Fig. A2. Metabolic profiling of B. cenocepacia H111 strains using BIOLOG microtiter plates. The H111 
wild type (wt), mutant H111-R, and the complemented mutant H111-R (cepR
+
) were grown in plates containing 
minimal medium supplemented with varying carbon (PM1), nitrogen (PM2), sulfur (PM3) and phosphorus 
sources (PM4). Pictures were taken after an incubation period for 24h at 37°C (2.4.7). 
 
 
 
 
 
 
             H111 wt                                          H111-R                                 H111-R (cepR+) 
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Figure A3 
 
 
Fig. A3. Growth differences between the B. cenocepacia H111 wild type and mutant strains on minimal 
medium supplemented mit D-arabinose. The B. cenocepacia H111 wild type (1), mutant H111-R (2), mutant 
H111-I (3), cepR complemented mutants H111-R (cepR
+
) (4) and H111 wt (cepR
+
) (5), mutant H111-R2 (6), and 
H111-R/R2 (7) were grown for 48h at 37°C on mineral salt medium (2.2.1) agar plates supplemented with D-
arabinose [10 mM]. Strains were dropped from overnight cultures grown in MSM medium with 10 mM D-
arabinose.  
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Table A1. Genes and ORFs, tRNA and intergenetic regions which are more than 2-fold differentially regulated in the H111-R 
transcriptome versus the H111 wild type. a) : Genes in bold type illustrate QS-regulated genes also identified in the transcriptome analysis of B. cenocepacia K56-2 
(O'Grady et al., 2009) and 
b)
 : QS-regulated genes identified by alternative approaches. References are: 1: (Huber et al., 2001), 2: (Riedel et al., 2003), 3: (Huber et al., 2004), 
4: (Weingart et al., 2005) 5: (Chambers et al., 2006), 6: (Subsin et al., 2007),  7: (Malott et al., 2009) and 8: (Ryan et al., 2009). 
 
Gene name 
a) 
 
Fold 
change 
Description 
 
Reference 
b) 
 
BCAS0293 167,20 nematocidal protein AidA 2;3;4;5;6;7 
BCAS0292 138,10 conserved hypothetical protein  
BCAM0194 52,24 conserved hypothetical protein 7 
BCAM0193 47,68 conserved hypothetical protein 7 
BCAM0192 46,78 conserved hypothetical protein 7 
BCAM0196 37,72 conserved hypothetical protein 7 
BCAM0195 34,03 putative non-ribosomal peptide synthetase 7 
BCAM1871 32,53 conserved hypothetical protein  
BCAM1870 26,99 N-acylhomoserine lactone synthase CepI 1;4;5 
BCAL3285 25,80 flavohemoprotein  
BCAM0190 22,11 putative aminotransferase - class III 7 
BCAM0191 12,83 putative non-ribosomal peptide synthetase 7 
BCAM0200 9,24 efflux system transport protein 7 
BCAM0186 9,02 lectin 7 
BCAM2307 8,72 zinc metalloprotease ZmpB 2;7 
BCAL1677 8,72 putative type-1 fimbrial protein 2 
BCAL1681 8,57 putative exported protein  
BCAL1678 6,44 putative membrane usher protein precursor  
BCAL1680 6,20 putative type-1 fimbrial protein  
BCAM1869 6,07 conserved hypothetical protein  
BCAL0510 5,67 conserved hypothetical protein  
BCAL1679 5,48 putative fimbrial chaperone  
BCAS0236 5,39 putative haemagglutinin-rel. autotransporter  
BCAM2308 5,32 putative leucyl aminopeptidase precursor  
BCAL1813 5,29 multidrug efflux system outer membrane protein  
BCAM2142 5,28 transport system outer membrane protein  
BCAM0028 5,10 putative FHA-domain protein  
BCAM0184 5,07 lectin  
BCAM2143 5,06 cable pilus associated adhesin protein  
BCAL3178 4,97 LysR family regulatory protein  
BCAS0498 4,94 muconate cycloisomerase I 2  
BCAL0358 4,69 metallo peptidase, family M1 5 
BCAM2141 4,42 ABC transporter ATP-binding membrane protein  
BCAM2720 4,42 putative phospholipase C  
BCAS0409 4,36 zinc metalloprotease ZmpA 5;6;7 
BCAM0835 4,32 AraC family regulatory protein  
BCAM0188 4,13 N-acylhomoserine lactone dependent regulatory 7 
BCAM0393 4,05 putative beta-lactamase, class D  
BCAM0189 3,89 AraC family regulatory protein 7 
BCAM0392 3,83 putative acetyltransferase 5 
BCAL1921 3,49 conserved hypothetical protein  
BCAL3179 3,38 probable D-lactate dehydrogenase  
BCAL0121 3,30 aquaporin Z  
BCAM0185 3,25 lectin 2 
BCAL0831 3,23 putative storage protein 5 
BCAM0030 3,14 conserved hypothetical protein  
BCAM2140 3,10 transporter system transport protein  
BCAL0833 3,02 putative Acetoacetyl-CoA reductase  
BCAM2684 2,95 putative acetyltransferase  
BCAL1142 2,94 putative transposase  
BCAM2419 2,90 putative outer membrane protein A precursor  
BCAM0166 2,89 NADH dehydrogenase  
BCAL0625 2,81 LysR family regulatory protein  
BCAL2786 2,80 putative selenium-binding protein  
BCAL1731 2,80 Major Facilitator Superfamily protein  
BCAS0259 2,79 putative sodium:dicarboxylate symporter family  
BCAM0622 2,75 two-component regulatory system, sensor kinase  
BCAS0258 2,74 GntR family regulatory protein  
BCAM0130 2,72 putative acyl-CoA dehydrogenase 6 
BCAM2771 2,68 putative dihydrodipicolinate synthetase  
BCAM0341 2,67 acyl carrier protein phosphodiesterase 6 
BCAM2340 2,66 putative (R)-3-hydroxydecanoyl-ACP:CoA  
BCAM1697 2,65 putative membrane-associated amino terminal  
BCAM1413a 2,63 conserved hypothetical protein  
BCAM0031 2,55 conserved hypothetical protein  
BCAL3006 2,55 cold shock-like protein 6 
BCAM2444 2,52 putative exported protein  
BCAL0834 2,48 putative membrane protein  
BCAL0665 2,43 dethiobiotin synthetase  
BCAM1811 2,42 conserved hypothetical protein  
BCAM0633 2,42 conserved hypothetical protein  
BCAS0225 2,39 shiny variant regulator ShvR  
BCAS0497 2,39 catechol 1,2-dioxygenase 2  
BCAL2397 2,38 putative lipoprotein  
BCAM1673 2,38 Major Facilitator Superfamily protein  
BCAM1412 2,38 conserved hypothetical protein  
BCAM1010 2,36 putative UTP-glucose-1-phosphate  
BCAS0335 2,33 putative haemagglutinin-related autotransporter  
BCAM0634 2,31 hypothetical protein  
BCAM1876A 2,30 hypothetical phage protein  
BCAS0249 2,30 chromate resistance transport protein  
BCAM2770 2,23 putative sulfur-binding protein  
BCAL2353 2,23 putative sulfate transporter  
BCAS0771 2,22 putative adenylosuccinate synthetase  
BCAS0412 2,22 putative membrane protein  
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BCAL3187 2,22 putative oxidoreductase  
BCAM1005 2,21 putative acyltransferase  
BCAL1551 2,20 ROK family regulatory protein  
BCAS0260 2,19 hypothetical protein  
BCAL3007 2,18 conserved hypothetical protein  
BCAM2227 2,18 putative pyochelin biosynthetic protein PchG  
BCAL1542 2,13 TetR family regulatory protein  
BCAM0197 2,12 LysR family regulatory protein  
BCAM1672 2,11 mannonate dehydratase  
BCAM2169 2,10 putative outer membrane autotransporter  
BCAL1722 2,07 putative exported chitinase 1 
BCAS0496 2,04 benzoate 1,2-dioxygenase alpha subunit  
BCAM0476a 2,04 hypothetical protein  
BCAL1806 2,04 conserved hypothetical protein  
BCAL1524 2,04 putative lipoprotein  
BCAS0739 2,04 putative acetyl-CoA synthetase  
BCAM1927 2,01 putative exported protein  
BCAM0695 2,00 putative lipoprotein  
BCAM2725 0,50 putative oligopeptide ABC transporter  
BCAL2598 0,49 putative DNA-binding protein  
BCAM2623 0,49 conserved hypothetical protein  
BCAM2489 0,48 putative transmembrane phosphate transporter  
BCAL2050 0,48 4Fe-4S ferredoxin  
BCAM1376 0,48 putative porin  
BCAL0722 0,48 C4-dicarboxylate transport protein  
BCAM1405 0,47 levansucrase  
BCAL1619 0,47 alkanesulfonate monooxygenase  
BCAM0391 0,47 putative exported protein  
BCAM1777A 0,47 putative exported protein  
BCAL1620 0,46 putative aliphatic sulfonates transport permease  
BCAL1688 0,45 sigma factor 70 EcfI (OrbS)  
BCAM1198 0,45 conserved hypothetical protein  
BCAS0257 0,45 putative acetyltransferase  
BCAL0124 0,45 flagellar regulon master regulator subunit FlhD  
BCAL3001 0,45 TonB-dependent siderophore receptor  
BCAM0776 0,45 putative cNMP-binding domain protein  
BCAL1063 0,45 succinylarginine dihydrolase  
BCAM1745 0,44 putative magnesium-transporting ATPase  
BCAM1283 0,44 putative phosphoesterase  
BCAM2060 0,44 putative divalent cation transporter  
BCAL2049 0,44 fumarate reductase/succinate dehydrogenase  
BCAM1804 0,44 methyl-accepting chemotaxis protein  
BCAL1114 0,43 putative ABC transport system, membrane protein  
BCAM1199 0,43 two-component regulatory system, response  
BCAL1272 0,42 phosphate transport system permease protein 
BCAM1282 0,41 putative di-haem cytochrome c peroxidase  
BCAM1197 0,41 conserved hypothetical protein  
BCAL1275 0,40 phosphate regulon two-component regulatory  
BCAL1270 0,39 phosphate transport system, substrate-binding  
BCAM1149 0,39 putative lipoprotein 5 
BCAL2607 0,38 putative exported protein  
BCAM2504 0,38 conserved hypothetical protein  
BCAL1622 0,37 molybdenum-pterin binding protein II  
BCAM0628 0,37 putative low molecular weight phosphotyrosine  
BCAL1273 0,37 phosphate ABC transporter ATP-binding protein  
BCAL1113 0,37 ABC transporter ATP-binding protein  
BCAM1195 0,37 two-component regulatory system, sensor kinase  
BCAM2679 0,36 conserved hypothetical protein  
BCAM2723 0,36 putative outer membrane porin protein  
BCAL0696 0,36 putative 2',3'-cyclic-nucleotide  
BCAM2498 0,35 extracellular solute-binding protein  
BCAL1674 0,35 multidrug efflux system AmrA protein  
BCAL3473 0,34 putative outer membrane porin  
BCAL1274 0,34 phosphate transport system-related protein  
BCAM0502 0,34 conserved hypothetical protein  
BCAL1117 0,33 LacI family regulatory protein  
BCAM2010 0,33 conserved hypothetical protein  
BCAL2819 0,32 putative permease protein  
BCAL1271 0,31 phosphate transport system permease protein  
BCAM2009 0,25 2OG-Fe(II) oxygenase superfamily protein  
BCAL1083 0,25 putative exported alkaline phosphatase  
BCAM2007 0,23 TonB-dependent siderophore receptor  
BCAM1187 0,13 TonB-dependent siderophore receptor 5 
    
IG2_2089610 73,40 interG_chr2_pos_1036_2089610:2090371  
IG1_1836014 9,43 interG_chr1_pos_1002_1836014:1836102  
IG2_2087974 9,06 interG_chr2_pos_1034_2087974:2088183  
IG2_230868 7,05 interG_chr2_pos_110_230868:232940  
IG2_2589126 6,46 interG_chr2_pos_1238_2589126:2589204  
IG3_811123 5,16 interG_chr3_pos_363_811123:815031  
IG1_3476475 4,67 interG_chr1_pos_1693_3476475:3476645  
IG1_2117018 4,20 interG_chr1_pos_1109_2117018:2120766  
IG1_3297972 3,99 interG_chr1_pos_1609_3297972:3298473  
IG1_901672 3,96 interG_chr1_pos_504_901672:902168  
IG2_219668 3,59 interG_chr2_pos_104_219668:220648  
IG1_2653432 2,98 interG_chr1_pos_1304_2653432:2653684  
IG2_1926503 2,94 interG_chr2_pos_955_1926503:1926918  
IG1_2605106 2,64 interG_chr1_pos_1279_2605106:2605488  
IG2_1120955 2,62 interG_chr2_pos_580_1120955:1123103  
IG1_1814299 2,58 interG_chr1_pos_989_1814299:1814586  
IG2_943874 2,46 interG_chr2_pos_486_943874:943947  
IG3_289386 2,38 interG_chr3_pos_152_289386:289561  
IG2_1853918 2,35 interG_chr2_pos_929_1853918:1854189  
IG1_680158 2,34 interG_chr1_pos_393_680158:681471  
IG1_2651825 2,31 interG_chr1_pos_1303_2651825:2652279  
IG2_840130 2,28 interG_chr2_pos_425_840130:840302  
IG1_2166257 2,24 interG_chr1_pos_1130_2166257:2171209  
IG1_1224302 2,24 interG_chr1_pos_668_1224302:1224367  
IG1_3180610 2,24 interG_chr1_pos_1539_3180610:3180736  
IG2_2036821 2,22 interG_chr2_pos_1014_2036821:2037459  
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IG3_736569 2,21 interG_chr3_pos_333_736569:744787  
IG1_48129 2,11 interG_chr1_pos_34_48129:48505  
IG1_846330 2,08 interG_chr1_pos_482_846330:846415  
IG2_836365 2,00 interG_chr2_pos_424_836365:839355  
IG2_3061820 0,50 interG_chr2_pos_1426_3061820:3063511  
IG2_2970010 0,40 interG_chr2_pos_1386_2970010:2971563  
IG2_2227257 0,32 interG_chr2_pos_1118_2227257:2227324  
IG1_3089813 0,32 interG_chr1_pos_1515_3089813:3093964  
    
BCALr0472 5,21 tRNA Phe anticodon GAA, Cove score 86.97 
BCALr0800 4,64 tRNA Gln anticodon TTG, Cove score 73.12 
BCALr0218c 4,57 tRNA Thr anticodon GGT, Cove score 90.12 
BCALr3029 3,73 tRNA Ser anticodon CGA, Cove score 71.72 
BCALr0457 3,70 tRNA Lys anticodon CTT, Cove score 94.68 
BCALr1551a 3,43 tRNA Leu anticodon CAG, Cove score 72.78 
BCALr0409c 3,14 tRNA Ala anticodon TGC, Cove score 90.89 
BCALr1625 2,97 tRNA His anticodon GTG, Cove score 78.40 
BCALr2852a 2,78 tRNA Cys anticodon GCA, Cove score 64.58 
BCALr1899 2,76 Bacterial signal recognition particle RNA (RF00169) 
BCALr2281 2,75 tRNA Ser anticodon GGA, Cove score 70.94 
BCALr0080 2,74 Perfect repeat flanking prophage 
BCALr2344 2,69 tRNA Leu anticodon GAG, Cove score 63.68 
BCALr2006 2,66 tRNA Leu anticodon TAG, Cove score 75.32 
BCALr3009b 2,58 tRNA Arg anticodon ACG, Cove score 87.10 
BCALr1290 2,46 Perfect repeat flanking genomic island  
BCALr3075 2,41 Perfect repeat flanking genomic island  
BCALr2125e 2,21 tRNA Asp anticodon GTC, Cove score 95.34 
BCALr2458 2,13 tRNA Arg anticodon CCT, Cove score 72.32 
BCALr3205 2,09 tRNA Lys anticodon TTT, Cove score 90.90 
BCALr1614 2,08 tRNA Met anticodon CAT, Cove score 86.01 
BCALr1279 2,06 tRNA Pro anticodon TGG, Cove score 89.00 
BCALr2219 2,02 tRNA Met anticodon CAT, Cove score 86.80 
BCAMr1592 0,48 Cobalamin riboswitch as predicted by Rfam, RF00174 
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Table A2. Genes and ORFs, tRNA and intergenetic regions which are more than 2-fold differentially regulated in the H111-R (cepR
+
) 
transcriptome versus the H111 wild type. a): Genes in bold type illustrate QS-regulated genes also identified in the transcriptome analysis of B. cenocepacia K56-2 
(O´Grady et al., 2009) and 
b)
 : QS-  regulated genes identified by alternative approaches. References are: 1: (Huber et al., 2001), 2: (Riedel et al., 2003), 3: (Huber et al., 
2004), 4: (Weingart et al., 2005) 5: (Chambers et al., 2006), 6: (Subsin et al., 2007),  7: (Malott et al., 2009) and 8: (Ryan et al., 2009). 
 
Gene name 
a) 
 
Fold 
change 
Description 
 
Reference 
b) 
 
BCAM2062 4,97 conserved hypothetical protein  
BCAL0566 4,87 basal-body rod modification protein FlgD  
BCAL0140 4,79 flagellar biosynthetic protein FlhB  
BCAL3507 4,78 flagellar FliL protein  
BCAL0523 4,37 flagellar assembly protein FliH  
BCAL3501 4,10 flagellar biosynthetic protein FliR  
BCAM1777A 4,09 putative exported protein  
BCAL0142 4,06 putative flagellar biosynthesis protein  
BCAL0564 4,02 flagellar basal body rod protein FlgB  
BCAL0042 4,01 trifunctional transcriptional regulator PutA  
BCAL0144 4,00 RNA polymerase sigma factor for flagellar  
BCAL3505 3,99 flagellar motor switch protein FliN  
BCAL1731 3,98 Major Facilitator Superfamily protein  
BCAM1804 3,76 methyl-accepting chemotaxis protein  
BCAL3187 3,69 putative oxidoreductase  
BCAL0110 3,67 putative aminotransferase  
BCAL0571 3,66 flagellar basal body P-ring protein  
BCAL3506 3,56 flagellar motor switch protein FliM 6 
BCAL1056 3,55 histidine transport system permease protein  
BCAL0522 3,54 flagellum-specific ATP synthase FliI  
BCAL0568 3,48 flagellar basal body rod protein FlgF  
BCAL0143 3,41 putative flagellar biosynthesis protein  
BCAL0528 3,37 conserved hypothetical protein  
BCAL0572 3,36 flagellar rod assembly protein/muramidase FlgJ  
BCAL1818 3,35 metallo-beta-lactamase superfamily protein  
BCAL1055 3,32 histidine transport system permease protein  
BCAM2021 3,27 methyl-accepting chemotaxis protein  
BCAM0778 3,22 OmpA family protein  
BCAL1500 3,21 conserved hypothetical protein  
BCAL2705 3,14 ABC transporter ATP-binding protein  
BCAL0200 3,14 putative lipoprotein  
BCAL0570 3,12 flagellar basal body L-ring protein  
BCAM1097 3,12 putative membrane protein  
BCAL0526 3,11 flagellar hook-basal body complex protein FliE  
BCAL0569 3,11 flagellar basal body rod protein FlgG  
BCAM1745 3,03 putative magnesium-transporting ATPase  
BCAL0525 3,02 flagellar M-ring protein FliF  
BCAL2706 2,97 ABC transporter ATP-binding protein  
BCAM1811 2,97 conserved hypothetical protein  
BCAL0524 2,97 flagellar motor switch protein FliG  
BCAM0776 2,94 putative cNMP-binding domain protein  
BCAL0521 2,92 flagellar FliJ protein 8 
BCAL2708 2,92 putative amino-acid transport permease protein  
BCAL0668 2,91 serine peptidase, family S9 unassigned  
BCAL0520 2,90 putative flagellar hook-length protein FliK  
BCAL0198 2,90 putative outer membrane protein  
BCAL0660 2,89 biotin carboxylase  
BCAM1378 2,88 ABC transporter permease protein  
BCAL0561 2,87 flagella synthesis protein FlgN  
BCAL1819 2,81 conserved hypothetical protein  
BCAL2615 2,80 putative exported outer membrane porin  
BCAM1377 2,78 ABC transporter ATP-binding protein  
BCAL2707 2,72 putative transport system permease protein  
BCAL0128 2,71 chemotaxis two-component response regulator 
CheY 
 
BCAL0766 2,70 putative branched-chain amino acid transport  
BCAM2060 2,70 putative divalent cation transporter  
BCAL2819 2,69 putative permease protein  
BCAL2905 2,68 hypothetical protein  
BCAL0567 2,67 flagellar hook protein 1 FlgE1  
BCAM2374 2,67 putative methyl-accepting chemotaxis protein  
BCAL0043 2,66 putative extracellular ligand-binding protein  
BCAL2709 2,66 conserved hypothetical protein  
BCAM1488 2,66 putative proline racemase  
BCAL0126 2,65 chemotaxis protein MotA  
BCAL3237 2,64 putative transposase  
BCAM1166 2,63 putative membrane protein  
BCAM0613 2,63 ABC transporter ATP-binding protein  
BCAL1142 2,61 putative transposase  
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BCAM1744 2,61 serine peptidase, family S9  
BCAL2028 2,61 LysR family regulatory protein  
BCAL2246 2,59 histidine ammonia-lyase  
BCAM1768 2,56 conserved hypothetical protein  
BCAL0527 2,56 flagellar protein FliS  
BCAL1549 2,54 putative sugar ABC transport system, 
membrane 
 
BCAM2502 2,53 3-dehydroquinate dehydratase  
BCAM2679 2,52 conserved hypothetical protein  
BCAM0163 2,50 putative microcin immunity protein  
BCAL0665 2,49 dethiobiotin synthetase  
BCAM2201 2,48 conserved hypothetical protein  
BCAM0130 2,47 putative acyl-CoA dehydrogenase 6 
BCAM0603 2,47 conserved hypothetical protein  
BCAL0659 2,46 allophanate hydrolase subunit 1  
BCAL0287 2,46 putative outer membrane protein  
BCAL0124 2,45 flagellar regulon master regulator subunit FlhD  
BCAS0498 2,43 muconate cycloisomerase I 2  
BCAL0132 2,43 chemotaxis protein methyltransferase  
BCAL3499 2,42 ABC transporter ATP-binding protein  
BCAM2730 2,41 putative tripeptide permease  
BCAL0691 2,41 putative cytidylyltransferase  
BCAL1547 2,40 carbohydrate kinase  
BCAM2685 2,40 conserved hypothetical protein  
BCAL0762 2,39 putative methyl-accepting chemotaxis protein  
BCAL0127 2,39 chemotaxis protein MotB  
BCAL0133 2,38 put. chemoreceptor glutamine deamidase cheD  
BCAL0129 2,38 chemotaxis two-component sensor kinase CheA  
BCAS0050 2,37 putative amidohydrolase  
BCAM1165 2,37 putative membrane protein 6 
BCAL3184 2,36 homogentisate 1,2-dioxygenase  
BCAM2501 2,35 shikimate 5-dehydrogenase  
BCAM1831 2,35 putative cyclase  
BCAL0111 2,34 putative TPR repeat protein 6 
BCAM2720 2,34 putative phospholipase C  
BCAM2327 2,34 AraC family regulatory protein  
BCAM1286 2,33 secondary glycine betaine transporter betu  
BCAL0125 2,32 flagellar regulon master regulator subunit FlhC  
BCAL3001 2,32 TonB-dependent siderophore receptor  
BCAM2836 2,32 putative diguanylate cyclase  
BCAL0134 2,31 chemotaxis-specific methylesterase  
BCAL0662 2,30 LamB/YcsF family protein  
BCAM0749 2,30 lysine-specific permease  
BCAL0584 2,29 putative outer membrane porin protein  
BCAL2741 2,29 putative exported protein  
BCAL0065 2,28 conserved hypothetical protein  
BCAM1167 2,26 conserved hypothetical protein  
BCAM1205 2,26 putative membrane protein  
BCAL3040 2,25 ABC transporter, membrane permease  
BCAM2746 2,25 carbon starvation protein A  
BCAM2723 2,22 putative outer membrane porin protein  
BCAM1376 2,20 putative porin  
BCAL2833 2,20 putative membrane protein  
BCAS0151 2,20 hypothetical protein  
BCAL0576 2,19 flagellar hook-associated protein 1 (HAP1)  
BCAL0529 2,18 conserved hypothetical protein  
BCAL3183 2,17 putative hydrolase  
BCAM1315 2,16 acylamide amidohydrolase  
BCAM2063 2,16 putative carbohydrate-selective porin  
BCAM0761 2,16 histidine transport system permease  
BCAM0341 2,15 FMN-dependent NADH-azoreductase 6 
BCAL1635a 2,15 putative exported protein  
BCAL0661 2,15 putative biotin-binding protein  
BCAL0726 2,15 putative lipoprotein  
BCAM2482 2,14 agmatinase  
BCAL2791 2,13 putative kynureninase  
BCAL3473 2,13 putative outer membrane porin  
BCAM1810 2,12 putative cold shock protein  
BCAL2904 2,11 conserved hypothetical protein  
BCAL1550 2,10 putative sugar ABC transporter ATP-binding 6 
BCAM2563 2,10 methyl-accepting chemotaxis protein  
BCAM1957 2,10 ABC transporter ATP-binding protein  
BCAM2500 2,09 putative glucarate transporter  
BCAL3186 2,09 conserved hypothetical protein  
BCAL3039 2,09 ABC transporter, membrane permease  
BCAL0767 2,08 ABC transporter ATP-binding protein  
BCAL2740 2,08 high-affinity nickel transport protein  
BCAS0236 2,07 putative haemagglutinin-related autotransporter  
BCAM1460 2,06 Major Facilitator Superfamily protein  
BCAM1769 2,06 putative D-alanyl-D-alanine dipeptidase  
BCAS0398 2,06 putative diguanylate cyclase  
BCAL0413 2,06 conserved hypothetical protein  
BCAM2171 2,05 putative rod shape-determining protein  
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BCAL0950 2,05 Major Facilitator Superfamily protein  
BCAL3317 2,05 putative membrane protein  
BCAL3502 2,04 flagellar biosynthetic protein FliQ  
BCAL0768 2,04 conserved hypothetical protein  
BCAL2245 2,04 putative histidine utilization repressor  
BCAL0113 2,03 B-type flagellar hook-associated protein 2  
BCAL0577 2,03 flagellar hook-associated protein 3 (HAP3)  
BCAL1270 2,02 phosphate transport system, substrate-binding  
BCAL1119 2,02 conserved hypothetical protein  
BCAS0630 2,02 putative transporter - NRAMP family  
BCAL2370 2,02 putative membrane protein  
BCAS0247 2,01 hypothetical protein  
BCAM2739A 0,50 hypothetical protein  
BCAM2169 0,50 putative outer membrane autotransporter  
BCAL1085 0,50 putative membrane protein  
BCAS0773 0,50 putative exported protein  
BCAL1833 0,50 putative exported protein  
BCAM2041 0,49 type III secretion system protein BcscR 6 
BCAM1800 0,49 conserved hypothetical protein  
BCAM0549 0,49 10 kDa chaperonin 2  
BCAM1175 0,49 putative iron-sulfur cluster protein  
BCAM1411 0,49 putative short-chain dehydrogenase  
BCAM1414 0,49 conserved hypothetical protein  
BCAL2472 0,49 alpha,alpha-trehalose-phosphate synthase  
BCAM1012 0,48 putative histone-like protein  
BCAM0633 0,48 conserved hypothetical protein  
BCAM0015 0,48 conserved hypothetical protein  
BCAM2446 0,48 putative gram-negative porin  
BCAS0001 0,48 conserved hypothetical protein  
BCAM0952 0,48 ABC transporter ATP-binding protein  
BCAL2218 0,48 putative transposase  
BCAL0193 0,48 putative exported protein  
BCAS0479 0,48 conserved hypothetical protein  
BCAS0732 0,48 putative cytosine/purines, uracil, thiamine,  
BCAM2385 0,48 rifampin ADP-ribosyl transferase  
BCAM1066 0,48 hypothetical phage protein  
BCAM0507 0,47 CsbD-like protein  
BCAM0262 0,47 ABC transporter ATP-binding protein  
BCAS0260 0,47 hypothetical protein  
BCAM2477 0,47 serine peptidase, family S10  
BCAM1358 0,47 gluconate dehydrogenase cytochrome c subunit  
BCAM2042 0,47 type III secretion system protein  
BCAM0541 0,47 putative DNA-binding protein  
BCAS0258 0,46 GntR family regulatory protein  
BCAM2286 0,46 putative short chain dehydrogenase  
BCAL1573 0,46 hypothetical phage protein  
BCAM2289 0,46 conserved hypothetical protein  
BCAM0863 0,46 putative glycosyltransferase  
BCAM2233 0,46 putative pyochelin biosynthetic protein PchC  
BCAM1004 0,46 GCP-mannose 4,6-dehydratase  
BCAL0002 0,46 carboxylate-amine ligase YbdK  
BCAS0480 0,46 putative exported protein  
BCAM2049 0,45 type III secretion system protein  
BCAM2340 0,45 putative (R)-3-hydroxydecanoyl-ACP:CoA  
BCAM2051 0,45 type III secretion system protein  
BCAL2512 0,45 putative membrane protein  
BCAM0843 0,45 putative lipoprotein  
BCAM0227 0,45 hybrid two component system kinase-response  
BCAL2206 0,44 phasin-like protein  
BCAL2301 0,44 putative exported protein 6 
BCAM2779 0,44 putative N-isopropylammelide isopropyl  
BCAM0214 0,44 putative glycosyltransferase  
BCAM1742 0,44 putative exported protein  
BCAM0853 0,44 conserved hypothetical protein  
BCAL0831 0,44 putative storage protein  
BCAM0652 0,44 putative gram-negative porin  
BCAL1664 0,44 conserved hypothetical protein  
BCAM0213 0,44 putative membrane protein  
BCAM0857 0,44 phosphotyrosine phosphatase BceD  
BCAM1871 0,44 conserved hypothetical protein  
BCAL3322 0,44 putative DNA-binding protein  
BCAM2224 0,43 putative pyochelin receptor protein FptA  
BCAL1297 0,43 hypothetical protein  
BCAM2378 0,43 putative Xaa-Pro dipeptidyl-peptidase  
BCAM0906 0,43 putative dienelactone hydrolase family protein  
BCAM2034 0,43 putative UDP-glucose 6-dehydrogenase  
BCAL1689 0,43 MbtH-like protein OrbH  
BCAL3298 0,43 conserved hypothetical protein  
BCAS0658 0,43 putative transposition-related protein  
BCAL1294 0,42 conserved hypothetical protein  
BCAM2140 0,42 transporter system transport protein  
BCAL0834 0,42 putative membrane protein  
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BCAL1513 0,42 MarR family regulatory protein 6 
BCAS0636 0,42 conserved hypothetical protein  
BCAL0926 0,42 putative glycerol-3-phosphate dehydrogenase  
BCAM0189 0,42 AraC family regulatory protein 7 
BCAL3229 0,42 conserved hypothetical protein  
BCAL3006 0,42 cold shock-like protein 6 
BCAL2786 0,41 putative selenium-binding protein  
BCAM0663 0,41 putative gram-negative porin  
BCAM2336 0,41 putative sugar transferase  
BCAL0683 0,41 conserved hypothetical protein  
BCAM0810 0,40 putative aromatic oxygenase  
BCAL0531 0,40 putative membrane protein  
BCAM0021 0,40 putative patatin-like phospholipase  
BCAM2050 0,40 type III secretion system protein  
BCAL0358 0,40 metallo peptidase, family M1 5 
BCAM1454 0,39 putative exported protein  
BCAL2353 0,39 putative sulfate transporter  
BCAS0153 0,39 conserved hypothetical protein  
BCAS0341 0,39 putative binding-protein-dependent transport  
BCAL3179 0,38 probable D-lactate dehydrogenase  
BCAM0096 0,38 ABC transporter ATP-binding protein  
BCAL0282 0,38 putative ABC transporter extracellular solute-  
BCAM2143 0,38 cable pilus associated adhesin protein  
BCAM1959 0,38 putative membrane protein  
BCAL1952 0,37 conserved hypothetical protein  
BCAS0323 0,37 LacI family regulatory protein  
BCAM1540 0,37 putative dehydrogenase, molybdopterin binding  
BCAL1665 0,37 SpoVR like protein  
BCAM1861 0,36 calcineurin-like phosphoesterase  
BCAM2653 0,36 putative exported protein  
BCAM0934 0,36 efflux system transport protein  
BCAS0637 0,35 60 kDa chaperonin 3  
BCAM0855 0,35 UDP-glucose dehydrogenase BceC  
BCAL2297 0,34 conserved hypothetical protein  
BCAL2352 0,34 putative carbonic anhydrase  
BCAM0861 0,34 putative glycosyltransferase  
BCAM1374 0,34 conserved hypothetical protein  
BCAM0860 0,34 glycosyltransferase 6 
BCAM1010 0,32 putative UTP-glucose-1-phosphate  
BCAL3321 0,32 glyoxalase/bleomycin resistance  
BCAM1867 0,31 putative Mg(2+) transport ATPase (MgtC)  
BCAL1974 0,31 putative lipoprotein  
BCAL1372 0,31 putative exported protein  
BCAM0031 0,30 conserved hypothetical protein  
BCAM0184 0,30 lectin  
BCAM0548 0,30 60 kDa chaperonin 2  
BCAM0634 0,30 hypothetical protein  
BCAM0854 0,30 bifunct. exopolysaccharide biosynthesis BceA  
BCAL2290 0,29 putative bacterioferritin ferredoxin protein  
BCAM1964 0,29 putative exported protein 
BCAS0053 0,29 FMN reductase  
BCAM0191 0,29 putative non-ribosomal peptide synthetase 7 
BCAS0409 0,29 zinc metalloprotease ZmpA 5;6;7 
BCAM0803 0,29 muconolactone delta-isomerase  
BCAM0835 0,29 AraC family regulatory protein  
BCAL1688 0,28 sigma factor 70 EcfI (OrbS)  
BCAM0859 0,28 tyrosine autokinase BceF  
BCAM0804 0,28 catechol 1,2-dioxygenase 1  
BCAL1151 0,26 putative short-chain dehydrogenase  
BCAM0844 0,26 conserved hypothetical protein  
BCAM0392 0,25 putative acetyltransferase 5 
BCAM2771 0,25 putative dihydrodipicolinate synthetase  
BCAS0638 0,25 10 kDa chaperonin 3  
BCAL1813 0,24 multidrug efflux system outer membrane protein  
BCAM0030 0,24 conserved hypothetical protein  
BCAM2770 0,23 putative sulfur-binding protein  
BCAM0188 0,22 N-acylhomoserine lactone dependent regulatory 7 
BCAL0833 0,22 putative Acetoacetyl-CoA reductase  
BCAM1669 0,22 putative exported protein  
BCAM0504 0,20 CsbD-like protein  
BCAM0201 0,20 Major Facilitator Superfamily protein 7 
BCAM0505 0,20 putative membrane-attached protein  
BCAM0186 0,20 lectin 7 
BCAM2052 0,19 putative type III secretion system protein  
BCAM2505 0,19 AraC family regulatory protein  
BCAM0393 0,18 putative beta-lactamase, class D  
BCAM2308 0,18 putative leucyl aminopeptidase precursor  
BCAM0199 0,17 outer membrane efflux protein 7 
BCAM0190 0,17 putative aminotransferase - class III 7 
BCAM0192 0,16 conserved hypothetical protein 7 
BCAM0196 0,16 conserved hypothetical protein 7 
BCAM2053 0,16 putative type III secretion system protein  
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BCAM2307 0,15 zinc metalloprotease ZmpB 2;7 
BCAM0193 0,15 conserved hypothetical protein 7 
BCAM0195 0,14 putative non-ribosomal peptide synthetase 7 
BCAM0197 0,14 LysR family regulatory protein  
BCAS0292 0,13 conserved hypothetical protein  
BCAM0194 0,12 conserved hypothetical protein 7 
BCAM0957 0,11 putative pepstatin-insensitive carboxyl 5 
BCAM1413a 0,08 conserved hypothetical protein  
BCAM1412 0,07 conserved hypothetical protein  
BCAM0200 0,07 efflux system transport protein 7 
BCAM1868 0,05 N-acylhomoserine lactone dependent regulatory 5 
BCAS0293 0,04 nematocidal protein AidA 2;3;4;5;6;7 
    
IG1_619308 5,51 interG_chr1_pos_364_619308:619404  
IG1_631117 5,16 interG_chr1_pos_374_631117:631394  
IG2_2295883 4,84 interG_chr2_pos_1135_2295883:2295972  
IG1_147730 4,25 interG_chr1_pos_68_147730:147909  
IG2_1187397 3,94 interG_chr2_pos_634_1187397:1190643  
IG2_840130 2,98 interG_chr2_pos_425_840130:840302  
IG1_3180610 2,90 interG_chr1_pos_1539_3180610:3180736  
IG1_679012 2,83 interG_chr1_pos_392_679012:679194  
IG1_3319801 2,81 interG_chr1_pos_1624_3319801:3321792  
IG3_811123 2,76 interG_chr3_pos_363_811123:815031  
IG2_1953120 2,71 interG_chr2_pos_965_1953120:1953814  
IG2_1299473 2,67 interG_chr2_pos_679_1299473:1300656  
IG1_52439 2,63 interG_chr1_pos_35_52439:52522  
IG1_3822505 2,63 interG_chr1_pos_1830_3822505:3822812  
IG2_836365 2,61 interG_chr2_pos_424_836365:839355  
IG2_831218 2,52 interG_chr2_pos_420_831218:831479  
IG2_187443 2,47 interG_chr2_pos_93_187443:192081  
IG2_671659 2,46 interG_chr2_pos_350_671659:674180  
IG1_3664357 2,44 interG_chr1_pos_1786_3664357:3666206  
IG1_582769 2,41 interG_chr1_pos_345_582769:583037  
IG1_2653432 2,37 interG_chr1_pos_1304_2653432:2653684  
IG3_536263 2,29 interG_chr3_pos_259_536263:537450  
IG3_319296 2,27 interG_chr3_pos_169_319296:321635  
IG1_3089813 2,27 interG_chr1_pos_1515_3089813:3093964  
IG1_3537906 2,26 interG_chr1_pos_1722_3537906:3539109  
IG1_3436208 2,22 interG_chr1_pos_1681_3436208:3448228  
IG2_1176685 2,22 interG_chr2_pos_619_1176685:1177107  
IG2_208795 2,20 interG_chr2_pos_100_208795:209162  
IG2_961669 2,19 interG_chr2_pos_497_961669:962112  
IG2_1985968 2,15 interG_chr2_pos_982_1985968:1986037  
IG1_579967 2,15 interG_chr1_pos_341_579967:580205  
IG1_830187 2,14 interG_chr1_pos_476_830187:830345  
IG1_3414831 2,13 interG_chr1_pos_1677_3414831:3418039  
IG2_2731412 2,13 interG_chr2_pos_1296_2731412:2731800  
IG1_2994853 2,12 interG_chr1_pos_1473_2994853:3000458  
IG1_155066 2,11 interG_chr1_pos_74_155066:155230  
IG1_603517 2,11 interG_chr1_pos_356_603517:606750  
IG1_2334236 2,09 interG_chr1_pos_1197_2334236:2334625  
IG1_825611 2,03 interG_chr1_pos_472_825611:825836  
IG1_2332334 2,01 interG_chr1_pos_1196_2332334:2332690  
IG2_219668 0,49 interG_chr2_pos_104_219668:220648  
IG2_439284 0,49 interG_chr2_pos_216_439284:439750  
IG2_2789309 0,48 interG_chr2_pos_1319_2789309:2790989  
IG3_27594 0,47 interG_chr3_pos_10_27594:27691  
IG2_2304176 0,47 interG_chr2_pos_1139_2304176:2304510  
IG2_2586922 0,44 interG_chr2_pos_1237_2586922:2587412  
IG1_1495942 0,43 interG_chr1_pos_805_1495942:1496283  
IG1_2166257 0,42 interG_chr1_pos_1130_2166257:2171209  
IG2_1565086 0,41 interG_chr2_pos_799_1565086:1565425  
IG2_2087974 0,40 interG_chr2_pos_1034_2087974:2088183  
IG2_949283 0,39 interG_chr2_pos_490_949283:949344  
IG2_2590456 0,38 interG_chr2_pos_1239_2590456:2590587  
IG2_943874 0,36 interG_chr2_pos_486_943874:943947  
IG2_2263493 0,35 interG_chr2_pos_1132_2263493:2263684  
IG1_2543049 0,31 interG_chr1_pos_1258_2543049:2543266  
IG2_230868 0,31 interG_chr2_pos_110_230868:232940  
IG1_901672 0,31 interG_chr1_pos_504_901672:902168  
IG2_2089610 0,31 interG_chr2_pos_1036_2089610:2090371  
IG2_1120955 0,30 interG_chr2_pos_580_1120955:1123103  
IG1_2935724 0,25 interG_chr1_pos_1444_2935724:2936297  
IG2_2589126 0,19 interG_chr2_pos_1238_2589126:2589204  
    
BCALr0472 6,88 tRNA Phe anticodon GAA, Cove score 86.97 
BCALr0457 6,43 tRNA Lys anticodon CTT, Cove score 94.68 
BCALr2006 5,41 tRNA Leu anticodon TAG, Cove score 75.32 
BCALr0080 5,26 Perfect repeat flanking prophage 
BCALr2852a 4,52 tRNA Cys anticodon GCA, Cove score 64.58 
BCALr0218c 4,46 tRNA Thr anticodon GGT, Cove score 90.12 
BCALr0800 4,43 tRNA Gln anticodon TTG, Cove score 73.12 
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BCALr3029 4,37 tRNA Ser anticodon CGA, Cove score 71.72 
BCALr0409c 4,21 tRNA Ala anticodon TGC, Cove score 90.89 
BCALr1551a 4,07 tRNA Leu anticodon CAG, Cove score 72.78 
BCALr2344 3,98 tRNA Leu anticodon GAG, Cove score 63.68 
BCALr1614 3,89 tRNA Met anticodon CAT, Cove score 86.01 
BCALr1625 3,75 tRNA His anticodon GTG, Cove score 78.40 
BCALr2219 3,64 tRNA Met anticodon CAT, Cove score 86.80 
BCALr3205 3,64 tRNA Lys anticodon TTT, Cove score 90.90 
BCALr1492 3,54 tRNA Pro anticodon GGG, Cove score 81.38 
BCALr2687 3,54 tRNA Leu anticodon CAA, Cove score 75.09 
BCALr2994 3,51 tRNA Thr anticodon CGT, Cove score 87.03 
BCALr2281 3,46 tRNA Ser anticodon GGA, Cove score 70.94 
BCALr2145 3,29 tRNA Ser anticodon GCT, Cove score 69.97 
BCALr3443 2,98 tRNA Pro anticodon CGG, Cove score 81.43 
BCALr3075 2,90 Perfect repeat flanking genomic island  
BCALr3009b 2,83 tRNA Arg anticodon ACG, Cove score 87.10 
BCAMr0918 2,64 tRNA Met anticodon CAT, Cove score 71.40 
BCALr1279 2,50 tRNA Pro anticodon TGG, Cove score 89.00 
BCALr2125e 2,48 tRNA Asp anticodon GTC, Cove score 95.34 
BCALr1899 2,45 Bacterial signal recognition particle RNA (RF00169) 
BCALr1290 2,37 Perfect repeat flanking genomic island  
BCALr0332 2,35 tRNA Thr anticodon TGT, Cove score 81.30 
BCALr0949 2,21 tRNA Met anticodon CAT, Cove score 88.36 
BCALr2852d 2,19 tRNA Gly anticodon GCC, Cove score 89.05 
BCALr2125c 2,15 tRNA Asp anticodon GTC, Cove score 90.27 
BCALr1993b 2,10 tRNA Val anticodon TAC, Cove score 94.99 
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Table A3.  QS-regulated proteins which are more than 1.5-fold differentially expressed in mutant H111-I and/or mutant H111-R.                                
(1257 proteins were identfied in total in analyses a and b).   
 
 
Criteria:  identified in the cepI and/or cepR mutant 
 extracellular or whole cell proteins 
 identified in analyses a and / or b 
              normalized factor = (√ factor a x factor b ) 
 
 
 
Abbreviations: EC (extracellular proteins) 
 WC (whole cell proteins = intracellular and surface-associated proteins) 
                 CepR (H111-R mutant) 
 CepI (H111-I mutant)   
 WT (H111 wild type) 
 
Differentially regulated in the proteome of H111-I and/or H111-R versus the H111 wild type 
Differentially regulated in the proteome of H111-I and/or H111-R and the transcriptome of H111-R versus the H111 wild type 
 
Extracellular proteins 
          Threshold reached 
    Avg.     Avg.     Avg.   ≥1.5 => up-regulated (1) 
    iTRAQ     iTRAQ     iTRAQ   ≤0.67=> down-regulated (-1) 
    Ratio   EC Ratio   EC Ratio   EC  
Accession 
No. Protein Name 116/117* 115/114* cepR / WT 115/117* 116/114* cepI / WT 114/117* 117/114* 
cepI+C8-
HSL / WT EC 
    a b normalized a b normalized a b normalized cepR cepI 
BCAL0009 pterin-4-alpha-carbinolamine dehydratase  4.763  4.763 2.032  2.032 1.721  1.721 1 1 
BCAL0012 putative adenylate cyclase  3.219 2.796 3.000 1.089 1.498 1.277 0.853 1.119 0.977 1 0 
BCAL0032 ATP synthase B chain                 
BCAL0036 
(gi105894680) 
ATP synthase F1, beta subunit [Burkholderia 
cenocepacia AU 1054] 0.62  0.620 0.836  0.836 1.028  1.028 -1 0 
BCAL0037 ATP synthase epsilon chain 1.525 1.808 1.660 0.631 0.843 0.729 0.656 0.913 0.774 1 0 
BCAL0038 
(gi117992142) 
AMP-dependent synthetase and ligase 
[Burkholderia phytofirmans PsJN] 0.363 0.353 0.358 0.609 0.601 0.605 0.593 0.511 0.550 -1 -1 
BCAL0043 putative extracellular ligand-binding protein  3.573 2.972 3.259 0.935 1.105 1.016 1.403 1.335 1.369 1 0 
BCAL0052 
(gi117984267) 
FAD linked oxidase-like [Burkholderia phymatum 
STM815]                
BCAL0074 glycine cleavage system H protein  1.282 1.508 1.390 1.125 1.163 1.144 1.115 1.006 1.059 0 0 
BCAL0077 putative oxidoreductase                 
BCAL0080 putative cytochrome                 
BCAL0095 putative phage major tail sheath protein  0.543  0.543 1.329  1.329 1.976  1.976 -1 0 
BCAL0114 
(gi105894597) flagellin-like [Burkholderia cenocepacia AU 1054] 0.891 0.776 0.832 0.58 0.526 0.552 1.062 0.869 0.961 0 -1 
BCAL0115 30S ribosomal protein S21 1  1.529 1.639 1.583 0.928 1.437 1.155 1.247 1.263 1.255 1 0 
Appendix 
117 
 
BCAL0122 histone-like nucleoid-structuring (H-NS)                 
BCAL0154 histone-like nucleoid-structuring (H-NS)  5.66  5.660 1.66  1.660 1.358  1.358 1 1 
BCAL0202 putative flavoprotein                 
BCAL0210 TetR family regulatory protein                
BCAL0215 phenylacetic acid degradation protein PaaB  3.047 2.644 2.838 1.175 1.29 1.231 1.043 1.137 1.089 1 0 
BCAL0216 phenylacetic acid degradation protein PaaA 1.626  1.626 1.571  1.571 1.534  1.534 1 1 
BCAL0217 
(gi52427635) 
lipase/acylhydrolase, putative [Burkholderia mallei 
ATCC 23344]  0.455 0.455  1.461 1.461  0.699 0.699 -1 0 
BCAL0221 transcription antitermination protein NusG  1.781  1.781 1.096  1.096 0.978  0.978 1 0 
BCAL0224 50S ribosomal protein L10  0.507  0.507 1.167  1.167 1.139  1.139 -1 0 
BCAL0231 elongation factor G  0.482 0.89 0.655 0.83 0.986 0.905 0.903 1.153 1.020 -1 0 
BCAL0236 50S ribosomal protein L23  2.736  2.736 0.994  0.994 1.22  1.220 1 0 
BCAL0237 50S ribosomal protein L2  0.525 0.741 0.624 0.838 0.904 0.870 1.117 1.237 1.175 -1 0 
BCAL0238 30S ribosomal protein S19   1.951 1.951  0.831 0.831  1.367 1.367 1 0 
BCAL0239 50S ribosomal protein L22                
BCAL0240 30S ribosomal protein S3  0.564 0.827 0.683 0.645 0.613 0.629 1.389 2.307 1.790 0 -1 
BCAL0241 50S ribosomal protein L16  0.842  0.842 0.656  0.656 0.98  0.980 0 -1 
BCAL0243 30S ribosomal protein S17  1.707 1.447 1.572 0.706 0.869 0.783 1.083 0.935 1.006 1 0 
BCAL0245 50S ribosomal protein L24 2.289 2.725 2.498 0.706 0.89 0.793 0.954 1.228 1.082 1 0 
BCAL0247 30S ribosomal protein S14 2.15 1.893 2.017 1.285 1.135 1.208 1.186 1.062 1.122 1 0 
BCAL0249 50S ribosomal protein L6  3.825 3.688 3.756 1.145 1.381 1.257 1.165 1.253 1.208 1 0 
BCAL0251 30S ribosomal protein S5 2.347 1.569 1.919 1.225 0.956 1.082 1.352 0.859 1.078 1 0 
BCAL0253 50S ribosomal protein L15  1.551 1.467 1.508 0.876 0.837 0.856 1.269 1.167 1.217 1 0 
BCAL0255 translation initiation factor IF-1 2.027 1.197 1.558 0.98 0.899 0.939 0.946 0.806 0.873 1 0 
BCAL0258 30S ribosomal protein S11  1.528  1.528 1.234  1.234 1.102  1.102 1 0 
BCAL0264 delta-aminolevulinic acid dehydratase  0.676  0.676 0.66  0.660 0.714  0.714 0 -1 
BCAL0273 protein CyaY 1.783  1.783 1.184  1.184 0.99  0.990 1 0 
BCAL0327 conserved hypothetical protein                 
BCAL0332 putative stringent starvation protein B  2.566 1.776 2.135 0.709 1.098 0.882 0.634 0.732 0.681 1 0 
BCAL0334 periplasmic solute-binding protein                 
BCAL0341O conserved hypothetical protein  2.534 4.499 3.376 1.573 1.682 1.627 1.325 1.985 1.622 1 1 
BCAL0342 conserved hypothetical protein                 
BCAL0343 conserved hypothetical protein 3 0.253 0.424 0.328 0.3 0.348 0.323 0.539 0.761 0.640 -1 -1 
BCAL0347 protease associated ATPase ClpB                 
BCAL0349 putative outer membrane protein                 
BCAL0353  putative membrane protein  1.772 1.571 1.668 0.793 0.806 0.799 0.639 0.728 0.682 1 0 
BCAL0358 metallo peptidase, family M1 0.273 0.52 0.377 0.275 0.521 0.379 0.836 0.976 0.903 -1 -1 
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BCAL0360 conserved hypothetical protein   1.687 1.687  1.142 1.142  0.968 0.968 1 0 
BCAL0371 putative aromatic acid decarboxylase                
BCAL0387 putative GTP-binding protein                 
BCAL0426 putative membrane protein  1.016 0.809 0.907 0.998 0.946 0.972 1.276 1.116 1.193 0 0 
BCAL0482 putative rod shape-determining protein                 
BCAL0487 endonuclease/exonuclease/phosphatase family  0.208  0.208 0.965  0.965 1.147  1.147 -1 0 
BCAL0502 DksA/TraR C4-type zinc finger family protein 2.53 5.262 3.649 1.344 1.726 1.523 1.139 1.532 1.321 1 1 
BCAL0503 putative cobalamin synthesis protein 0.616  0.616 1.177  1.177 0.969  0.969 -1 0 
BCAL0507 diaminopimelate epimerase                 
BCAL0529 conserved hypothetical protein                
BCAL0536 ferredoxin--NADP reductase 0.652  0.652 0.807  0.807 0.9  0.900 -1 0 
BCAL0557 putative glutathione S-transferase protein                 
BCAL0562 negative regulator of flagellin synthesis  0.827 0.886 0.856 0.605 0.639 0.622 0.558 0.469 0.512 0 -1 
BCAL0565 flagellar basal-body rod protein FlgC  1.983 1.517 1.734 1.379 1.074 1.217 1.079 0.761 0.906 1 0 
BCAL0567 flagellar hook protein 1 FlgE1  0.434 0.56 0.493 0.47 0.545 0.506 0.444 0.481 0.462 -1 -1 
BCAL0568 flagellar basal-body rod protein FlgF  0.593 0.601 0.597 0.541 0.625 0.581 0.435 0.474 0.454 -1 -1 
BCAL0569 flagellar basal-body rod protein FlgG  0.506 0.581 0.542 0.798 0.795 0.796 0.525 0.603 0.563 -1 0 
BCAL0576 flagellar hook-associated protein 1 (HAP1)  0.436  0.436 0.588  0.588 0.342  0.342 -1 -1 
BCAL0577 flagellar hook-associated protein 3 (HAP3)  0.62 0.71 0.663 0.794 0.871 0.832 0.645 0.711 0.677 -1 0 
BCAL0616 
(gi83653191) 
uncharacterized ACR, COG1565 superfamily 
[Burkholderia thailandensis E264]                
BCAL0617 conserved hypothetical protein                 
BCAL0626 putative 2-nitropropane dioxygenase                 
BCAL0650 putative pyruvate-flavodoxin oxidoreductase   0.551 0.551  0.687 0.687  0.626 0.626 -1 0 
BCAL0658 allophanate hydrolase subunit 2                 
BCAL0677 thiol:disulfide interchange protein 7 2.045 1.807 1.922 1.284 1.248 1.266 1.419 1.324 1.371 1 0 
BCAL0680 conserved hypothetical protein  4.913  4.913 2.118  2.118 1.37  1.370 1 1 
BCAL0690 conserved hypothetical protein                
BCAL0703 serine peptidase, family S9                 
BCAL0704 D-alanyl-D-alanine carboxypeptidase   1.063 1.063  1.123 1.123  1.481 1.481 0 0 
BCAL0728 conserved hypothetical protein 1.836 1.564 1.695 2.148 1.489 1.788 0.773 1.039 0.896 1 1 
BCAL0738 C-terminal processing protease-3  0.911 1.22 1.054 1.021 0.318 0.570 1.227 0.934 1.071 0 -1 
BCAL0742 protein-export protein   0.489 0.489  1.289 1.289  1.278 1.278 -1 0 
BCAL0763 putative exported protein  1.816 1.593 1.701 0.96 0.908 0.934 0.964 0.882 0.922 1 0 
BCAL0764 putative exported protein                 
BCAL0783 putative membrane protein                
BCAL0788 putative exported protein 0.433 0.973 0.649 1.248 1.975 1.570 1.178 2.503 1.717 -1 1 
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BCAL0794 conserved hypothetical protein                 
BCAL0799 ribosomal L25p family protein  2.321 2.223 2.271 0.919 1.034 0.975 0.945 0.971 0.958 1 0 
BCAL0800 ribose-phosphate pyrophosphokinase                 
BCAL0804 putative membrane protein  4.307 4.307  2.035 2.035  1.444 1.444 1 1 
BCAL0812  sigma-54 modulation protein  5.332 4.143 4.700 1.596 1.424 1.508 1.382 1.072 1.217 1 1 
BCAL0817 putative 3-deoxy-D-manno-octulosonate                
BCAL0825 excinuclease ABC subunit A                 
BCAL0831 putative storage protein                 
BCAL0849  metallo peptidase, subfamily M48B                
BCAL0874  putative membrane protein  0.655 0.888 0.763 1.649 2.377 1.980 1.107 1.491 1.285 0 1 
BCAL0878 conserved hypothetical protein  0.677 0.556 0.614 0.807 0.948 0.875 0.528 0.565 0.546 -1 0 
BCAL0895 putative peptidyl-prolyl cis-trans isomerase 2.114 1.872 1.989 1.278 1.399 1.337 1.062 1.036 1.049 1 0 
BCAL0926 putative glycerol-3-phosphate dehydrogenase                 
BCAL0934 putative periplasmic cytochrome c containing  0.496  0.496 1.523  1.523 1.151  1.151 -1 1 
BCAL0935 putative periplasmic cytochrome c protein  2.211  2.211 2.172  2.172 1.489  1.489 1 1 
BCAL0965 putative hydrolase 1                
BCAL0980 
(gi83653798) 
molybdopterin biosynthesis moeA protein 
[Burkholderia thailandensis E264] 0.48  0.480 0.34  0.340 0.355  0.355 -1 -1 
BCAL1044 GntR family regulatory protein  2.319  2.319 1.028  1.028 0.857  0.857 1 0 
BCAL1065 periplasmic solute-binding protein  1.705 1.547 1.624 0.859 1.214 1.021 0.835 0.752 0.792 1 0 
BCAL1072 conserved hypothetical protein   0.55 0.550  1.359 1.359  0.9 0.900 -1 0 
BCAL1092 ABC transporter extracellular solute-binding 2.602  2.602 1.365  1.365 1.376  1.376 1 0 
BCAL1215 dihydrolipoamide dehydrogenase                 
BCAL1216 
(gi116647358) 
male sterility C-terminal domain [Burkholderia 
cenocepacia HI2424] 1.635  1.635 0.88  0.880 0.796  0.796 1 0 
BCAL1259 
(gi117988480) 
hypothetical protein [Burkholderia phytofirmans 
PsJN] 0.422  0.422 1.148  1.148 0.706  0.706 -1 0 
BCAL1262 carbamoyl-phosphate synthase large chain  0.52  0.520 1.084  1.084 1.261  1.261 -1 0 
BCAL1263 transcription elongation factor  2.495  2.495 1.205  1.205 0.93  0.930 1 0 
BCAL1394 putative exported protein                 
BCAL1411 putative exported protein  0.593 0.672 0.631 0.627 0.699 0.662 0.42 0.476 0.447 -1 -1 
BCAL1413 glutaminyl-tRNA synthetase  0.431  0.431 0.891  0.891 1.121  1.121 -1 0 
BCAL1416 alanyl-tRNA synthetase                 
BCAL1472 succinyl-CoA:3-ketoacid-coenzyme A transferase                 
BCAL1478 putative hydrolase                 
BCAL1482 translation initiation factor IF-3  1.634  1.634 0.911  0.911 0.912  0.912 1 0 
BCAL1484 50S ribosomal protein L20  0.755  0.755 0.976  0.976 0.957  0.957 0 0 
BCAL1486 phenylalanyl-tRNA synthetase beta chain   1.113 1.113  0.936 0.936  1.429 1.429 0 0 
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BCAL1496 putative exported protein  1.128  1.128 0.592  0.592 0.7  0.700 0 -1 
BCAL1497 
(gi91686933) 
putative lipoprotein transmembrane [Burkholderia 
xenovorans LB400]  0.602 0.602  1.462 1.462  0.724 0.724 -1 0 
BCAL1501 
(gi117993520) 
transcriptional regulator, LysR family 
[Burkholderia phytofirmans PsJN]                
BCAL1504 RNA pseudouridylate synthase family protein  0.531 0.37 0.443 1.142 0.628 0.847 0.916 0.912 0.914 -1 0 
BCAL1506 N utilization substance protein A 1.967 2.386 2.166 1.284 1.319 1.301 1.134 1.445 1.280 1 0 
BCAL1507 translation initiation factor IF-2  0.165 0.373 0.248 0.849 0.983 0.914 0.435 1.021 0.666 -1 0 
BCAL1515 2-oxoglutarate dehydrogenase E1 component  0.444 0.61 0.520 0.867 0.913 0.890 0.941 1.172 1.050 -1 0 
BCAL1530  flp pilus type assembly protein                 
BCAL1611 dihydroorotate dehydrogenase                
BCAL1636 putative exported endonuclease                 
BCAL1657 putative ribose transport system 1.919 1.728 1.821 0.983 0.951 0.967 1.09 0.823 0.947 1 0 
BCAL1663 PrkA family serine protein kinase                 
BCAL1675 
(gi76580894)  
TetR family regulatory protein [Burkholderia 
pseudomallei 1710b] 0.621 0.629 0.625 1.076 0.947 1.009 0.601 0.676 0.637 -1 0 
BCAL1677 putative type-1 fimbrial protein  0.176 0.147 0.161 0.225 0.149 0.183 0.242 0.188 0.213 -1 -1 
BCAL1696 
(gi83650419)  
nonribosomal peptide synthetase, putative 
[Burkholderia thailandensis E264]                
BCAL1722 
(gi116647781) chitinase [Burkholderia cenocepacia HI2424] 0.351 0.57 0.447 0.64 0.83 0.729 0.942 1.026 0.983 -1 0 
BCAL1824 putrescine-binding periplasmic protein  1.561  1.561 0.89  0.890 1.314  1.314 1 0 
BCAL1831 putative betaine aldehyde dehydrogenase  0.463  0.463 0.828  0.828 1.01  1.010 -1 0 
BCAL1849 putative exported protein  0.57 0.664 0.615 0.69 0.816 0.750 0.556 0.693 0.621 -1 0 
BCAL1850 putative dehydrogenase                
BCAL1868 conserved hypothetical protein  6.442 3.79 4.941 1.337 1.261 1.298 1.01 0.778 0.886 1 0 
BCAL1869 putative exported protein 0.971 0.833 0.899 1.067 1.076 1.071 1.075 0.882 0.974 0 0 
BCAL1872 putative nucleotide phosphoribosyltransferase                 
BCAL1874 putative ATP phosphoribosyltransferase                 
BCAL1879  Hfq protein  1.082 0.625 0.822 2.301 1.358 1.768 0.979 0.915 0.946 0 1 
BCAL1892 RNA polymerase sigma factor  1.916  1.916 1.221  1.221 0.899  0.899 1 0 
BCAL1898 conserved hypothetical protein                 
BCAL1900 thioredoxin 1.578  1.578 1.59  1.590 1.396  1.396 1 1 
BCAL1905 50S ribosomal protein L31  2.842 2.055 2.417 1.044 0.889 0.963 0.952 0.875 0.913 1 0 
BCAL1917 putative exported protein  0.295 0.407 0.347 0.595 0.653 0.623 0.505 0.556 0.530 -1 -1 
BCAL1919 
(gi118654245) 
ATPase AAA-2 [Burkholderia cenocepacia MC0-
3]                
BCAL1934 UDP-glucuronic acid decarboxylase                
BCAL1942 50S ribosomal protein L9 3.276 2.508 2.866 1.45 1.338 1.393 1.87 1.453 1.648 1 0 
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BCAL1943 30S ribosomal protein S18  2.927 2.727 2.825 1.164 1.242 1.202 1.55 1.284 1.411 1 0 
BCAL1945 putative 30S ribosomal protein S6  1.77 1.991 1.877 0.932 1.009 0.970 0.98 1.007 0.993 1 0 
BCAL1946 
(gi52427005) 
conserved hypothetical protein [Burkholderia 
mallei ATCC 23344]                
BCAL1956 putative lipoprotein  0.561  0.561 1.425  1.425 1.017  1.017 -1 0 
BCAL1961 
(gi105898095) 
ankyrin repeat protein [Burkholderia cenocepacia 
AU 1054]                
BCAL1964 putative thymidylate kinase                 
BCAL1971 conserved hypothetical protein                 
BCAL1982 peptide methionine sulfoxide reductase                 
BCAL1985 putative exported isomerase  4.22 2.964 3.537 1.589 1.348 1.464 1.439 1.143 1.282 1 0 
BCAL1992 
(gi77967434) lipolytic enzyme, G-D-S-L [Burkholderia sp. 383]  2.952 2.952  1.222 1.222  0.841 0.841 1 0 
BCAL1995 ATP-dependent Clp protease ATP-binding subunit                 
BCAL1996 ATP-dependent Clp protease proteolytic subunit  1.019  1.019 1.742  1.742 1.159  1.159 0 1 
BCAL1997 trigger factor  3.307 3.539 3.421 0.999 1.235 1.111 1.227 1.236 1.231 1 0 
BCAL1998 putative kinase                 
BCAL2013 AhpC/TSA family protein  1.211 1.225 1.218 0.894 0.894 0.894 0.825 0.917 0.870 0 0 
BCAL2018 
(gi105898280) 
transcriptional regulator, GntR family 
[Burkholderia cenocepacia AU 1054] 3.562  3.562 0.868  0.868 1.257  1.257 1 0 
BCAL2022 PspA/IM30 family protein  3.133 2.65 2.881 1.26 0.776 0.989 0.82 0.933 0.875 1 0 
BCAL2039 putative uricase                 
BCAL2063 inosine-5'-monophosphate dehydrogenase  0.557 0.716 0.632 1.146 0.84 0.981 1.068 1.119 1.093 -1 0 
BCAL2082  chaperone protein Skp precursor  1.92  1.920 1.297  1.297 0.671  0.671 1 0 
BCAL2083 
(gi118657256) 
surface antigen (D15) [Burkholderia multivorans 
ATCC 17616] 0.53  0.530 1.243  1.243 0.882  0.882 -1 0 
BCAL2088 ribosome recycling factor  2.439 2.03 2.225 1.075 1.072 1.073 1.371 0.931 1.130 1 0 
BCAL2091 30S ribosomal protein S2  2.273 1.267 1.697 1.467 1.051 1.242 1.383 1.059 1.210 1 0 
BCAL2094 
(gi91688077) 
pseudouridine synthase, Rsu [Burkholderia 
xenovorans LB400] 0.578 0.742 0.655 0.404 0.438 0.421 0.412 0.497 0.453 -1 -1 
BCAL2098 putative chromosome partition protein  1.403 1.403  2.137 2.137  1.104 1.104 0 1 
BCAL2110 
(gi52427334) 
alanine racemase [Burkholderia mallei ATCC 
23344]                
BCAL2123 conserved hypothetical protein                 
BCAL2126 glutamyl-tRNA synthetase                 
BCAL2150 cysteinyl-tRNA synthetase                 
BCAL2152 peptidyl-prolyl cis-trans isomerase A precursor  0.672 0.889 0.773 0.883 0.787 0.834 0.683 0.536 0.605 0 0 
BCAL2166 putative lipoprotein 1.251  1.251 1.672  1.672 1.367  1.367 0 1 
BCAL2180 putative 2-dehydro-3-deoxyphosphooctonate                 
BCAL2189 peptide chain release factor 2  0.801 0.512 0.640 1.541 0.872 1.159 0.853 0.594 0.712 -1 0 
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BCAL2190 
(gi117980152) 
lysyl-tRNA synthetase [Burkholderia phymatum 
STM815]                
BCAL2206 phasin-like protein   0.498 0.498  0.862 0.862  1.66 1.660 -1 0 
BCAL2209 pyruvate dehydrogenase E1 component 0.75 0.864 0.805 1.067 0.94 1.001 1.223 1.15 1.186 0 0 
BCAL2211 two-component regulatory system, response 1.776 1.431 1.594 1.179 1.097 1.137 1.16 0.992 1.073 1 0 
BCAL2226 putative molybdopterin-binding protein                 
BCAL2288 bacterioferritin  0.864 1.237 1.034 1.42 1.664 1.537 1.029 1.253 1.135 0 1 
BCAL2300 putative exported protein  0.876  0.876 0.459  0.459 0.554  0.554 0 -1 
BCAL2329 NUDIX hydrolase                
BCAL2336 putative NADH dehydrogenase I chain I  1.163  1.163 1.856  1.856 1.545  1.545 0 1 
BCAL2340 putative NADH dehydrogenase I chain E                 
BCAL2342 NADH dehydrogenase I chain C  1.543 1.048 1.272 1.897 1.349 1.600 1.473 1.031 1.232 0 1 
BCAL2349 30S ribosomal protein S15  1.767 1.335 1.536 0.939 0.941 0.940 1.322 0.977 1.136 1 0 
BCAL2354 2-isopropylmalate synthase                 
BCAL2359 acetolactate synthase isozyme III large subunit                 
BCAL2384 quinone oxidoreductase  0.475 0.745 0.595 1.455 1.504 1.479 1.289 1.59 1.432 -1 0 
BCAL2388 conserved hypothetical protein  2.166 1.531 1.821 1.558 0.907 1.189 1.766 1.154 1.428 1 0 
BCAL2394 
(gi52428872) maf protein [Burkholderia mallei ATCC 23344]                
BCAL2396 conserved hypothetical protein 4.409 2.567 3.364 1.506 1.305 1.402 1.381 1.073 1.217 1 0 
BCAL2401 putative exported protein  0.548 0.542 0.545 0.792 0.729 0.760 0.516 0.417 0.464 -1 0 
BCAL2409 
(gi121229043) 
DNA polymerase III, alpha subunit, form 1 
[Burkholderia mallei SAVP1] 0.994 0.839 0.913 0.736 0.591 0.660 0.637 0.579 0.607 0 -1 
BCAL2415 phosphoribosylglycinamide formyltransferase 2                 
BCAL2418 putative exported protein  0.605 0.593 0.599 1.206 0.773 0.966 0.918 0.791 0.852 -1 0 
BCAL2429 putative cytochrome C precursor-related protein  1.995  1.995 1.462  1.462 1.019  1.019 1 0 
BCAL2446 putative aminotransferase                 
BCAL2476a conserved hypothetical protein (fragment)  2.077 2.056 2.066 1.189 1.327 1.256 0.994 1.064 1.028 1 0 
BCAL2606 two-component regulatory system, response  2.472 2.472  1.9 1.900  1.255 1.255 1 1 
BCAL2607 putative exported protein   3.55 3.550  0.609 0.609  0.533 0.533 1 -1 
BCAL2616 nitrogen regulatory protein P-II 2  1.53  1.530 1.523  1.523 1.133  1.133 1 1 
BCAL2622 inorganic pyrophosphatase 1.929  1.929 1.366  1.366 1.223  1.223 1 0 
BCAL2630 putative porphobilinogen deaminase protein                 
BCAL2649 conserved hypothetical protein  1.992 1.514 1.737 1.478 1.1 1.275 0.913 0.902 0.907 1 0 
BCAL2653  ParA family ATPase                
BCAL2657 putative bifunctional cobalamin biosynthesis                 
BCAL2666 conserved hypothetical protein   1.474 1.474  1.311 1.311  0.681 0.681 0 0 
BCAL2669 putative exported protein  1.195 1.28 1.237 0.948 0.929 0.938 1.023 0.818 0.915 0 0 
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BCAL2676 aminopeptidase A                 
BCAL2700 putative oxidoreductase  1.201 1.167 1.184 2.071 1.236 1.600 1.676 1.294 1.473 0 1 
BCAL2710 4-hydroxy-3-methylbut-2-enyl diphosphate   0.647 0.647  0.848 0.848  0.64 0.640 -1 0 
BCAL2714 50S ribosomal protein L28  1.757 2.047 1.896 1.331 1.247 1.288 0.999 1.169 1.081 1 0 
BCAL2732  cold shock-like protein 0.726 0.849 0.785 0.883 1.006 0.942 0.73 0.835 0.781 0 0 
BCAL2733 
(gi115282608) 
multicopper oxidase, type 3 [Burkholderia cepacia 
AMMD]                
BCAL2736 isocitrate dehydrogenase  0.853  0.853 1.57  1.570 1.669  1.669 0 1 
BCAL2754 
(gi52429288) 
chromate transport protein [Burkholderia mallei 
ATCC 23344] 1.572  1.572 0.727  0.727 0.691  0.691 1 0 
BCAL2757  superoxide dismutase SodB  1.072  1.072 1.515  1.515 1.867  1.867 0 1 
BCAL2762 putative adenylate kinase 1.877 2.291 2.074 0.914 1.167 1.033 0.981 0.958 0.969 1 0 
BCAL2765 putative 30S ribosomal protein S20  2.278  2.278 1.387  1.387 1.986  1.986 1 0 
BCAL2769 conserved hypothetical protein  1.713  1.713 1.174  1.174 0.951  0.951 1 0 
BCAL2773 
(gi117980128) 
phage integrase [Burkholderia phymatum 
STM815] 1.627  1.627 1.705  1.705 1.329  1.329 1 1 
BCAL2785 putative peptide methionine sulfoxide reductase 0.262 0.867 0.477 0.511 0.941 0.693 0.311 0.816 0.504 -1 0 
BCAL2791 putative kynureninase 0.663 0.973 0.803 1.797 1.261 1.505 1.782 1.319 1.533 0 1 
BCAL2796 
(gi118659676) 
aldehyde dehydrogenase [Burkholderia 
multivorans ATCC 17616]                
BCAL2821  RND family efflux system transporter protein  0.596  0.596 1.265  1.265 1.455  1.455 -1 0 
BCAL2828 putative exported protein  0.427 0.453 0.440 0.548 0.544 0.546 0.451 0.426 0.438 -1 -1 
BCAL2839 fructose-bisphosphate aldolase  0.949  0.949 1.134  1.134 1.347  1.347 0 0 
BCAL2858 hypothetical protein  1.75  1.750 0.802  0.802 1.039  1.039 1 0 
BCAL2864 hypothetical protein                
BCAL2888 ribonuclease E 1  0.532 0.396 0.459 1.268 1.015 1.134 1.114 0.655 0.854 -1 0 
BCAL2911 
(gi115281004) 
conserved hypothetical protein [Burkholderia 
cepacia AMMD]                
BCAL2915 dihydrofolate reductase                 
BCAL2929 
(gi91690051) 
L-sorbosone dehydrogenase [Burkholderia 
xenovorans LB400]                
BCAL2935 electron transfer flavoprotein beta-subunit  2.466 4.022 3.149 1.08 1.266 1.169 1.502 1.532 1.517 1 0 
BCAL2941 putative exported transglycosylase                 
BCAL2943 putative exported protein  0.363 0.353 0.358 0.609 0.601 0.605 0.593 0.511 0.550 -1 -1 
BCAL2950 30S ribosomal protein S1  2.531 2.033 2.268 1.18 0.969 1.069 1.182 1.069 1.124 1 0 
BCAL2954 
(gi77966373) 
chorismate mutase/Prephenate dehydratase 
[Burkholderia sp. 383]                
BCAL2958 putative ompA family protein  2.52 2.672 2.595 1.088 1.259 1.170 1.032 1.163 1.096 1 0 
BCAL2961 
(gi83650624) integrase [Burkholderia thailandensis E264] 0 0.638 0.638 2.443 0.841 1.433 3.167 0.329 1.021 -1 0 
BCAL2966 conserved hypothetical protein                 
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BCAL3006 cold shock-like protein  0.914 0.884 0.899 0.623 0.629 0.626 0.859 0.721 0.787 0 -1 
BCAL3008 putative outer membrane porin protein  0.433 0.54 0.484 0.821 0.98 0.897 0.988 1.205 1.091 -1 0 
BCAL3024 
(gi105892254) 
conserved hypothetical protein [Burkholderia 
cenocepacia AU 1054] 1.747  1.747 0.637  0.637 1.009  1.009 1 -1 
BCAL3036 hypothetical protein                 
BCAL3041 maltose-binding protein  1.11  1.110 0.99  0.990 1.041  1.041 0 0 
BCAL3051 riboflavin synthase alpha chain                 
BCAL3054 6,7-dimethyl-8-ribityllumazine synthase 1.627 2.912 2.177 1.03 1.216 1.119 1.07 0.546 0.764 1 0 
BCAL3055 probable N utilization substance protein B   5.784 5.784  1.593 1.593  1.072 1.072 1 1 
BCAL3111 conserved hypothetical protein 0.706 0.999 0.840 0.992 1.098 1.044 1.302 1.162 1.230 0 0 
BCAL3113 
(gi118651602) 
Phosphomannomutase [Burkholderia 
cenocepacia MC0-3] 0.58  0.580 0.821  0.821 1.007  1.007 -1 0 
BCAL3115 
(gi117991085) 
glycosyl transferase, family 2 [Burkholderia 
phytofirmans PsJN]                
BCAL3136 
(gi118656806) 
apaH, bis(5'nucleosyl)-tetraphosphatase, ApaH 
[Burkholderia multivorans ATCC 17616]                
BCAL3142 conserved hypothetical protein                 
BCAL3146 60 kDa chaperonin 1  1.832 1.805 1.818 1.404 1.316 1.359 1.397 1.448 1.422 1 0 
BCAL3147 10 kDa chaperonin 1  1.856 2.42 2.119 1.124 1.282 1.200 0.928 1.206 1.058 1 0 
BCAL3166 putative lipoprotein 1.112  1.112 0.605  0.605 0.673  0.673 0 -1 
BCAL3178 LysR family regulatory protein   0.642 0.642  0.611 0.611  0.888 0.888 -1 -1 
BCAL3183 putative hydrolase                
BCAL3186 conserved hypothetical protein                 
BCAL3191 putative glutaryl-CoA dehydrogenase                 
BCAL3197 serine hydroxymethyltransferase  0.534 0.749 0.632 0.983 0.949 0.966 0.933 1.045 0.987 -1 0 
BCAL3204 putative OmpA family lipoprotein  1.616 1.919 1.761 1.229 1.581 1.394 0.968 1.2 1.078 1 0 
BCAL3205 putative exported protein  1.542 2.19 1.838 0.81 1.443 1.081 0.933 1.341 1.119 1 0 
BCAL3220 
(gi115285990) 
beta-ketoacyl synthase [Burkholderia cepacia 
AMMD]                
BCAL3244 
(gi83654978) 
possible glycosyltransferase WbpX, putative 
[Burkholderia thailandensis E264] 2.315  2.315 0.984  0.984 1.197  1.197 1 0 
BCAL3270 putative DnaK chaperone protein  2.355 2.135 2.242 1.022 1.084 1.053 1.233 1.132 1.181 1 0 
BCAL3272 putative heat shock protein  2.509  2.509 1.634  1.634 1.006  1.006 1 1 
BCAL3299  peroxidase/catalase KatB  0.44  0.440 0.89  0.890 1.096  1.096 -1 0 
BCAL3316 
(gi117985821) 
protein of unknown function DUF330 
[Burkholderia phymatum STM815]                
BCAL3332 aminopeptidase P                 
BCAL3347 30S ribosomal protein S9  2.237 2.363 2.299 0.99 1.1 1.044 1.095 1.371 1.225 1 0 
BCAL3358 periplasmic glutamate/aspartate-binding protein  2.809 3.404 3.092 1.255 1.327 1.290 1.207 1.497 1.344 1 0 
BCAL3359 putative glutamate dehydrogenase  0.652  0.652 1.242  1.242 1.425  1.425 -1 0 
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BCAL3368 
(gi117980776) 
transcriptional regulator, RpiR family [Burkholderia 
phymatum STM815]  2.952 2.952  1.222 1.222  0.841 0.841 1 0 
BCAL3370 gamma-glutamyl phosphate reductase                 
BCAL3377 putative outer membrane protein                
BCAL3378 ferric uptake regulator 3.536 1.448 2.263 1.955 1.042 1.427 1.741 0.701 1.105 1 0 
BCAL3388 glyceraldehyde 3-phosphate dehydrogenase 1  0.646  0.646 1.294  1.294 1.166  1.166 -1 0 
BCAL3389 transketolase 1  0.482 0.857 0.643 0.967 1.094 1.029 1.151 1.133 1.142 -1 0 
BCAL3402 
(gi118641093) 
short-chain dehydrogenase/reductase SDR 
[Burkholderia ambifaria MC40-6] 0.377  0.377 1.195  1.195 0.78  0.780 -1 0 
BCAL3425 putative sugar kinase 3                
BCAL3426 putative lipoprotein  0.423  0.423 0.991  0.991 0.992  0.992 -1 0 
BCAL3427 histone H1-like protein 2.854 4.975 3.768 0.858 1.68 1.201 1.159 1.899 1.484 1 0 
BCAL3429 putative ribonucleoside reductase  0.439 0.589 0.508 0.884 1.01 0.945 1 1.101 1.049 -1 0 
BCAL3436 prolyl-tRNA synthetase                 
BCAL3467 
UDP-N-acetylmuramoylalanyl-D-glutamate-2,6-
diaminopimelate                
BCAL3489 
(gi76583601) 
conserved hypothetical protein [Burkholderia 
pseudomallei 1710b]                
BCAL3507 flagellar FliL protein 1.979 1.301 1.605 2.01 1.135 1.510 1.467 1.235 1.346 1 1 
BCAL3523  general secretory pathway protein G 1.115  1.115 1.596  1.596 0.945  0.945 0 1 
BCAL3529 putative cobalamin synthesis protein/P47K                 
BCAL3530 DNA-binding protein HU-alpha  6.238 6.765 6.496 1.049 1.296 1.166 1.355 1.329 1.342 1 0 
BCAM0006 conserved hypothetical protein                 
BCAM0026 putative siderophore-interacting protein                
BCAM0058 3-oxoadipate CoA-transferase subunit A                 
BCAM0060 
(gi52421938) 
3-carboxy-cis,cis-muconate cycloisomerase 
[Burkholderia mallei ATCC 23344]                
BCAM0149 
(gi77971729) 
phospholipase D/Transphosphatidylase 
[Burkholderia sp. 383] 0.3 0.412 0.352 0.596 0.723 0.656 0.69 0.638 0.663 -1 -1 
BCAM0173 ATP-independent RNA helicase                 
BCAM0175 
(gi77971682) 
malate dehydrogenase (acceptor) [Burkholderia 
sp. 383] 0.086  0.086 0.168  0.168 0.18  0.180 -1 -1 
BCAM0184 lectin                
BCAM0186 lectin  0.45 0.528 0.487 0.528 0.647 0.584 0.539 0.627 0.581 -1 -1 
BCAM0276 
(gi115285786) 
UspA domain protein [Burkholderia cepacia 
AMMD] 1.486 1.66 1.571 1.162 1.237 1.199 1.132 1.439 1.276 1 0 
BCAM0297 
(gi115283858) 
acetoacetyl-CoA reductase [Burkholderia cepacia 
AMMD] 0.642  0.642 1.174  1.174 0.774  0.774 -1 0 
BCAM0313 putative exported protein  1.692  1.692 1.263  1.263 0.833  0.833 1 0 
BCAM0357 LysR family regulatory protein  0.377 0.389 0.383 1.22 1.484 1.346 0.547 0.776 0.652 -1 0 
BCAM0502 conserved hypothetical protein  1.86 1.498 1.669 1.429 1.167 1.291 1.447 1.107 1.266 1 0 
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BCAM0504 CsbD-like protein  3.716 3.463 3.587 1.042 1.095 1.068 0.933 1.043 0.986 1 0 
BCAM0505 putative membrane-attached protein 1.312 2.559 1.832 0.503 1.002 0.710 0.689 1.027 0.841 1 0 
BCAM0507 CsbD-like protein  2.993 2.908 2.950 0.596 0.763 0.674 1.814 1.373 1.578 1 0 
BCAM0589 conserved hypothetical protein                
BCAM0600 conserved hypothetical protein   0.274 0.274  1.076 1.076  0.974 0.974 -1 0 
BCAM0602 
(gi134135913) 
molecular chaperone-like protein [Burkholderia 
vietnamiensis G4]                
BCAM0630 putative dehydrogenase  0.951  0.951 1.671  1.671 0.884  0.884 0 1 
BCAM0684 putative oxidoreductase                 
BCAM0759 
(gi134132844) 
extracellular solute-binding protein, family 3 
[Burkholderia vietnamiensis G4]                
BCAM0767 
(gi117992836) 
ABC transporter related [Burkholderia 
phytofirmans PsJN]                
BCAM0795 
(gi117992171) 
transcriptional regulator, MarR family 
[Burkholderia phytofirmans PsJN] 1.55  1.550 1.346  1.346 1.819  1.819 1 0 
BCAM0811 putative aromatic oxygenase                 
BCAM0829 putative riboflavin synthase alpha chain                 
BCAM0832 
(gi105893144) 
Dyp-type peroxidase [Burkholderia cenocepacia 
AU 1054]                
BCAM0833 
(gi118660931) 
OsmC family protein [Burkholderia multivorans 
ATCC 17616] 2.833 2.619 2.724 1.599 1.465 1.531 1.126 1.063 1.094 1 1 
BCAM0844 conserved hypothetical protein 2.969 3.316 3.138 1.362 1.408 1.385 1.3 1.142 1.218 1 0 
BCAM0910 putative geranyltranstransferase                 
BCAM0915 30S ribosomal protein S21 2  3.003 2.543 2.763 1.677 1.534 1.604 2.327 1.709 1.994 1 1 
BCAM0916 conserved hypothetical protein  1.589  1.589 1.264  1.264 1.168  1.168 1 0 
BCAM0917 putative DNA primase                 
BCAM0953 extracellular solute-binding protein                 
BCAM0961 aconitate hydratase  0.433 1.002 0.659 1.341 0.821 1.049 1.511 1.593 1.551 -1 0 
BCAM0963 putative exported protein 2.112 2.268 2.189 0.936 1.165 1.044 1.04 1.006 1.023 1 0 
BCAM0972 citrate synthase 1 0.605 0.885 0.732 0.482 0.728 0.592 0.581 0.773 0.670 0 -1 
BCAM0986 aspartate-semialdehyde dehydrogenase                 
BCAM0987 flagellar hook protein 2 FlgE2  0.436  0.436 0.471  0.471 0.454  0.454 -1 -1 
BCAM0988 putative exported protein  0.771 0.959 0.860 0.9 1.034 0.965 0.861 0.579 0.706 0 0 
BCAM1003 putative epimerase   0.908 0.908  0.644 0.644  0.799 0.799 0 -1 
BCAM1012 putative histone-like protein 6.108 7.259 6.659 1.435 1.796 1.605 1.707 1.729 1.718 1 1 
BCAM1015 putative porin  0.433 0.656 0.533 0.947 1.095 1.018 0.984 1.375 1.163 -1 0 
BCAM1021 protein FdhE homologue                 
BCAM1062 hypothetical phage protein  2.679  2.679 1.465  1.465 1.28  1.280 1 0 
BCAM1111 ornithine decarboxylase  1 1.159 1.077 1.966 1.265 1.577 1.97 1.372 1.644 0 1 
Appendix 
127 
 
BCAM1123 
(gi91692859) 
hypothetical protein [Burkholderia xenovorans 
LB400]  0.615 0.615  1.227 1.227  0.835 0.835 -1 0 
BCAM1189 
(gi115283494)  
transcriptional regulator, LysR family 
[Burkholderia cepacia AMMD]                
BCAM1204 alanine racemase, catabolic                
BCAM1234 conserved hypothetical protein  1.627  1.627 1.705  1.705 1.329  1.329 1 1 
BCAM1250 
(gi77964942) 
acetyl-CoA hydrolase/transferase [Burkholderia 
sp. 383]                
BCAM1291 L-asparaginase                 
BCAM1304 conserved hypothetical protein                 
BCAM1351 putative regulatory protein   1.887 1.887  0.963 0.963  0.825 0.825 1 0 
BCAM1380 
(gi118650657) 
transcriptional regulator, GntR family 
[Burkholderia cenocepacia MC0-3] 1.935 1.901 1.918 1.143 1.275 1.207 0.848 1.053 0.945 1 0 
BCAM1407 DJ-1/PfpI family protein  1.58 1.219 1.388 0.967 0.632 0.782 0.788 0.694 0.740 0 0 
BCAM1411 putative short-chain dehydrogenase                 
BCAM1412 
(gi105895814) 
conserved hypothetical protein [Burkholderia 
cenocepacia AU 1054]                
BCAM1443 putative exported protein  2.306  2.306 1.093  1.093 1.064  1.064 1 0 
BCAM1464 
(gi116650430) 
putative cytoplasmic protein [Burkholderia 
cenocepacia HI2424] 0.35 0.565 0.445 0.616 0.629 0.622 0.798 1.276 1.009 -1 -1 
BCAM1481 conserved hypothetical protein  1.408 1.717 1.555 0.864 1.053 0.954 0.859 0.983 0.919 1 0 
BCAM1491 
(gi116650457) 
conserved hypothetical protein [Burkholderia 
cenocepacia HI2424]                
BCAM1538 putative dehydrogenase, monooxygenase subunit 7.769 7.287 7.524 2.23 3.182 2.664 3.306 3.379 3.342 1 1 
BCAM1542 putative aldehyde dehydrogenase  0.595  0.595 1.31  1.310 1.608  1.608 -1 0 
BCAM1553 putative dehydrogenase, molybdenum-binding                
BCAM1570 alcohol dehydrogenase 0.53 0.666 0.594 0.919 0.943 0.931 0.918 0.981 0.949 -1 0 
BCAM1581 phosphoenolpyruvate carboxykinase [GTP]  0.835  0.835 1.669  1.669 1.123  1.123 0 1 
BCAM1619 putative DNA-binding cold-shock protein 0.818 0.775 0.796 0.867 0.805 0.835 0.793 0.733 0.762 0 0 
BCAM1654 
(gi77969268) 
Short-chain dehydrogenase/reductase SDR 
[Burkholderia sp. 383] 0.668 0.778 0.721 0.639 0.689 0.664 0.441 0.511 0.475 0 -1 
BCAM1669 putative exported protein                 
BCAM1679 
(gi117985553) 
protein of unknown function DUF472 
[Burkholderia phymatum STM815] 2.446  2.446 1.25  1.250 1.507  1.507 1 0 
BCAM1700 
(gi117993315) 
GCN5-related N-acetyltransferase [Burkholderia 
phytofirmans PsJN]                
BCAM1744 serine peptidase, family S9 0.661 0.634 0.647 1.275 0.838 1.034 0.919 0.716 0.811 -1 0 
BCAM1800 conserved hypothetical protein                 
BCAM1824 conserved hypothetical protein                 
BCAM1857 conserved hypothetical protein  0.36  0.360 0.847  0.847 1.004  1.004 -1 0 
BCAM1919 
(gi118648785) 
conserved hypothetical protein [Burkholderia 
cenocepacia MC0-3]                
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BCAM1926 conserved hypothetical protein                 
BCAM1931 putative porin  0.369 0.616 0.477 0.928 1.078 1.000 1.043 1.35 1.187 -1 0 
BCAM2001 
(gi118650319) 
short-chain dehydrogenase/reductase SDR 
[Burkholderia cenocepacia MC0-3]                
BCAM2006 putative aspartate carbomyltransferase                 
BCAM2068 conserved hypothetical protein                
BCAM2081 conserved hypothetical protein  1.265  1.265 0.775  0.775 0.656  0.656 0 0 
BCAM2143 cable pilus associated adhesin protein  0.131 0.229 0.173 0.222 0.17 0.194 0.272 0.499 0.368 -1 -1 
BCAM2159 putative exported protein 2.165 2.018 2.090 0.821 0.77 0.795 0.864 0.86 0.862 1 0 
BCAM2167 conserved hypothetical protein  3.645  3.645 1.188  1.188 1.045  1.045 1 0 
BCAM2192 enoyl-CoA hydratase/isomerase family protein                 
BCAM2195 putative AMP-binding enzyme                 
BCAM2234 
(gi76582946) 
salicylate biosynthesis protein [Burkholderia 
pseudomallei 1710b]                
BCAM2307 zinc metalloprotease ZmpB  0.272 0.446 0.348 0.197 0.285 0.237 0.71 0.906 0.802 -1 -1 
BCAM2308 putative leucyl aminopeptidase precursor  0.493  0.493 0.527  0.527 0.661  0.661 -1 -1 
BCAM2310 
(gi52422765) 
putative transporter [Burkholderia mallei ATCC 
23344]                
BCAM2378 putative Xaa-Pro dipeptidyl-peptidase  0.443 0.417 0.430 0.624 0.582 0.603 1.085 1.329 1.201 -1 -1 
BCAM2407 
(gi117982799) 
major facilitator superfamily MFS_1 [Burkholderia 
phymatum STM815] 1.707  1.707 0.963  0.963 1.121  1.121 1 0 
BCAM2456 
(gi118660218) 
peptidoglycan glycosyltransferase [Burkholderia 
multivorans ATCC 17616]                
BCAM2463 putative membrane protein  0.654  0.654 1.361  1.361 0.948  0.948 -1 0 
BCAM2468 putative aldehyde dehydrogenase family protein   0.607 0.607  0.826 0.826  0.823 0.823 -1 0 
BCAM2478 serine-carboxyl peptidase                 
BCAM2480 
(gi52423083) 
transcriptional regulator, AsnC family 
[Burkholderia mallei ATCC 23344] 1.888 2.261 2.066 1.209 1.278 1.243 0.931 1.065 0.996 1 0 
BCAM2556 putative purine nucleoside permease  0.398 0.839 0.578 0.814 0.865 0.839 1.027 0.937 0.981 -1 0 
BCAM2618 putative periplasmic  2.085 2.125 2.105 0.933 1.165 1.043 0.996 1.014 1.005 1 0 
BCAM2671 putative low-specificity L-threonine aldolase   1.11 1.110  1.515 1.515  1.901 1.901 0 1 
BCAM2702 2-methylcitrate synthase  0.334 1.166 0.624 0.759 1.303 0.994 0.567 1.54 0.934 -1 0 
BCAM2707 putative FAA-hydrolase family protein                 
BCAM2755 putative exported protein  2.116 2.476 2.289 0.716 0.866 0.787 0.93 1.08 1.002 1 0 
BCAM2783 
(gi117988745) 
glycoside hydrolase, family 28 [Burkholderia 
phytofirmans PsJN]                
BCAM2821 malate synthase G                 
BCAM2827 putative exported protein  1.917 1.696 1.803 1.246 1.216 1.231 1.347 1.001 1.161 1 0 
BCAS0010 
(gi77965393) 
protein of unknown function DUF6, 
transmembrane [Burkholderia sp. 383] 2.487 1.889 2.167 1.394 1.053 1.212 1.148 1.094 1.121 1 0 
BCAS0013 putative molybdenum transport protein                
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BCAS0070 
(gi118660709) 
histidine kinase [Burkholderia multivorans ATCC 
17616] 4.169  4.169 1.043  1.043 1.135  1.135 1 0 
BCAS0151 hypothetical protein 0.417 0.438 0.427 0.656 0.665 0.660 0.467 0.369 0.415 -1 -1 
BCAS0190 putative H-NS family DNA-binding protein 4.788 3.732 4.227 1.209 1.224 1.216 1.156 0.938 1.041 1 0 
BCAS0292 conserved hypothetical protein AidA'  0.246  0.246 0.434  0.434 0.986  0.986 -1 -1 
BCAS0293 nematocidal protein AidA  0.08 0.339 0.165 0.169 0.364 0.248 1.022 1.3 1.153 -1 -1 
BCAS0334 
(gi134132307) 
response regulator receiver protein [Burkholderia 
vietnamiensis G4]  1.96 1.960  1.024 1.024  1.307 1.307 1 0 
BCAS0382 
(gi117994159) 
transcriptional regulator, AsnC family 
[Burkholderia phytofirmans PsJN]                
BCAS0407 hypothetical protein                 
BCAS0409 zinc metalloprotease ZmpA  0.459 0.552 0.503 0.454 0.447 0.450 0.683 0.826 0.751 -1 -1 
BCAS0421 
(gi76580611) 
ABC transporter, ATP-binding protein 
[Burkholderia pseudomallei 1710b]  1.918 1.918  1.1 1.100  0.835 0.835 1 0 
BCAS0455 putative CopG family protein                 
BCAS0516 
(gi115281897) hypothetical protein [Burkholderia cepacia AMMD] 1.304 1.886 1.568 0.796 1.054 0.916 0.616 0.666 0.641 1 0 
BCAS0609 putative electron transfer                
BCAS0637 60 kDa chaperonin 3  1.83 1.706 1.767 1.485 1.277 1.377 1.549 1.266 1.400 1 0 
BCAS0638 10 kDa chaperonin 3  1.368 1.099 1.226 0.628 0.832 0.723 0.92 0.835 0.876 0 0 
BCAS0666 putative ankyrin-repeat exported protein                
BCAS0708 
(gi91686888) 
hypothetical protein [Burkholderia xenovorans 
LB400]                
BCAS0730 
(gi77964328) 
Na+ dependent nucleoside transporter 
[Burkholderia sp. 383]                
BCAS0739 putative acetyl-CoA synthetase  0.534  0.534 1.3  1.300 1.058  1.058 -1 0 
BCAS0747 
(gi117980068) 
SMC protein-like [Burkholderia phymatum 
STM815]                
BCAS0765 
(gi77969929)  
hydrophobe/amphiphile efflux pump, HAE1 family 
[Burkholderia sp. 383]  2.226 2.226  1.993 1.993  1.545 1.545 1 1 
BCAS0773 putative exported protein  2.771  2.771 0.691  0.691 1.491  1.491 1 0 
rmlC 
(gi52210708) 
dTDP-6-deoxy-D-glucose-3,5 epimerase 
[Burkholderia pseudomallei K96243]                
wbiF 
(gi134134232) 
glycosyl transferase, family 2 [Burkholderia 
vietnamiensis G4] 0.951  0.951 1.671  1.671 0.884  0.884 0 1 
xdhA 
(gi115283038) 
transcriptional regulator, LysR family 
[Burkholderia cepacia AMMD] 2.679  2.679 1.465  1.465 1.28  1.280 1 0 
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Whole cell proteins 
           Threshold reached 
    Avg.     Avg.     Avg.     ≥1.5 => up-regulated (1) 
    iTRAQ     iTRAQ     iTRAQ     ≤0.67=> down-regulated (-1) 
    Ratio   WC Ratio   WC Ratio   WC     
Accession 
No. Protein Name 116/117* 115/114* cepR / WT 115/117* 116/114* cepI / wT 114/117* 117/114* 
cepI+C8-
HSL / WT WC 
    a b normalized a b normalized a b normalized cepR cepI 
BCAL0009 pterin-4-alpha-carbinolamine dehydratase  1.187 1.298 1.241 1.471 1.489 1.480 0.866 1.198 1.019 0 0 
BCAL0012 putative adenylate cyclase  1.058 0.82 0.931 1.569 0.998 1.251 0.968 0.733 0.842 0 0 
BCAL0032 ATP synthase B chain  1.14 0.808 0.960 0.788 0.506 0.631 1.006 0.855 0.927 0 -1 
BCAL0036 
(gi105894680) 
ATP synthase F1, beta subunit [Burkholderia 
cenocepacia AU 1054] 0.882 0.889 0.885 0.861 0.641 0.743 0.942 1.152 1.042 0 0 
BCAL0037 ATP synthase epsilon chain                 
BCAL0038 
(gi117992142) 
AMP-dependent synthetase and ligase 
[Burkholderia phytofirmans PsJN]                 
BCAL0043 putative extracellular ligand-binding protein  1.311 1.394 1.352 1.26 1.188 1.223 1.113 1.012 1.061 0 0 
BCAL0052 
(gi117984267) 
FAD linked oxidase-like [Burkholderia 
phymatum STM815] 1.391  1.391 1.587  1.587 1.077  1.077 0 1 
BCAL0074 glycine cleavage system H protein  1.366 0.98 1.157 1.931 1.339 1.608 0.909 1.064 0.983 0 1 
BCAL0077 putative oxidoreductase    0.733 0.733  0.596 0.596  1.114 1.114 0 -1 
BCAL0080 putative cytochrome    1.362 1.362  0.513 0.513  1.207 1.207 0 -1 
BCAL0095 putative phage major tail sheath protein                  
BCAL0114 
(gi105894597) 
flagellin-like [Burkholderia cenocepacia AU 
1054]                 
BCAL0115 30S ribosomal protein S21 1  0.959 1.194 1.070 0.777 0.998 0.881 0.762 0.883 0.820 0 0 
BCAL0122 histone-like nucleoid-structuring (H-NS)  0.413 0.476 0.443 0.416 0.328 0.369 0.44 0.446 0.443 -1 -1 
BCAL0154 histone-like nucleoid-structuring (H-NS)                  
BCAL0202 putative flavoprotein  1.452 1.058 1.239 3.559 1.202 2.068 1.26 0.925 1.080 0 1 
BCAL0210 TetR family regulatory protein 1.636 1.28 1.447 1.802 1.629 1.713 1.497 1.506 1.501 0 1 
BCAL0215 phenylacetic acid degradation protein PaaB  0.946 0.883 0.914 0.991 0.868 0.927 0.887 0.955 0.920 0 0 
BCAL0216 phenylacetic acid degradation protein PaaA 0.974  0.974 0.986  0.986 1.313  1.313 0 0 
BCAL0217 
(gi52427635) 
lipase/acylhydrolase, putative [Burkholderia 
mallei ATCC 23344]                 
BCAL0221 transcription antitermination protein NusG  1.279 1.19 1.234 1.504 1.063 1.264 0.975 0.984 0.979 0 0 
BCAL0224 50S ribosomal protein L10  1.013 0.906 0.958 1.002 0.64 0.801 0.906 0.777 0.839 0 0 
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BCAL0231 elongation factor G  0.866 0.781 0.822 0.826 0.705 0.763 1.054 0.943 0.997 0 0 
BCAL0236 50S ribosomal protein L23  1.258 0.981 1.111 1.365 0.953 1.141 0.997 0.783 0.884 0 0 
BCAL0237 50S ribosomal protein L2  1.069 1.168 1.117 0.984 1.022 1.003 0.787 0.695 0.740 0 0 
BCAL0238 30S ribosomal protein S19  0.821 0.889 0.854 0.696 0.745 0.720 1.057 1.02 1.038 0 0 
BCAL0239 50S ribosomal protein L22 1.243 1.952 1.558 1.317 1.509 1.410 0.977 1.128 1.050 1 0 
BCAL0240 30S ribosomal protein S3  0.779 1.082 0.918 0.594 0.707 0.648 0.706 0.958 0.822 0 -1 
BCAL0241 50S ribosomal protein L16  1.269 1.342 1.305 0.851 0.61 0.720 0.763 0.924 0.840 0 0 
BCAL0243 30S ribosomal protein S17  0.915 0.851 0.882 0.739 0.838 0.787 0.807 0.835 0.821 0 0 
BCAL0245 50S ribosomal protein L24 1.046 1.09 1.068 0.817 1.182 0.983 0.803 1.015 0.903 0 0 
BCAL0247 30S ribosomal protein S14   2.003 2.003  0.787 0.787  1.127 1.127 1 0 
BCAL0249 50S ribosomal protein L6  1.075 0.968 1.020 1.218 0.899 1.046 0.804 0.741 0.772 0 0 
BCAL0251 30S ribosomal protein S5 0.993 1.11 1.050 0.872 1.023 0.944 0.959 0.96 0.959 0 0 
BCAL0253 50S ribosomal protein L15  1.182 0.974 1.073 1.401 0.856 1.095 0.775 0.743 0.759 0 0 
BCAL0255 translation initiation factor IF-1 0.869 1.054 0.957 0.979 2.117 1.440 1.105 1.301 1.199 0 0 
BCAL0258 30S ribosomal protein S11  0.928  0.928 0.907  0.907 0.818  0.818 0 0 
BCAL0264 delta-aminolevulinic acid dehydratase  1.159 1.151 1.155 1.569 1.238 1.394 1.063 0.951 1.005 0 0 
BCAL0273 protein CyaY 1.019 1.305 1.153 1.075 1.637 1.327 0.993 1.459 1.204 0 0 
BCAL0327 conserved hypothetical protein  1.27 1.214 1.242 1.932 1.323 1.599 1.143 0.994 1.066 0 1 
BCAL0332 putative stringent starvation protein B    1.078 1.078  1.036 1.036  0.72 0.720 0 0 
BCAL0334 periplasmic solute-binding protein    1.126 1.126  2.371 2.371  1.171 1.171 0 1 
BCAL0341O conserved hypothetical protein  0.635 0.831 0.726 0.74 0.886 0.810 0.857 1.321 1.064 0 0 
BCAL0342 conserved hypothetical protein  0.654 0.671 0.662 0.539 1.175 0.796 1.063 1.628 1.316 -1 0 
BCAL0343 conserved hypothetical protein 3 0.896 1.018 0.955 0.771 0.866 0.817 0.93 1.047 0.987 0 0 
BCAL0347 protease associated ATPase ClpB  0.45  0.450 0.386  0.386 0.795  0.795 -1 -1 
BCAL0349 putative outer membrane protein    1.932 1.932  1.477 1.477  1.583 1.583 1 0 
BCAL0353  putative membrane protein  0.54  0.540 0.687  0.687 0.946  0.946 -1 0 
BCAL0358 metallo peptidase, family M1                 
BCAL0360 conserved hypothetical protein  0.72 0.322 0.481 0.951 0.872 0.911 0.859 0.945 0.901 -1 0 
BCAL0371 putative aromatic acid decarboxylase 1.635  1.635 1.325  1.325 1.55  1.550 1 0 
BCAL0387 putative GTP-binding protein  0.773 0.953 0.858 0.831 0.523 0.659 1.137 0.977 1.054 0 -1 
BCAL0426 putative membrane protein    0.71 0.710  0.638 0.638  0.583 0.583 0 -1 
BCAL0482 putative rod shape-determining protein  0.752 0.644 0.696 0.769 0.212 0.404 0.932 0.539 0.709 0 -1 
BCAL0487 
endonuclease/exonuclease/phosphatase 
family                  
BCAL0502 DksA/TraR C4-type zinc finger family protein 0.967 1.021 0.994 1.241 1.033 1.132 0.966 0.888 0.926 0 0 
BCAL0503 putative cobalamin synthesis protein 0.891  0.891 0.756  0.756 1.111  1.111 0 0 
BCAL0507 diaminopimelate epimerase    0.679 0.679  0.576 0.576  0.917 0.917 0 -1 
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BCAL0529 conserved hypothetical protein   1.142 1.142  1.553 1.553  2.132 2.132 0 1 
BCAL0536 ferredoxin--NADP reductase 0.931 0.922 0.926 0.866 1.147 0.997 0.998 1.086 1.041 0 0 
BCAL0557 putative glutathione S-transferase protein    0.681 0.681  0.57 0.570  0.874 0.874 0 -1 
BCAL0562 negative regulator of flagellin synthesis    1.888 1.888  1.665 1.665  1.435 1.435 1 1 
BCAL0565 flagellar basal-body rod protein FlgC                  
BCAL0567 flagellar hook protein 1 FlgE1  1.249  1.249 1.219  1.219 1.329  1.329 0 0 
BCAL0568 flagellar basal-body rod protein FlgF                  
BCAL0569 flagellar basal-body rod protein FlgG    1.599 1.599  1.453 1.453  1.697 1.697 1 0 
BCAL0576 flagellar hook-associated protein 1 (HAP1)                  
BCAL0577 flagellar hook-associated protein 3 (HAP3)    0.882 0.882  1.061 1.061  1.066 1.066 0 0 
BCAL0616 
(gi83653191) 
uncharacterized ACR, COG1565 superfamily 
[Burkholderia thailandensis E264] 0.849  0.849 0.567  0.567 0.813  0.813 0 -1 
BCAL0617 conserved hypothetical protein  1.861  1.861 0.945  0.945 1.391  1.391 1 0 
BCAL0626 putative 2-nitropropane dioxygenase    0.719 0.719  0.638 0.638  0.674 0.674 0 -1 
BCAL0650 putative pyruvate-flavodoxin oxidoreductase                  
BCAL0658 allophanate hydrolase subunit 2    1.524 1.524  1.255 1.255  1.029 1.029 1 0 
BCAL0677 thiol:disulfide interchange protein 7 0.799 0.824 0.811 0.888 0.778 0.831 0.979 0.807 0.889 0 0 
BCAL0680 conserved hypothetical protein  0.972 0.909 0.940 1.961 0.919 1.342 1.09 0.571 0.789 0 0 
BCAL0690 conserved hypothetical protein 2.348  2.348 2.669  2.669 1.831  1.831 1 1 
BCAL0703 serine peptidase, family S9    0.845 0.845  1.581 1.581  1.401 1.401 0 1 
BCAL0704 D-alanyl-D-alanine carboxypeptidase    0.49 0.490  0.694 0.694  0.846 0.846 -1 0 
BCAL0728 conserved hypothetical protein 0.958 0.998 0.978 0.818 0.792 0.805 1.068 0.761 0.902 0 0 
BCAL0738 C-terminal processing protease-3  0.897 0.802 0.848 1.123 0.993 1.056 1.213 1.161 1.187 0 0 
BCAL0742 protein-export protein  0.935 1.187 1.053 1.029 0.524 0.734 1.15 0.794 0.956 0 0 
BCAL0763 putative exported protein  0.998 1.069 1.033 1.138 1.126 1.132 0.974 1.101 1.036 0 0 
BCAL0764 putative exported protein    1 1.000  1.518 1.518  1.274 1.274 0 1 
BCAL0783 putative membrane protein   1.583 1.583  0.814 0.814  0.903 0.903 1 0 
BCAL0788 putative exported protein 0.928 1.023 0.974 1.431 1.375 1.403 1.219 1.486 1.346 0 0 
BCAL0794 conserved hypothetical protein    1.035 1.035  1.593 1.593  1.393 1.393 0 1 
BCAL0799 ribosomal L25p family protein  0.924 1.169 1.039 1.15 0.933 1.036 0.754 0.654 0.702 0 0 
BCAL0800 ribose-phosphate pyrophosphokinase  0.556 1.311 0.854 0.4 0.82 0.573 0.772 1.104 0.923 0 -1 
BCAL0804 putative membrane protein 0.951 1.035 0.992 1.077 1.035 1.056 1.199 1.22 1.209 0 0 
BCAL0812  sigma-54 modulation protein  1.373 1.194 1.280 1.461 1.418 1.439 1.181 0.988 1.080 0 0 
BCAL0817 putative 3-deoxy-D-manno-octulosonate   1.743 1.743  1.458 1.458  0.962 0.962 1 0 
BCAL0825 excinuclease ABC subunit A  0.813  0.813 0.594  0.594 1.124  1.124 0 -1 
BCAL0831 putative storage protein    0.284 0.284  0.432 0.432  0.423 0.423 -1 -1 
BCAL0849  metallo peptidase, subfamily M48B 0.637 0.587 0.611 0.495 0.577 0.534 0.485 0.316 0.391 -1 -1 
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BCAL0874  putative membrane protein  1.192 0.893 1.032 1.189 1.024 1.103 0.957 1.036 0.996 0 0 
BCAL0878 conserved hypothetical protein  1.09 1.254 1.169 1.362 1.383 1.372 0.987 1.181 1.080 0 0 
BCAL0895 putative peptidyl-prolyl cis-trans isomerase 1.064 1.096 1.080 1.264 1.236 1.250 1.121 1.068 1.094 0 0 
BCAL0926 putative glycerol-3-phosphate dehydrogenase  0.665  0.665 0.598  0.598 0.915  0.915 -1 -1 
BCAL0934 putative periplasmic cytochrome c containing    0.974 0.974  1.13 1.130  1.235 1.235 0 0 
BCAL0935 putative periplasmic cytochrome c protein  1.431 0.898 1.134 2.577 0.667 1.311 1.389 0.956 1.152 0 0 
BCAL0965 putative hydrolase 1   0.62 0.620  1.205 1.205  0.88 0.880 -1 0 
BCAL0980 
(gi83653798) 
molybdopterin biosynthesis moeA protein 
[Burkholderia thailandensis E264]                 
BCAL1044 GntR family regulatory protein                  
BCAL1065 periplasmic solute-binding protein  0.958 1.11 1.031 1.317 0.996 1.145 0.873 0.844 0.858 0 0 
BCAL1072 conserved hypothetical protein    1.025 1.025  1.153 1.153  1.076 1.076 0 0 
BCAL1092 ABC transporter extracellular solute-binding 0.92 0.698 0.801 1.822 0.802 1.209 0.994 0.925 0.959 0 0 
BCAL1215 dihydrolipoamide dehydrogenase    1.763 1.763  0.73 0.730  1.149 1.149 1 0 
BCAL1216 
(gi116647358) 
male sterility C-terminal domain [Burkholderia 
cenocepacia HI2424]                 
BCAL1259 
(gi117988480) 
hypothetical protein [Burkholderia 
phytofirmans PsJN]                 
BCAL1262 carbamoyl-phosphate synthase large chain                  
BCAL1263 transcription elongation factor  0.96 1.205 1.076 0.884 1.061 0.968 0.79 0.867 0.828 0 0 
BCAL1394 putative exported protein    1.253 1.253  1.654 1.654  1.558 1.558 0 1 
BCAL1411 putative exported protein  0.965 1.075 1.019 0.878 1.135 0.998 0.857 1.083 0.963 0 0 
BCAL1413 glutaminyl-tRNA synthetase    1.294 1.294  1.446 1.446  1.292 1.292 0 0 
BCAL1416 alanyl-tRNA synthetase  0.867 0.393 0.584 0.951 0.825 0.886 1.46 1.43 1.445 -1 0 
BCAL1472 
succinyl-CoA:3-ketoacid-coenzyme A 
transferase  1.136 0.945 1.036 2.051 1.386 1.686 1.638 1.917 1.772 0 1 
BCAL1478 putative hydrolase    0.991 0.991  0.608 0.608  0.673 0.673 0 -1 
BCAL1482 translation initiation factor IF-3  0.932 1.349 1.121 0.807 1.024 0.909 0.863 1.193 1.015 0 0 
BCAL1484 50S ribosomal protein L20  1.122 2.041 1.513 0.967 1.624 1.253 0.77 1.598 1.109 1 0 
BCAL1486 phenylalanyl-tRNA synthetase beta chain    1.321 1.321  0.544 0.544  1.308 1.308 0 -1 
BCAL1496 putative exported protein  1.169 1.011 1.087 2.119 0.539 1.069 0.808 0.285 0.480 0 0 
BCAL1497 
(gi91686933) 
putative lipoprotein transmembrane 
[Burkholderia xenovorans LB400]                 
BCAL1501 
(gi117993520) 
transcriptional regulator, LysR family 
[Burkholderia phytofirmans PsJN]   0.656 0.656  1.04 1.040  0.846 0.846 -1 0 
BCAL1504 RNA pseudouridylate synthase family protein  0.857 0.953 0.904 0.848 1.208 1.012 1.299 0.984 1.131 0 0 
BCAL1506 N utilization substance protein A 0.958 0.956 0.957 0.854 1.033 0.939 1.038 0.838 0.933 0 0 
BCAL1507 translation initiation factor IF-2  0.832 0.956 0.892 0.868 1.08 0.968 1.077 1.269 1.169 0 0 
BCAL1515 2-oxoglutarate dehydrogenase E1 component  1.1 2.88 1.780 0.867 1.601 1.178 1.294 1.398 1.345 1 0 
BCAL1530  flp pilus type assembly protein    1.516 1.516  0.827 0.827  1.351 1.351 1 0 
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BCAL1611 dihydroorotate dehydrogenase   1.424 1.424  1.521 1.521  1.104 1.104 0 1 
BCAL1636 putative exported endonuclease    0.886 0.886  0.63 0.630  1.346 1.346 0 -1 
BCAL1657 putative ribose transport system 1.292 1.024 1.150 1.684 0.971 1.279 0.923 0.702 0.805 0 0 
BCAL1663 PrkA family serine protein kinase  0.926 0.705 0.808 0.58 0.522 0.550 1.233 1.026 1.125 0 -1 
BCAL1675 
(gi76580894)  
TetR family regulatory protein [Burkholderia 
pseudomallei 1710b]                 
BCAL1677 putative type-1 fimbrial protein                  
BCAL1696 
(gi83650419)  
nonribosomal peptide synthetase, putative 
[Burkholderia thailandensis E264] 1.114  1.114 0.633  0.633 1.194  1.194 0 -1 
BCAL1722 
(gi116647781) chitinase [Burkholderia cenocepacia HI2424]                 
BCAL1824 putrescine-binding periplasmic protein  0.855 0.963 0.907 1.054 0.994 1.024 1.173 1.246 1.209 0 0 
BCAL1831 putative betaine aldehyde dehydrogenase  1.388 1.167 1.273 1.145 1.056 1.100 0.904 1.279 1.075 0 0 
BCAL1849 putative exported protein  0.608 0.906 0.742 0.575 0.431 0.498 0.86 0.767 0.812 0 -1 
BCAL1850 putative dehydrogenase   0.524 0.524  0.67 0.670  1.281 1.281 -1 0 
BCAL1868 conserved hypothetical protein  1.188 1.13 1.159 1.531 1.073 1.282 0.823 0.79 0.806 0 0 
BCAL1869 putative exported protein   4.543 4.543  1.779 1.779  2.858 2.858 1 1 
BCAL1872 putative nucleotide phosphoribosyltransferase    0.753 0.753  0.645 0.645  0.543 0.543 0 -1 
BCAL1874 putative ATP phosphoribosyltransferase    0.601 0.601  0.899 0.899  0.8 0.800 -1 0 
BCAL1879  Hfq protein  0.731 1.005 0.857 0.707 0.922 0.807 0.862 0.959 0.909 0 0 
BCAL1892 RNA polymerase sigma factor  1.083 0.91 0.993 1.569 1.169 1.354 0.876 1.232 1.039 0 0 
BCAL1898 conserved hypothetical protein    0.656 0.656  0.774 0.774  1.215 1.215 -1 0 
BCAL1900 thioredoxin 0.991 0.97 0.980 1.087 1.344 1.209 1.223 1.175 1.199 0 0 
BCAL1905 50S ribosomal protein L31  1.204 1.267 1.235 1.096 1.172 1.133 1.111 1.079 1.095 0 0 
BCAL1917 putative exported protein  0.815 0.879 0.846 0.817 1.086 0.942 0.747 1.102 0.907 0 0 
BCAL1919 
(gi118654245) 
ATPase AAA-2 [Burkholderia cenocepacia 
MC0-3]   0.592 0.592  0.711 0.711  1.234 1.234 -1 0 
BCAL1934 UDP-glucuronic acid decarboxylase   0.871 0.871  0.579 0.579  0.569 0.569 0 -1 
BCAL1942 50S ribosomal protein L9 1.182 1.211 1.196 1.323 1.084 1.198 0.926 0.883 0.904 0 0 
BCAL1943 30S ribosomal protein S18  0.965  0.965 0.721  0.721 0.806  0.806 0 0 
BCAL1945 putative 30S ribosomal protein S6  1.181 1.277 1.228 0.999 1.081 1.039 1.319 0.563 0.862 0 0 
BCAL1946 
(gi52427005) 
conserved hypothetical protein [Burkholderia 
mallei ATCC 23344] 0.722  0.722 0.3  0.300 1.151  1.151 0 -1 
BCAL1956 putative lipoprotein  0.806  0.806 0.73  0.730 0.883  0.883 0 0 
BCAL1961 
(gi105898095) 
ankyrin repeat protein [Burkholderia 
cenocepacia AU 1054]   0.616 0.616  0.642 0.642  0.652 0.652 -1 -1 
BCAL1964 putative thymidylate kinase  0.691 0.832 0.758 0.616 0.665 0.640 0.902 0.605 0.739 0 -1 
BCAL1971 conserved hypothetical protein    0.653 0.653  0.495 0.495  0.865 0.865 -1 -1 
BCAL1982 peptide methionine sulfoxide reductase    0.602 0.602  0.866 0.866  0.926 0.926 -1 0 
BCAL1985 putative exported isomerase  1.212 1.062 1.135 1.474 1.192 1.326 1.253 1.06 1.152 0 0 
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BCAL1992 
(gi77967434) 
lipolytic enzyme, G-D-S-L [Burkholderia sp. 
383] 1.447  1.447 1.11  1.110 1.188  1.188 0 0 
BCAL1995 
ATP-dependent Clp protease ATP-binding 
subunit  1.816 0.831 1.228 2.597 0.867 1.501 1.279 1.116 1.195 0 1 
BCAL1996 
ATP-dependent Clp protease proteolytic 
subunit  1.087 0.844 0.958 1.328 0.972 1.136 1.009 0.713 0.848 0 0 
BCAL1997 trigger factor  1.11 0.999 1.053 1.352 0.94 1.127 0.898 0.906 0.902 0 0 
BCAL1998 putative kinase  0.891 1.924 1.309 1.345 2.199 1.720 1.37 1.951 1.635 0 1 
BCAL2013 AhpC/TSA family protein  0.7 0.692 0.696 0.628 0.685 0.656 0.871 0.856 0.863 0 -1 
BCAL2018 
(gi105898280) 
transcriptional regulator, GntR family 
[Burkholderia cenocepacia AU 1054] 0.944  0.944 0.83  0.830 0.867  0.867 0 0 
BCAL2022 PspA/IM30 family protein  0.872 1.067 0.965 0.873 0.899 0.886 0.914 0.927 0.920 0 0 
BCAL2039 putative uricase    0.898 0.898  0.503 0.503  0.703 0.703 0 -1 
BCAL2063 inosine-5'-monophosphate dehydrogenase  1.126 1.291 1.206 1.289 0.888 1.070 1.056 1.146 1.100 0 0 
BCAL2082  chaperone protein Skp precursor  1.033 1.042 1.037 1.166 1.149 1.157 1.157 1.061 1.108 0 0 
BCAL2083 
(gi118657256) 
surface antigen (D15) [Burkholderia 
multivorans ATCC 17616]                 
BCAL2088 ribosome recycling factor    1.176 1.176  1.201 1.201  1.016 1.016 0 0 
BCAL2091 30S ribosomal protein S2  1.14 0.884 1.004 1.036 0.919 0.976 0.995 0.934 0.964 0 0 
BCAL2094 
(gi91688077) 
pseudouridine synthase, Rsu [Burkholderia 
xenovorans LB400]                 
BCAL2098 putative chromosome partition protein                 
BCAL2110 
(gi52427334) 
alanine racemase [Burkholderia mallei ATCC 
23344] 1.534  1.534 1.387  1.387 0.711  0.711 1 0 
BCAL2123 conserved hypothetical protein    1.84 1.840  1.622 1.622  1.489 1.489 1 1 
BCAL2126 glutamyl-tRNA synthetase    0.789 0.789  0.548 0.548  1.04 1.040 0 -1 
BCAL2150 cysteinyl-tRNA synthetase  1.437 0.973 1.182 2.714 0.988 1.638 1.549 1.209 1.368 0 1 
BCAL2152 peptidyl-prolyl cis-trans isomerase A precursor  1.213 1.079 1.144 1.797 1.405 1.589 1.193 1.22 1.206 0 1 
BCAL2166 putative lipoprotein 1.361  1.361 1.146  1.146 1.437  1.437 0 0 
BCAL2180 putative 2-dehydro-3-deoxyphosphooctonate  1.891 1.983 1.936 1.177 1.394 1.281 0.81 1.006 0.903 1 0 
BCAL2189 peptide chain release factor 2  1.308 0.8 1.023 1.146 0.79 0.951 1.155 1.009 1.080 0 0 
BCAL2190 
(gi117980152) 
lysyl-tRNA synthetase [Burkholderia 
phymatum STM815] 1.598 1.468 1.532 1.353 1.028 1.179 2.135 1.009 1.468 1 0 
BCAL2206 phasin-like protein  0.953 1.029 0.990 1.141 1.136 1.138 1.251 1.588 1.409 0 0 
BCAL2209 pyruvate dehydrogenase E1 component 0.821 0.893 0.856 0.633 0.547 0.588 0.796 0.756 0.776 0 -1 
BCAL2211 two-component regulatory system, response 0.917  0.917 0.914  0.914 1.127  1.127 0 0 
BCAL2226 putative molybdopterin-binding protein    0.425 0.425  0.55 0.550  2.222 2.222 -1 -1 
BCAL2288 bacterioferritin  1.186 1.106 1.145 1.278 1.019 1.141 0.968 0.95 0.959 0 0 
BCAL2300 putative exported protein  1.392 1.019 1.191 1.006 1.457 1.211 1.209 1.145 1.177 0 0 
BCAL2329 NUDIX hydrolase 1.389  1.389 1.557  1.557 1.498  1.498 0 1 
BCAL2336 putative NADH dehydrogenase I chain I                  
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BCAL2340 putative NADH dehydrogenase I chain E  0.865 1.858 1.268 0.936 0.275 0.507 1.012 2.929 1.722 0 -1 
BCAL2342 NADH dehydrogenase I chain C                  
BCAL2349 30S ribosomal protein S15  1.299 1.028 1.156 1.367 0.947 1.138 0.827 0.707 0.765 0 0 
BCAL2354 2-isopropylmalate synthase  0.478 0.467 0.472 0.698 0.486 0.582 1.069 0.673 0.848 -1 -1 
BCAL2359 
acetolactate synthase isozyme III large 
subunit  0.663  0.663 0.667  0.667 0.772  0.772 -1 -1 
BCAL2384 quinone oxidoreductase  1.169 1.058 1.112 1.795 1.343 1.553 1.323 1.359 1.341 0 1 
BCAL2388 conserved hypothetical protein  0.913 1.562 1.194 0.871 2.277 1.408 0.988 2.094 1.438 0 0 
BCAL2394 
(gi52428872) maf protein [Burkholderia mallei ATCC 23344] 0.707 0.834 0.768 0.556 0.723 0.634 1.093 1.325 1.203 0 -1 
BCAL2396 conserved hypothetical protein 0.989 1.403 1.178 1.028 1.115 1.071 0.919 1.399 1.134 0 0 
BCAL2401 putative exported protein                  
BCAL2409 
(gi121229043) 
DNA polymerase III, alpha subunit, form 1 
[Burkholderia mallei SAVP1]                 
BCAL2415 
phosphoribosylglycinamide formyltransferase 
2    0.647 0.647  0.815 0.815  1.139 1.139 -1 0 
BCAL2418 putative exported protein    0.935 0.935  1.266 1.266  1.353 1.353 0 0 
BCAL2429 
putative cytochrome C precursor-related 
protein  0.655 1.016 0.816 0.821 0.791 0.806 1.109 0.882 0.989 0 0 
BCAL2446 putative aminotransferase    0.734 0.734  0.468 0.468  1.354 1.354 0 -1 
BCAL2476a conserved hypothetical protein (fragment)                  
BCAL2606 two-component regulatory system, response 0.958 1.196 1.070 0.956 1.013 0.984 0.777 1.291 1.002 0 0 
BCAL2607 putative exported protein  0.882 0.932 0.907 0.933 1.052 0.991 0.733 0.628 0.678 0 0 
BCAL2616 nitrogen regulatory protein P-II 2  1.264 1.143 1.202 1.212 1.224 1.218 1.102 0.971 1.034 0 0 
BCAL2622 inorganic pyrophosphatase 1.201 0.908 1.044 0.811 0.937 0.872 1.15 0.98 1.062 0 0 
BCAL2630 putative porphobilinogen deaminase protein  0.754 0.736 0.745 0.671 0.666 0.668 0.84 0.866 0.853 0 -1 
BCAL2649 conserved hypothetical protein  0.977 1.255 1.107 1.01 0.977 0.993 0.975 0.98 0.977 0 0 
BCAL2653  ParA family ATPase   0.754 0.754  0.547 0.547  0.422 0.422 0 -1 
BCAL2657 putative bifunctional cobalamin biosynthesis    0.809 0.809  1.656 1.656  1.035 1.035 0 1 
BCAL2666 conserved hypothetical protein  1.354 1.114 1.228 2.153 1.108 1.545 0.947 0.752 0.844 0 1 
BCAL2669 putative exported protein  0.607 0.838 0.713 0.578 0.665 0.620 0.477 0.573 0.523 0 -1 
BCAL2676 aminopeptidase A  0.926 1.383 1.132 0.879 0.362 0.564 1.022 0.925 0.972 0 -1 
BCAL2700 putative oxidoreductase  0.823 0.63 0.720 0.722 0.557 0.634 0.97 0.895 0.932 0 -1 
BCAL2710 4-hydroxy-3-methylbut-2-enyl diphosphate  0.859 0.825 0.842 0.831 0.846 0.838 1.168 0.845 0.993 0 0 
BCAL2714 50S ribosomal protein L28    0.795 0.795  0.716 0.716  0.727 0.727 0 0 
BCAL2732  cold shock-like protein 1.587 1.16 1.357 2.087 1.416 1.719 0.889 0.911 0.900 0 1 
BCAL2733 
(gi115282608) 
multicopper oxidase, type 3 [Burkholderia 
cepacia AMMD]   1.521 1.521  1.49 1.490  1.115 1.115 1 0 
BCAL2736 isocitrate dehydrogenase  1.043 0.826 0.928 0.982 0.77 0.870 1.102 0.916 1.005 0 0 
BCAL2754 chromate transport protein [Burkholderia                 
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(gi52429288) mallei ATCC 23344] 
BCAL2757  superoxide dismutase SodB  1.082 0.732 0.890 1.343 0.765 1.014 1.268 0.955 1.100 0 0 
BCAL2762 putative adenylate kinase 0.892 0.843 0.867 0.887 0.778 0.831 0.918 0.809 0.862 0 0 
BCAL2765 putative 30S ribosomal protein S20  1.058 1.447 1.237 1.568 0.988 1.245 1.028 0.781 0.896 0 0 
BCAL2769 conserved hypothetical protein  1.018 1.364 1.178 0.937 1.125 1.027 0.885 1.064 0.970 0 0 
BCAL2773 
(gi117980128) 
phage integrase [Burkholderia phymatum 
STM815]                 
BCAL2785 
putative peptide methionine sulfoxide 
reductase 1.042 1.581 1.284 1.348 1.442 1.394 0.962 1.445 1.179 0 0 
BCAL2791 putative kynureninase   1.016 1.016  1.115 1.115  1.1 1.100 0 0 
BCAL2796 
(gi118659676) 
aldehyde dehydrogenase [Burkholderia 
multivorans ATCC 17616] 2.015  2.015 3.542  3.542 0.62  0.620 1 1 
BCAL2821  RND family efflux system transporter protein                  
BCAL2828 putative exported protein  0.769 0.682 0.724 0.867 0.77 0.817 0.724 0.655 0.689 0 0 
BCAL2839 fructose-bisphosphate aldolase  0.884 1 0.940 0.711 0.601 0.654 1.339 0.862 1.074 0 -1 
BCAL2858 hypothetical protein  1.118 0.902 1.004 1.26 0.798 1.003 0.93 0.729 0.823 0 0 
BCAL2864 hypothetical protein   0.511 0.511  0.526 0.526  0.687 0.687 -1 -1 
BCAL2888 ribonuclease E 1    0.983 0.983  1.418 1.418  1.304 1.304 0 0 
BCAL2911 
(gi115281004) 
conserved hypothetical protein [Burkholderia 
cepacia AMMD] 0.905  0.905 0.619  0.619 1.395  1.395 0 -1 
BCAL2915 dihydrofolate reductase    1.097 1.097  1.703 1.703  1.065 1.065 0 1 
BCAL2929 
(gi91690051) 
L-sorbosone dehydrogenase [Burkholderia 
xenovorans LB400] 0.873  0.873 0.541  0.541 0.878  0.878 0 -1 
BCAL2935 electron transfer flavoprotein beta-subunit                  
BCAL2941 putative exported transglycosylase    0.458 0.458  0.559 0.559  0.412 0.412 -1 -1 
BCAL2943 putative exported protein                  
BCAL2950 30S ribosomal protein S1  1.189 1.122 1.155 1.22 0.73 0.944 0.981 0.784 0.877 0 0 
BCAL2954 
(gi77966373) 
chorismate mutase/Prephenate dehydratase 
[Burkholderia sp. 383]   0.628 0.628  0.655 0.655  0.6 0.600 -1 -1 
BCAL2958 putative ompA family protein  0.693 0.786 0.738 0.55 0.623 0.585 0.797 0.767 0.782 0 -1 
BCAL2961 
(gi83650624) integrase [Burkholderia thailandensis E264]                 
BCAL2966 conserved hypothetical protein  1.162 1.54 1.338 1.683 2.074 1.868 1.466 1.859 1.651 0 1 
BCAL3006 cold shock-like protein    0.824 0.824  0.921 0.921  1.004 1.004 0 0 
BCAL3008 putative outer membrane porin protein                  
BCAL3024 
(gi105892254) 
conserved hypothetical protein [Burkholderia 
cenocepacia AU 1054]                 
BCAL3036 hypothetical protein    0.658 0.658  0.965 0.965  0.819 0.819 -1 0 
BCAL3041 maltose-binding protein  1.115  1.115 1.576  1.576 0.945  0.945 0 1 
BCAL3051 riboflavin synthase alpha chain  2.868  2.868 1.681  1.681 2.45  2.450 1 1 
BCAL3054 6,7-dimethyl-8-ribityllumazine synthase 1.118 1.249 1.182 1.242 1.118 1.178 0.988 1.108 1.046 0 0 
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BCAL3055 probable N utilization substance protein B  0.75 0.704 0.727 0.75 1.471 1.050 1.01 0.987 0.998 0 0 
BCAL3111 conserved hypothetical protein   0.917 0.917  0.656 0.656  0.675 0.675 0 -1 
BCAL3113 
(gi118651602) 
Phosphomannomutase [Burkholderia 
cenocepacia MC0-3]   0.884 0.884  0.984 0.984  1.031 1.031 0 0 
BCAL3115 
(gi117991085) 
glycosyl transferase, family 2 [Burkholderia 
phytofirmans PsJN]   1.285 1.285  1.545 1.545  1.358 1.358 0 1 
BCAL3136 
(gi118656806) 
apaH, bis(5'nucleosyl)-tetraphosphatase, 
ApaH [Burkholderia multivorans ATCC 17616]   1.414 1.414  2.322 2.322  1.543 1.543 0 1 
BCAL3142 conserved hypothetical protein    0.664 0.664  0.672 0.672  1.003 1.003 -1 0 
BCAL3146 60 kDa chaperonin 1  0.888 0.905 0.896 1.224 1.05 1.134 1.052 0.942 0.995 0 0 
BCAL3147 10 kDa chaperonin 1  1.062 1.009 1.035 1.471 0.772 1.066 1.034 0.791 0.904 0 0 
BCAL3166 putative lipoprotein 0.84 1.035 0.932 0.99 1.121 1.053 0.983 1.13 1.054 0 0 
BCAL3178 LysR family regulatory protein  0.792 0.516 0.639 0.709 0.588 0.646 0.827 0.7 0.761 -1 -1 
BCAL3183 putative hydrolase 1.296 1.277 1.286 1.824 1.335 1.560 1.121 1.152 1.136 0 1 
BCAL3186 conserved hypothetical protein  0.4  0.400 1.108  1.108 0.853  0.853 -1 0 
BCAL3191 putative glutaryl-CoA dehydrogenase  0.664 0.663 0.663 0.744 0.749 0.746 1.013 0.898 0.954 -1 0 
BCAL3197 serine hydroxymethyltransferase  1.003 0.433 0.659 1.088 0.803 0.935 1.034 0.984 1.009 -1 0 
BCAL3204 putative OmpA family lipoprotein  0.876 0.977 0.925 0.629 0.825 0.720 0.913 1.191 1.043 0 0 
BCAL3205 putative exported protein  0.915 0.876 0.895 1.02 0.994 1.007 1.01 1.004 1.007 0 0 
BCAL3220 
(gi115285990) 
beta-ketoacyl synthase [Burkholderia cepacia 
AMMD] 0.587 1.251 0.857 0.209 1.692 0.595 0.815 2.471 1.419 0 -1 
BCAL3244 
(gi83654978) 
possible glycosyltransferase WbpX, putative 
[Burkholderia thailandensis E264]                 
BCAL3270 putative DnaK chaperone protein  1.108 1.006 1.056 1.161 0.873 1.007 0.994 0.789 0.886 0 0 
BCAL3272 putative heat shock protein  1.133 1.226 1.179 1.048 1.062 1.055 1.07 0.927 0.996 0 0 
BCAL3299  peroxidase/catalase KatB  1.282 1.222 1.252 1.533 1.51 1.521 1.111 1.054 1.082 0 1 
BCAL3316 
(gi117985821) 
protein of unknown function DUF330 
[Burkholderia phymatum STM815] 0.624  0.624 0.375  0.375 0.872  0.872 -1 -1 
BCAL3332 aminopeptidase P    0.683 0.683  0.546 0.546  0.694 0.694 0 -1 
BCAL3347 30S ribosomal protein S9  0.92 0.711 0.809 0.829 0.785 0.807 0.652 0.558 0.603 0 0 
BCAL3358 
periplasmic glutamate/aspartate-binding 
protein  1.213 1.18 1.196 1.51 1.148 1.317 1.003 0.85 0.923 0 0 
BCAL3359 putative glutamate dehydrogenase  1.221 0.844 1.015 1.194 0.878 1.024 1.048 1.312 1.173 0 0 
BCAL3368 
(gi117980776) 
transcriptional regulator, RpiR family 
[Burkholderia phymatum STM815] 1.447  1.447 1.11  1.110 1.188  1.188 0 0 
BCAL3370 gamma-glutamyl phosphate reductase    0.73 0.730  0.564 0.564  0.848 0.848 0 -1 
BCAL3377 putative outer membrane protein   4.041 4.041  3.388 3.388  1.71 1.710 1 1 
BCAL3378 ferric uptake regulator 0.556 1.048 0.763 0.626 0.96 0.775 0.657 0.617 0.637 0 0 
BCAL3388 glyceraldehyde 3-phosphate dehydrogenase 1  1.198 1.208 1.203 1.377 1.382 1.379 1.213 1.206 1.209 0 0 
BCAL3389 transketolase 1  0.743  0.743 0.903  0.903 0.943  0.943 0 0 
BCAL3402 short-chain dehydrogenase/reductase SDR                 
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(gi118641093) [Burkholderia ambifaria MC40-6] 
BCAL3425 putative sugar kinase 3   0.555 0.555  1.045 1.045  0.713 0.713 -1 0 
BCAL3426 putative lipoprotein    1.17 1.170  0.716 0.716  1.167 1.167 0 0 
BCAL3427 histone H1-like protein 1.434 1.092 1.251 1.964 0.791 1.246 0.575 0.294 0.411 0 0 
BCAL3429 putative ribonucleoside reductase  0.618 0.797 0.702 0.477 0.796 0.616 0.874 0.76 0.815 0 -1 
BCAL3436 prolyl-tRNA synthetase    0.923 0.923  0.665 0.665  0.86 0.860 0 -1 
BCAL3467 
UDP-N-acetylmuramoylalanyl-D-glutamate-
2,6-diaminopimelate   1.281 1.281  1.54 1.540  1.094 1.094 0 1 
BCAL3489 
(gi76583601) 
conserved hypothetical protein [Burkholderia 
pseudomallei 1710b]   1.446 1.446  1.804 1.804  1.875 1.875 0 1 
BCAL3507 flagellar FliL protein   1.087 1.087  1.094 1.094  1.131 1.131 0 0 
BCAL3523  general secretory pathway protein G   1.334 1.334  0.967 0.967  1.496 1.496 0 0 
BCAL3529 putative cobalamin synthesis protein/P47K  1.459  1.459 1.504  1.504 1.502  1.502 0 1 
BCAL3530 DNA-binding protein HU-alpha  1.014 1.065 1.039 1.008 0.74 0.864 0.956 0.65 0.788 0 0 
BCAM0006 conserved hypothetical protein  0.609  0.609 0.672  0.672 0.807  0.807 -1 0 
BCAM0026 putative siderophore-interacting protein 0.308  0.308 0.327  0.327 0.871  0.871 -1 -1 
BCAM0058 3-oxoadipate CoA-transferase subunit A    1.168 1.168  1.784 1.784  2.035 2.035 0 1 
BCAM0060 
(gi52421938) 
3-carboxy-cis,cis-muconate cycloisomerase 
[Burkholderia mallei ATCC 23344] 0.722  0.722 0.3  0.300 1.151  1.151 0 -1 
BCAM0149 
(gi77971729) 
phospholipase D/Transphosphatidylase 
[Burkholderia sp. 383] 1.052 0.925 0.986 0.9 0.851 0.875 0.873 0.901 0.887 0 0 
BCAM0173 ATP-independent RNA helicase    0.569 0.569  0.709 0.709  1.427 1.427 -1 0 
BCAM0175 
(gi77971682) 
malate dehydrogenase (acceptor) 
[Burkholderia sp. 383]                 
BCAM0184 lectin 0.387 0.51 0.444 0.351 0.549 0.439 1.004 1.222 1.108 -1 -1 
BCAM0186 lectin  0.851 0.432 0.606 0.727 0.39 0.532 0.999 0.764 0.874 -1 -1 
BCAM0276 
(gi115285786) 
UspA domain protein [Burkholderia cepacia 
AMMD] 1.048 0.745 0.884 0.892 0.652 0.763 0.782 0.689 0.734 0 0 
BCAM0297 
(gi115283858) 
acetoacetyl-CoA reductase [Burkholderia 
cepacia AMMD]                 
BCAM0313 putative exported protein                  
BCAM0357 LysR family regulatory protein                  
BCAM0502 conserved hypothetical protein                  
BCAM0504 CsbD-like protein  1.105 1.026 1.065 0.968 0.681 0.812 0.798 0.566 0.672 0 0 
BCAM0505 putative membrane-attached protein 1.104 0.977 1.039 1.046 0.863 0.950 0.793 0.806 0.799 0 0 
BCAM0507 CsbD-like protein  0.897 0.887 0.892 0.732 1.069 0.885 0.741 1.019 0.869 0 0 
BCAM0589 conserved hypothetical protein   3.914 3.914  3.942 3.942  2.907 2.907 1 1 
BCAM0600 conserved hypothetical protein    0.89 0.890  0.906 0.906  1.052 1.052 0 0 
BCAM0602 
(gi134135913) 
molecular chaperone-like protein 
[Burkholderia vietnamiensis G4] 1.534  1.534 1.387  1.387 0.711  0.711 1 0 
BCAM0630 putative dehydrogenase                  
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BCAM0684 putative oxidoreductase    1.55 1.550  0.846 0.846  0.854 0.854 1 0 
BCAM0759 
(gi134132844) 
extracellular solute-binding protein, family 3 
[Burkholderia vietnamiensis G4] 0.783  0.783 0.459  0.459 1.135  1.135 0 -1 
BCAM0767 
(gi117992836) 
ABC transporter related [Burkholderia 
phytofirmans PsJN] 0.624  0.624 0.469  0.469 1.005  1.005 -1 -1 
BCAM0795 
(gi117992171) 
transcriptional regulator, MarR family 
[Burkholderia phytofirmans PsJN]                 
BCAM0811 putative aromatic oxygenase    0.402 0.402  0.909 0.909  1.308 1.308 -1 0 
BCAM0829 putative riboflavin synthase alpha chain  1.564 0.757 1.088 1.855 1.585 1.715 2.207 1.121 1.573 0 1 
BCAM0832 
(gi105893144) 
Dyp-type peroxidase [Burkholderia 
cenocepacia AU 1054] 1.387 1.39 1.388 1.825 1.384 1.589 1.045 0.97 1.007 0 1 
BCAM0833 
(gi118660931) 
OsmC family protein [Burkholderia multivorans 
ATCC 17616]                 
BCAM0844 conserved hypothetical protein 1.096 0.993 1.043 0.776 0.808 0.792 0.876 1.017 0.944 0 0 
BCAM0910 putative geranyltranstransferase  0.79  0.790 0.501  0.501 1.013  1.013 0 -1 
BCAM0915 30S ribosomal protein S21 2  1.315 1.056 1.178 1.406 1.134 1.263 1.161 1.072 1.116 0 0 
BCAM0916 conserved hypothetical protein  0.926 1.13 1.023 1.054 1.235 1.141 0.983 1.279 1.121 0 0 
BCAM0917 putative DNA primase  1.455  1.455 1.616  1.616 1.818  1.818 0 1 
BCAM0953 extracellular solute-binding protein  0.971 0.458 0.667 1.032 1.696 1.323 0.9 1.055 0.974 -1 0 
BCAM0961 aconitate hydratase  1.106 1.055 1.080 1.245 0.733 0.955 1.36 1.233 1.295 0 0 
BCAM0963 putative exported protein 0.934 0.985 0.959 1.238 1.202 1.220 1.342 1.442 1.391 0 0 
BCAM0972 citrate synthase 1 1.12 0.972 1.043 0.508 0.396 0.449 0.44 0.389 0.414 0 -1 
BCAM0986 aspartate-semialdehyde dehydrogenase  1.038 1.107 1.072 1.618 1.7 1.658 1.362 1.639 1.494 0 1 
BCAM0987 flagellar hook protein 2 FlgE2                  
BCAM0988 putative exported protein    1.712 1.712  2.279 2.279  1 1.000 1 1 
BCAM1003 putative epimerase                  
BCAM1012 putative histone-like protein 1.198 1.038 1.115 1.371 0.899 1.110 0.888 0.775 0.830 0 0 
BCAM1015 putative porin    0.85 0.850  0.998 0.998  1.182 1.182 0 0 
BCAM1021 protein FdhE homologue    0.529 0.529  0.659 0.659  0.48 0.480 -1 -1 
BCAM1062 hypothetical phage protein                  
BCAM1111 ornithine decarboxylase    1.102 1.102  1.318 1.318  1.115 1.115 0 0 
BCAM1123 
(gi91692859) 
hypothetical protein [Burkholderia xenovorans 
LB400]                 
BCAM1189 
(gi115283494)  
transcriptional regulator, LysR family 
[Burkholderia cepacia AMMD] 0.735  0.735 0.489  0.489 0.998  0.998 0 -1 
BCAM1204 alanine racemase, catabolic   0.855 0.855  0.395 0.395  0.835 0.835 0 -1 
BCAM1234 conserved hypothetical protein                  
BCAM1250 
(gi77964942) 
acetyl-CoA hydrolase/transferase 
[Burkholderia sp. 383] 0.907  0.907 0.581  0.581 1.13  1.130 0 -1 
BCAM1291 L-asparaginase    0.915 0.915  0.652 0.652  0.688 0.688 0 -1 
BCAM1304 conserved hypothetical protein  0.541  0.541 0.433  0.433 1.13  1.130 -1 -1 
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BCAM1351 putative regulatory protein    1.036 1.036  1.054 1.054  0.656 0.656 0 0 
BCAM1380 
(gi118650657) 
transcriptional regulator, GntR family 
[Burkholderia cenocepacia MC0-3]                 
BCAM1407 DJ-1/PfpI family protein  0.776 0.997 0.880 0.609 0.688 0.647 0.718 0.765 0.741 0 -1 
BCAM1411 putative short-chain dehydrogenase    0.715 0.715  0.626 0.626  1.06 1.060 0 -1 
BCAM1412 
(gi105895814) 
conserved hypothetical protein [Burkholderia 
cenocepacia AU 1054] 0.384  0.384 0.233  0.233 0.655  0.655 -1 -1 
BCAM1443 putative exported protein  0.681 1.022 0.834 0.525 0.952 0.707 0.545 0.849 0.680 0 0 
BCAM1464 
(gi116650430) 
putative cytoplasmic protein [Burkholderia 
cenocepacia HI2424] 0.918 1.254 1.073 0.868 1.359 1.086 0.923 1.485 1.171 0 0 
BCAM1481 conserved hypothetical protein  0.842 1.011 0.923 0.759 1.035 0.886 0.962 1.073 1.016 0 0 
BCAM1491 
(gi116650457) 
conserved hypothetical protein [Burkholderia 
cenocepacia HI2424]   1.864 1.864  1.768 1.768  0.605 0.605 1 1 
BCAM1538 
putative dehydrogenase, monooxygenase 
subunit 0.906 1.402 1.127 1.406 1.044 1.212 1.21 0.998 1.099 0 0 
BCAM1542 putative aldehyde dehydrogenase  0.911 0.879 0.895 1.138 0.99 1.061 1.389 1.362 1.375 0 0 
BCAM1553 putative dehydrogenase, molybdenum-binding   1.635 1.635  1.139 1.139  1.125 1.125 1 0 
BCAM1570 alcohol dehydrogenase 0.921 0.826 0.872 1.041 0.761 0.890 0.93 0.828 0.878 0 0 
BCAM1581 phosphoenolpyruvate carboxykinase [GTP]  0.892 0.892 0.892 0.678 0.83 0.750 0.877 0.727 0.798 0 0 
BCAM1619 putative DNA-binding cold-shock protein   0    1.892 1.892  0    1 
BCAM1654 
(gi77969268) 
Short-chain dehydrogenase/reductase SDR 
[Burkholderia sp. 383]                 
BCAM1669 putative exported protein  0.767 0.973 0.864 1.189 0.274 0.571 0.916 1.105 1.006 0 -1 
BCAM1679 
(gi117985553) 
protein of unknown function DUF472 
[Burkholderia phymatum STM815]                 
BCAM1700 
(gi117993315) 
GCN5-related N-acetyltransferase 
[Burkholderia phytofirmans PsJN]   1.793 1.793  1.948 1.948  1.332 1.332 1 1 
BCAM1744 serine peptidase, family S9                 
BCAM1800 conserved hypothetical protein    1.555 1.555  1.235 1.235  1.641 1.641 1 0 
BCAM1824 conserved hypothetical protein    1.605 1.605  1.052 1.052  1.469 1.469 1 0 
BCAM1857 conserved hypothetical protein                  
BCAM1919 
(gi118648785) 
conserved hypothetical protein [Burkholderia 
cenocepacia MC0-3] 0.848  0.848 0.553  0.553 0.751  0.751 0 -1 
BCAM1926 conserved hypothetical protein  0.83 0.517 0.655 0.989 0.774 0.875 0.837 0.462 0.622 -1 0 
BCAM1931 putative porin                  
BCAM2001 
(gi118650319) 
short-chain dehydrogenase/reductase SDR 
[Burkholderia cenocepacia MC0-3] 1.067  1.067 0.643  0.643 1.14  1.140 0 -1 
BCAM2006 putative aspartate carbomyltransferase    0.467 0.467  1.626 1.626  0.957 0.957 -1 1 
BCAM2068 conserved hypothetical protein 0.87  0.870 0.564  0.564 0.79  0.790 0 -1 
BCAM2081 conserved hypothetical protein  1.565  1.565 3.032  3.032 1.198  1.198 1 1 
BCAM2143 cable pilus associated adhesin protein  0.535 0.603 0.568 0.349 0.578 0.449 0.614 0.764 0.685 -1 -1 
BCAM2159 putative exported protein 1.313 1.152 1.230 1.211 0.892 1.039 0.969 0.822 0.892 0 0 
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BCAM2167 conserved hypothetical protein  1.167 1.087 1.126 1.149 1.271 1.208 0.9 1.083 0.987 0 0 
BCAM2192 enoyl-CoA hydratase/isomerase family protein  1.317 1.271 1.294 2.137 1.629 1.866 1.21 0.972 1.084 0 1 
BCAM2195 putative AMP-binding enzyme  0.537 0.644 0.588 0.683 0.728 0.705 1.032 1.004 1.018 -1 0 
BCAM2234 
(gi76582946) 
salicylate biosynthesis protein [Burkholderia 
pseudomallei 1710b] 0.949  0.949 0.48  0.480 1.223  1.223 0 -1 
BCAM2307 zinc metalloprotease ZmpB  0.251 0.328 0.287 0.296 0.362 0.327 0.815 0.804 0.809 -1 -1 
BCAM2308 putative leucyl aminopeptidase precursor    0.265 0.265  0.291 0.291  0.816 0.816 -1 -1 
BCAM2310 
(gi52422765) 
putative transporter [Burkholderia mallei 
ATCC 23344]   0.71 0.710  0.565 0.565  0.26 0.260 0 -1 
BCAM2378 putative Xaa-Pro dipeptidyl-peptidase                  
BCAM2407 
(gi117982799) 
major facilitator superfamily MFS_1 
[Burkholderia phymatum STM815]                 
BCAM2456 
(gi118660218) 
peptidoglycan glycosyltransferase 
[Burkholderia multivorans ATCC 17616] 0.999  0.999 0.606  0.606 0.93  0.930 0 -1 
BCAM2463 putative membrane protein                  
BCAM2468 
putative aldehyde dehydrogenase family 
protein                  
BCAM2478 serine-carboxyl peptidase    0.856 0.856  0.476 0.476  1.207 1.207 0 -1 
BCAM2480 
(gi52423083) 
transcriptional regulator, AsnC family 
[Burkholderia mallei ATCC 23344]                 
BCAM2556 putative purine nucleoside permease  0.9 0.811 0.854 0.837 0.572 0.692 1.052 0.871 0.957 0 0 
BCAM2618 putative periplasmic  1.122 1.108 1.115 1.409 1.154 1.275 1.035 0.952 0.993 0 0 
BCAM2671 putative low-specificity L-threonine aldolase  1.387 0.94 1.142 1.951 1.11 1.472 1.181 1.087 1.133 0 0 
BCAM2702 2-methylcitrate synthase  0.904 0.901 0.902 0.825 0.849 0.837 0.801 0.838 0.819 0 0 
BCAM2707 putative FAA-hydrolase family protein  1.062 1.423 1.229 1.496 1.521 1.508 1.207 1.521 1.355 0 1 
BCAM2755 putative exported protein  0.873 0.941 0.906 0.945 0.751 0.842 0.749 0.743 0.746 0 0 
BCAM2783 
(gi117988745) 
glycoside hydrolase, family 28 [Burkholderia 
phytofirmans PsJN]   1.09 1.090  1.83 1.830  2.021 2.021 0 1 
BCAM2821 malate synthase G  0.98 0.643 0.794 0.686 0.637 0.661 0.843 0.83 0.836 0 -1 
BCAM2827 putative exported protein  1.092 1.032 1.062 1.024 1.11 1.066 1.083 1.006 1.044 0 0 
BCAS0010 
(gi77965393) 
protein of unknown function DUF6, 
transmembrane [Burkholderia sp. 383] 1.085 0.91 0.994 1.033 0.934 0.982 1.065 0.888 0.972 0 0 
BCAS0013 putative molybdenum transport protein 0.867 2.937 1.596 0.838 2.451 1.433 1.041 3.243 1.837 1 0 
BCAS0070 
(gi118660709) 
histidine kinase [Burkholderia multivorans 
ATCC 17616]                 
BCAS0151 hypothetical protein                 
BCAS0190 putative H-NS family DNA-binding protein 1.051 1.022 1.036 0.939 0.919 0.929 0.736 0.899 0.813 0 0 
BCAS0292 conserved hypothetical protein AidA'    0.262 0.262  0.177 0.177  0.735 0.735 -1 -1 
BCAS0293 nematocidal protein AidA  0.023 0.06 0.037 0.044 0.01 0.021 0.566 0.633 0.599 -1 -1 
BCAS0334 
(gi134132307) 
response regulator receiver protein 
[Burkholderia vietnamiensis G4]                 
BCAS0382 transcriptional regulator, AsnC family 0.846  0.846 0.417  0.417 0.855  0.855 0 -1 
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(gi117994159) [Burkholderia phytofirmans PsJN] 
BCAS0407 hypothetical protein  0.613  0.613 0.812  0.812 0.852  0.852 -1 0 
BCAS0409 zinc metalloprotease ZmpA  0.799 0.672 0.733 0.92 0.743 0.827 1.02 0.967 0.993 0 0 
BCAS0421 
(gi76580611) 
ABC transporter, ATP-binding protein 
[Burkholderia pseudomallei 1710b]                 
BCAS0455 putative CopG family protein    1.454 1.454  1.65 1.650  1.818 1.818 0 1 
BCAS0516 
(gi115281897) 
hypothetical protein [Burkholderia cepacia 
AMMD]                 
BCAS0609 putative electron transfer   0.616 0.616  0.609 0.609  0.948 0.948 -1 -1 
BCAS0637 60 kDa chaperonin 3  0.819 0.781 0.800 1.036 0.945 0.989 1.119 1.133 1.126 0 0 
BCAS0638 10 kDa chaperonin 3  1.233 0.868 1.035 2.31 1.056 1.562 1.359 1.017 1.176 0 1 
BCAS0666 putative ankyrin-repeat exported protein   1.798 1.798  1.851 1.851  1.228 1.228 1 1 
BCAS0708 
(gi91686888) 
hypothetical protein [Burkholderia xenovorans 
LB400]   0.636 0.636  0.697 0.697  0.755 0.755 -1 0 
BCAS0730 
(gi77964328) 
Na+ dependent nucleoside transporter 
[Burkholderia sp. 383] 0.902  0.902 0.619  0.619 1.013  1.013 0 -1 
BCAS0739 putative acetyl-CoA synthetase                  
BCAS0747 
(gi117980068) 
SMC protein-like [Burkholderia phymatum 
STM815] 0.61 1.107 0.822 0.312 1.255 0.626 0.746 1.285 0.979 0 -1 
BCAS0765 
(gi77969929) 
Holden 
antidrug resist 
hydrophobe/amphiphile efflux pump, HAE1 
family [Burkholderia sp. 383]                 
BCAS0773 putative exported protein  0.922 0.98 0.951 1.197 1.301 1.248 0.752 1.236 0.964 0 0 
rmlC 
(gi52210708) 
dTDP-6-deoxy-D-glucose-3,5 epimerase 
[Burkholderia pseudomallei K96243]   1.503 1.503  1.343 1.343  1.156 1.156 1 0 
wbiF 
(gi134134232) 
glycosyl transferase, family 2 [Burkholderia 
vietnamiensis G4]                 
xdhA 
(gi115283038) 
transcriptional regulator, LysR family 
[Burkholderia cepacia AMMD]                 
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